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Thomas James O’Brien 
In vitro recapitulation of the polymicrobial communities 
associated with cystic fibrosis airway infections 
 
Abstract 
The airways of persons with cystic fibrosis (CF) are prone to lifelong colonisation with dense 
microbial ecosystems comprised of a diverse combination of bacteria and fungi. The role of 
interspecies interactions in modulating changes in gene expression and the metabolism of 
individual members of a polymicrobial community, compared with growth as an axenic 
population, is becoming increasingly apparent within the field of medical microbiology. In part, 
these poorly understood interactions explain why, regardless of intense research efforts, 
therapeutic treatments designed to clear such chronic airway infections often fail within the 
clinical setting. The paucity of existing in vitro and in vivo models used to study CF-associated 
infections greatly hinders research into the behaviours of polymicrobial communities. Species 
that coexist within the same in situ environment often outcompete one another when grown 
as a mixed population using traditional culture methods. The work presented in this 
dissertation redresses these problems. I describe the development and characterisation of a 
novel in vitro continuous-flow culture model. This experimental system permits the stable co-
cultivation of distinctly different microbial species commonly-associated with CF airway 
infections; species that ordinarily readily outcompete one another in existing models. I 
demonstrate that the metabolic state and mutation rates of species cultured within the model 
remain stable for extended periods of time. Furthermore, I show that antimicrobial compounds 
display decreased efficacy against their target organism when grown as part of a polymicrobial 
community. I also show that different combinations of microbial species display different 
biofilm-forming potential. This work provides the basis of future research efforts aimed at the 
in vitro recapitulation of an entire polymicrobial community directly derived from persons with 
CF. Ultimately, this will help to bridge the bench-to-bedside gap for the development of more 
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1.1 Cystic Fibrosis (CF) 
Cystic fibrosis (CF) is the most common life-limiting genetic disorder within the Caucasian 
population, estimated to affect 70,000 people worldwide (Cystic Fibrosis Foundation, 
www.cff.org). However, improved new-born screening and carrier testing programs have 
recently identified an emerging change in CF epidemiology within developing and lower-
middle income countries (LMICs) as more individuals of non-European decent are being 
identified to have the disease (Bell et al., 2020). As current genetic tests for CF are largely 
based on the more common Caucasian-specific mutation databases, it is likely that the global 
number of persons with CF is underrepresented in the above estimates. 
The 1980s saw a surge in our understanding of the molecular and genetic causes 
underpinning the pathophysiology of CF. First in 1983, when Quinton demonstrated chloride 
impermeability in sweat glands as the cause of raised sweat electrolytes in CF patients 
(Quinton, 1983), advancing the basic understanding of defective electrolyte transport across 
membranes. Then the concerted efforts of three research groups in 1989 identified CF as an 
autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane 
conductance regulator (CFTR) gene (Kerem et al., 1989, Riordan et al., 1989, Rommens et 
al., 1989). The CFTR gene is found on the long arm of chromosome 7 and to date the CF 
Genetic Analysis Consortium have identified over 1800 mutations known to cause CF 
(www.genet.sickkids.on.20ca/cftr/). The most common CFTR mutation, accounting for over 
70% of CF cases within the Caucasian population, is caused by the deletion of 3 nucleotides, 
resulting in the in-frame deletion of a phenylalanine residue at position 508 in the CFTR 
protein, termed phe508del (Bobadilla et al., 2002). The phe508del mutation causes a 
trafficking defect, as abnormally folded CFTR fails to be targeted for insertion into the plasma 
membrane and the misfolded protein is subsequently degraded by the proteasome (Ward et 
al., 1995). A group of 15-20 less common mutations comprise a further 15% of the CF alleles 
seen in Caucasians, with varying degrees of disease severity pertaining to the amount of 
CFTR correctly localised in the plasma membrane (Boyle and De Boeck, 2013, Fraser-Pitt 
and O'Neil, 2015). Figure 1.1. summarises the different classes of CFTR mutations for 
reference. 
CFTR is a member of the ABC transporter class of ion channel proteins and is responsible for 
the transport of chloride ions across the apical membrane of epithelial cells in tissues of the: 
airways, intestine, pancreas, kidneys, sweat glands and male reproductive tract (Boucher, 
2002, Chambers et al., 2007, Elborn, 2016, Hwang and Kirk, 2013, Lubamba et al., 2012, 












Figure 1.1. Classes of CFTR mutations and examples of their genetic causes.  
Mutations within the CFTR gene can be divided into six distinct classes. Class I mutations 
result in no protein production. Class II mutations cause a trafficking defect and retention of 
misfolded protein at the endoplasmic reticulum, followed by proteasomal degradation. Class 
III mutations affect regulation of the CFTR channel and impair channel opening. Class IV 
mutations cause a decrease in ion conduction across the membrane. Class V mutations cause 
a significant decrease in gene transcription, and/or protein translation and synthesis. Class VI 
mutations reduce CFTR stability within the plasma membrane. Figure reproduced from (Boyle 
and De Boeck, 2013) by permission of Elsevier.  
9 
 
such as the secretion of bicarbonate to regulate the pH of airway surface liquid and hydration 
of mucins and airway secretions through inhibition of the epithelial sodium channel (ENaC) 
(Chmiel and Davis, 2003, Gentzsch and Mall, 2018, Mall et al., 2004, Pezzulo et al., 2012). 
CF is characterised as a multiorgan disease, but perhaps the most striking manifestation of 
dysfunctional CFTR activity is the overproduction of nutrient-rich, mucilaginous sputum within 
the airways. This accumulates within the lumen of the bronchioles and blocks the airways to 
generate a highly heterogenous environment with steep oxygen gradients and a lowered pH 
(Boucher, 2002, Tate et al., 2002, Worlitzsch et al., 2002). 
Common modern CF management techniques, such as high calorie diets, pancreatic enzyme 
replacement therapy, airway clearance techniques and the use of bronchodilators have all 
helped to improve the longevity and welfare of CF patients in recent decades (Bell et al., 2020). 
Further advancements in potentiator and corrective therapies that help to improve correct 
CFTR function, e.g. ivacaftor and lumacaftor, are showing additional positive impacts on 
clinical outcomes for patients with the more common CF mutations (Ratjen et al., 2017, 
Wainwright et al., 2015). However, approximately 90% of CF patients still succumb to 
respiratory failure brought on by a sustained immune response and airway scarring caused 
by chronic microbial infection of the airways (Figure 1.2.) (Carmody et al., 2013, Carmody et 
al., 2015, Chmiel and Davis, 2003, Elborn, 2016, Lammertyn et al., 2017, Lubamba et al., 
2012, Lyczak et al., 2002, Rajan and Saiman, 2002, Rogers et al., 2010b, Rogers et al., 2010a, 
Sibley et al., 2006). Therefore, effective management of the microbiota associated with the 
CF airways remains the most important therapeutic strategy for improving the health and 
prognosis of all persons with CF. This is particularly true when considering the emergence of 
CF in LMICs, where access to CFTR corrective therapies remain limited and the multifaceted 
genetic causes of CF makes the development of a ‘catch-all’ corrective therapy unlikely 
(Cutting, 2010). An in-depth understanding of the CF-associated microbiome and how this 
changes over the course of a patient’s life is therefore necessary to identify novel drug targets 
and develop improved therapeutic treatment regimens to manage such airway infections. 
 
1.2 CF Airway Associated Infections 
1.2.1 Predisposition for Airway Infections 
Chronic obstruction of the airways through the overproduction of sputum generates a unique 
and heterogenous environment that is rich in mucins, amino acids and nitrates (Ghio et al., 
2013, Grasemann et al., 1998, Jones et al., 2000, Palmer et al., 2007). As such, the airways 
of CF patients are prone to lifelong microbial colonisation, with the viscous lung secretions 
















Figure 1.2. Schematic flow-diagram demonstrating disease progression and 
pathophysiology of CF airway associated infections. 
Disruption of CFTR activity causes an imbalance of sodium and chloride ion transport within 
the airways, leading to the accumulation of thick airway secretions that cannot be cleared via 
the mucociliary escalator. The end-stages of lung disease are characterised by a positive 
feedback loop of chronic microbial infection triggering a sustained immunological response 
and scarring of the airways, causing a severe decline in pulmonary function (red boxes). 




antimicrobial treatment or immune clearance (Knowles and Boucher, 2002). Furthermore, CF 
gene modifiers, such as MBL2 (encoding mannose-binding lectin), have been correlated 
within an alteration in a host’s immune response or susceptibility to microbial infection, further 
predisposing CF patients to these persistent and ultimately fatal infections (Carlsson et al., 
2005). 
 
1.2.2 Culture-based analysis of CF airway associated microbiota 
Traditionally, culture-based examination of expectorated sputum, bronchioalveolar lavage 
(BAL) or nasopharyngeal swab samples has been used to identify the causative agents of 
chronic CF airway infection (Burns and Rolain, 2014). In line with Koch’s postulates, a 
relatively small number of easily culturable species were thought to be the cause of such 
infections (Govan and Nelson, 1993). Species such as Staphylococcus aureus (SA) and 
Haemophilus influenzae were identified as being prevalent among infant and adolescent 
patients (Greenberg and Stutman, 1991). This is often followed by invasion and subsequent 
domination of the airway microbiota by Pseudomonas aeruginosa (PA) (Høiby et al., 1987), 
alongside the occasional co-infection by other ‘keystone’ respiratory pathogens, such as 
Burkholderia cepacia complex and Stenotrophomonas maltophilia (Bittar and Rolain, 2010, 
Hauser et al., 2011, Lipuma, 2010, Sajjan et al., 2001, Valenza et al., 2008). 
 
1.2.3 Culture-independent analysis of CF airway-associated microbiota 
More recently, advances in next generation sequencing technologies (NGS) have permitted 
the widespread uptake of culture-independent molecular profiling approaches, for example 
sequencing of the hypervariable 16S rRNA and fungal ribosomal internal transcribed spacer 
(ITS) regions, to capture the true diversity of species present within metagenomic samples 
(Rogers et al., 2009, Rogers et al., 2010a). This has enabled the identification of fastidious 
and ‘unculturable’ microbial species, missed using traditional microbiological investigative 
techniques (Mahboubi et al., 2016).  
The culture-independent analysis of CF-derived samples revealed a dynamic polymicrobial 
community of unprecedented species diversity, comprised of both bacteria and fungi (Ahmed 
et al., 2019, Boutin et al., 2015, Carmody et al., 2013, Carmody et al., 2015, Hogan et al., 
2016, Jorth et al., 2019, Rogers et al., 2010b, Rogers et al., 2010a, Sibley et al., 2008, Zhao 
et al., 2012). This should perhaps be unsurprising, given the heterogenous nature of the 
airway environment, which affords an array of biochemically and spatially distinct habitat 
niches to support the diversification and evolution of separate microbial communities.  
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Longitudinal studies and sampling of the CF airway associated microbiota at different stages 
of a patient’s life or during altered disease states have been performed in an attempt to 
decipher how these complex communities evolve and contribute towards a decline in lung 
function. Earlier studies suggested that fermentative aerobic species, such as SA and H. 
influenzae, initially colonise and dominate the airways (Conrad et al., 2013, Rogers et al., 
2005, Tunney et al., 2008). However, more recent investigation into the microbiota of CF 
infants suggests that Streptococcus spp. dominate the airways, alongside a mixture of 
anaerobic and aerobic species, such as: Veillonella, Prevotella, Granulicatella, Neisseria and 
Haemophilus (Ahmed et al., 2019, Field et al., 2010, Frayman et al., 2017b, Frayman et al., 
2017a, Sibley et al., 2008). The total bacterial load within the airways is thought to remain 
constant over the course of a patient’s life and by age 20, 60-70% of CF patients show 
intermittent PA colonisation (Folkesson et al., 2012, Stressmann et al., 2011). The 
establishment of chronic PA infections (defined as a person testing positive with PA in more 
than 50% of the explored points of sampling (Proesmans et al., 2006)) later in life is correlated 
with a decrease in species diversity and a decline in pulmonary function, with the earlier 
acquisition of PA being associated with a more rapid deterioration of health and worsened 
patient prognosis (Cox et al., 2010, Emerson et al., 2002, Klepac-Ceraj et al., 2010, Valenza 
et al., 2008, Zhao et al., 2012). Species of Aspergillus and Candida are the most common 
fungal members of the polymicrobial community associated with the CF airways, with their 
presence being identified in up to 50% of CF patients (Chotirmall et al., 2010, Garczewska et 
al., 2016, Pihet et al., 2009, Valenza et al., 2008). 
 
1.2.4 Variable microbiotas exist between persons with CF 
Existing literature surrounding the true diversity of the CF-associated microbiome has recently 
been challenged by the work of Jorth et al. Through direct sampling of the lavage fluid of CF 
children, the authors suggest that, to a degree, the airway microbiota in previous reports arises 
through sample contamination within the oral cavity and further contamination during sample 
processing (Jorth et al., 2019). This notwithstanding, a core population of ‘non-conventional 
pathogens’ such as Veillonella, Prevotella and Staphylococcus spp. still exists alongside the 
‘traditional CF pathogens’, e.g. PA. This affirms that CF-associated infections are indeed 
polymicrobial in nature. 
A myriad of environmental, genetic and stochastic variables contributes towards conflicting 
hypotheses and a lack of cohesive knowledge surrounding the adaptive and evolutionary 
events occurring within the CF airways over time (Ahmed et al., 2018, Charlson et al., 2011, 
Cuthbertson et al., 2014, Prevaes et al., 2017, Renwick et al., 2014, Salter et al., 2014). 
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Primarily, the onset of a decline in lung function is met with prompt clinical intervention in the 
form of aggressive antimicrobial treatment (Stanojevic et al., 2017). Such therapies aim to 
reduce the microbial load of a principal pathogen, usually PA, but they also indiscriminately 
target other members of the population, thereby perturbing the entire polymicrobial community 
present. Furthermore, the practical limitations of sample collection often prevent detailed, 
temporally-resolved analysis of the biochemical and community-wide ecological changes that 
accompany such community perturbation. Therefore, little is known about the natural 
evolutionary trajectory of communities associated with CF airway infection or the true extent 
to which current therapeutic interventions impact upon this.  
 
1.3 Polymicrobial Infections 
1.3.1 Interspecies interactions 
With the CF airways harbouring dense and varied microbial ecosystems, it could be 
hypothesised a complex web of interspecies interactions exists between members of the 
community. Species may ‘communicate’, advertently or inadvertently, through the recognition 
of cell surface proteins, receptors or other cell wall components and through the 
secretion/uptake of extracellular small metabolites, such as antimicrobial compounds or 
quorum sensing (QS) molecules. Such interspecies interactions may be antagonistic or 
synergistic in nature, causing changes in gene expression that subsequently impact upon the 
metabolic potential and activity of the microbiome (Antonic et al., 2013, Armbruster et al., 
2010, Armbruster et al., 2016, Baldan et al., 2014, Barnabie and Whiteley, 2015, Beaume et 
al., 2015, Briaud et al., 2019, Conrad et al., 2013, Dalton et al., 2011, Diggle et al., 2007, Elias 
and Banin, 2012, Fugère et al., 2014, Hotterbeekx et al., 2017, Hibbing et al., 2010, Ibberson 
et al., 2017, Ibberson and Whiteley, 2020, Korgaonkar et al., 2013, Leekha et al., 2011, 
Mastropaolo et al., 2005, Peters et al., 2012a, Quinn et al., 2014, Rogers et al., 2010b, Rogers 
et al., 2009, Rogers et al., 2010a, Vega et al., 2013, Weimer et al., 2010). It is important to 
note that the direct recognition or uptake of extracellularly secreted compounds may not be 
the only stimuli that impact upon the community, as changes to the surrounding biochemical 
environment, e.g. an alteration in the pH of airway secretions, will be felt by all species.  
A succession of different microbial populations is associated with the CF airways over the 
course of a patient’s life, yet it remains unclear how new environmental species and strain 
variants, such as those which might originate from the oral cavity or nasopharynx, interact with 
the pre-existing microbiota. It is also unclear which airway-associated species can be 
considered as ‘beneficial’ commensals, helping to prevent chronic colonisation of the airways 
by classical pathogens. Similarly, it is unclear which species may promote colonisation by 
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pathogenic organisms, for example through the production of public goods or alteration of the 
airway environment to favour colonisation by certain species (Bjornson et al., 1982, Conrad et 
al., 2013, Kirketerp-Møller et al., 2008). To address these types of question, it will be essential 
to study entire patient-derived polymicrobial communities in order to unravel the impact of less 
abundant (‘rare’) and typically avirulent species on the wider community.  
 
1.3.2 Species co-cultivation alters gene expression 
Striking differences have been observed in the gene expression profiles of species cultured 
axenically or as mixed population co-cultures. Comparisons of the core essential genome of 
SA cultured using in vitro and in vivo infection models have identified an approximate 25% 
difference in the expression of genes required for growth as an axenic population compared 
to the genes expressed during co-culture with PA (Ibberson et al., 2017). Such alterations will 
cause variations in metabolism and the expression of virulence determinants by a 
microorganism, thereby causing deviations from the behaviours observed when studying a 
species in isolation. Indeed, recent transcriptomic studies on co-cultures of clinical SA and PA 
isolates revealed that PA isolates specifically cause the differential dysregulation of >200 
genes, some of which are linked to virulence, antimicrobial resistance and even central 
metabolism in SA (Briaud et al., 2019).  
 
1.3.3 Stable and disturbed disease states 
The CF airway-associated microbiome is thought to exist in either a stable or disturbed state, 
with little known about the factors contributing towards a transition between the two (Conrad 
et al., 2013). Efforts made in trying to identify net changes in the composition of a CF 
community prior to and during periods of severe lung function decline, termed acute pulmonary 
exacerbations (APEs) (Stenbit and Flume, 2011), yielded little in the way of interesting 
observations (Zhao et al., 2012). Conrad et al. (2013) therefore proposed the intriguing notion 
that the species responsible for triggering such episodes of extreme immunological response 
and scarring of the patient airways are present in both the stable and disturbed airway 
associated microbiomes. Instead, they argue that it is changes in the metabolic activity of key 
species, e.g. PA, caused by the presence or altered activity of other members of the 
community, that contributes towards a worsening of patient prognosis and the onset of APEs 
(Gjødsbøl et al., 2006). Therefore, species typically considered avirulent may play a role in 




1.3.4 Modulation of microbial consortium and host environment 
One clear example of how interspecies interactions may underpin changes within both the 
composition of a microbial population and impact upon the disease state of a host is provided 
by Korgaonkar et al. (2013). Using an in vivo co-infection model, PA was found to specifically 
detect N-acetylglucosamine (GlcNAc) shed from the walls of Gram-positive species through a 
putative two-component response regulator encoded by gene PA0601. This environmental 
cue was used to increase the production and secretion of pyocyanin (discussed further in 
Section 4.4) and elastase, an extracellular protease lytic against both prokaryotic and 
eukaryotic cells. Coinfection of a rat lung model with PA and Gram-positive bacteria also 
caused an increase in lung damage and enhanced virulence factor production compared to 
infecting the model with PA only. Furthermore, bacterial peptidoglycan has also been found to 
elicit changes in the behaviour of Candida albicans (CA) and Bacillus subtilis in in vitro models 
(Shah et al., 2008, Xu et al., 2008). In combination, these studies identify the ability of PA, and 
other members of a polymicrobial co-culture, to survey the ecological composition and 
chemical space of mixed species infections and the ability of microorganisms to utilise 
extracellular cues to drive changes in the expression of virulence-associated genes. Additional 
studies co-infecting murine models with PA and B. cenocepacia have identified an increase in 
virulence factor production and an enhancement of the host immune response compared to 
infection with axenic populations of either microorganism. (Bragonzi et al., 2012, Chattoraj et 
al., 2010). Taken together, these data indicate that interspecies interactions may play a vital 
role in triggering bouts of excessive immunological inflammation, leading towards the onset of 
APEs. 
A novel Winogradsky-based CF model, termed WinCF, combining the use of chemical 
indictors and the culture-independent analysis of sputum samples obtained at the onset of 
APEs, was used to try and dissect how changes in a polymicrobial community directly 
contribute towards a worsened disease state (Quinn et al., 2015). A 2-unit reduction in pH and 
a 30% increase in gas production caused by the increased growth of fermentative species 
was observed prior to the onset of exacerbations. A separate study, co-culturing PA and SA 
with a physiologically relevant CF phe508del airway epithelial cell line, further demonstrated 
PA’s ability to modulate the metabolic activity of SA (Filkins et al., 2015). With this study 
demonstrating that SA to adopts a fermentative metabolic profile and undergoes significant 
phenotypic changes, such as small colony variant growth. Combined, these studies point 
towards a complex interplay between the polymicrobial composition of a community and the 
impact which interspecies interactions have upon altering the total metabolic output of the 




1.3.5 Quorum sensing among species 
The use of autoinducer QS molecules to regulate population density and coordinate 
community-wide changes in gene expression has been characterised in both Gram-positive 
and Gram-negative bacterial species. The regulatory networks of Gram-negative bacteria, e.g. 
PA, are primarily controlled by the environmental concentration of bacterially-derived N-acyl 
homoserine lactones (AHLs) (Papenfort and Bassler, 2016). The QS network in PA is among 
the most widely and extensively studied, primarily due to its link with the regulation of virulence 
factor production and importance in establishing infections and regulating biofilm formation in 
a number of in vivo and in vitro models (de Kievit, 2009, Rutherford and Bassler, 2012). A 
hierarchical two-tiered acyl-homoserine lactone (AHL)-based QS network is employed by PA, 
with the rhlIR system subordinate to the lasIR system (Lee and Zhang, 2015). Autoinducer 
synthases for the production of N-(3-Oxododecanoyl)-L-homoserine lactone (OdDHL) and N-
butanoyl-L-homoserine lactone (BHL) are encoded by lasI and rhlI, respectively. Under 
traditional culture methods these signalling molecules accumulate in a culture in a cell-density 
dependent manner and, once a critical threshold concentration of each signal is attained, form 
a complex with their corresponding intracellular receptors (LasR and RhlR, respectively). This 
signal-receptor complex then activates (or, more rarely, also represses) the transcription of 
target genes (Schuster and Greenberg, 2006). PA also possess a non-AHL signalling 
molecule: 2-heptyl-3-hydroxy-4-quinolone (the Pseudomonas quinolone signal, PQS) which 
is able to further modulate expression of the las and rhl systems (Diggle et al., 2003, Diggle 
et al., 2006). Over 30 different PA virulence factors are known to be under QS control 
(Bjarnsholt and Givskov, 2007). Some, such as proteases and elastases, are linked with 
interspecies competition and the elimination of rival species, e.g. SA, from traditional batch 
co-cultures (Section 1.8.1) (Hotterbeekx et al., 2017, Mashburn et al., 2005).   
Alternatively, Gram-positive species such as SA and Streptococcus spp., utilise post-
translationally modified thiolactone peptides, termed accessory gene regulators (Agr), as QS 
signals (Le and Otto, 2015). QS-like signalling networks have even been described in fungi, 
with species such as CA utilising farnesol accumulation (discussed further in Section 3.4.1) 
as a signalling molecule for the coordination of cellular processes (Nickerson et al., 2006). To 
date little is known about what effects QS molecules produced by an individual member of a 
polymicrobial consortium have at the community-wide level. Yet a degree of molecular cross-
recognition has been identified in certain species in vitro (Armbruster et al., 2010, Diggle et 
al., 2007). For example, autoinducer-2 (AI-2) is a universal QS molecule produced by many 
bacteria (Vendeville et al., 2005). Despite PA not producing AI-2, studies have demonstrated 
that the addition of exogenous AI-2 regulates PA biofilm formation and virulence factor 
production in a dose-dependent manner (Li et al., 2015). Given the array of virulence 
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associated genes under the regulatory control of QS networks (Rutherford and Bassler, 2012), 
it is likely that such indirect interspecies signalling events contribute towards the progression 
and pathogenesis of CF-associated infections and other polymicrobial infection scenarios.  
 
1.3.6 Antimicrobial treatment  
The majority of therapeutic antimicrobial strategies aim to eradicate or reduce the load of a 
principal pathogen from the site of infection. However, polymicrobial communities display an 
altered, and often refractory, response to the action of antimicrobials compared with the 
treatment of a species in isolation (Fodor et al., 2012, Lopes et al., 2012, Peters et al., 2012a). 
These observations can, in part, be attributed to failings in drug discovery efforts and currently-
used treatment regimens aimed at the prevention and clearance of chronic infections from the 
airways of CF patients. For example, in vitro co-cultures of PA, SA and S. maltophilia were 
found to be less susceptible to the action of ciprofloxacin (a clinically-used antimicrobial 
belonging to the fluroquinolone class of compounds) when compared with mono-species 
cultures (Magalhães et al., 2016). Increased doses of ciprofloxacin caused a reduction in the 
viability of PA but not the other species in the co-culture, leading to speculation that PA may 
exert a protective effect against antimicrobial action on the other species. An array of 
interspecies interactions, which may either enhance or reduce the susceptibility of species to 
therapeutic intervention or immune clearance, are likely to exist in the CF airways and cause 
a dramatically altered responses to therapeutic intervention.  
Since the indiscriminatory action of some antimicrobial compounds may wipe out the more 
susceptible members of the commensal airway microbiota, such interventions may create 
opportunities for invasion of the niche by drug-resistant species or strain variants (Ciofu et al., 
2013, Conrad et al., 2013). This could contribute to further complications in the future 
treatment and a decline in pulmonary function of the patient in the long-term. Therefore, there 
is a clear need to evaluate the action of antimicrobials on entire polymicrobial populations, not 
just a single target species. 
 
1.4 Pseudomonas aeruginosa (PA) 
1.4.1 Genome and general characteristics 
PA is a Gram-negative bacillus, ranging from 1.5 – 5 µm in length. The organism is motile, 
primarily through the use of a single, polar flagellum (Palleroni, 2004). PA belongs to the 
Gammaproteobacteria class. Some members of this bacterial class are also known as the 
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‘fluorescent pseudomonads’ due to their ability to produce fluorescent pigments, such as the 
blue-green redox-active phenazine dye, pyocyanin, discussed further in Section 4.4.  
The first PA genome sequenced was that of the common laboratory reference strain PAO1, 
isolated from a burn wound in 1955 (Holloway, 1955). With the PAO1 genome comprising of 
6.3 million base pairs, predicted to encode 5570 open reading frames (ORFs) (Stover et al., 
2000), the coding complexity of PA strains approach that of simple eukaryotic cells. Indeed, 
PA has over 1300 more ORFs than most species of Escherichia coli (Blattner et al., 1997). 
Importantly, these extra ORFs do not simply encode for higher numbers of the same types of 
genes, but rather, an increased number of distinct gene families, indicative of a large functional 
and metabolic potential (Stover et al., 2000).  
 
1.4.2 Adaptive metabolic potential  
The immense metabolic range and ecological diversity of PA is demonstrated by its ubiquitous 
presence within the environment, with PA frequently isolated from soil and aquatic 
environments (Kulasekara and Lory, 2004). PA is a well-known opportunistic pathogen, hardly 
ever infecting healthy individuals but a breach in host defence mechanisms provides PA with 
the opportunity to establish an infection. Approximately 6% of healthy individuals harbour PA 
within their oropharynx, but this number is thought to approach 50% in hospitalised patients 
(van Delden, 2004) as PA can colonise virtually all mucosal surfaces and invade tissues and 
the bloodstream. With almost one-tenth of its genomic repertoire (9.3% of ORFs) encoding 
transcriptional regulators or two-component systems (Kulasekara and Lory, 2004), PA can 
tightly regulate its metabolic activity in response to environmental stimuli (Palmer et al., 2007, 
Stover et al., 2000). These features likely contribute towards enabling PA to inhabit some of 
the broadest environmental niches of any known bacterial species. 
 
1.4.3 CF airway infection 
PA preferentially utilises aerobic and oxidative metabolic pathways, but can easily adapt to 
life in microaerophilic and anaerobic environments by using nitrate or nitrite as a terminal 
electron acceptor (Zannoni, 1989, Zumft, 2004). Mucus plugging and obstruction of the 
bronchiolar lumen leads to the formation of steep oxygen gradients with hypoxic and even 
anoxic regions in the CF airways (Worlitzsch et al., 2002). Therefore, the ability of PA to 
tolerate changes in environmental oxygen concentration is significant for the bacterium’s 
ability to chronically colonise all parts of the CF airway microenvironment. Furthermore, PA 
has been demonstrated to grow to high cell densities (>109 CFU mL-1) in the CF airways 
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through utilisation of its phosphatidylcholine catabolism pathways (Singh et al., 2000, Son et 
al., 2007, Storey et al., 1992). Phosphatidylcholine constitutes approximately 80% of the total 
lipids present in lung surfactant and is found in high abundance in the CF airways (Bernhard 
et al., 2001). The action of PA-produced lipases and phospholipase C cleaves 
phosphatidylcholine into a phosphorylcholine headgroup, one molecule of glycerol and two 
long-chain fatty acids (Son et al., 2007, Sun et al., 2014). These molecules are then fed into 
the choline, glycerol and β-oxidation degradation pathways. Five operons have been identified 
to be involved in the degradation of fatty acids, termed fadBA-operons, with three of these 
being dominant for the utilisation of medium- and long-chain fatty acids. Triple knock-out 
mutants lacking these fatty acid degradation operons show a severe reduction in fitness, but 
not virulence factor production, when grown in vivo (Sun et al., 2014). By contrast, E. coli 
possess only a single fad operon (Clark, 1981).  
 
1.4.4 Virulence factors 
As previously mentioned in Section 1.3, the establishment of chronic PA infection in the CF 
airways is significantly correlated with a reduction in species diversity and a progressive 
decline in patient lung function. In addition to a complex and adaptive metabolic network, the 
PA genome also encodes for an arsenal of virulence factors and determinants, such as: iron 
scavenging/sequestering molecules (termed siderophores, discussed further in Section 4.5); 
elastases; proteases; phospholipases; rhamnolipids; exotoxin A, S, T, U and Y; AprA, AprX 
and HasAP. See Ben Haj Khalifa et al. (2011), van Delden (2004)  and Kung et al. (2010), for 
a detailed review of PA virulence factors, functions and their regulation.  
The ability of PA to modulate it’s surrounding environment is further exemplified by the all four 
of the extracellular secretion systems described in Gram-negative bacteria (reviewed in depth 
by (Green and Mecsas, 2016)) being identified in the PA genome (Bleves et al., 2010). 
Primarily, PA utilises the Type II secretion system to secrete virulence factors, such as 
exotoxin A, into its local environment (Cianciotto, 2005). Exotoxin A is considered the most 
potent extracellular virulence factor produced by PA, causing the inactivation of eukaryotic 
elongation factor 2 and thereby arresting protein translation to cause cell death and tissue 
necrosis (Michalska and Wolf, 2015). Additionally, the Type III secretion system, sometimes 
referred to as the ‘injectisome’, uses a needle-like structure to directly deliver effector proteins 
such as exotoxin S, T, U and Y, directly into the cytoplasm of a target cell via contact-
dependent mechanisms (Engel and Balachandran, 2009). It is important to note that PA can 
produce virulence factors harmful against both prokaryotic and eukaryotic cells. For instance, 
rhamnolipids, which are essentially biological detergents, have both antimicrobial and 
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haemolytic activity (Espinosa-Urgel, 2003, Jensen et al., 2007, Soberón-Chávez et al., 2005). 
The array of virulence determinants and secretion systems encoded by PA is summarised in 
Figure 1.3 and these demonstrate the ability of this pathogen to directly influence the metabolic 
activity, composition and evolutionary trajectory of the CF airway-associated microbiome. 
Furthermore, some extracellular virulence factors secreted by PA also act upon host tissues 
and the surrounding CF-airway environment to cause irreversible tissue damage and a decline 
in pulmonary function (Dalton et al., 2011). 
 
1.4.5 Antimicrobial resistance  
Once established, PA infections of the CF airways are almost impossible to eradicate (Fodor 
et al., 2012, Pressler et al., 2011). The primary focus of research into CF-associated infections 
has therefore centred on understanding the growth of PA in this environment, in an attempt to 
identify novel targets for the attenuation of virulence or the reduction of a microbial loads in 
situ (Döring et al., 2004). Yet despite decades of research, PA remains on the World Health 
Organisations’ list of “priority 1: critical pathogens” for the development of new antimicrobial 
compounds (Asokan et al., 2019). The prolonged overuse of antimicrobials and a lack of novel 
compound classes entering the drug discovery pipeline, has led to a worrying rise in 
antimicrobial resistance (AMR) among bacterial species, and an innovation gap in the 
development of novel antimicrobials to combat this (Renwick et al., 2016). Furthermore, 
aggressive antimicrobial treatment at the onset of APEs is common and almost certainly 
contributes towards the emergence of AMR isolates in the CF airways (Sousa and Pereira, 
2014, Stressmann et al., 2012). 
AMR may arise through several different mechanisms, including direct inactivation of an 
antimicrobial through enzyme modification/cleavage, modification of a compound’s target and 
prevention of a compound from reaching its target either by sequestration, or a decrease in 
uptake or an increase in efflux (Pang et al., 2019, Poole, 2011). In clinical PA isolates, the 
most prevalent AMR defence mechanism observed is a reduction in outer membrane (OM) 
permeability (Li et al., 2012). The relatively narrow size of the major membrane porin, OprF, 
ensures reduced penetration of solutes across the OM (by around two orders of magnitude, 
compared with E. coli (Hancock and Brinkman, 2002, Nikaido, 2003)). Multidrug efflux (Mex) 
pumps further facilitate the export of a large range of molecules, including antimicrobials from 
the cell (Li and Nikaido, 2009). An increase in the expression of Mex-systems works in 
conjunction with a down-regulation of OM porins during chronic airway infections, contributing 
to the rapid emergence of AMR PA isolates amongst microbial communities associated with 









Figure 1.3. Pseudomonas aeruginosa virulence factors and secretion systems.  
PA produces a large number of virulence factors. Some of these are cell-associated (flagellum, 
lipopolysaccharide (LPS), type IV pili, non-pilus adhesins) whereas others are secreted into 
the extracellular environment. Extracellular virulence factors are comprised of chemical agents 
(alginate/exopolysaccharides, hydrogen cyanide, pyocyanin, rhamnolipids, siderophores, 
signalling molecules) and proteins secreted via one of the three secretion systems. Type I 
substrates (alkaline protease, AprX, HasAP) have a C-terminal signal peptide. The 
periplasmic fusion protein interacts with the inner membrane ABC transporter and the outer 
membrane channel forming protein. Type II substrates (elastase, exotoxin A, lipase, 
phospholipase C, protease IV) have an N-terminal signal sequence, which is cleaved in the 
periplasm, where protein folding takes place. Transport then proceeds via a gated outer 
membrane channel protein. Type III effectors (exotoxins S, T, U and Y) are injected directly 
into the cytoplasm of a target host-cell via the secretion apparatus or ‘injectisome’.  
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1.4.6 PA in the context of polymicrobial infections 
To date, research into the role of PA as the primary pathogen of CF-associated infections has 
relied on studying the axenic growth of different strains using a variety of in vitro and in vivo 
models. Although such studies are beneficial in advancing a fundamental understanding of 
metabolic pathways, bacterial lifestyles and key virulence determinants, they do not accurately 
reflect the behaviour of PA when present as part of a polymicrobial community. Given the 
ability of PA to sense chemical and ecological changes in the environment, and it’s adaptive 
metabolic and virulence potential, I hypothesise that during co-culture, PA will adopt a 
distinctly different lifestyle when compared with mono-microbiological growth (O'Brien and 
Fothergill, 2017, Winstanley et al., 2016). Possible drug targets identified and validated using 
axenic growth models may be down-regulated, made redundant or even absent during co-
culture and could, in part, explain some of the failings of modern efforts aimed at eradicating 
PA from the CF airway. 
The dynamic and successive nature of CF-associated airway infections leads to changes in 
the composition of microbial species harboured by the lungs over the course of a patient’s life. 
This will in turn impact upon the wealth of interspecies interactions and communication events 
occurring inside the airways, leading to modulations in behaviour and the evolutionary 
trajectory of PA and other key pathogens over time. Such changes that affect the evolution of 
the CF-airway associated microbiota may drive pathogens, or even typically avirulent species, 
towards a more persistent and multi-drug resistant lifestyle. Only by considering the presence 
of other species and their potential to perturb and influence the surrounding members of a 
polymicrobial community will it be possible to more accurately model and study the in situ 
behaviour of PA in the laboratory.  
 
1.5 Biofilms 
1.5.1 Historical perspective 
Since the foundation of microbiology as scientific discipline, microbiologists have studied the 
growth of microorganisms in liquid culture (the “planktonic” growth state). The first published 
account of surface-associated bacteria was from Henrici in 1933, who noted that “It is quite 
evident for the most part bacteria are not free floating organisms, but grow upon submerged 
surfaces” (Henrici, 1933). In 1943, Zobell then showed that the fouling of submerged slides in 
seawater was caused by sessile marine bacteria (Zobell, 1943). Costerton was the first to 
formally coin the term biofilm in 1978 (Costerton et al., 1978), promptly followed by an 
exponential increase of research into this field, with over 5600 articles on biofilms published 
in 2019 alone (PubMed).  
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1.5.2 General characteristics 
In recent years it has been made clear that the majority of microorganisms in nature and a 
disease setting reside as spatially-structured biofilm communities. With constant advances in 
the field of biofilm biology, what exactly constitutes a ‘biofilm’ is undergoing continual revision. 
However, a universally accepted basic biofilm definition is: a microbially-derived sessile 
community, irreversibly attached to a substratum, interface or each other which is encased 
within a matrix of self-produced extracellular polymeric substances (EPS, consisting of 
polysaccharides, protein and extracellular DNA), and exhibits an altered phenotype with 
respect to growth rate and gene transcription (Donlan, 2002). 
Biofilms can form a highly diverse array of differentiated structures in the environment. Some 
biofilms simply consist of flat confluent communities, whereas others form complex 
mushroom-like towers, separated by fluid filled channels thought to deliver nutrients to the 
centre of the structure (Tolker-Nielsen and Molin, 2004). The high level of cellular coordination 
observed in the formation of biofilms, has led some to theorise that biofilm formation is a 
programmed developmental progress, similar to those seen within eukaryotic systems (Sauer, 
2003, Stoodley et al., 2002). Others argue that these structures arise in response to a series 
of successive temporal events, reflecting the adaptation of individual members of a community 
to changes in the local microenvironment and nutrient availability, meaning biofilm formation 
could follow numerous pathways (Hentzer et al., 2005, Tolker-Nielsen and Molin, 2004). 
 
1.5.3 Biofilms in infection 
One crucial feature of microbial biofilms, and the reason for such intense research into this 
area, is their increased ability to bypass effective immune clearance and to avoid antimicrobial 
action (Leid et al., 2005). In fact, some bacterial biofilm communities have been determined 
to be 1000-times more resistant to antimicrobial treatment compared with their planktonic cell 
counterparts (Parsek, 2003). Over 60% of bacterial infections in the western world are 
believed to involve the formation of biofilms (Fux et al., 2005) and CF is no exception. In fact, 
the extensive formation of biofilms in the mucus obstructed airways is often cited as a key 
reason for the failings of therapeutic strategies aimed at eradicating chronic PA and other key 
pathogens from the airways of CF patients (Bjarnsholt et al., 2009, Folkesson et al., 2012, 
Elias and Banin, 2012, Høiby et al., 2010b, Leekha et al., 2011, Lopes et al., 2012, Mowat et 
al., 2011, Römling et al., 1994). As such, the inhalation of human deoxyribonuclease 
(rhDNases) such as dornase alfa and pulmozyme to aid in the degradation of extracellular 




1.5.4 Biofilms and Pseudomonas 
Alongside being the primary pathogen of late-stage CF airway infections, PA readily forms 
biofilms on numerous abiotic and biological interfaces, and so is frequently used as a model 
organism in the study of biofilm formation (Moreau-Marquis et al., 2008). The formation of PA 
biofilms is thought to follow five distinct developmental stages: reversible attachment, 
irreversible attachment, two stages of maturation and dispersal (Figure 1.4) (Maunders and 
Welch, 2017, Stoodley et al., 2002). However, the environment in which a biofilm grows is 
known to substantially alter the structure and developmental process of biofilm formation 
(Deretic et al., 1990, Høiby et al., 2010b).  
PA is found to undergo striking phenotypic adaptations throughout the course of chronic CF 
airway infections. Isolates transition from a motile, non-mucoid lifestyle (associated with acute, 
early-stage infections) towards a non-motile, mucoid phenotype during late-stage chronic 
infection (Folkesson et al., 2012, Smith et al., 2006). The mucoid phenotype of PA is due to 
overproduction of alginate, a major polysaccharide component of the EPS matrix, enabling 
mucoid isolates to more readily form biofilms and display increased antimicrobial tolerance 
(Boyd and Chakrabarty, 1995, Franklin et al., 2011, Hentzer et al., 2001). Alginate 
overproduction is often caused by mutations in mucA, with over 80% of mucoid PA isolates 
recovered from late-stage CF airway infections containing mutations or insertions in the 
mucABCD gene cluster (Boucher et al., 1997, Pulcrano et al., 2012). mucA encodes for the 
anti-sigma factor MucA that binds and sequesters AlgU, an alternative sigma factor and 
positive regulator of alginate biosynthesis (Hershberger et al., 1995, Lizewski et al., 2004, 
Pulcrano et al., 2012). The loss of motility within mucoid phenotypes is accounted for by AlgU 
negatively regulating flagella production (Tart et al., 2005), highlighting a reciprocal 
relationship between motility and the establishment of chronic infection in the CF airways. 
 1.5.5 Evolution and adaptation within biofilms  
The formation of DNA-damaging free-radicals and the bacterial ‘SOS’ response are the 
fundamental driving forces behind the emergence of mutations in microbial populations 
(Spiers et al., 2000). Microbial mutation, coupled with competition and the unique selection 
pressures of different niches in a heterogenous environment, such as biofilms in the CF 
airways, cause the adaptive divergence of members of a polymicrobial community (Markussen 
et al., 2014, Schick and Kassen, 2018, Winstanley et al., 2016). Most of the research into 
biofilm formation has focused on a single species, such as PA, in isolation. These studies 
therefore neglect how the presence of other species influences the evolution and adaptation 









Figure 1.4. Biofilm development and life cycle.  
Formation of model single-species PA biofilms begins when motile planktonic cells reversibly 
adhere to a surface. Cells proliferate and undergo phenotypic adaptation as microcolonies 
form and irreversibly adhere to the surface, motility apparatus is down-regulated and the 
production of extracellular polymeric substances is up-regulated to encase the biofilm 
community. Biofilms then undergo several maturation stages to form mushroom-like structures 
comprised of heterogenic microbial populations. In response to certain environmental 
conditions members of the population may revert to a motile phenotype and disseminated 
from the fixed biofilm structure to colonise new environmental niches. Figure reproduced from 




about the formation, composition or structure of polymicrobial biofilm communities, especially 
in the context of CF. Whilst the transition towards a biofilm-centred, mucoid phenotype is 
commonly viewed as a global response to environmental stress (Davies et al., 2016), evidence 
is emerging to support that interspecies interactions within polymicrobial communities may 
play a crucial role in shaping biofilm formation, either positively or negatively (Bragonzi et al., 
2012, Burmølle et al., 2006, Elias and Banin, 2012, C.J. et al., 2018, Hibbing et al., 2010, 
Lopes et al., 2012, Lopes et al., 2017, Makovcova et al., 2017, Wolcott et al., 2013, Woods et 
al., 2018). As an example, the co-culture of Inquilinus limosus with PA caused a reduction in 
the total biomass of the polymicrobial biofilm, whereas co-culturing S. maltophilia with PA 
caused an increase in the total biomass of the biofilm (Magalhães et al., 2016). Furthermore, 
ethanol produced by CA stimulates biofilm formation in PA (DeVault et al., 1990). Conversely, 
the protein SpA, secreted by SA, inhibits the formation of PA biofilms (Armbruster et al., 2016).  
The production of exopolysaccharides plays a vital role in the spatial organisation of biofilms. 
The polysaccharide Pel, produced by PA, is required for close association of the bacterium 
with SA in biofilms, yet the polysaccharide Psl causes PA to grow as a single-species biofilm 
atop SA (Chew et al., 2014). What triggers changes in the production of factors key for biofilm 
formation, such as exopolysaccharides, in the CF airways are not yet clear, but the role of 
these factors in modulating biofilm formation is evident. 
 
1.6 CF Infection Models 
1.6.1 A need for polymicrobial infection models 
A dynamic polymicrobial community is associated with the CF airways throughout the course 
of a patient’s life (Section 1.2). Increasing evidence is indicating the emerging role interspecies 
interactions between members of a population may play in driving changes in the composition, 
evolutionary trajectory and transcriptional profile of the consortium (Section 1.3). Modulations 
in metabolic activity will not only impinge upon microbe-microbe interactions, but such 
alterations may trigger species, such as PA, to adopt a more pathogenic lifestyle. The 
subsequent increase in the expression of virulence factors will impact upon the surrounding 
host microenvironment and possibly also contribute towards tissue damage, a decline in 
pulmonary function and the onset of APEs. There is an essential need to consider the role of 
all species present in a polymicrobial population, not simply the principal pathogen of infection. 
Researchers are therefore being urged to move away from the study of axenic cultures in 
favour of more physiologically representative co-culture models to more accurately model 
natural infection events associated with the CF airways. 
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The development of physiologically-relevant laboratory models to permit the stable, long-term 
co-culture of species associated with the CF airways, or even an entire polymicrobial 
community derived from a CF patient’s airways (i.e. from sputum or bronchoalveolar lavage 
samples) would be of enormous benefit to the respiratory research community. Such models 
would permit the real-time study of interspecies interactions and evolutionary events likely to 
occur in situ inside the airways, as well as allowing the capture of entire population dynamics 
in the face of external perturbation. Understanding what community-wide changes in 
population composition or gene expression occur amongst a polymicrobial community in 
response to antimicrobial treatment would enable a more informed understanding of why 
current strategies fail to eradicate chronic infections, adversely affect the commensal 
microbiota, or contribute towards the rise of AMR. Similarly, how a pre-established 
polymicrobial consortium responds to the introduction of new species or strain variants could 
also be assessed in such an experimental model. For example, how does a PA-negative 
polymicrobial community, associated with the early stages of airway infection, respond to the 
addition of PA? Such experiments could be used to model an initial infection event.  
 
1.6.2 Existing models 
Despite the clear need to consider the role of all species present in a polymicrobial infection 
setting, relatively little is known about what interspecies interactions and events are occurring 
in the CF airways. This is partly owing to the complexity of these populations, but it is the 
paucity of existing CF models that significantly hampers research efforts. Often laboratory 
models are insufficient at maintaining mixed species co-cultures for any length of time (O'Brien 
and Welch, 2019b). This is because the dominant CF pathogens rapidly outcompete other 
species in a co-culture and fastidious species simply do not grow. It is therefore difficult to 
discern what interspecies interactions occur between members of a CF-associated community 
and researchers are often forced to neglect the presence of unconventional and fastidious 
species. 
The advantages and limitations of existing in vivo, in vitro and in silico CF models and the 
most feasible route for the development of a true polymicrobial model capable of recapitulating 
the entire CF associated microbiome in the laboratory setting have been recently reviewed in 
depth (O'Brien and Welch, 2019b). Therefore, these points will not be addressed further in this 
work. Instead, I direct the reader to the publications chapter of this document for further 




1.7  Aims of the Current Work 
1.7.1  Development and Characterisation of an in vitro model to enable long-term co-
culture of key CF-associated pathogens 
Under traditional laboratory growth conditions, key CF associated pathogens, such as PA, 
rapidly outcompete and remove other microbial species present in a polymicrobial consortium. 
This limits the experimental analysis of interspecies interactions and population evolution. The 
primary aim of this work was to develop a physiologically-relevant and experimentally tractable 
model to enable the successful, long-term co-cultivation of key pathogens associated with CF 
airway infections. An in vitro continuous-flow co-culture model was designed, developed and 
characterised for this purpose. Using this model, the successful long-term co-culture of three 
distinct CF-associated pathogens, P. aeruginosa (PA), S. aureus (SA) and C. albicans (CA) 
could be maintained. Section 1.8 details the rationale behind my choice of experimental 
approach.  
1.7.2 Response of Polymicrobial Co-cultures to Therapeutic Intervention 
Antimicrobial compounds are often developed and tested on axenic microbial populations to 
limit or eradicate the growth of a principal pathogen. As discussed previously (Section 1.3), 
microbial species display altered genetic and metabolic profiles when grown as part of a co-
culture, meaning they may respond differently to antimicrobial treatment compared to what is 
expected from the study of axenic cultures. Due to species out-competition using traditional 
batch culture methods, previous work has relied heavily on studying the response of 
polymicrobial biofilms to antimicrobial agents. As predicted, these studies have found that 
polymicrobial biofilms display altered antimicrobial resistance profiles compared to single-
species biofilms. My novel in vitro model, developed as the primary aim of this work (Section 
1.7.1), provides an unparalleled opportunity to study how an actively-growing polymicrobial 
community differs in response to external perturbation following antimicrobial treatment. In this 
study, I compared the treatment of steady-state axenic and polymicrobial populations of PA, 
SA and CA with clinically-relevant antimicrobial compounds (colistin, fusidic acid and 
fluconazole) that specifically target each of the species present. However, in theory, any 
number/combination of antimicrobial compound classes or microbial species could be tested 










• >14 models with different CFTR 
mutations in different genetic 
backgrounds available 
 
• Allows the immune response and 
host-pathogen interactions to be 
studied 
 
• Cheapest vertebrate CF model 
 
• Well characterised with large 
genetic manipulation toolbox 
available 
 
• Widely available 
• Knockout of the CFTR gene alone not 
sufficient to cause a disease phenotype; 
additional mutations are required which 
may have off-target effects 
 
• Does not develop spontaneous airway 
infections 
 
• Only suitable for acute infection studies; 
species are rapidly cleared from the 
airways unless immobilised within beads 
 






• Develop spontaneous 
polymicrobial airway infections 
with a similar species composition 
as humans 
 
• Allows the immune response and 
host-pathogen interactions to be 
studied 
 
• Shares 92% CFTR homology with 
humans 
 
• Only suitable for acute infection studies 
 
• Airway infections stimulate rapidly fatal 
immune responses; neonatal CF ferrets 
require prophylactic treatment with 
antibiotics to survive weaning 
CF Pig 
(in vivo) 
• Develop spontaneous 
polymicrobial airway infections 
with a similar species composition 
as adolescent CF patients 
 
• Allows the immune response and 
host-pathogen interactions to be 
studied 
 
• Spatial organisation of porcine and 
human airways share a 
remarkable degree of degree of 
homology with humans 
 
• Shares 91% CFTR homology with 
humans 
 
• Very costly to maintain 
 
• Requires highly specialised research 
facilities and technically demanding 
 
• Data does not exist on the long-term 
survival of model or how airway 






• Low cost and minimal 
expertise/equipment required 
 
• Effective for high-throughput 
screening of mutant libraries 
 
• Limited similarities in innate 
immune response compared with 
vertebrate species 
• Limited range of CF associated species 
can establish an infection 
 
• Only suitable for acute infection studies 
(up to 48 hours) 
 
• Little physiological similarity to CF 
airways 
 
• Screening results should be viewed with 
caution as some hits may be missed, 
and false positives discovered 
 
In vitro • Low cost and minimal 
expertise/equipment required 
 
• No host cells/ immune system present 
(only useful for studying interspecies 
interactions and changes within 
microbial composition present) 
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• Highly defined and experimentally 
tractable culture conditions 
 
• Lack of ethical concerns 
(experimentally perturbable) 
 
• Biochemically representative of 
CF airway environment 
 




• Real-time and sensitive 
measurement of chemical and 






• Lack of spatial organisation (although 
using an ex vivo porcine lung model or 
cell culture of an airway epithelial cell 
line, e.g. phe508del, could introduce 
this) 
 
In silico • Accurately predicts composition 
and metabolic activity of a 
polymicrobial community from 
published datasets 
 
• Able to identify very subtle 
changes in gene expression and 
metabolism that may be missed 






• No ethical concerns 
 
• Useful for informing future “wet-
lab” validation and experimental 
research efforts 
 
• Relies on the quality of existing 
experimental data for accurate 
population modelling, therefore 
uncommon and fastidious species are 
poorly characterised and 
underrepresented within predictions 
(although this will improve as more 
experimental data is gathered) 
 
Table 1.1. Overview of the key advantages and limitations of existing CF models.  
Table provides a summary of the suitability of existing CF model types for the development of 
a long-term co-culture model that enables an entire polymicrobial community associated with 







1.7.3 Analysis of Polymicrobial Biofilms in the Context of CF 
As highlighted in Section 1.5, biofilms are implicated in the majority of chronic infection 
scenarios and their association with the CF microenvironment is no exception. Despite the 
importance of understanding biofilm behaviour and formation, relatively little is known about 
the formation of polymicrobial biofilms in the CF airways. I sought to compare biofilm formation 
in axenic and polymicrobial cultures of PA, SA and CA using a CF-relevant growth medium 
(artificial sputum medium, Section 1.8.2) in nutrient limited (batch) and continuous-flow culture 
conditions. Furthermore, I developed a method for reproducibly culturing biofilm populations 
upon removable pieces of solid substratum within the in vitro continuous-flow model and 
compared how two different substrata, agar chunks and porcine lung tissue sections, affect 
the composition of polymicrobial biofilms over time.  
 
1.7.4  Growth of Patient Derived Polymicrobial Communities in vitro 
Following the success of the aim described in Section 1.7.1, I aimed to refine the continuous-
flow model’s culture conditions to permit direct inoculation of the culture vessel with 
expectorated sputum samples collected from persons with CF. Through this I hoped to 
recapitulate the entire microbiota associated with CF airway infections, thereby enabling the 
study of patient-derived polymicrobial populations in vitro.  
 
1.8 Experimental Approach 
1.8.1 Continuous-flow culture  
As summarised in (O'Brien and Welch, 2019b) the most feasible approach for the laboratory-
based development of a polymicrobial community representative of those in the CF airways is 
through the development of an in vitro model. The inherent benefits and limitations of my in 
vitro co-culture model are discussed further in Section 8.5.  
The inability of species to grow per se, or out-competition between members of a community 
are the most common reasons why existing experimental co-culture models fail. Some species 
have an extremely limited host range, thereby severely limiting the use of in vivo models to 
study polymicrobial communities. For example, H. influenzae is only able to infect human 
hosts (Pan et al., 2014). An in vitro model which closely mimics the nutritional and chemical 
environment of the CF airways is likely to be sufficient to permit the growth of such human-
specific and fastidious species. Through inoculation of a model with an entire patient derived 
polymicrobial community, i.e. those contained within an expectorated sputum sample, 
auxotrophic strains and species reliant on the production of public goods produced by other 
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members of a community should still be cross-fed, allowing growth to be maintained within a 
culture vessel (Germerodt et al., 2016). Furthermore, the presence of animal-specific species 
and potential unwanted environmental “contaminants” are excluded when using a closed in 
vitro model system, allowing for interactions between members of the initial inoculum to be 
studied with confidence.  
Competition between species in a community increases when the selection pressure for 
limited space and nutrients in an environmental niche mount. For example, PA and SA can be 
co-isolated from the airways of ~31% of CF patients (Hogan et al., 2016, Limoli et al., 2016, 
Wakeman et al., 2016, Zolin et al., 2019), yet attempts to co-culture these species together in 
vitro often result in the rapid killing and removal of SA from the co-culture (discussed further 
in Section 3). One limiting factor for the growth of all microbial species is likely to be iron 
availability (Zughaier and Cornelis, 2018). Studies of the essential PA genome during mono- 
and dual-species co-culture with SA under iron-limited conditions found that 5% of the total 
PA genome is differentially expressed (Mashburn et al., 2005). Interestingly, the genes 
associated with iron acquisition were down-regulated during co-culture, suggesting PA is able 
to outcompete SA and use the resulting cell lysate as a source of iron to support its own growth 
when environmental levels are limited (Barnabie and Whiteley, 2015, Nguyen et al., 2015, 
Nguyen and Oglesby-Sherrouse, 2016).  
To date, the majority of existing in vitro co-culture models have attempted to grow mixed 
species consortia under batch culture conditions. A finite supply of nutrients is provided to 
support growth and space in the culture is limited. As the population grows the total cell density 
increases and nutrients become depleted (Wanner and Egli, 1990). This imposes a strong 
selection pressure on the community as it enters the stationary phase, causing species to 
aggressively compete with other members of the co-culture for the scant remaining resources. 
This underpins the killing and removal of some species by the more aggressive members of 
the population. 
I hypothesised that though the use of a continuous-flow model, not unlike a small scale 
chemostat or microbial fermenter (see Section 2.3 for model details), it may be possible to 
maintain a long-term, stable co-culture of CF-associated pathogens in vitro. By providing a 
continual supply of fresh nutrients, competition for nutrients and space is likely to be reduced 
(Ziv et al., 2013). This continual provision of fresh nutrients may therefore enable mixed-
species populations to be held at a stable carrying capacity inside the culture vessel for 
extended periods of time without entering the stationary phase of growth. My approach was 
intended to mimic the constant over-production of nutrient rich sputum in the CF airways 
alongside the periodic removal of “waste” sputum from the lungs by expectoration. The 
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abundance of nutrients in the CF airways may be the reason why co-cultures of species known 
to outcompete each other in vitro are commonly found together in situ in sputum samples. By 
altering the flowrate (Q) of my continuous-flow model, it should be possible to modulate the 
total carrying capacity of the culture vessel. Furthermore, altering Q may also allow for different 
phases of microbial growth, e.g. the stationary or exponential phase, to be experimentally 
studied. 
 
1.8.2 Artificial Sputum Medium  
Artificial sputum medium (ASM), or synthetic cystic fibrosis sputum, is a previously developed 
and chemically defined synthetic growth medium that captures the nutritional composition of 
CF airway secretions (Haley et al., 2012, Kirchner et al., 2012, Sousa et al., 2018, Sriramulu 
et al., 2005, Turner et al., 2015). Comparison of the essential genome of PA grown in vitro in 
ASM or in sputum derived from CF patients, established virtually no difference between the 
two (Turner et al., 2015). Furthermore, global transcription profiles of P. aeruginosa PA14 
grown in ASM established that key genes associated with the growth of PA in the CF airways 
were expressed and that the transcriptional profile of PA was similar to that observed in situ 
(Fung et al., 2010). ASM also induces PA to exhibit significant phenotypic adaptations that 
closely resemble the behaviour of PA in sputum samples. For instance, PA grows as 
microcolonies closely associated with the mucin present in ASM (Sriramulu et al., 2005). In 
combination, these studies highlight the suitability of ASM as the ‘gold-standard’ synthetic 
medium for the growth of CF-associated species in vitro under physiologically-relevant 
conditions.  
To the best of my knowledge, no study has yet attempt to grow an entire CF-associated 
microbial consortium in ASM. As all the essential nutrients and growth factors found in this 
environmental niche should be captured in ASM, the growth of all airway-associated species 
should be supported. An additional benefit of using a defined growth medium, is that the 
composition of ASM can be easily modified. Slightly altering the composition of ASM to include 
additional growth factors may help support the growth of some particularly fastidious species. 
Additionally, how variations in the availability of a particular nutrient component affects the 
population can be readily studied. As the composition of fresh ASM is known, subtle changes 
in the chemical composition of the culture medium can be characterised and directly attributed 





2. Materials and Methods 
2.1 Strains 
All microbial stains used in this work at shown in Table 2.1. Strains were routinely cultured in 
lysogeny broth (LB) (Formedium) with vigorous aeration at 37°C overnight. Where necessary, 
cultures were supplemented with: 50 µg mL-1 carbenicillin (to maintain pSB1057 in the N-(3-
Oxododecanoyl)-L-homoserine lactone OdDHL biosensor strain and pET23Lys in lysostaphin 
expression strain); 10 µg mL−1 tetracycline (to maintain pSB536 in the N-butanoyl-L-
homoserine lactone BHL biosensor strain) or 20 µg mL−1 tetracycline (to select for transposon-
containing mutants in QS-associated genes obtained from the Pseudomonas aeruginosa 
PAO1 mutant library). 
Candida albicans SC5314 was obtained from Prof. Andres Floto, Laboratory of Molecular 
Biology (Cambridge). Escherichia coli DH5α(pET23Lys) for the inducible expression and 
purification of recombinant lysostaphin was obtained from Dr Christopher Randall, University 
of Leeds.  
 
2.2 Growth media and solutions 
Unless otherwise stated, artificial sputum medium (ASM) was the growth medium employed 
in all experiments. To reduce media costs ASM was made using a modified version of the 
recipe published by Turner et al. (2015). Briefly, bovine maxillary mucin (£304 g-1, Sigma) was 
replaced with 1.25 g L−1 porcine stomach mucin type-II (£0.95 g-1, Sigma) and salmon sperm 
DNA (£102 g-1, Sigma) was replaced with 1.25 g L−1 fish sperm DNA (£1.98 g-1, Sigma) as 
described by Kirchner et al. (2012). A detailed protocol for preparing ASM can be found in 
Appendix 2.1.  





Strain Description Reference 
PAO1 Pseudomonas aeruginosa, spontaneous 
chloramphenicol-resistant derivative. Used worldwide 




ATCC 25923 Staphylococcus aureus Rosenbach (ATCC®25923D-
5™), methicillin sensitive clinical isolate. Laboratory 
reference strain lacking recombinases and mecA 
(isolated Seattle, 1945) 
(Treangen et 
al., 2014) 
SC5314 Candida albicans, clinical isolate commonly used as 
a wild-type laboratory reference strain (isolated New 
York, 1980’s) 




PQS biosensor strain. ΔpqsA mutant of PAO1 
containing a pqsA promoter :: luxCDABE fusion 
integrated at a neutral site in the chromosome 




OdDHL biosensor strain. Escherichia coli JM109 
containing pSB1057 




BHL biosensor strain. Escherichia coli JM109 
containing pSB536  




Escherichia coli transformation strain containing 
pET23Lys, encoding lysostaphin gene from 
Staphylococcus simulans cloned into pET23B+ 
expression system for the overproduction of 
recombinant his-tagged lysostaphin 





E. coli BL21 lacZY derivatives optimized for the 
production of proteins from target genes cloned into 
pET vectors. Also encodes a T7 lysozyme to 
suppress basal expression of T7 RNA polymerase 
 
Novagen 
DE3(pET23Lys) E. coli DE3 transformed with pET23Lys plasmid. 
Allows inducible production of His6-tagged 
lysostaphin for ‘in house’ purification 
Current work 
 




Media/ Solution Composition (per litre unless otherwise 
stated) 
Growth media 
Lysogeny Broth (LB) 20 g LB-broth Lennox (Formedium)  
LB-agar As for LB but with 15 g Bacto Agar  
2xYT Broth 16 g Tryptone (Duchefa Biochemie) 
10 g Yeast extract (Duchefa Biochemie) 




48.4 g Dehydrated pseudomonas isolation agar powder 
(Oxoid) 
10 mL glycerol (Acros Organics) 
200 mg Cetrimide (Sigma) 
15 mg Sodium nalidixate (Alfa Aesar) 
 
[Final concentration (g L-1): bacto agar (11), peptone (16), 
casein hydrolysate (10) magnesium chloride (1.4), potassium 
sulfate (10), glycerol (1% v/v), cetrimide (0.2), sodium 
nalidixate (0.015). pH 7.1] 
Mannitol Salt Agar (MSA, 
also known as Chapman’s 
medium) 
111 g Dehydrated mannitol salt agar powder (Oxoid) 
 
[Final concentration (g L-1): bacto agar (15), peptone (10), 
beef extract (1), sodium chloride (75), mannitol (10), phenol 
red (0.025). pH 7.4] 
BiGGY agar (BiGGY-A, 
also known as Nickerson’s 
medium) 
45 g Dehydrated BiGGY agar powder (Oxoid)  
 
[Final concentration (g L-1): bacto agar (16), bismuth 
ammonium citrate (5), dextrose (10), glycine (10), sodium 
sulfite (3), yeast extract (1). pH 6.8]  
N.B: media is not autoclaved, but boiled gently for 1 minute 
before pouring 
Glycerol stocks 700 µL overnight culture 
300 µL 50% glycerol 




[Final concentration (g L-1): sodium chloride (8), potassium 
chloride (0.2), di-sodium hydrogen phosphate (1.15), 
potassium dihydrogen phosphate (0.2). pH 7.3] 
Antibiotics 
Carbenicillin stock solution 20 mg mL-1 carbenicillin disodium salt (Melford) in ddH2O. 
Filter sterilised through 0.22 µM membrane and stored at -
20°C until use. 
Chloramphenicol stock 
solution 
20 mg mL-1 chloramphenicol (Sigma) in 95% ethanol. Stored 
at -20°C until use 
Ciprofloxacin stock 
solution 
20 mg mL-1 ciprofloxacin (Sigma) in 0.1 M HCl. Made fresh 
prior to each experiment. 
Colistin stock solution 10 mg mL-1 colistin sulfate salt (Sigma) in ddH2O and filter 
sterilised. Made fresh prior to each experiment. 
Fluconazole stock solution 15 mg mL-1 fluconazole (Sigma) in 95% ethanol. Made fresh 
prior to each experiment. 
Fusidic acid stock solution 10 mg mL-1 fusidic acid sodium salt (Sigma) in 95% ethanol. 
Made fresh prior to each experiment. 
Gentamicin stock solution 20 mg mL-1 gentamicin sulfate (Melford) in ddH2O. Stored at 
-20°C until use 
Itraconazole stock solution  0.5 mg mL-1 itraconazole (Sigma) in dimethyl sulfoxide. Made 
fresh prior to each experiment 
Rifampicin stock solution 20 mg mL-1 rifampicin (Sigma) in dimethyl sulfoxide. Made 
fresh prior to each experiment 
Tetracycline stock solution 10 mg mL-1 tetracycline hydrochloride (Sigma) in ddH2O. 
Stored at -20°C until use 
Siderophore assays 
CAS stock solution 1.21 g L-1 Chrome azurol S (in ddH2O) 
Fe Stock Solution 1 mM FeCl3 (Sigma) 
10 mM HCl 
PIPES buffer 0.1 M PIPES (Sigma), pH 6.8 
HDTMA solution 0.438 g hexadecyltrimethylammonium bromide 
([CH3(CH2)15](CH3)3NBr, Acros Organics) 
Shuttle solution 0.2 M 5-sulfosalicyclic acid (Sigma) 
CAS assay solution 
(100 mL) 
50 mL HDTMA solution 
1.5 mL Fe stock solution 
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7.5 mL CAS stock solution 
30 mL PIPES buffer 
(Store in dark above 25°C) 
Quorum sensing molecules 
OdDHL stock solution 25 mM N-(3-Oxododecanoyl)-L-homoserine lactone 
(courtesy of David Spring, Dept. Chemistry, University of 
Cambridge) in DMSO 
BHL stock solution 25 mM N-butanoyl-L-homoserine lactone (courtesy of David 
Spring, Dept. Chemistry, University of Cambridge) in DMSO 
PQS stock solution 25 mM pseudomonas quinolone signal (2-heptyl-3-hydroxy-
4-quinolone) (courtesy of David Spring, Dept. Chemistry, 
University Cambridge) in DMSO 
Biofilm assays 
0.1% CV solution 1 g L-1 crystal violet (Sigma) in ddH2O 
 
30% Acetic acid 300 mL acetic acid (Sigma) 
700 mL ddH2O 
XTT solution 4 mg 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-
Tetrazolium-5-Carboxanilide (Thermo Fisher) in 10 mL PBS. 
Solution filter sterilised (0.22 µm pore size) and stored in the 
dark at -80°C until use 
Menadione solution 10 mM menadione sodium bisulfite (Sigma) in 100% 
acetone. Stored at -80°C until use 
XTT-menadione solution 1 µL menadione solution 
10 mL XTT solution 
(Use immediately) 
DMEM/RPMI solution 500 mL Dulbecco's Modified Eagle Medium (DMEM, 
ThermoFisher) 
500 mL Roswell Park Memorial Institute (RPMI) 1640 
medium (ThermoFisher) 
50 µg mL-1 ampicillin (Melford) 
Protein purification 
Lysis buffer 50 mM Sodium dihydrogen phosphate (Fisher Scientific) 
300 mM Sodium chloride  
10 mM Imidazole (Sigma) 
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pH 8.0 and stored at 4°C 
Wash/ equilibration buffer 50 mM Sodium dihydrogen phosphate  
300 mM Sodium chloride  
20 mM Imidazole  
pH 8.0 and stored at 4°C 
Elution buffer 50 mM Sodium dihydrogen phosphate  
300 mM Sodium chloride  
250 mM Imidazole 
pH 8.0 and stored at 4°C 
Dialysis buffer 20 mM Tris-HCl (Sigma) (pH 7.5) 
500 mM Sodium chloride 
Sputum Sample Processing 
0.85% Saline solution 8.5 g L-1 Sodium chloride in ddH2O 
Sputasol 6.5 mM Dithiothreitol (DTT, Sigma) 
128.3 mM Sodium chloride 
2.7 mM Potassium chloride (Sigma) 
7.9 mM Sodium dihydrogen phosphate 
1.5 mM Potassium dihydrogen phosphate (Fisher Scientific) 
Filter sterilised (0.22 µm pore size) and stored at 4°C for up 
to one week. 
SDS-PAGE 
1 x SDS running buffer 2.5 mM Tris base (Sigma) (pH 8.3) 
19.2 mM glycine (Melford) 
0.01% sodium dodecyl sulfate (SDS, Sigma) 
Resolving gel (8%) 
(10 mL total) 
4.7 mL ddH2O 
2.7 mL acrylamide (30%) 
2.5 mL 1.5 M tris (pH 8.8) 
50 µL SDS (20%) 
100 µL ammonium persulfate (10%) 
100 µL TEMED 
Stacking gel (6%) 
(10 mL total) 
2.7 mL ddH2O 
0.8 mL acrylamide (30%) 
0.5 mL 1 M tris (pH 6.8) 
20 µL SDS (20%) 
40 µL Ammonium persulfate (10%) 
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4 µL TEMED 
5 x Sample buffer 10% w/v SDS 
0.2 M Tris-HCl (pH 6.) 
20% Glycerol  
10 mM β-mercaptoethanol 




4.6% acetic acid 
0.1 % Coomassie Brilliant Blue R-250 (ThermoFisher) 
Destaining solution 5% Methanol 
7.5% Acetic acid 
 
Table 2.2. Growth media and solutions. 
List of all growth media and solutions used in the described experiments are listed in the 




2.3 Growth conditions 
2.3.1 Continuous-flow culture model 
A schematic diagram of the continuous-flow culture system is shown in Figure 2.1. The culture 
vessel consists of a 100 mL flask (Duran), fitted with an assembled 4-port HPLC GL80 screw 
cap (Duran). A 24-channel IPC ISM934C standard-speed digital peristaltic pump (Ismatec) 
was used to deliver sterile ASM from a media reservoir at a defined flowrate (Q) through 1.5 
mm bore sterilin silicon tubing (Fisher Scientific) to the culture vessel. A different channel of 
the same pump was used to remove waste culture into a discard jar at the same flowrate. The 
entire culture system was maintained at 37°C and contents of the culture vessel kept 
homogenous via stirring (100 rpm) using a magnetic stir bar.  
Overnight cultures were washed three times in PBS prior to inoculating the culture vessel. 
Pre-warmed ASM (100 mL) in the culture vessel was inoculated with the required combination 
of microbial species. Each species was introduced into the culture vessel to achieve a starting 
optical density (600 nm, OD600 nm) of 0.05. The vessel was incubated for three hours prior to 
staring the flow of medium. For mono-species and co-culture experiments not containing CA, 
the Q = 170 µL min-1. For co-culture experiments including CA, Q was decreased to 145 µL 
min-1. For all continuous-flow experiments, samples (1 mL volume) for cell enumeration and 
optical density measurements were withdrawn using a syringe fitted with a sterile 19-gauge 
needle (Terumo) inserted through the rubber septa in the HPLC ports. 
When necessary, OD600 nm of a culture vessel was monitored by passing the removed waste 
culture through an in-line 6715 UV series spectrophotometer (Jenway) fitted with a continuous-
flow cuvette, as demonstrated in Figure 2.2. When taking continuous OD600 nm measurements 
a bubble trap (obtained from Janus A. Haagensen, Biocentrum-DTU, Technical University of 
Denmark) was fitted before the spectrophotometer. Prior to inoculation, the model was primed 
by pumping sterile ASM from the media reservoir throughout the entire system to purge any 
air bubbles that might interfere with OD600 nm measurements. 
As a 24-channel peristaltic pump was used to provide a continuous flowrate and each culture 
vessel has one input and one outlet line, the model can easily be multiplexed to study up to 
12 different culture vessels in tandem. Figure 2.3. demonstrates a representative image of five 
culture vessels grown concurrently on an 85 mm MULTISTIRRER6 multi-position magnetic 
stirrer (Velp Scientific). When measuring the optical density of multiple culture vessels, 
samples were removed from the HPLC ports (as described above) and OD600 nm measured 












Figure 2.1 Schematic diagram of the in vitro continuous-flow culture system used in 
this study.  
The main culture vessel (centre) is a 100 mL Duran bottle fitted with a 4-port HPLC GL80 
screwcap lid, containing 4 sealable inlet/outlet ports. A multichannel peristaltic pump delivers 
fresh media (ASM) into the culture vessel from a reservoir, and also removes waste culture at 
the same rate of flow (Q). Arrows show the direction of flow. The culture vessel and media 
reservoirs are incubated at 37°C and the contents are kept homogenous through gentle stirring 
(100 rpm). If required, a bubble trap and in-line spectrophotometer fitted with a continuous-
flow cuvette can be included in the setup prior to the discard jar (see Figure 2.2). The value 













Figure 2.2 Model with in-line spectrophotometer and bubble trap. 
A representative image of the continuous-flow model set up with an in-line spectrophotometer 
to take automated optical density (600 nm) measurements of the culture vessel. A bubble trap 
(right image) is included prior to the spectrophotometer to prevent bubbles from interfering 
with OD600 nm readings. The bubble trap is custom made from polycarbonate and has been 
constructed to fit a standard 5 ml syringe barre, with the O-ring providing an airtight seal for 
the system. The tip of the syringe is covered with either a syringe cap or parafilm. Prior to 
microbial inoculation, the entire culture system is filled with medium to purge air from the 
bubble trap. If any bubbles do enter the system, they rise to the top of the syringe barrel. As 













Figure 2.3 Multiplexing of continuous-flow model. 
Representative image of the continuous-flow model multiplexed to study five separate culture 
vessels in tandem. A 24-channel peristaltic pump delivers fresh ASM from the media 
reservoirs (wrapped in aluminium foil, left side of image) to the culture vessels (right side of 
image) and removes waste culture at the same rate of flow to the discard jars (front of image). 
Culture vessel contents are kept homogenous via stirring (100 rpm) on a multi-position 




2.3.2 Batch culture conditions 
For aerobic batch cultures, 250 mL Erlenmeyer flasks containing 100 mL pre-warmed ASM 
were inoculated with the indicated strain (washed three times in PBS, as in Section 2.3.1) to 
a starting OD600 nm of 0.05. Flasks were incubated at 37°C in a water bath with 180 rpm shaking. 
Stirred batch cultures were set up as described for the continuous-flow experiments (Section 
2.3.1), except Q = 0 µL min-1. Samples (1 mL) were aseptically removed from the batch 
cultures for measurement of OD600 nm (as described above) and viable cell counting (Section 
2.5). 
 
2.4 Calibration of flowrates 
Prior to growing any microbial strains, the speed of the multichannel peristaltic pump was 






Equation 2.1 Calculation of flowrate.  
Q = flowrate, V = volume of culture vessel and Rt = residency time. 
 
The volume (V) of the culture vessel (100 mL) is constant for all experiments. To determine 
residency time (Rt) the model was set up to include an in-line spectrophotometer (Section 
2.3.1). ASM within the media reservoir was stained with Coomassie Brilliant Blue R-250 
(ThermoFisher) to a final absorbance (465 nm) of 1.0. Displacement of unstained media within 
the culture vessel was followed by measuring Abs465 nm every 5 min, with Rt taken as the time 
at which Abs465 nm reaches an asymptote of 1.0. 
Figure 2.4 demonstrates a representative example of how Q was determined for continuous-
flow experiments using mono-species PA cultures and PA-SA co-cultures. The function for 
the non-linear regression model of this displacement curve is displayed on the figure. When 












Figure 2.4 Determination of flow rate within culture vessel. 
Representative displacement curve within the culture vessel (100 mL) when flow rate (Q) = 
170 µL min-1. Absorbance (465 nm) of vessel contents was measured every 5 min using an 
in-line spectrophotometer and continuous-flow cuvette. Unstained ASM was displaced by 
media stained with Coomassie Brilliant Blue (Abs465 nm 1.0) from the reservoir tank. Data 
represented as the mean ± standard deviation from three independent experiments, fitted with 
a non-linear regression model. Function of the curve and R2 values are displayed and the 
residency time (Rt) is calculated as the value for x when y = 1.0. 
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2.5 CFU mL-1 Enumeration 
Colony forming units (CFU) per mL of culture were determined using the single plate-serial 
dilution spotting method, as described previously (Thomas et al., 2015). Serial dilutions were 
made in sterile PBS and 20 µL of each dilution was spotted onto the appropriate selective 
agar. PA was isolated on pseudomonas isolation agar (PIA, Oxoid), SA was isolated on 
mannitol salt agar (MSA, Oxoid) and CA was isolated on BiGGY agar (Oxoid). During co-
culture experiments involving CA, the agar plates used to isolate PA and SA were further 
supplemented with 5 µg mL-1 itraconazole to inhibit the growth of CA. All plates were incubated 
at 37°C.  PIA and MSA plates were incubated overnight (16 hr) and BiGGY agar plates were 
incubated for 24 hr. CFU mL-1 counts are averages taken from three technical repeats.  
Axenic overnight cultures of PA, SA and CA were routinely grown and plated out for CFU mL-
1 enumeration on non-selective (LB-agar) and the appropriate selective agar. There was no 
significant difference between total CFU mL-1 counts of microbial cultures between the 
selective and non-selective agar (Figure 2.5). 
 
2.6 Quantitative real-time PCR (RT-PCR) 
2.6.1 RNA extraction 
Single species cultures of PA were grown in ASM under continuous-flow and batch culture 
conditions, as described in Sections 2.3.1 and 2.3.2 respectively. Cells were harvested by 
removing 2 mL of the culture on ice, pelleting via centrifugation (13,000 x g, 1 min, 4°C) and 
immediately resuspending the pellet in 750 µL of RNAlater (Invitrogen). Culture/RNAlater 
mixtures were incubated at 4°C overnight and stored at -80°C until use. 
Before extraction, samples were thawed on ice. Cells in the culture/RNAlater solution were 
sedimented by centrifugation (13,000 x g, 5 min, 4°C) and the supernatant carefully removed. 
Cells were resuspended in 1 mg mL-1 lysozyme (Sigma) in DEPEC-treated water (Ambion) 
and incubated for 10 min at room temp with 50 rpm shaking. RNA was extracted using RNeasy 
Plus Mini Kit (Qiagen) following the manufacturers bacterial extraction protocol. RNA was 
eluted in 30 µL DEPEC-treated water and stored at -80°C. RNA concentration was quantified 
using a Nanodrop ND-1000 Spectrophotometer (Labtech International), with an A260/A280 
ratio of >1.8 and an A260/230 ratio of >2.0 considered acceptable purity. Final concentrations 














Figure 2.5 Comparison of total CFU mL-1 counts between selective and non-selective 
agar. 
Viable cell counts (CFU mL-1) of overnight single-species cultures of P. aeruginosa PAO1 
(PA), S. aureus 25923 (SA) and C. albicans SC5314 (CA) on non-selective (black bars) and 
selective (grey bars) agar plates. Data represented as mean ± standard deviation from three 





2.6.3 cDNA synthesis 
The cDNA synthesis was performed using a single step reaction using High-Capacity cDNA 
Reverse Transcription Kit (ThermoFisher) within a thermocycler and. The reaction mixture and 
cycling conditions for cDNA synthesis are shown in Table 2.3. RNA was removed by adding 
NaOH (20 µL, 1 M) to each sample, incubating at 65°C for 30 min then cooling to 4°C and 
neutralising with HCl (20 µL, 1 M). cDNA was purified using GeneJET PCR Purification Kit 
(ThermoFisher) following the manufacturer’s instructions. Samples were stored at -20°C until 
use. 
As a control cDNA samples and purified RNA (from Section 2.6.2) were used as templates for 
the amplification of the 16S rRNA housekeeping gene encoding for the 30S subunit (Clarridge, 
2004, Kolbert and Persing, 1999, Woese, 1987) using the protocol described in detail within 
Section 2.14.4. A clear, single band corresponding to the correct size (1500 bp) of the 16S 
rRNA gene can be seen in the reactions using synthesised cDNA and genomic DNA (positive 
control) as templates only. As RNA cannot be amplified by Taq polymerase, no bands can be 
observed in the reaction utilising RNA as the template, indicating no DNA contamination of 
the RNA samples (Figure 2.6).  
 
2.6.4 RT-PCR primer design 
To determine the metabolic state of cells harvested in Section 2.6.1, four stationary phase-
specific and four exponential-phase specific PA genes were selected from a previously 
published transcriptomic dataset (Mikkelsen et al., 2007). Primer-BLAST software (NCBI, 
www.ncbi.nlm.nih.gov/tools/primer-blast/) was used to identify suitable primer pairs with an 
approximate Tm of 58°C and yielding an amplicon product of 150 bp, compatible with SYBR 
Green RT-PCR conditions (Table 2.4). A validated primer pair for RT-PCR amplification of the 
PA 16S rRNA housekeeping gene was obtained from Dr. Shunsuke Numata (University of 
Cambridge, personal communication) and are included at the bottom of Table 2.4. 
 
2.6.4 RT-PCR  
RT-PCR amplification was carried out in MicroAmp Optical 96-well Reaction Plates (Applied 
Biosystems) sealed with MicroAmp Optical Adhesive Film (Applied Biosystems) using a 7300 
Real-Time PCR System (Applied Biosystems). Reactions were carried out in 20 µL total 
volumes, using Universal PowerUp SYBR Green Master Mix (Applied Biosystems), following 









Component Volume/amount Final concentration 
Total RNA 10 µg 0.5 µg µL-1 
10 x RT Buffer 2 µL - 
dNTP mix (100 mM) 0.8 µL 4 mM 
MultiScribe Reverse 
Transcriptase 
1 µL 2.5 U µL-1 
Nuclease-free H2O 3.2 µL - 
Total reaction volume 20 µL  
Thermocycler conditions 
Step Temperature (°C) Time (min) 
1 25 10 
2 37 120 
3 85 5 
4 4 ∞ 
 
Table 2.3. Synthesis of cDNA. 
Reaction mixture and thermocycling conditions for cDNA synthesis from purified RNA using 

















Figure 2.6 RNA and cDNA synthesis quality control. 
PCR amplification of the 16S ribosomal RNA housekeeping using the conditions described in 
Section 2.14.4. Lane I: Hyperladder 1 kb DNA marker (Bioline). Lane II: PCR amplification 
using synthesised cDNA as the template. Lane III: PCR amplification using extracted RNA as 
the template. Lane IV: PCR amplification using PAO1 genomic DNA as the template (positive 
control). Bright bands of approximately 1500 bp, corresponding to the size of the 16S rRNA 
gene, can be seen for the positive control (lane IV) and when using cDNA as the template 
(lane II) indicating successful cDNA synthesis. The absence of a band in lane III indicates that 







5’ - 3’ Sequence Growth 
Phase 
rpsM-F rpsM CGTCGCGAAATCAACATGAAC E 
rpsM-R TTACTTGCGGATCGGCTTAC 
rplM-F rplM TACCACCACTCCGGCTTC E 
rplM-R CACCTTCAGCTTGCGATACA 
rpoA-F rpoA GCACCGAAGTGGAACTGTTG E 
rpoA-R CAGTGGCCTTGTCGTCTTTC 
sodB-F sodB AACACCTACGTGGTGAACCT E 
sodB-R GCTCAGGCAGTTCCAGTAGA 
rmf-F rmf ACGGCATAACCGGTAAATCTC S 
rmf-R GCTGGAGTTGATTGAGACGTT 
rsmA-F rsmA CCCTGATGGTAGGTGACGAC S 
rmsA-R GGTTTGGCTCTTGATCTTTCTCT 
rpoS-F rpoS AAGCTCGACCACGAACCTT S 
rpoS-R CGTATCCAGCAGGGTCTTGT 











Table 2.4 Primer pairs for RT-PCR analysis of metabolic state of axenic PA cultures. 
Forward and reverse primers for a specific target gene are denoted by ‘-F’ or ‘-R’ respectively 
and growth phase indicates at what point within a typical growth curves these genes are 













Component Volume Final Concentration 
2 x PowerUp SYBR 
Green Master mix 
10 µL  
Forward Primer 1 µL 2.5 nM 
Reverse Primer 1 µL 2.5 nM 
cDNA Template 0.4 µL 10 ng µL-1 
Nuclease-free water 7.6 µL  
Thermocycler conditions 
Temperature (°C) Time No. Cycles 
50 2 min Hold 
95 2 min Hold 
95 15 secs 
40 
60 2 min 
4 ∞ Hold 
 
Table 2.5 RT-PCR reaction mixture and conditions.  
Reaction mixture (20 µL total volume) and thermocycling conditions for RT-PCR of target 





mixture and cycle conditions used for all RT-PCR reactions is displayed in Table 2.5. RT-PCR 
of 16S rRNA housekeeping gene was performed for each cDNA sample tested on every 96-
well reaction plate to normalise results (Section 2.6.5) and account for plate-to-plate variability 
between reactions. As a control, amplicon products were resolved on a 1.4% (w/v) agarose 
gel to check that a single band of approximately 150 bp in size was present, Figure 2.7 shows 
a representative image of this.  
 
2.6.5 Data analysis  
Cycle threshold (Ct) values of cDNA samples obtained by RT-PCR were analysed through the 
comparative ΔΔCt method (Giulietti et al., 2001). For each gene target, this method compares 
the Ct value of the test sample with the Ct value from a reference sample. In this work samples 
collected from the continuous-flow model (test sample) are compared with samples collected 
from batch culture (reference sample) at the same corresponding time points. For each target 
gene Ct values are normalised according to the Ct value of the constitutively expressed 16S 
rRNA housekeeping gene on the same reaction plate, as shown in Equation 2.2. 
Subsequently, the relative expression (RE) of normalised Ct values obtained from the 
continuous-flow test sample were compared with the corresponding Ct values obtained from 
the same target gene after the same length of incubation from the reference sample as shown 
in Equation 2.3. 
∆𝐶𝑡 = 𝐶𝑡(𝑡𝑎𝑟𝑔𝑒𝑡 𝑔𝑒𝑛𝑒) − 𝐶𝑡(ℎ𝑜𝑢𝑠𝑒𝑘𝑒𝑒𝑝𝑖𝑛𝑔 𝑔𝑒𝑛𝑒) 
Equation 2.2. Normalisation of Ct values. 
Where Ct(target gene) is the cycle threshold value for the gene of interest and Ct 
(housekeeping gene) is the cycle threshold value for the 16S rRNA housekeeping gene from 
the same RT-PCR reaction. ΔCt is the normalised cycle threshold value for the gene of 
interest. 
 
𝑅𝐸 = 2− ∆∆𝐶𝑡  [𝑤ℎ𝑒𝑟𝑒 ∆∆𝐶𝑡 =  ∆𝐶𝑡(𝑡𝑒𝑠𝑡 𝑠𝑎𝑚𝑝𝑙𝑒) −  ∆𝐶𝑡(𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑠𝑎𝑚𝑝𝑙𝑒)] 
Equation 2.3 Calculation of relative gene expression from normalised Ct values. 
Where RE indicates relative gene expression, ΔCt(test sample) indicates normalised Ct value 
of the target gene from the continuous-flow model and ΔCt(reference sample) indicates 
normalised Ct value of the same target gene from the batch culture sample. Normalised Ct 















Figure 2.7 RT-PCR amplification products. 
Representative image demonstrating amplification products from RT-PCR reactions, 
described in Section 2.6.4, resolved on a 1.4% w/v agarose gel. Lane I: Quick-load 100 bp 
DNA ladder (NEB). Lanes II – XV: RT-PCR amplification products. A single clear band of 
approximately 150 bp, corresponding to the predicted size of all RT-PCR products in this 
study, can be observed in every lane demonstrating that the reaction was successful and 





2.7.1 Determination of mutation rates 
The rate of mutation (µ) for single-species and co-cultures of PA and SA was inferred 
experimentally under batch culture and continuous-flow conditions. The emergence of 
spontaneous ciprofloxacin resistant (cipr) or rifampicin resistant (rifr) isolates within a 
population was used as a proxy to measure mutant accumulation (m) under the different 
experimental conditions. Then µ was calculated using the methods reviewed by Foster (2006). 
In order to identify the emergence of cipr and rifr isolates, the minimum inhibitory concentration 
(MIC) of ciprofloxacin and rifampicin to inhibit the growth of PA and SA on PIA and MSA 
selective plates was determined. Overnight bacterial cultures were struck out onto selective 
plates supplemented with antimicrobials at a range of concentrations and the MIC was 
determined as the lowest concentration sufficient to inhibit the growth of single colonies (data 
not shown). Based on these data, in the subsequent mutation rate experiments, PIA plates 
were supplemented with 60 µg mL-1 rifampicin or 0.12 µg mL-1 ciprofloxacin and MSA plates 
were supplemented with 0.05 µg mL-1 rifampicin or 0.6 µg mL-1 ciprofloxacin.   
 
2.7.2 Continuous-flow mutation rates 
Mutation rates within a continuous-flow model can be determined by measuring mutant 
accumulation (Kubitschek and Gustafson, 1964, Novick and Szilard, 1950). As the population 
within the culture vessel is continually dividing (Section 4.2) µ can therefore be calculated 
using Equation 2.4 (Drake, 1970). 
 




𝑟2 𝑜𝑟 3 − 𝑟1
𝑡2 𝑜𝑟 3 − 𝑡1
 
Equation 2.4 Calculation of mutation rates within a continuous-flow vessel. 
Where µ indicates mutation rate (mutations per cell division), N is total cell count (CFU mL-1) 
in the culture vessel, λ is the growth rate constant, r is the number of observed resistant 
isolates (CFU mL-1) and t is time (hrs). 
 
Initially, the growth rate constant (λ) associated with the exponential growth of PA or SA during 
mono-species or dual-species growth was determined. A stirred batch culture was inoculated 
and incubated as described in Section 2.3.2, and samples were removed hourly for CFU mL-
1 enumeration and values for λ determined from the resulting growth curve. 
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Fresh bacterial cultures were inoculated into the continuous-flow culture vessel and incubated 
as described in Section 2.3.1. Total cell counts (N) for each culture condition were taken as 
an average of CFU mL-1 counts onto selective plates without antibiotics every 24 hrs. The 
value for N did not change appreciably after 24 hrs of incubation (Section 3.). The number of 
spontaneous antibiotic-resistant mutants (r) were measured by plating 15 x 100 µL culture 
aliquots onto selective agar plates supplemented with antibiotics (as described in Section 
2.7.1) after 0, 24 and 96 hrs of incubation (t1, t2 and t3 respectively). Plates were incubated at 
37°C for 24 hrs before counting, with one CFU assumed to be the progeny of a single resistant 
isolate.  
 
2.7.2 Batch culture mutation rates 
Mutation accumulation (m) within axenic and mixed microbial cultures under batch culture 
conditions were estimated experimentally using a modified version of the Luria-Delbrück 
fluctuation assay (Luria and Delbrück, 1943) and m calculated using the Jones median 
estimator, Equation 2.5 (Jones et al., 1994). This method improves upon the original Lea-
Coulson model which quantified the distribution of mutants within a bacterial population and 
identified this to be a Poisson distribution (Lea and Coulson, 1949). A value for µ can then be 
calculated using Equation 2.6 (Armitage, 1952). 
 
𝑚 =  
(
?̃?𝑜𝑏𝑠
𝑧⁄ ) − ln(2)
𝑙𝑛 (
?̃?𝑜𝑏𝑠
𝑧⁄ ) + ln[ln(2)]
 
Equation 2.5 The Jones median estimator of mutation accumulation. 
Where m is mutant accumulation, r õbs is median number of resistant isolates observed within 
a fluctuation assay and z is the dilution factor (fraction of the bacterial population plated within 
a fluctuation assay).  
 




Equation 2.6 Calculation of mutation rate from estimates of mutant accumulation. 
Where µ is mutation rate (mutations per cell division), m is mutation accumulation (calculated 




To achieve precision whilst calculating m, fluctuation assays rely on mutant accumulation to 
be measured across a large number of parallel cultures (c) (Foster, 2006). Batch culture 
methods described in Section 2.3.2 were not feasibly compatible with this approach and batch 
culture fluctuation assays were instead performed using a microtiter plate format. Overnight 
cultures were washed in PBS, then diluted to OD600 nm 0.05 in fresh pre-warmed ASM. 
Normalised bacterial suspensions were used to inoculate 80 cultures in parallel (1 mL per 
well) within flat bottomed 24-well microtiter plates (Nunc). For mixed species cultures a 1:1 
ratio of normalised cultures (500 µL of each) was inoculated within wells. Plates were sealed 
with Breathe-Easy gas permeable adhesive membranes (Sigma) and incubated for 24 hrs at 
37°C with 100 rpm shaking. To ensure no cipr or rifr isolates were present within the starting 
cultures, aliquots (10 x 100 µL) were plated onto selective plates supplemented with antibiotics 
(as discussed in Section 2.7.1).  
After incubation, OD600 nm of saturated cultures was measured using a FLUOstar Omega plate 
reader (BMG). Forty parallel cultures within OD600 nm 0.1 of each other were chosen at random 
for plating (c = 40). If c > 40 there is little gain in precision when determining m (Jones et al., 
1999, Rosche and Foster, 2000). Total cell number (Nt) within individual populations was 
determined by removing 100 µL of culture for CFU mL-1 enumeration and Nt was calculated 
as the average of CFU mL-1 counts across all parallel cultures. Variations in Nt between 
cultures selected for plating were not statistically significant (data not shown).  
Cells in the remaining culture (900 µL) were sedimented by centrifugation (13,000 x g, 5 min, 
room temp) and pellets resuspended in 300 µL PBS. For single species cultures 3 x 100 µL 
aliquots were plated onto selective media supplemented with antibiotics and for co-cultures 3 
x 50 µL aliquots were plated onto both types of selective media supplemented with antibiotics. 
Plates were incubated for 24 hrs and the total number cipr and rifr isolates (r) for each culture 
within a parallel series was calculated. Plates containing too many colonies to accurately count 
were truncated at 150 CFU mL-1, previously reported to give little loss in precision (Asteris and 
Sarkar, 1996, Jones et al., 1999). The median number of resistant isolates across the 40 
parallel cultures was taken as the value for r õbs. The dilution factor (z) is 0.9 and 0.45 for the 
single-species and co-culture fluctuation assays respectively, as 90% or 45% of the 




2.8 Pyocyanin quantification 
Pyocyanin quantification was performed following chloroform extraction of the pigment (Knight 
et al., 1979). Aliquots (10 mL volume) of culture were collected after 96 hrs growth and cells 
were pelleted by centrifugation (4000 × g, 30 min, 4°C). The culture supernatants were filter 
sterilised (0.22 µm pore size). Chloroform (4.5 mL) was added to 7.5 mL of the cell-free culture 
supernatant and the suspension was vigorously vortexed for 30 sec. The immiscible layers 
were separated by centrifugation (4000 × g, 10 min, 4°C). An aliquot (3 mL volume) of the 
blue-green chloroform phase was removed and mixed with 1.5 mL 0.2 M HCl. The immiscible 
layers were then separated by further centrifugation and 1 mL of the rose-pink phase was 
transferred to a cuvette. Pyocyanin absorbance was measured at 520 nm using a 
BioSpectrometer Kinetic spectrophotometer (Eppendorf) and converted to concentration (µg 
mL -1) by multiplying the Abs520 nm value by 26.6. 
 
2.9 Siderophore quantification 
Siderophores in culture supernatants were quantified using the Chrome Azurol S (CAS) assay 
described by (Payne, 1994), with minor modifications to enable the assay to be performed in 
a 96 well microtiter plate format. Aliquots (1.5 mL volume) of culture supernatant were 
collected every 24 hrs throughout incubation and cells sedimented by centrifugation in a 
benchtop centrifuge (15,000 × g, 5 min, 4°C). Supernatants were filter sterilised (0.22 µm pore 
size), snap-frozen in liquid nitrogen and stored at -20°C. Samples were thawed on ice and 100 
µL of supernatant was mixed with 100 µL CAS assay solution and 10 µL shuttle solution in a 
clear flat-bottomed 96-well plate (Nunc). Plates were incubated in the dark for 15 min at 30°C 
with 50 rpm shaking. Loss of blue colour was recorded by measuring Abs630 nm in a FLUOstar 
Omega plate reader (BMG). For each set of samples, a medium only control was included for 
reference and a standard curve was constructed of deferoxamine mesylate salt (Sigma) 
dissolved in ASM. It should be noted that some culture supernatants (primarily batch culture 
supernatants) had to be diluted in ddH2O so that the concentration of siderophores fell within 
the linear portion of the standard curve, this dilution factor was accounted for when normalising 
final concentrations.   
 
2.10 QS signal molecule quantification 
Aliquots (1.5 mL volume) of culture supernatant were collected every 24 hrs throughout 
incubation and cells sedimented by centrifugation in a benchtop centrifuge (15,000 × g, 5 min, 
20°C). Supernatants were then filter sterilised (0.22 µm pore size), snap-frozen in liquid 
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nitrogen and stored at -20°C. OdDHL was detected using JM109(pSB1057). BHL was 
detected using JM109(pSB536). PQS was detected using PAO1 ΔpqsA CTX-lux∷pqsA. 
Overnight starter cultures of the reporter strains were sub-cultured in LB supplemented with 
the appropriate antibiotics and grown to OD600 nm = 1.0. Following this, aliquots (60 µL volume) 
of the normalised cell culture were transferred to a sterile clear-bottomed black opaque 96-
well plate (Greiner Bio-One) containing an equal volume of thawed culture supernatant. The 
plates were incubated at 30°C with shaking (100 rpm) for 3 hrs. Bioluminescence was 
recorded using a FLUOstar Omega plate reader (BMG). On each plate standard curves to 
calibrate the biosensor outputs were constructed using known concentrations of synthetic 
quorum sensing molecules dissolved in ASM. It should be noted that some culture 
supernatants (primarily batch culture supernatants) had to be diluted in ddH2O so that the 
concentration of QS molecules fell within the linear portion of the standard curve, this dilution 
factor was accounted for when normalising final concentrations.   
 
2.11 External perturbation of steady-state microbial populations 
2.11.1 Introduction of PA to steady-state SA-CA co-cultures 
Dual species co-cultures of S. aureus 25923 and C. albicans SC5314 were grown to a steady-
state for 24 hrs under continuous-flow conditions (as described in Section 2.3.1). Routine 
overnight cultures of P. aeruginosa PAO1 were then washed three times in PBS and 
introduced into the culture vessel to final OD600 nm 0.05, 0.1, 0.25 or 0.5. The culture vessel 
was then incubated under continuous-flow conditions, Q = 145 µL min-1. Supernatant samples 
were aseptically removed from the culture vessel for OD600 nm measurements or CFU 
enumeration as described in Section 2.3.1 and Section 2.5, respectively. 
 
2.11.2 Minimum inhibitory concentrations in ASM 
Minimum inhibitory concentration (MIC) of colistin, fluconazole and fusidic acid against P. 
aeruginosa PAO1, S. aureus 25923 and C. albicans SC5314 in ASM were determined using 
the broth microdilution method described by the Clinical and Laboratory Standards Institute 
(CLSI, 2019). Briefly, stock solutions of the antimicrobials were freshly prepared prior to each 
experiment (Table 2.2). Serial 2-fold dilutions of the antimicrobials were prepared in fresh pre-
warmed ASM in a 96-well microtiter plate (Nunc). Routine overnight cultures of the microbial 
strains were washed three times in sterile PBS and normalised cultures were inoculated into 
the wells to OD600 nm 0.05 (final well volume 150 µL). Plates were sealed with a gas permeable 
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Breathe-Easy membrane and incubated for 16 hrs at 37°C with 100 rpm shaking. The MIC 
was taken as the lowest antimicrobial concentration able to inhibit visible microbial growth. 
 
2.11.3 Antimicrobial perturbation of steady-state cultures 
Mono-species or triple-species cultures of P. aeruginosa PAO1, S. aureus 25923 and C. 
albicans SC5314 were grown to a steady-state for 24 hrs under continuous-flow conditions 
(as described in Section 2.3.1). Pre-established microbial cultures were then treated with the 
appropriate antimicrobial compound at a final concentration of 1 x, 2 x or 5 x MIC determined 
in Section 2.11.2 (Table 5.1). Cultures were incubated for 1 h under batch culture conditions, 
Q = 0 µL min-1. An appropriate flowrate, Q = 170 µL min-1 for PA and SA mono-species cultures 
and Q = 145 µL min-1 for CA mono-species and triple-species cultures, was then applied to 
the culture vessel and the model incubated as standard for 48 hrs. Samples were aseptically 
removed from the culture vessel for OD600 nm measurements and CFU enumeration as 
described in Section 2.3.1 and Section 2.5, respectively. 
 
2.11.4 Antimicrobial susceptibility of isolates from perturbed steady-state communities 
Four PA single colonies were randomly selected after 1, 8, 24 and 48 hrs incubation with 
different concentrations of colistin from PIA pates during CFU enumeration and four SA or CA 
isolates were randomly selected during CFU enumeration onto MSA or BiGGY-A plates after 
3, 8, 24 and 48 hrs incubation with different concentrations of fusidic acid or fluconazole (as 
in Section 2.11.4). Isolates (48 of each species from mono-species cultures and 48 of each 
species from polymicrobial co-cultures) were routinely cultured in LB overnight and stored at 
-80°C. Strains were tested against increasing concentrations of colistin, fluconazole or fusidic 
acid in ASM in the 96-well microtiter plate format (as described in Section 2.11.2) and the MIC 
of each isolate was compared to that of the parental strain. Inhibition of growth was determined 
by eye and MICs were confirmed over three independent experiments using fresh ASM and 
antimicrobial stocks. 
 
2.11.5 Whole genome sequencing  
Eight PA isolates able to grow in the presence of 1 mg mL-1 colistin were selected for whole 
genome sequencing (WGS) alongside the parental PAO1 strain. Two resistant isolates were 
selected from: the mono-species culture after 1 h exposure to 8 µg mL-1 colistin (isolates A 
and B); the mono-species culture after 8 hrs exposure to colistin (isolates E and F); the 
polymicrobial co-culture after 1 h exposure to colistin (isolates C and D) and the polymicrobial 
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co-culture after 8 hrs exposure to colistin (isolates G and H). WGS of the isolates was 
performed by MicrobesNG (Birmingham, UK) using the Nextera XT library prep protocol v.05 
(Illumina) on an Illumina MiSeq platform using 2 x 250 bp paired-end reads. The reads were 
adapter-trimmed using Trimmomatic v0.30 with a sliding window quality cut-off of Q15. 
Taxonomic classification of sequences and assessment of sequence contamination was 
performed using Kraken (Wood and Salzberg, 2014). The de novo assembly of contigs was 
performed using SPAdes v3.14.0 using the default parameter settings and the automated 
annotation of the resulting contigs was performed using Prokka v1.12. Variants were called 
using Snippy v2.5/Freebayes v0.9.21-7 (https://github.com/tseemann/snippy) with a minimum 
base quality of 20, read coverage of 10x and a 90% read concordance at a locus for a variant 
to be reported. Variants in the different isolates were compared against the progenitor strain 
(PAO1) to determine mutations arising during treatment with 8 µg mL-1 colistin. Called variants 
were visually inspected by mapping the reads on the reference genome (accession number 
NC_002516) using the software Artemis (http://sanger-pathogens.github.io/Artemis/Artemis/). 
 
2.12 Biofilm assays 
The formation of single-species and polymicrobial biofilms within ASM over time under batch 
(Section 2.12.1) and continuous-flow (Sections 2.12.2 and 2.12.3) conditions was assayed 
using a range of methods. Crystal violet (CV) staining was used to quantify total biofilm 
biomass and the total metabolic activity and viability of biofilms was assayed using XTT (2,3-
Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) staining. Actively 
respiring cells convert water-soluble XTT into an orange product via a formazan reaction which 
can be measured colorimetrically (Roslev and King, 1993). CFU mL-1 enumeration was also 
used to determine the ecological composition of both the biofilms and supernatant.  
 
2.12.1 Batch culture biofilms 
Biofilm growth under batch conditions was measured using a microtiter plate format. Overnight 
cultures were washed in PBS and resuspended to OD600 nm 0.05 in fresh, pre-warmed ASM. 
Normalised cell suspensions were then transferred to the wells of a round bottomed 96-well 
microtiter plate (Nunc) to give a final volume of 150 µL per well. Equal volumes of normalised 
cell cultures of the individual species were inoculated during dual-species (75 µL each 
species) and triple-species co-culture (50 µL each species) experiments. Plates were sealed 
with a gas permeable Breathe-Easy membrane and incubated without the plate lid in a sealed 
box lined with damp tissue at 37°C with 100 rpm shaking. An average of four technical 
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replicates were recorded for each biological replicate and media only controls were included 
on every plate.    
For CFU mL-1 enumeration, 100 µL of the culture supernatant was removed and plated out as 
described in Section 2.5. Residual supernatant was carefully removed and loosely attached, 
planktonic bacteria removed by gently washing the wells three times with 200 µL sterile 
ddH2O, taking care not to dislodge the attached biofilm. PBS (100 µL) was then added to the 
wells and biofilm disrupted by scraping with a pipette tip, vigorous pipetting and vortexing. The 
homogenised biofilm fraction was then plated onto selective plates as normal.  
For both the CV and XTT assays, the culture supernatant was carefully aspirated and the 
attached biofilm carefully washed three times in 200 µL ddH2O. For CV staining, 0.1% CV 
solution (120 µL) was added to each well and plates incubated for 15 min at room temperature. 
The dye was aspirated, the stained biofilm washed three times in ddH2O and plates dried. 
Acetic acid (30%, 120 µL) was added to each well and the plate vortexed to solubilise the dye. 
Abs590 nm was then measured in a FLUOstar Omega plate reader. For XTT staining, 120 µL of 
XTT-menadione solution was added to washed biofilm and plates incubated in the dark at 
37°C for 2 hrs with 100 rpm shaking. Aliquots of the resulting yellow-orange solution (100 µL) 
were then transferred to the wells of a clean microtiter plate and Abs450 nm measured in a 
FLUOstar plate reader. Readings for both assays were normalised by subtracting background 
absorbance measured in the culture-only wells.  
 
2.12.2 Microtiter plate continuous-flow setup  
A schematic diagram of the Kadouri drip-fed model (Merritt et al., 2005) used to study biofilm 
formation under continuous-flow conditions within a microtiter plate format is shown in Figure 
2.8. The model consists of a flat bottomed 6-well culture dish (Nunc) fitted with a modified lid, 
constructed as part of this study. Holes (1.06 mm diameter) were bored into the lid at opposite 
ends of each well. Acetal resin standard tubing connectors (2.5 mm, Ismatec) were then fixed 
over the holes to act as spacers and securely hold the needle tips. A 2.54 cm 19-guage needle 
was inserted though the inlet hole and a 3.81 cm 19-guage needle through the outlet. Before 
use, the plate lid was UV irradiated overnight (needle side up) in a laminar flow hood. 
Overnight cultures were washed in PBS and normalised to OD600 nm 0.05 in fresh, pre-warmed 
ASM. Each well was inoculated with 3 mL normalised culture, with equal volumes of each 
species inoculated during the co-culture experiments. Plates were incubated at 37°C with 100 
rpm shaking and Q = 55 µL min-1 (following the protocol of (Crusz et al., 2012)) was applied 















Figure 2.8 Schematic diagram of the microtiter continuous-flow biofilm model. 
Bacterial cultures (3 mL) were cultured within the wells of a 6-well culture dish (centre). Two 
holes above each well were bored into the lid of the plate and standard sized pipe connectors 
for 2.5 mm diameter tubing were attached as spacers. A 2.54 cm 19-guage needle was 
inserted into the inlet hole (right) and a 3.81 cm 19-guage needle was inserted into the outlet 
hole (submerged within the media, left). A multichannel peristaltic pump delivers fresh media 
(ASM) into each well and removes waste culture at a flow rate of 60 µL min-1. Arrows show 
the direction of flow. The entire system was incubated at 37°C and the plate contents kept 





For CFU mL-1 enumeration, 100 µL of the supernatant fraction was removed and plated out 
as described above. The remaining supernatant was discarded and the biofilm gently washed 
three times in 3 mL sterile ddH2O. PBS (1 mL) was then added to each well and the biofilm 
disrupted using a sterile cell scraper (Greiner). Plates were vortexed to homogenise samples 
and the resulting biofilm fraction plated out as previously described.  
For CV staining, 0.1% CV solution (3 mL) was added to each well and plates incubated for 15 
min at room temp. The dye was then aspirated and the stained biofilm washed three times in 
ddH2O and plates left to dry. Once dried, 30% acetic acid (3 mL) was added to each well and 
the plate vortexed. For XTT staining, 3 mL of XTT-menadione solution was added to the pre-
washed biofilm and plates incubated as described in Section 2.11.1. Aliquots (150 µL) were 
transferred to the wells of a clean 96-well microtiter plate and absorbance at the appropriate 
wavelength measured as described in Section 2.11.1.  
 
2.12.3 Culture-vessel biofilm growth 
Biofilm formation within the continuous-flow culture vessel was measured on two types of solid 
substratum, agar chunks and ex vivo porcine lung tissue (EVPL) sections. To keep the 
substratum suspended in the culture media and prevent contact with the magnetic stir bar, 
bespoke cylindrical biofilm containers (25 mm diameter x 35 mm length) were constructed by 
hand for this study from stainless steel wire gauze (Fisher Scientific) (Figure 2.9.A and 2.9.B). 
Containers were then suspended in the culture vessel via hanging from a piece of silicon 
tubing threaded through two of the unused HPLC ports (Figure 2.9.C). 
Agar plates (2.5% w/v bacto agar in ddH2O) were poured to a depth of 5 mm. Using sterile 
scalpel and forceps, cubes of approximately 5 mm x 5 mm were cut from the plate and 
transferred into the sterile biofilm container. Biofilm work using EVPL sections was performed 
in collaboration with Freya Harrison at the University of Warwick, using previously described 
methods (Harrison and Diggle, 2016). Briefly, fresh pig lungs were collected from the butchers 
(John Taylors, Coventry, UK) and processed within the hour. To remove surface 
contaminants, a heated palette knife was briefly tapped (< 1 s) on the area to be dissected. A 
sterile razor blade was used to excise the bronchiole and remove all alveolar tissue, a cleaned 
bronchiole can be seen in Figure 2.10. Bronchioles were washed in DMEM/RPMI solution (40 
mL) and cut into 5 mm wide strips with sterile dissection scissors. The strips were washed in 
DMEM/RPMI and cut into 5 mm x 5 mm squares. EVPL sections were washed again in 
DMEM/RPMI, then transferred to a petri dish containing 40 mL ASM and irradiated in UV 
lightbox for 5 min before being aseptically transferred to the biofilm container. The culture 
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vessel was filled with ASM (100 mL) and the system warmed to 37°C before being inoculated 
and incubated as described in Section 2.3.1.  
At the point of sampling, pieces of substratum were aseptically transferred to 500 µL PBS 
within 24-well microtiter plates. Loosely attached planktonic cells were removed from the 
substratum by swirling the plates. Samples were homogenised in 2 mL bead beating tubes, 
containing 1 mL PBS and 18 x 2.38 mm metal beads (Qiagen), using a FastPrep-24 5G 
benchtop homogeniser (MP Biomedicals) for 40 secs at 4 m s-1. CFU mL-1 counts were 
performed as described in Section 2.3.1, three separate substratum pieces were sampled per 
timepoint.  
 
2.13 Culturing patient derived sputum samples 
2.13.1 Sample collection 
Spontaneously expectorated sputum samples from healthy CF outpatients were collected by 
clinical staff as part of routine monthly appointments at the Adult Cystic Fibrosis Centre 
(Cambridge Centre for Lung Infection, Royal Papworth Trust Hospital [with the ethical approval 
of the Hospital Research Tissue Bank T02449 (October 1st 2018)]). Samples were 
preferentially collected from patients believed to harbour a diverse airway-associated 
microbiota (as determined by clinical staff during previous appointments) and all samples were 
fully anonymised, with no patient data being collected. Samples were transported on ice and 
immediately processed upon arrival at the lab. Saliva and oral contaminants were removed by 
gently washing sputum in approximately five-times volume of 0.85% saline. An equal volume 
of sputasol was added to the sputum and the solution incubated at 37°C with gentle agitation 
until homogenous (approximately 30 min) (Mcclean et al., 2010). Samples were stored as 1 
mL aliquots with 10% glycerol at -80°C until use. 
 
2.13.2 Model inoculation and incubation 
The continuous-flow culture vessel was set up with 2.5% w/v agar chunks for solid substratum 
within the biofilm container, as described in Section 2.12.3. Sputum aliquots were thawed on 
ice and cell material sedimented via centrifugation (13,000 x g, 5 min, 4°C). Cell pellets were 
gently resuspended in 600 µL PBS. A 100 µL aliquot of the sample was removed and stored 
at -80°C to act as a t = 0 timepoint. The remaining culture was inoculated into the culture 

























Figure 2.9 Container for culturing biofilms within the continuous-flow model. 
Representative photographs of the biofilm container constructed from stainless steel gauze 
by hand for this study. Biofilm containers consisted of a cylinder, 35 mm in length and 25 mm 
in diameter (Ø), connected to 2 stainless steel arms (45 mm in length) that suspend the 
container from the HPLC screw-port lid. (A) Side view of the container with dimensions. (B) 
Bottom view of the container. Single strands of stainless-steel wire were threaded across the 
bottom of the container to form a mesh and prevent solid substratum from falling through. A 
small gap was also included for the outlet tube to be threaded through to allow the removal of 
culture media during incubation. (C) View of the 4-port HPLC screw cap lid. The bottom left 
port is the media inlet, the top right port is the media outlet and the two remaining ports are 
threaded with a single piece of rubber tubing (1.5 mm bore), which the arms from the container 
are fitted onto prior to autoclaving. (D) Biofilm container in use within a 100 mL Durant flask. 
Note that the container is completely submerged within the growth medium but is separated 





















Figure 2.10 Ex vivo porcine bronchiole. 
A single bronchiole excised from porcine lungs after cleaning and a single wash in 
DMEM/RPMI solution. All alveolar and vascular tissue was removed using a razor blade and 
dissection scissors. After cleaning bronchiole tissue was cut into 5 mm x 5 mm squares for 





2.13.3 Sample collection and gDNA extraction 
Supernatant samples were collected by aseptically removing 2 mL of culture from the vessel. 
Aliquots (1.5 mL) were centrifuged (13,000 x g, 5 min, room temp) and the pellet stored at -
80°C for genomic DNA (gDNA) extraction. The remaining culture supernatant was used for 
CFU mL-1 enumeration and OD600 nm measurements. Three pieces of biofilm substratum were 
removed from the container per timepoint and transferred to 500 µL PBS in 24-well microtiter 
plates. Planktonic cells were removed by gently swirling the plates and the substratum pieces 
pooled in sterile 2 mL tubes, stored at -80°C. 
Samples were thawed at room temperature and total gDNA was extracted using FastDNA 
SPIN kit for soil (MP Biomedicals). To ensure complete lysis and improve gDNA extraction 
from Gram-positive and Gram-negative species within the samples 100 µg mL-1 recombinant 
lysostaphin (produced in-house for this work, see Appendix 2.2), 100 µg mL-1 mutanolysin 
(Sigma) and 20 mg mL-1 lysozyme (Sigma) were combined with the sodium phosphate buffer 
(at step 2 of the manufacturer’s instructions) and samples incubated at 37°C with 180 rpm 
shaking for 30 min, as described by (Gill et al., 2016, Wada, 2001). Manufacturer’s instructions 
were followed from step 2 onwards. The concentration and quality of DNA was assessed using 
a Nanodrop ND-1000 Spectrophotometer, and samples were stored at -20°C. 
 
2.13.4 Sample library preparation and sequencing 
Libraries for sequencing were prepared following the protocol described by Duarte et al 
(Duarte et al., 2017). Briefly, the full length bacterial 16S rRNA 30S ribosomal subunit 
encoding gene was PCR amplified using primers, 27F and U1492R (Table 2.6), and the 
reaction conditions described in Table 2.7. Amplification products were resolved on a 1.4% 
(w/v) agarose gel to check for the presence of a single clear band corresponding to the 
approximate size of the target gene (1522 base pairs). Figure 2.11.A shows a representative 
image of a successful amplification of the entire 16S rRNA gene. PCR products were cleaned 
up with GeneJet PCR Purification kit (ThermoFisher) and the V3 to V4 hypervariable region 
was then amplified from full length 16S rRNA gene using Illumina-compatible primers, MiSeq 
16S rRNA-F and MiSeq 16S rRNA-R (Table 2.6), and the reaction conditions described in 
Table 2.8, as detailed by Illumina (Illumina, 2013). Samples with Illumina-adaptor overhangs 
were resolved on a 1.4% agarose gel and bands of approximately 460 base pairs were excised 
and DNA purified using GeneJet Gel Extraction kit (ThermoFisher). Figure 2.11.B 
demonstrates a representative image of the resulting PCR products separated via 












Primer 5’ - 3’ Sequence Reference 
27F AGAGTTTGATCMTGGCTCAG 
(Weisburg et al., 
1991) 
U1492R GGTTACCTTGTTACGACTT 























Component Volume/amount Final Concentration 
10 x Reaction buffer 5 µL 1 x 
dNTP mx (100 mM) 1 µL 2 mM 
Forward primer (27F) 1 µL 2 µM 
Reverse primer (U1492R) 1 µL 2 µM 
Genomic DNA 50 – 100 ng 1 – 2 ng µl-1 
Q5 High-Fidelity 
Polymerase 
0.25 µL 1.25 U µL-1 
Nuclease-free H2O Up to 50 µL  
Thermocycler Conditions 
Temperature (°C) Time No. Cycles 
94 4 min 1 
94 1 min 
30 48 30 secs 
72 1 min 30 secs 
72 7 min 1 
4 ∞ - 
 
Table 2.7 PCR amplification of full 16S rRNA gene. 
Reaction mixture (50 µL total volume) and cycle conditions for PCR amplification of bacterial 










Figure 2.11 Preparation of sample libraries for sequencing. 
Sample libraries for sequencing were prepared in two separate PCR amplification steps. For 
images (A) and (B), Lane I: Hyperladder 1kb DNA marker (Bioline). Lanes II-X: representative 
sample libraries prepared as part of the current work. (A) Amplification of full length 16S rRNA 
encoding gene from total extracted genomic DNA. A clear band of approximately 1522 bp, 
corresponding to the size of the full 16S rRNA gene, can be seen in all sample lanes. (B) 
Amplification of V3 – V4 hypervariable region with Illumina compatible primers from full length 
16S rRNA amplicon generated in (A). A bright band of approximately 480 bp, corresponding 
to the size of the sequence libraries, alongside a band of approximately 600 bp and a smear 
at 1000 bp in size can be seen in most sample lanes. Bands of the correct size (~480 bp) were 









Component Volume/ amount Final Concentration 
10 x Reaction buffer 5 µL  
dNTP mx (100 mM) 1 µL 2 mM 
Forward primer (27F) 1 µL 2 µM 
Reverse primer (U1492R) 1 µL 2 µM 
Template DNA 25 ng 1 ng µl-1 
Q5 High-Fidelity 
Polymerase 
0.1 µL 1 U µL-1 
Nuclease-free H2O Up to 25 µL  
Thermocycler Conditions 
Temperature (°C) Time No. Cycles 
95 4 min 1 
95 30 secs 
25 55 30 secs 
72 30 secs 
72 5 min 1 
4 ∞ - 
 
Table 2.8 PCR amplification of full hypervariable V3/V4 region. 
Reaction mixture (25 µL total volume) and cycle conditions for PCR amplification of the V3 – 
V4 hypervariable region of the 16S rRNA gene with Illumina-compatible primers. Full 16S 




(Department of Biochemistry, University of Cambridge) for high-throughput paired-end 
sequencing using an Illumina MiSeq instrument and 600-cycles with reagent kit v3 (Illumina). 
  
2.13.5 Data analysis 
Sequence reads were de-noised and analysed by following the Qiime2-Deblur pipeline (Amir 
et al., 2017, Bolyen et al., 2019) using the opensource bioinformatics software QIIME 2 
2020.6.0 within a VirtualBox 64-bit Ubuntu operating system (Oracle VM VirtualBox). 
Commands used to filter and cluster sequences into operational taxonomic units (OTUs) and 
perform subsequent phylogenetic metric tests are described in detail in Appendix 2.3. 
 
2.13.6 ASM supplementation 
The composition of modified ASM used in the culture of patient derived sputum samples are 
described in Table 2.9. The standard protocol for making ASM was followed (Appendix 2.1), 
with media supplemented with the appropriate components before filter sterilisation. Culture 
vessels were inoculated and incubated as described in Section 2.13.2, with Q = 55 µL min-1. 
 
2.14 Statistical analysis  
Unless otherwise stated, all data represent the mean ± SD of three independent biological 
experiments. Results were analysed by one-way or two-way ANOVA, or Student’s unpaired t-






Name Supplement composition [notes] 
ASM + 40 µM FeSO4 40 µM FeSO4 
[11.111 mL of FeSO4.7H2O stock (Appendix 2.1) within 1 
L of ASM, Replaces 3.6 µM FeSO4 in standard ASM] 
ASM + 5 mM Met/Cys 5 mM Methionine 
5 mM Cysteine 
[50 mL of Met and Cys amino acid stocks (Appendix 2.1) 
in 1 L ASM, replaces 633 µM methionine and 160 µM 
cysteine in standard ASM] 
ASM + micronutrients 30 nM Ammonium molybdate tetrahydrate 
4 µM Boric acid 
300 nM Cobalt chloride 
100 nM Cupric sulfate 
800 nM Manganese chloride 
100 nM Zinc sulfate 
[1 mL of 100x micronutrient stock (LaBauve and Wargo, 
2012) diluted in 1 L standard ASM]  
ASM + 1 mM KNO3 1 mM KNO3 
[1mL of KNO3 stock (Appendix 2.1) in 1 L ASM, replaces 
348 µM KNO3 in standard ASM] 
ASM + desferrioxamine 50 mg L
-1 Desferrioxamine mesylate salt (Sigma) 
[Powder dissolved directly in ASM] 
ASM + NAM 1 mg L
-1 N-Acetylmuramic acid (NAM or MurNAc) 
(Sigma) 
[Powder dissolved directly in ASM] 
ASM + Sodium pyrophosphate 100 µM Disodium dihydrogen pyrophosphate (Sigma) 
[Powder dissolved directly in ASM] 
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ASM + vitamins 5 µg ml
-1 Ascorbic acid [vitamin C] (Sigma) 
5 µg ml-1 Biotin [vitamin B7] (Sigma) 
5 µg ml-1 Cyanocobalamin [vitamin B12] (Sigma) 
5 µg ml-1 Folic acid [vitamin B9] (Sigma) 
5 µg ml-1 α-lipoic acid (Sigma) 
5 µg ml-1 Nicotinamide [vitamin B3] (Sigma) 
5 µg ml-1 Pantothenic acid [vitamin B5] (Sigma) 
5 µg ml-1 Pyridoxamine [vitamin B6] (Sigma) 
5 µg ml-1 Riboflavin [vitamin B2] (Sigma) 
5 µg ml-1 Thiamine [vitamin B1] (Sigma) 
[Stock solutions made in ddH2O kept in the dark at 4°C 
for up to 1 week before use] 
ASM + FBS (1%) 1% Heat inactivated foetal bovine calf serum (FBS, 
Sigma)  
[Lot number: BCBZ5076] 
ASM + FBS (5%) 5% Heat inactivated FBS 
[Lot number: BCBZ5076] 
ASM + FBS (10%) 10% Heat inactivated FBS  
[Lot number: BCBZ5076] 
ASM + BSA 2.5% Bovine serum albumin (BSA, FisherScientific) 
[25 g powder directly dissolved in 1 L standard ASM] 
ASM + Charcoal stripped FBS 5% Charcoal stripped Heat inactivated FBS 
(FisherScientific)  
ASM + ≥ 30 kDa FBS 50 mL heat inactivated FBS was centrifuged (4000 x g, 1 
hr, 4°C) in a 30 kDa MWCO Vivaspin column (GE 
Healthcare) and retentate added to 1 L standard ASM 
[FBS lot number: BCBZ5076] 
ASM + 5 – 30 kDa FBS Permeate from 50 mL of ≥ 30 kDa FBS fraction (above) 
was centrifuged (4000 x g, 1 hr, 4°C) in a 30 kDa MWCO 
Vivaspin column (GE Healthcare) and retentate added to 
1 L standard ASM 
[FBS lot number: BCBZ5076] 
ASM + ≤ 5 kDa FBS Permeate from 50 mL of 5 – 30 kDa FBS fraction 
(above) added to 1 L standard ASM 
[FBS lot number: BCBZ5076] 
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ASM + hemin 100 mg L
-1 Hemin from bovine (Sigma)  
[Lyophilised powder added directly to ASM] 
ASM + hemoglobin 100 mg L
-1 Hemoglobin from bovine blood (Sigma) 
[Lyophilised powder added directly to ASM] 
ASM + micronutrients and 40 
µM FeSO4 
ASM + micronutrients prepared as described above, 
supplemented with 40 µM FeSO4  
ASM + micronutrients, 40 µM 
FeSO4 and FBS 
ASM + micronutrients and 40 µM FeSO4 prepared as 
described above, supplemented with 5% FBS 
[FBS lot number: BCBZ5076] 
 
Table 2.9 Composition of supplemented ASM. 
Standard ASM was prepared according to Appendix 2.1, with medium supplemented with the 





3. In vitro maintenance of polymicrobial co-cultures 
3.1 Introductory comments 
The work presented in this chapter describes the maintenance of stable co-cultures of 
commonly used laboratory reference strains in the continuous-flow culture model. These 
strains were chosen to represent the three major classes of microbial species associated with 
CF airway infections: P. aeruginosa (PA, Gram-negative bacteria), S. aureus (SA, Gram-
positive bacteria) and C. albicans (CA, dimorphic fungi/yeast). I first confirmed that all three 
species could grow in ASM. Each species was inoculated into a flat-bottomed 96-well 
microtiter plate (Nunc) containing ASM. Plates were incubated at 37°C with 180 rpm shaking 
within a FLUOStar Omega plate reader and culture density (OD600 nm) measured ever 15 min. 
All species grew rapidly in ASM, achieving a final OD600 nm of >1.0 after 24 hrs (Appendix 3.1). 
Media flowrate (Q) within the model was paramount to achieving successful co-cultures. If Q 
is too high, a washout of species within the culture vessel occurs. If Q is too low, the microbial 
density within the vessel becomes saturated and species begin to out-compete one another. 
To the best of my knowledge, this study is the first to attempt the co-culture of polymicrobial 
communities using a continuous-flow model. As such, a lot of time was spent optimising 
parameters such as the diameter of tubing, culture vessel size and values for Q. For the sake 
of brevity, only results using optimised conditions are reported. Speed of the peristaltic pump 
and Q were calibrated experimentally using the methods described in Section 2.4 and Figure 
2.4 demonstrates a representative image of this. This work has been published in Frontiers in 
Microbiology (O'Brien and Welch, 2019a).  
 
3.2 Mono-species growth of PA 
Mono-species growth of PA under continuous-flow and batch culture conditions was followed 
by measuring OD600 nm (Figure 3.1). The laboratory reference strain PAO1 was inoculated into 
the culture vessel (Q = 170 µL min-1) and OD600 nm measured every 30 min using an in-line 
spectrophotometer (as described in Section 2.3.1). OD600 nm of the culture increased linearly 
for the first 8 hrs of incubation, before reaching a plateau of OD600 nm ≈ 0.4 after 10 hrs of 
incubation. Turbidity of the culture remained consistent for the remainder of incubation, with 
no statistically significant changes in OD600 nm occurring after T = 10 hrs.  
When PA was grown under stirred batch culture conditions (Q = 0 µL min-1, Section 2.3.2) 
OD600 nm exceeded 0.4 after 8 hrs of incubation and a final OD600 nm of > 1.0 was reached. After 

























Figure 3.1 PA mono-species growth. 
Growth of P. aeruginosa PAO1 in ASM in both batch and continuous-flow culture conditions. 
Growth is monitored by optical density (OD600 nm) during (A) continuous-flow culture (Q = 170 
µL min–1); (B) batch culture (Q = 0 µL min–1). Data represent the mean ± standard deviation 
from three independent experiments. 
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suggesting the culture had entered the stationary phase of growth. Using the continuous-flow 
model, a mono-species PA culture can be maintained at a steady-state carrying capacity with 
OD600 nm measurements kept well-below what is associated with entry into the stationary phase 
of growth in ASM. 
 
3.3 Mixed-species co-culture (PA-SA) 
3.3.1 Comments 
SA is another species commonly associated with CF airway infections and can be isolated 
from over 50% of early adult CF patients (Jarry and Cheung, 2006). As mentioned in Section 
1.2, PA often displaces SA over time to become the dominant pathogen of the CF airways. 
Some reports even suggest pre-colonisation of the airways with SA is a risk factor contributing 
towards the establishment of chronic PA infections (Cigana et al., 2018, Hoffman et al., 2006, 
Junge et al., 2016, Maselli et al., 2003). Despite the fact PA and SA can be co-isolated from 
the lungs of ~31% of CF patients (Hogan et al., 2016, Limoli et al., 2016, Wakeman et al., 
2016, Zolin et al., 2019), previous attempts at co-culturing these species in in vitro and in vivo 
models have failed (Hotterbeekx et al., 2017). As discussed in Section 1.4.4, PA produces a 
wealth of extracellular virulence factors (van Delden, 2004), some of which are directly harmful 
to SA (e.g. pyocyanin, 4-hydroxy-2-alkylquinolone, 4-hydroxy-2-heptaquinolone-N-oxide, 
rhamnolipids, elastase and proteases) and prevent the long-term co-culture of these species 
being maintained within experimental models (Cardozo et al., 2013, DeLeon et al., 2014, 
Fugère et al., 2014, Hoffman et al., 2006, Hotterbeekx et al., 2017, Korgaonkar and Whiteley, 
2011, Korgaonkar et al., 2013, Mashburn et al., 2005, Mitchell et al., 2010, Palmer et al., 
2005). These interspecies interactions are not all one-sided, as mentioned in Section 1.5.1, 
SpA produced by SA is known to modulate the ability of PA to form biofilms (Armbruster et al., 
2016). As no models yet exist which permit the successful long-term co-cultivation of PA and 
SA within the laboratory, research into how interspecies interaction may modulate gene 
expression and the evolutionary trajectory of these microorganisms in the CF 
microenvironment is severely hindered.  
 
3.3.2 Batch culture 
In accordance with existing reports, when PA and S. aureus 25923 are co-cultured in ASM 
under batch culture conditions, PA rapidly outcompetes SA in the culture vessel (Figure 3.2). 
During aerobic batch culture, no viable SA cells can be recovered from the flask after 96 hrs 








Figure 3.2 PA-SA co-culture grown in batch culture conditions. 
Viable cell counts [colony forming units (CFUs) per mL] of P. aeruginosa PAO1 (PA, black 
bars) and S. aureus 25923 (SA, white bars) during co-culture in ASM in (A) aerobic batch 
culture and (B) stirred batch culture conditions. Data represented as mean ± standard 
deviation from three independent experiments. Asterisks represent significant (*P < 0.05) 
differences in CFU mL-1 counts in comparison with the data from the 24 hrs time point. 
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SA, albeit at a slower rate. Viable SA cells can still be recovered from the culture vessel after 
96 hrs of incubation, but a significant 3 log-fold decrease in CFU mL-1 counts is observed 
between T = 24 and T = 96 hrs (Figure 3.2.B).  
 
3.3.3 Continuous-flow culture 
Culturing PA and SA under continuous-flow conditions (Q = 170 µL min-1) enabled both 
species to be readily maintained together as a co-culture (Figure 3.3). After 24 hrs of 
incubation bacterial populations established a stable, steady-state composition of 
approximately 107 SA CFU mL-1 and 108 PA CFU mL-1 in the culture vessel. There was no 
significant difference in viable cell counts for either species after T = 24 hrs (P > 0.05). 
 
3.3.4 OD600 nm Measurements 
No significant difference (P > 0.05) in OD600 nm measurements can be observed between the 
batch or continuous-flow culture vessels for the first 8 hrs of incubation (Figure 3.4). After 24 
hrs of incubation OD600 nm of the continuous-flow vessel is significantly lower than both the 
stirred batch (P < 0.005) and aerobic batch (P < 0.0001) co-cultures. A gradual but non-
significant (P > 0.9) increase in OD600 nm of the continuous-flow co-culture occurs between 24 
hrs (OD600 nm ≈1.4) and 96 hrs (OD600 nm ≈1.6) of incubation. The optical density of the 
continuous-flow culture never reached peak OD600 nm values observed in either batch culture 
populations.  Turbidity of the aerobic co-culture begins to decrease after T = 24 hrs and the 
same trend is observed for the stirred batch culture vessel after T = 72 h. This suggests that 
both batch culture populations enter the stationary phase of growth, whereas populations 
cultured under continuous-flow conditions do not. Automated optical density measurements 
of the continuous-flow co-culture taken every 30 min using the in-line spectrophotometer are 
included in Appendix 3.2. 
 
3.4 Mixed species co-culture (PA-CA) 
3.4.1 Comments 
Fungal species are also commonly associated with CF airway infections and more than 50% 
of CF patients test positive for colonisation with species of Candida or Aspergillus 
(Garczewska et al., 2016, Valenza et al., 2008). It is therefore essential that my model can 
support co-cultures of bacteria and fungi. The role of C. albicans (CA) as part of the 
polymicrobial communities associated with the CF airways is poorly characterised, but 





















Figure 3.3 PA-SA co-culture grown under continuous-flow conditions. 
Viable cell counts (CFU mL-1) of P. aeruginosa PAO1 (PA, black bars) and S. aureus 25923 
(SA, white bars) during co-culture in ASM in the continuous-flow model. Flowrate (Q) = 170 


















Figure 3.4 Growth of PA-SA co-cultures in batch and continuous-flow conditions. 
Growth (monitored as OD600 nm) of P. aeruginosa PAO1 and S. aureus 25923 dual species co-
cultures in ASM in aerobic batch (triangles), stirred batch (squares) and continuous-flow 
(circles) growth conditions. Q = 170 µL min-1 in the continuous-flow culture vessel.  Data 







species PA-CA biofilms display an up-regulation in the secretion of virulence factors, such as 
phenazines, rhamnolipids and pyoverdine, when compared with single-species PA biofilms 
(Cugini et al., 2007, Gibson et al., 2009, Hogan and Kolter, 2002, Hogan et al., 2004). 
Enhanced phenazine production can cause CA to switch from aerobic respiration to 
fermentation (Morales et al., 2013), thereby up-regulating the production of ethanol which 
causes PA to adopt a mucoid phenotype (DeVault et al., 1990, Morales et al., 2013). 
Furthermore, direct signalling events have been described between the two species. The PA 
QS molecule OdDHL promotes CA to grow as a yeast (Holcombe et al., 2010, McAlester et 
al., 2008), whereas farnesol produced by CA inhibits the production of PQS by P. aeruginosa 
(Cugini et al., 2007, Cugini et al., 2010), thereby modulating the expression of virulence factors 
and other genes under the control of this QS regulatory network (Lin et al., 2018). As in Section 
3.3, no study has yet described the successful long-term co-culture of PA with CA, and 
therefore, how interspecies interactions between these common CF-associated organisms 
impacts upon gene expression or the evolutionary trajectory of these species.  
 
3.4.2 Batch culture 
When PA and C. albicans SC5314 are co-cultured in ASM under batch culture conditions, PA 
outcompetes CA in the culture vessel (Figure 3.5). During the aerobic batch co-culture, PA 
rapidly removes CA from the culture flask and no viable CA cells can be recovered after T = 
72 h. A significant log-fold decrease (P < 0.005) in PA CFU mL-1 counts also occurs between 
T= 24 hrs and T = 96 hrs (Figure 3.5.A). Under stirred batch conditions PA also outcompetes 
CA, albeit at a slower rate than the aerobic batch co-culture (Figure 3.5.B). Viable CA cells 
can still be recovered from the culture vessel at the final sampling point, but a significant 2 log-
fold decrease in CA CFU mL-1 counts occurs between 24 and 96 hrs of incubation.  
 
3.4.3 Continuous-flow culture 
A successful long-term PA-CA co-culture could be readily maintained under continuous-flow 
conditions (Figure 3.6). To prevent washout of CA from the culture vessel over time the 
flowrate of the model was decreased to Q = 145 µL min-1. The culture carrying capacity for CA 
(≈105 CFU mL-1) is approximately 3 log-fold lower than that of PA (≈108 CFU mL-1) in the 
vessel. This notwithstanding, both species reached steady-state population densities after T 
= 24 hrs and no significant difference in PA or CA viable cell counts occurred after this point 











Figure 3.5 PA-CA co-culture during growth in batch culture conditions. 
Viable cell counts (CFU mL-1) of P. aeruginosa PAO1 (PA, black bars) and C. albicans SC5314 
(CA, grey bars) during co-culture in ASM in (A) aerobic batch culture and (B) stirred batch 
culture conditions. Data represented as mean ± standard deviation from three independent 
experiments. Asterisks represent significant (**P < 0.005, ****P < 0.0001) differences in CFU 












Figure 3.6 PA-SA co-culture during growth under continuous-flow conditions. 
Viable cell counts (CFU mL-1) of P. aeruginosa PAO1 (PA, black bars) and C. albicans SC5314 
(CA, grey bars) during co-culture in ASM in the continuous-flow model. Flowrate (Q) = 145 µL 






3.4.4 OD600 nm measurements  
OD600 nm of the PA-CA co-culture under aerobic batch culture conditions is significantly higher 
than the stirred batch and continuous-flow co-cultures after 8 hrs of incubation (Figure 3.7). At 
T = 24 hrs the cell density in the continuous-flow model is significantly lower than both the 
aerobic batch (P < 0.001) and stirred batch (P < 0.05) culture vessels. A steady-state carrying 
capacity (OD600 nm ≈ 1.0) is reached after 24 hrs of incubation in the continuous-flow vessel 
and optical density does not appreciably change for the remainder of the incubation period. 
The cell density of the aerobic batch co-culture peaks after 48 hrs of incubation (OD600 nm = 
4.9), followed by a significant 1.5 unit drop in OD600 nm values every 24 hrs following this. The 
optical density of the stirred batch culture vessel increases exponentially after 24 hrs of 
incubation, reaching a final OD600 nm of ≈ 4.0 at T = 96 h, approaching values observed during 
the peak of aerobic batch culture growth.  
 
3.5 Mixed species co-culture (SA-CA) 
3.5.1 Comments 
I next wanted to ensure a stable SA-CA co-culture could be maintained independent of the 
presence of PA in the continuous-flow model. As previously discussed, SA and CA are 
commonly isolated from CF sputum samples (Garczewska et al., 2016, Valenza et al., 2008), 
yet how these species interact within one another in the CF microenvironment is not known. 
CA and Staphylococcus species are commonly co-isolated from systemic bloodstream 
infections (Carolus et al., 2019, Kaufman et al., 2014) and SA aggregates on CA hyphae when 
co-cultured as polymicrobial biofilms (Peters et al., 2010, Tsui et al., 2016). The close physical 
association between these species suggests interspecies interactions may be prevalent 
between these microorganisms and a limited number of direct chemical interactions between 
SA and CA during co-culture have indeed been described. In addition to preventing yeast 
hyphal morphogenesis, thereby reducing SA-CA aggregation (Piispanen et al., 2011, Ramage 
et al., 2002), CA-produced farnesol can reduce the viability of SA cells through inducing an 
accumulation of intracellular reactive oxygen species (Vila et al., 2019). CA is also capable of 
inducing activation of the agr QS network of SA via an unelucidated mechanism, thereby 
directly modulating the expression of virulence factors and other QS-regulated genes during 
polymicrobial co-culture (Todd et al., 2019). Such interactions are, again, not all unidirectional, 
as lactate produced by SA during fermentation can prevent yeast hyphal morphogenesis 














Figure 3.7 Growth of PA-CA co-cultures in batch and continuous-flow conditions. 
Growth (monitored as OD600 nm) of P. aeruginosa PAO1 and C. albicans SC5314 dual species 
co-cultures in ASM in aerobic batch (triangles), stirred batch (squares) and continuous-flow 
(circles) growth conditions. Q = 145 µL min-1 in the continuous-flow culture vessel.  Data 





3.5.2 Batch culture 
When SA and CA are co-cultured under batch conditions CA outcompetes SA present in the 
culture vessel (Figure 3.8), despite the fact CA comprises only 0.1% of the total microbial titres 
present within the aerobic and stirred batch co-cultures at T = 24 h. During co-culture under 
aerobic batch conditions a 3 log-fold decrease in SA cells occurs at each sampling point 
following 24 hrs of incubation and no viable SA cells could be recovered from the flask at T = 
96 hrs (Figure 3.8.A). A significant 2 log-fold decrease (P < 0.01) in CA CFU mL-1 counts also 
occurs between T = 24 and T = 96 hrs. Under stirred batch conditions viable SA cells could 
still be recovered from the culture vessel after 96 hrs of incubation, but a 5 log-fold decrease 
in SA CFU mL-1 counts occurred between 24 and 96 hrs of incubation (Figure 3.8.B).  
 
3.5.3 Continuous-flow culture 
Under continuous-flow culture conditions (Q = 145 µL min-1) a stable SA-CA co-culture could 
be readily maintained (Figure 3.9). As in Section 3.4.4, titres of both species reached a steady 
state by T = 24 hrs and the carrying capacity for CA within the culture is three orders of 
magnitude lower than that of SA within the culture vessel. The ratio of SA:CA remained 
unchanged and no significant difference (P > 0.1) in the titres of either species within the 
vessel occurred after 24 hrs of incubation. 
 
3.5.4 OD600 nm Measurements 
OD600 nm measurements of the SA-CA co-culture in the aerobic shake flask were significantly 
higher than the continuous-flow (P < 0.0001) and stirred batch (P < 0.05) culture vessels after 
8 hrs of incubation (Figure 3.10). At T= 24 h, culture density in the continuous-flow model 
reached a steady-state carrying capacity (OD600 nm ≈ 1.35) significantly lower than both the 
aerobic and stirred batch co-cultures (P < 0.0001). 
No significant changes in OD600 nm measurements were observed in the continuous-flow vessel 
after 24 hrs incubation (P > 0.999). Culture density of the SA-CA culture under aerobic batch 
conditions was significantly higher than the stirred batch culture from T = 8 to 72 hrs (P < 
0.001). After T = 48 hrs the population within the aerobic batch culture appears to enter the 
stationary phase of growth and OD600 nm measurements began to decrease after 72 hrs of 
incubation. Co-culture density within the stirred batch culture vessel steadily increased for the 
entire length of incubation, reaching a final optical density similar to that within the aerobic 
batch vessel at T= 96 hrs (OD600 nm ≈3.5).  








Figure 3.8 SA-CA co-culture grown in batch culture conditions. 
Viable cell counts (CFU mL-1) of S. aureus 25923 (SA, white bars) and C. albicans SC5314 
(CA, grey bars) during co-culture in ASM in (A) aerobic batch culture and (B) stirred batch 
culture conditions. Data represented as mean ± standard deviation from three independent 
experiments. Asterisks represent significant (**P < 0.005, ***P < 0.001) differences in CFU 












Figure 3.9 SA-CA co-culture grown under continuous-flow conditions. 
Viable cell counts (CFU mL-1) of S. aureus 25923 (SA, white bars) and C. albicans SC5314 
(CA, grey bars) during co-culture in ASM in the continuous-flow model. Flowrate (Q) = 145 µL 
















Figure 3.10 Growth of SA-CA co-cultures in batch and continuous-flow conditions. 
Growth (monitored as OD600 nm) of S. aureus 25923 and C. albicans SC5314 dual species co-
cultures in ASM in aerobic batch (triangles), stirred batch (squares) and continuous-flow 
(circles) growth conditions. Q = 145 µL min-1 in the continuous-flow culture vessel.  Data 





3.6 Triple species co-culture 
3.6.1 Comments 
The continuous-flow model can readily maintain dual species co-cultures of PA-SA, PA-CA 
and SA-CA that would ordinarily outcompete one another under batch culture conditions. I 
next wanted to determine if all three species could be maintained as a stable, steady-state 
polymicrobial community within the continuous-flow culture vessel. To the best of my 
knowledge, this is the first study to experimentally co-culture all three of these microorganisms 
associated with CF airway infections.  
 
3.6.2 Batch culture 
During triple species batch culture growth, both SA and CA were outcompeted by PA (Figure 
3.11). Under aerobic batch culture conditions, a significant decline (P < 0.001) in SA CFUs 
recovered at each sampling point following T = 24 hrs was observed and no viable CA cells 
could be recovered from the flask at T = 72 hrs (Figure 3.11.A). No significant difference (P > 
0.1) in PA CFU mL-1 measurements occurred after T = 24 hrs. It should be noted that unlike 
the PA-SA dual species co-culture under aerobic batch conditions (Section 3.3.2), SA cells 
could still be recovered from the culture vessel at T = 96 hrs. When co-cultured under stirred 
batch conditions PA titres remained high (≈109 CFU mL-1) and did not appreciably change (P 
> 0.1) after 24 hrs of incubation (Figure 3.11.B). In contrast, a significant decline (P < 0.01) in 
SA CFUs recovered from the flask occurred at each sampling point after T = 24 hrs. The 
slower removal of SA under stirred batch conditions, compared with aerobic batch conditions, 
was accompanied by a decreased rate in the decline of CA titres in the vessel after 24 hrs of 
incubation also.  
 
3.6.3 Continuous-flow culture 
A stable triple species co-culture of PA, SA and CA could be maintained in the continuous-
flow culture vessel using Q = 145 µL min-1 (Figure 3.12). After 24 hrs of incubation, all species 
reached a steady-state carrying capacity in the culture vessel and no significant difference (P 
> 0.1) in CFU mL-1 counts for any species in the co-culture occurred following this point. Titres 
of PA and SA remained at ≈108 CFU mL-1 and CA titres (≈105 CFU mL-1) were maintained at 









Figure 3.11 Triple species co-culture grown in batch culture conditions. 
Viable cell counts (CFU mL-1) of P. aeruginosa PAO1 (PA, black bars), S. aureus 25923 (SA, 
white bars) and C. albicans SC5314 (CA, grey bars) during co-culture in ASM in (A) aerobic 
batch culture and (B) stirred batch culture conditions. Data represented as mean ± standard 
deviation from three independent experiments. Asterisks represent significant (**P < 0.005, 













Figure 3.12 Triple species co-culture under continuous-flow conditions. 
Viable cell counts (CFU mL-1) of P. aeruginosa PAO1 (PA, black bars) S. aureus 25923 (SA, 
white bars) and C. albicans SC5314 (CA, grey bars) during co-culture in ASM in the 
continuous-flow model. Flowrate (Q) = 145 µL min-1. Data represented as mean ± standard 






3.6.4 OD600 nm Measurements 
When comparing OD600 nm measurements of the triple species co-cultures under the different 
culture conditions, the density of the aerobic batch co-culture is significantly higher (P < 0.05) 
than the continuous-flow and stirred batch cultures after T = 4 hrs (Figure 3.13). Culture 
density of the aerobic batch population then plateaued after 24 hrs of incubation (OD600 nm ≈ 
3.5) and a significant decrease (P < 0.0001) in OD600 nm values occurred at T = 72 hrs. 
Contrastingly, density of the continuous-flow and stirred batch co-cultures increases steadily 
for the first 48 hrs of incubation and no significant change (P > 0.05) in the culture density of 
either population occurred at the points following this. Culture density of the continuous-flow 
co-culture was significantly lower than both the aerobic batch (P < 0.0001) and stirred batch 
(P < 0.001) co-cultures after 24 hrs of incubation. OD600 nm values of the continuous-flow co-
culture remained approximately two units lower than the stirred batch culture for the entirety 
of the incubation period.  
 
3.7 Conclusions 
Using the simple continuous-flow model it is possible to maintain long-term in vitro co-cultures 
of three distinct microbial species (PA, SA and CA) associated with CF airway infections. 
Ordinarily these species would outcompete one another when co-cultured under batch culture 
conditions. These results indicate the continual supply of fresh media and removal of waste 
products is crucial for permitting the maintenance of polymicrobial co-cultures. The finding that 
CA is able to outcompete SA when co-cultured under batch conditions, despite comprising 
just 0.1% of the total microbial population after 24 hrs incubation, affirms the notion that a 
numerically minor members of a microbiota can impinge the growth of other species present 
within a polymicrobial population. Furthermore, the decreased rate of SA removal from the 
triple species co-culture when compared with the PA-SA dual species co-culture under the 
same conditions suggests CA, present at just 0.05% of the population, can protect SA from 
PA to some degree. This could be through a modulation of virulence factor production via 
interspecies interactions, such as the production of farnesol, but this would require further 
investigation. Taken together, these findings confirm the importance of viewing CF as 
polymicrobial infection and not simply studying the major pathogens in isolation.  
A slower rate of species out-competition was observed in the stirred batch culture vessels 
when compared with the aerobic batch co-cultures of the same species. This may be due to 
the increased growth rate of species co-cultured under the aerobic batch conditions, 
evidenced by increased OD600 nm measurements during the first 8 hrs of growth. Populations 













Figure 3.13 Growth of triple species co-culture in batch and continuous-flow 
conditions. 
Growth (monitored as OD600 nm) of P. aeruginosa PAO1, S. aureus 25923 and C. albicans 
SC5314 triple species co-cultures in ASM under aerobic batch (triangles), stirred batch 
(squares) and continuous-flow (circles) growth conditions. Q = 145 µL min-1 in the continuous-
flow culture vessel.  Data represented as the mean ± standard deviation from three 





leading to an increase in interspecies competition and a faster removal of species from a co-
culture. Additionally, less vigorous aeration of the stirred batch culture vessel may limit oxygen 
availability amongst the culture. Hypoxic conditions have been identified to prolong the lag-
phase of microbial growth (Sabra et al., 2002). Furthermore, the action of PqsH, the enzyme 
responsible for catalysing the final step of PQS synthesis, is reliant on oxygen availability 
(Schertzer et al., 2010). Therefore, a decrease in the expression of PQS-controlled virulence 
factors and other gene may occur under these conditions. No information is available on how 
oxygen limitation affects the expression of CA virulence factors, but studies on other fungi (A. 
fumigatus and Saccharomyces pombe) suggest a down-regulation of virulence factor 
expression also occurs (Grahl et al., 2012).   
OD600 nm measurements were utilised to compare the total culture density of microbial 
populations. For every species co-culture combination, the density of the continuous-flow 
culture was kept below that of the batch cultures. For all dual species co-cultures, no 
significant changes in OD600 nm values occurred after 24 hrs of incubation. Indicating the entire 
population is maintained at steady-state and does not enter the death phase of growth. Within 
the triple species continuous-flow vessel the culture density did increase after 24 hrs of 
incubation, this is due to Q being reduced to prevent the washout of CA from the co-culture. 
As PA and SA have a constant growth rate in ASM, the total culture density gradually 
increases over the entire period of incubation.  
The results presented in this chapter provide the groundwork for the development of an in vitro 
culture model to permit the co-culture of an entire polymicrobial community associated with 
CF airway infections. They also provide proof-of-principle for an experimentally tractable 





4. Characterisation of Cultures 
4.1 Introductory comments 
As demonstrated in Section 3, polymicrobial communities of key pathogens associated with 
CF airway infections can be maintained for extended periods of time in the continuous-flow 
model. The work presented in this chapter aimed to characterise the metabolic state and 
mutability of microbial populations cultured in the model. Alongside investigating how the 
presence of co-cultivated species affects the accumulation of quorum sensing (QS) molecules 
and virulence-associated factors in the different conditions of growth to better understand why 
competition between species is decreased in the continuous-flow culture vessel. This work, 
where indicated, has been published in Frontiers in Microbiology. 
 
4.2 Metabolic state of continuous-flow culture 
To determine the metabolic state and growth phase of populations maintained in my 
continuous-flow model, the relative expression of exponential phase and stationary phase-
specific genes was compared between mono-species PA populations cultured in stirred batch 
and continuous-flow conditions. As described in Section 2.6, four genes up-regulated during 
exponential growth and four genes up-regulated during the stationary phase of growth were 
targeted for quantitative real-time PCR (RT-PCR) analysis. These genes were selected from 
a published transcriptomic dataset gathered by former Welch Lab member Dr Helga 
Mikkelsen, studying PAO1 growth in AGSY growth medium (Mikkelsen et al., 2007). By 
targeting eight genes encoding different products differentially expressed between the 
exponential and stationary phases of growth, discrepancies in the expression of genes due to 
differences in growth media should be mitigated, making more obvious any general trends 
regarding the metabolic state of the culture. All RT-PCR results were normalised by 
quantifying the expression of the constitutively expressed 16S rRNA gene (Clarridge, 2004, 
Kolbert and Persing, 1999, Woese, 1987) and results analysed using the comparative ΔΔCt 
method (Giulietti et al., 2001).  
The relative expression of all target genes in a mon-species culture of PAO1 under 
continuous-flow conditions (Q = 170 µL min-1) compared with stirred batch culture conditions 
(Q = 0 µL min-1) over 96 hrs of incubation are shown in Figure 4.1. Interestingly, at T = 6 hrs 
(mid-log phase of PAO1 growth in ASM) all genes were expressed at higher levels in the 
continuous-flow culture relative to the batch culture. However, the differences in relative 
expression levels between the two cultures at 6 hrs of incubation are significantly smaller than 




Figure 4.1 Relative expression of exponential and stationary phase specific genes by 
PA grown in batch and continuous-flow conditions.  
The fold change in the expression of the listed genes between P. aeruginosa PAO1 mono-
species cultures under continuous-flow (Q = 170 µL min-1) and stirred batch (Q = 0 µL min-1) 
conditions. (A) Genes associated with exponential growth phase; (B) genes associated with 
stationary phase of growth. Cycle threshold (Ct) values obtained by quantitative real-time PCR 
were normalised against expression of the 16S rRNA housekeeping gene and analysed using 
the comparative ΔΔCt method. Data represented as the mean ± standard deviation of three 
independent experiments.   
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target genes between the two culture conditions during this stage of growth. A significant 
increase (P < 0.05) in the relative expression of all genes associated with the exponential 
phase of growth occurs by T = 24 hrs (Figure 4.1.A). No significant change (P > 0.05) in the 
relative expression of rplM (encoding an early assembly protein of the 50S ribosomal subunit) 
or rpoA (encoding DNA-directed RNA polymerase α-chain) occurs after 24 hrs of incubation. 
A significant increase (P < 0.05) in the relative expression of rpsM (encoding the 30S 
ribosomal subunit protein, S13) and sodB (encoding a superoxide dismutase) occurs between 
T = 24 hrs and T = 96 hrs. At the final point of sampling all exponential phase associated 
genes are expressed >5.5 units higher in the continuous-flow culture relative to the stirred 
batch culture. 
Genes associated with the stationary phase of growth are displayed in Figure 4.1.B. All genes, 
except for rmf, had negative relative expression values by T = 24 hrs, indicating their 
decreased expression in the continuous-flow culture compared with the batch culture. The 
relative expression of rmf (encoding a ribosomal modulation factor that converts the 70S 
subunit to its inactive dimeric 100S form during the stationary phase) steadily decreases over 
time, becoming a negative value by T = 72 hrs. No significant difference in the relative 
expression of rmsA (encoding a putative carbon storage regulator) or rpoS (encoding an 
alternative sigma factor associated with the stationary phase stress response) occurred after 
24 hrs of incubation. A significant decrease (P < 0.0001) in the relative expression of sodM 
(encoding a superoxide dismutase) occurred between T = 24 and T = 48 hrs, and relative 
expression values for this gene remained below -16.9 for the remainder of the incubation 
period. By the final point of sampling, all stationary phase associated genes were relatively 
expressed at fewer than -3.0 relative units under continuous-flow conditions compared with 
stirred batch conditions.  
In summary, all exponential phase associated genes were positively up-regulated and all 
stationary phase associated genes negatively expressed under continuous-flow conditions 
relative to stirred batch conditions. Taken together, these results provide strong evidence to 
indicate that microbial populations maintained at a steady-state carrying capacity in the culture 
vessel remain metabolically active and do not enter the stationary phase of growth over the 
course of incubation.  
 
4.3 Estimation of mutation rates 
4.3.1 Comments 
As discussed in Section 1, a possible use of the continuous-flow culture model would be to 
investigate how the presence of co-cultivated species affects the evolutionary trajectory of a 
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polymicrobial community. I therefore wanted to ensure that the co-culturing species and 
maintenance of populations in a steady-state carrying capacity for extended periods of time 
had no adverse effects on the mutability of members of the consortium. To investigate this, I 
determined the mutation rate (µ) of PA and SA when cultured independently or as a dual-
species co-culture under continuous-flow and batch culture conditions using the methods 
described by Foster (2006), Section 2.7. Changes in µ overtime in the continuous-flow vessel 
were determined by measuring mutant accumulation (Kubitschek and Gustafson, 1964, 
Novick and Szilard, 1950) shortly after a steady-state population was attained (T = 24 hrs) and 
at the end of the experiment (T = 96 hrs). A modified version of the Luria-Delbrück fluctuation 
assay (Luria and Delbrück, 1943) and Jones median estimator (Jones et al., 1994) were used 
to determine µ for batch culture populations at T = 24 hrs, as described in Section 2.7.3. The 
emergence of spontaneous ciprofloxacin resistant (cipr) isolates and rifampicin resistant (rifr) 
isolates was used as a proxy to experimentally infer the rate of spontaneous mutation within 
a population. Part of the work in this section is published in Frontiers in Microbiology (O'Brien 
and Welch, 2019a). 
To ensure that mutations in the genes responsible for conferring resistance to either 
ciprofloxacin or rifampicin did not provide a selective advantage or disadvantage for the growth 
of species under the culture conditions, potentially skewing any observations, the emergence 
of either cipr or rifr isolates in independent experiments was measured. It should be noted that 
due to differences in experimental design and methods for estimating mutation rates in a 
continuously dividing population (continuous-flow) or a population that enters the stationary 
phase of growth (batch culture), values for µ cannot be directly compared between assays.  
 
4.3.2 Continuous-flow mutation rates 
The mean number of rifr-conferring and cipr-conferring mutations per cell division are displayed 
in Figure 4.2. There was no significant difference (P > 0.1) in the values for µ calculated 
between samples when using either the emergence of rifr-isolates (Figure 4.2.A) or cipr-
isolates (Figure 4.2.B) as proxy to estimate rates of spontaneous mutation. Values calculated 
for µ were between 8.97x10-9 and 2.55x10-8 mutations per cell division for all samples and 
timepoints. These values are comparable with previously reported PA and SA mutation rates 
(Dettman et al., 2016, Schaaff et al., 2002). Importantly, there was no significant change (P > 
0.1) in µ between the cultures sampled at T = 24 hrs or T = 96 hrs and no significant difference 
(P > 0.1) in mutations per cell division of PA or SA when cultured axenically or as a co-culture. 










Figure 4.2 Estimation of mutation rates in the continuous-flow culture vessel. 
Assumed mutation rates of P. aeruginosa PAO1 and S. aureus 25923 during single-species 
and dual species co-culture in the continuous-flow model after 24 and 96 hrs of incubation. 
Mutation rates were calculated as (A) the number of rifr-conferring mutations per cell division, 
or (B) the number of cipr-conferring mutations per cell division, using the methods described 
by (Foster, 2006). Data represented as the mean ± standard deviation from three independent 
experiments. P > 0.05 is considered no significant difference (ns). 
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over time under continuous-flow conditions and that the maintenance of steady-state co-
cultures of PA and SA in the model has no adverse effects on the mutability of either species. 
 
4.3.3 Batch culture mutation rates 
Mutation rates for PA and SA mono-species and dual species cultures incubated for 24 hrs 
under batch conditions are shown in Figure 4.3. As methods to estimate µ within a batch 
culture rely on the population not entering the death phase of growth, the T = 96 hrs point of 
sampling is not possible for this assay. As in Section 4.3.3, there was no significant difference 
(P > 0.2) in values for µ calculated using the emergence of rifr-isolates (Figure 3.3.A) or cipr-
isolates (Figure 4.3.B) as a proxy to estimate the rate of spontaneous mutation amongst the 
populations cultured under batch conditions. There was a significant (P < 0.05) log-fold 
decrease in the mean number of rifr-conferring mutations per cell division between PA cultured 
axenically and as a co-culture with SA. Similarly, a significant (P < 0.01) decrease in the mean 
number of cipr-conferring mutations per cell division also occurred between PA cultured alone 
or as a batch co-culture with SA. No spontaneous rifr or cipr SA isolates could be recovered 
from the dual species co-culture, despite viable SA cells being recovered at ≈104 – 105 CFU 
mL-1 from the culture vessel at this point of sampling. As such, no value for µ can be calculated 
for SA when co-cultured with PA under batch conditions.  
 
4.3.4 Conclusions 
No significant difference in the assumed rate of mutation of any culture was observed when 
measuring the emergence of spontaneous rifr or cipr isolates in a population. This indicates 
that the acquisition of mutations conferring resistance to rifampicin or ciprofloxacin does not 
affect the fitness and growth of species in ASM under these culture conditions, and that values 
for µ are reliable. Furthermore, the mutation rates of species cultured under continuous-flow 
conditions remained unchanged irrespective of the length of incubation or presence of other 
species in the culture. This finding provides strong evidence to demonstrate that the 
maintenance of microbial populations at a steady-state in the continuous-flow culture vessel 
does not adversely affect the mutability of members of the population. This, in turn, reinforces 
the notion that the model is suitable for studying how the presence of co-habiting species may 
impact upon the evolutionary trajectory of a polymicrobial consortium.  
By contrast the mutation rates of axenic and dual species populations were not stable under 
batch culture conditions, as evidenced by the significant decrease in µ observed when PA and 






















Figure 4.3 Estimation of mutation rates during batch culture. 
Assumed mutation rates of P. aeruginosa PAO1 and S. aureus 25923 during single-species 
and dual species co-culture in batch culture conditions after 24 hrs of incubation. Mutation 
rates were calculated as (A) the number of rifr-conferring mutations per cell division, or (B) the 
number of cipr-conferring mutations per cell division, using the methods described by (Foster, 
2006). Data represented as the mean ± standard deviation from three independent 
experiments. Asterisks represent significant (*P < 0.05, **P < 0.01) difference in mutations per 
cell division.  
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suggest that the genomic mutation rate of PA and SA is elevated during co-culture as a biofilm. 
Differences in the planktonic and biofilm microbial lifestyles may explain the inverse trend 
observed in this study, especially given that a 100-fold increase in µ has been previously 
reported between axenic planktonic and biofilm cultures of PA (Conibear et al., 2009) and that 
mutations are thought to accumulate more readily in biofilm populations (Banas et al., 2007). 
However, it is important to consider that stress and population density have also been found 
to affect the mutability of microbial species (Aanen and Debets, 2019, Frenoy and Bonhoeffer, 
2018, Krašovec et al., 2014, Krašovec et al., 2017). Therefore, the increased competition for 
space and limited resources under batch culture conditions is likely to impose enhanced 
selection pressures on all members of a population. As previously mentioned, the acquisition 
of spontaneous mutations conferring resistance to rifampicin or ciprofloxacin are not likely to 
impact upon the fitness or growth of species in ASM. As such, mutations beneficial for the 
survival or improved competition between co-cultured species are likely to be selected for 
under batch culture conditions, possibly explaining the decrease in rifr and cipr isolates 
observed in the batch culture fluctuation tests. For these reasons, the co-culture of species 
using traditional batch culture approaches are pivotal in identifying genes essential for 
competition and survival in an acute infection setting. However, these culture methods say 
little about how a polymicrobial community evolves naturally over time, whereas the 
continuous-flow model provides a means to test this process in a seemingly unbiased and 
robust manner. 
 
4.4 Pyocyanin quantification 
4.4.1 Comments 
As discussed in Section 1.4, PA produces a wide array of secreted extracellular factors such 
as phenazines, associated with virulence and competition between microbial species in the 
CF microenvironment. The most abundantly secreted phenazine by PA is pyocyanin, a blue-
green redox-active pigment. The exact physiological role(s) of pyocyanin remain unclear but 
the compound has potent-antimicrobial activity and in its reduced form pyocyanin can react 
with molecular oxygen to form toxic reactive oxygen species (Baron and Rowe, 1981, Lau et 
al., 2004, Muller, 2002, Noto et al., 2017). As described in Section 2.8, the concentration of 
pyocyanin in the supernatant of a microbial population can be easily assayed via chloroform 
extraction of the pigment and photometric methods (Knight et al., 1979). Thus, quantification 
of pyocyanin was used as a simple proxy to assess the general virulence factor production by 
PA within mono-species and mixed species populations grown under the different culture 
108 
 
conditions described in Section 2.3. The work presented in this section is published in 
Frontiers in Microbiology (O'Brien and Welch, 2019a). 
  
4.4.2 Concentration of pyocyanin 
The concentration of pyocyanin present in the culture supernatant of mono-species and mixed 
species populations containing PA under continuous-flow and batch culture conditions after 
96 hrs of incubation is shown in Figure 4.4. Axenic SA and CA cultures and the SA-CA co-
culture produce no pyocyanin (data not shown). The endpoint concentration of pyocyanin was 
significantly lower (P < 0.0001) in the supernatant of all microbial species combinations grown 
under continuous-flow conditions compared with the aerobic and stirred batch cultures. There 
was no significant difference (P > 0.3) in the accumulation of pyocyanin between the different 
co-culture combinations under continuous-flow conditions, and the concentration of pyocyanin 
was less than 1.5 µg mL-1 for all continuous-flow culture supernatants. Under batch culture 
conditions the presence of SA caused a significant increase (P < 0.0001) in the accumulation 
of pyocyanin in the PA-SA dual species co-culture compared with the mono-species PA 
culture. Conversely, the presence of CA caused a significant decrease (P < 0.0001) in the 
accumulation of pyocyanin in the PA-CA co-culture under batch culture conditions compared 
with the mono-species PA culture. The concentration of pyocyanin present in the triple species 
batch cultures supernatants is significantly lower (P < 0.0001) than both the mono-species PA 
and PA-SA co-culture, yet is significantly higher (P < 0.0001) than the PA-CA co-culture.  
 
4.4.3 Conclusions 
Pyocyanin accumulation was measured as a proxy to assess the concentration of 
extracellularly secreted virulence factors present in the supernatants of microbial populations 
grown under the different culture conditions. The dramatic decrease in the endpoint 
concentration of pyocyanin observed within the continuous-flow vessel compared with the 
batch culture populations therefore suggests a likely decrease in the production of other 
virulence factors and competition between PA and other species in a co-culture under these 
conditions. This finding, in part, explains why populations of species that would ordinarily 
outcompete one another during co-culture can be maintained at a steady-state, with respect 
to microbial titres (Section 3), for extended periods of time in the continuous-flow model. 
The presence of SA and CA within a co-culture under batch conditions did significantly alter 
the production of pyocyanin by PA. Just as Korganokar et al. (2013) reported that N-











Figure 4.4 Quantification of pyocyanin concentration under different culture conditions. 
The concentration (µg mL-1) of pyocyanin in the supernatants of single-species and mixed 
species co-cultures of P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) or C. albicans SC5314 
(CA) after 96 hrs of incubation under: continuous-flow (black bars); aerobic batch (grey bars) 
and; stirred batch (white bars) culture conditions. Data represented as the mean ± standard 
deviation of three independent experiments, P > 0.05 is considered no significant difference 
(ns).   
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production and secretion of PA extracellular virulence factors, SA caused a significant up-
regulation in the accumulation of pyocyanin in the PA-SA co-culture. Furthermore, the 
presence of CA caused a significant decrease in the accumulation of pyocyanin during batch 
culture growth with PA, despite CA comprising less than 0.1% of the total microbial population 
of the PA-CA co-culture after 24 hrs of incubation (Figure 3.4.2). This is perhaps unsurprising, 
given that CA produced farnesol (up-regulated during times of stress) can inhibit QS in PA 
(Section 1.3.5) ultimately modulating the expression of genes under the control of this 
regulatory network, such a pyocyanin (Trejo-Hernández et al., 2014). The complex interplay 
of interspecies interactions amongst all members present within a polymicrobial consortium 
can be exemplified in the triple species co-culture. Here the concentration of pyocyanin lies 
between the values observed for the dual species co-cultures, suggesting that both SA and 
CA are simultaneously exerting an effect on PA gene expression under these culture 
conditions. Taken together, these findings strongly affirm the importance of viewing CF airway-
associated infections as polymicrobial and to consider the impact which the presence of less 
abundant or avirulent species may have on the gene expression and virulence factor 
production by the dominant species and key pathogens.  
 
4.5 Siderophore quantification 
4.5.1 Comments 
Iron is an important cofactor for many enzymes that catalyse redox reactions, making access 
to iron an essential requirement for all biological organisms needing to carry out fundamental 
cellular processes such as replication and respiration (Andrews et al., 2003, Kraemer et al., 
2014). Bioavailability of iron is generally low in hosts, but it should be noted that iron levels 
within CF sputum are raised compared with healthy samples and that increased iron 
availability in the airways has been correlated with an increased ability of PA to establish 
persistent infections (Reid et al., 2007). Competition for iron acquisition between species is 
fierce and many microorganisms secrete iron scavenging molecules, termed siderophores, 
that bind iron for uptake via specific cell surface receptors (Guerinot, 1994, Miethke and 
Marahiel, 2007). PA is capable of synthesising two siderophores: pyoverdine and pyochelin 
(Cornelis and Matthijs, 2007), and SA produces a further two siderophores: staphyloferrin A 
and staphyloferrin B (Laakso et al., 2016). Siderophore production by PA and SA is essential 
for the full virulence of either species in in vivo models (Dale et al., 2004, Takase et al., 2000a, 
Takase et al., 2000b), where iron bioavailability is limited. Unlike other fungal species the CA 
genome does not harbour genes for the synthesis of siderophores (Haas, 2003), whereas A. 
fumigatus encodes for two siderophores (Hissen et al., 2004). However, CA does encode the 
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iron-chelate siderophore transporter complex Sti1/Arn1 enabling CA to uptake siderophores 
produced by other species (Ardon et al., 2001).   
Given the importance of iron acquisition for supporting microbial growth and the wealth of 
unique siderophore molecules produced by a large number of distinct species, the role of 
siderophores in mediating interspecies interactions among a polymicrobial population is only 
now beginning to be realised (Almeida et al., 2009, Bisht et al., 2020, Cornelis and Dingemans, 
2013, Harrison et al., 2008, Kramer et al., 2020, Lopez-Medina et al., 2015). Furthermore, the 
requirement of siderophores to establish full virulence within in vivo hosts makes these 
molecules a good proxy to study generalised virulence factor production amongst a population 
(Martin et al., 2011). The production of siderophores by cultures grown in ASM was measured 
using the chrome Azurol S (CAS) assay (Payne, 1994), as described in Section 2.9, to 
elucidate the role of interspecies competition with regards to the acquisition of iron between 
species cultured in a physiologically relevant CF growth medium under the different culture 
conditions.   
 
4.5.2 Concentration of siderophores 
The concentration of siderophores present in the culture supernatants of single-species and 
mixed species co-cultures under continuous-flow and batch culture conditions are shown in 
Figure 4.5 and Figure 4.6, respectively. Single-species cultures of CA produced no 
siderophores under any culture condition (data not shown). For all species combinations under 
continuous-flow conditions siderophores were present at a concentration of <1 µM, 
significantly lower (P < 0.0001) than the concentration of siderophores present in all batch 
culture populations. There was no significant change (P > 0.2) in the concentration of 
siderophores present in the continuous-flow cultures over time.  
Under aerobic batch culture conditions there was no significant difference (P > 0.1) in the 
concentration of siderophores between any of the species combinations at T = 24 hrs (Figure 
4.6.A). There was a significant (P < 0.0001) 4-fold increase in the concentration of 
siderophores present in the PA mono-species culture between T =24 and 48 hrs and no 
significant change (P > 0.8) in siderophore concentration after 48 hrs of incubation. 
Furthermore, siderophores were present at significantly higher concentration (P < 0.001) in 
the PA mono-species culture compared with all other species combinations after 48 hrs of 
incubation. There was a significant (P < 0.05) increase in siderophore concentration in the SA 
mono-species aerobic batch culture between T = 24 and 96 hrs of incubation. For the PA-SA 
dual species co-culture there was a significant (P < 0.05) 5-fold increase in siderophore 













Figure 4.5 Quantification of siderophores under continuous-flow conditions. 
Concentration (µM) of siderophores in the culture supernatants of single-species and mixed 
species populations of P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and C. albicans 
SC5314 (CA) cultured under continuous-flow conditions. Data represented as the mean ± 
standard deviation of three independent experiments, P > 0.05 is considered no significant 










Figure 4.6 Concentration of siderophores under batch culture conditions. 
Concentration (µM) of siderophores in the culture supernatants of single-species and mixed 
species populations of P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and C. albicans 
SC5314 (CA) cultured under (A) aerobic batch, and (B) stirred batch conditions. Data 
represented as the mean ± standard deviation of three independent experiments. 
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siderophore concentration between T = 72 and 96 hrs. The inverse trend was observed for 
the PA-CA dual species co-culture. A significant (P < 0.01) 2-fold decrease in the 
concentration of siderophores occurred between T = 24 and 48 hrs, followed by a significant 
(P < 0.001) 1.5-fold increase in concentration between T = 72 and 96 hrs. The concentration 
of siderophores present in the supernatant of the SA-CA dual species co-culture significantly 
decreased (P < 0.01) from ≈10 µM at T = 24 hrs to just 1.35 µM at T = 96 hrs. A significant (P 
< 0.001) 2.6-fold increase occurred for the concentration of siderophores present in the triple 
species co-culture supernatant between T = 24 and 96 hrs. At the final point of sampling there 
was no significant difference (P > 0.05) in the concentration of siderophores present between 
the SA mono-species and PA-SA or PA-CA co-cultures, yet siderophores were present at 
significantly higher (P < 0.001) concentrations in the triple-species co-culture and significantly 
lower (P < 0.001) concentrations in the SA-CA co-culture.  
As in the aerobic batch cultures, there was no significant difference (P > 0.05) in the 
concentration of siderophores between any species combination under stirred batch 
conditions at T = 24 hrs (Figure 4.6.B). There was a significant (P < 0.01) 2.3-fold increase in 
siderophores concentration in the PA mono-species culture between T = 24 and 48 hrs, 
followed by no significant change (P > 0.9) in values for the remainder of incubation. The 
concentration of siderophores in the PA mono-species culture was, again, significantly higher 
(P < 0.001) than all other species combinations at T = 48 hrs and the following timepoints. 
Under stirred batch conditions there was no significant difference in siderophore 
concentrations over time for any of the other species culture combinations following T = 24 
hrs. There was a slight, but not statistically significant, increase in siderophores concentration 
in the triple species co-culture over the course of incubation and a non-significant, but gradual, 
decrease in concentration in the SA-CA culture. At the end point of sampling, the concentration 
of siderophores in the triple species culture was significantly higher (P < 0.01) than the SA-
CA dual species culture. No significant difference was observed between siderophore 




When using the continuous-flow culture vessel, the concentration of siderophores present in 
all culture supernatants was well below the concentrations observed during growth in batch 
culture conditions. Unlike the batch culture populations, siderophore concentrations did not 
change over time or with the presence of different species combinations in the polymicrobial 
consortium. I therefore hypothesise that under continuous-flow conditions, with a constant 
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supply of fresh nutrients such as iron (not unlike the situation in the CF airways) there is a 
decrease in competition for abundant resources among species. As such the production of 
siderophores, and by extension other virulence factors such as pyocyanin (Section 4.4), are 
reduced. Thus, a stable and steady-state polymicrobial population of PA, SA and CA is 
maintained for extended periods of time within the model.  
There was a large alteration in the concentration of siderophores present in the supernatants 
of the different species combinations cultured under aerobic batch conditions, particularly after 
24 hrs of incubation. Previous studies have established that siderophores are produced at the 
highest concentration between 24 and 48 hrs of growth (Ferreira et al., 2019), perhaps 
explaining why at the initial point of sampling there was no significant difference in siderophore 
concentrations between the differing populations.  
Most notably, the presence of SA or CA caused a substantial decrease in the total 
concentration of siderophores present in the supernatant of co-culture populations when 
compared with the PA mono-species culture. The decrease in siderophore concentration in 
the PA-SA co-culture may be attributed to the ability of PA to lyse SA and utilise the resulting 
lysate as a source of free iron, as described by Mashburn et al. (2005), thereby decreasing 
the need of PA to produce siderophores for iron acquisition under these conditions. 
Alternatively, SA may down-regulate the production of siderophores via an, as yet, 
unelucidated mechanism. This finding directly contradicts the suggestion by Harrison et al. 
(2008) that co-culturing PA with SA causes an up-regulation in the production of siderophores. 
However, it should be noted that an iron chelating agent was present in the culture media used 
for this study. This is likely to not only decrease the bioavailability of iron, but also to chelate 
iron freed during SA lysis to cause an increased selection pressure for enhanced iron 
scavenging amongst the population.  
As discussed in Section 3.4, several antagonistic interactions have been described between 
PA and CA, including the farnesol-mediated inhibition of QS networks within PA (Cugini et al., 
2007, Fourie et al., 2016) and the subsequent suppression of pyochelin and pyoverdine 
biosynthesis (Lopez-Medina et al., 2015). The finding that the presence of CA caused a more 
pronounced decrease in siderophore concentration compared with the PA-SA co-culture may 
be attributable to the inability of CA to produce siderophores of its own, unlike SA. It is key to 
note that the complete removal of CA from the PA-CA co-culture under aerobic batch 
conditions by 72 hrs of incubation (Figure 3.5.A) was accompanied by an increase in 
siderophore production by the culture at this point. This demonstrates a clear role for 
interspecies interactions between the two microorganisms in modulating the production of 
siderophores by a co-culture. The loss of such interactions upon the removal of CA leads to 
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the production of siderophores at higher concentrations by the now axenic ‘PA-only’ 
population. Similarly, CA also caused a decrease in siderophore concentration in the SA-CA 
co-culture compared with the mono-species SA culture. This diminution may simply be 
attributed to the out-competition and complete removal of SA from the population by 72 hrs 
incubation (Figure 3.8.A). However, it is important not to disregard the impact that interspecies 
interactions may have upon this decrease in siderophore production, especially when 
considering that, when co-cultured with non-siderophore producing strains of Enterococcus 
faecalis, SA is known to down-regulate siderophore production in a Caenorhabditis elegans 
infection model (Ford et al., 2016).  
In summary, the results presented in this section demonstrate that the concentrations of 
siderophores in the continuous-flow culture vessel are maintained at consistently low levels, 
irrespective of the length of incubation or combination of species present. By contrast, the 
presence of co-cultured CA, comprising just 0.05% of the total microbiota under iron limited 
batch culture conditions, caused a significant modulation in siderophore concentrations, 
highlighting the essential need to consider the presence of less abundant species when 
studying polymicrobial infections.  
 
4.6 QS molecules quantification 
4.6.1 Comments 
As described in Section 1.3.5, quorum sensing (QS) regulatory networks coordinate multiple 
cellular processes, including the production of secondary metabolites and the expression of 
some extracellularly secreted and virulence associated compounds (Rutherford and Bassler, 
2012). Recently the role of interspecies QS recognition among polymicrobial populations is 
becoming apparent (Abisado et al., 2018, Armbruster et al., 2010, Lewenza et al., 2002, Popat 
et al., 2012, Qazi et al., 2006). As previously discussed, the removal and out-competition of 
SA by PA during co-culture is thought to be dependent on the lasR QS system (Mashburn et 
al., 2005). Similarly, the QS-like signalling network identified in CA utilises farnesol as a 
signalling molecule (Nickerson et al., 2006). Farnesol is linked to interspecies communication 
events and is even known to modulate the action of PQS signalling in PA (Cugini et al., 2007, 
Cugini et al., 2010). Furthermore, cross-recognition of AHL signalling molecules has been 
identified among different microbial species, for instance PA is able to recognise AHL 
molecules produced by B. cenocepacia, another CF airway-associated pathogen (Lewenza et 
al., 2002). Such interspecies QS-regulated events have been described to be either 
cooperative or competitive in nature, yet their full extent upon modulating true polymicrobial 
communities is largely unknown.  
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The role of QS events is highly-dependent on environmental factors and the conditions of 
culture. In 2003, three independent transcriptomic studies were performed on PA in three 
different laboratories under three different culture conditions (Hentzer et al., 2003, Schuster et 
al., 2003, Wagner et al., 2003). Although these studies identified large numbers of QS-
regulated genes, there was substantial divergence between expression profiles and only a 
small amount of overlap between the observed results. To determine how the presence of co-
habiting microbial species may impinge on QS in PA cultured under continuous-flow and batch 
culture conditions, the concentration of: 2-heptyl-3-hydroxy-4-quinolone (PQS), N-(3-
oxododecanoyl)-L-homoserine lactone (OdDHL) and N-butanoyl-L-homoserine lactone (BHL) 
present in the culture supernatants of axenic and mixed species cultures were measured using 
the biosensor strains and methods described in Section 2.10. The work presented in this 
section is published in Frontiers in Microbiology (O'Brien and Welch, 2019a). 
 
4.6.2 Concentration of QS molecules 
The concentration of all three PA QS molecules present in the supernatants of single and 
mixed species populations containing PA under the different culture conditions is shown in 
Figure 4.7. The concentration of all QS molecules in the continuous-flow model cultures was 
significantly lower (P < 0.0001) than their concentration in the aerobic and stirred batch 
cultures. Under continuous-flow conditions there were no significant changes (P > 0.1) in the 
concentration of PQS (Figure 4.7.A) or OdDHL (Figure 4.7.B) for any of the culture 
combinations between T = 24 and 96 hrs. There was, however, a significant (P < 0.05) 0.4 µM 
increase in the concentration of BHL (Figure 4.7.C) present in the PA-CA co-culture in the 
continuous-flow model over the incubation period. No other appreciable differences in the 
concentration of BHL present in the supernatants of co-cultures maintained at a steady-state 
in the continuous-flow model were observed.  
There was no significant difference (P > 0.9) in the concentration of PQS present in the 
supernatants of the PA mono-species or PA-SA co-cultures under batch culture conditions. 
There was a non-significant (P > 0.05) ≈0.6 µM decrease in [PQS] present in the PA-CA co-
culture compared with the PA mono-species or PA-SA co-culture under aerobic batch 
conditions for both T = 24 and 96 hrs. However, under stirred batch conditions the 
concentration of PQS present in the PA-CA co-culture was significantly higher (P < 0.001) 
than the PA mono-species or PA-SA co-cultures at both points of sampling. At T = 24 hrs the 
concentration of PQS in the triple species co-culture was significantly higher (P < 0.05) than it 
was in the PA mono-species or PA-SA co-culture under aerobic batch conditions. A significant 







Figure 4.7 Quantification of quorum sensing molecule accumulation. 
Concentration (µM) of the indicated quorum sensing molecules in the supernatants of single-
species and mixed species populations of P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) 
and C. albicans SC5314 (CA) cultured in the different culture conditions after 24 and 96 hrs of 
incubation (as indicated). (A) Pseudomonas quinolone signal (PQS); (B) N-(3-
oxododecanoyl)-L-homoserine lactone (OdDHL); (C) N-butanoyl-L-homoserine lactone (BHL). 




batch culture occurred between T = 24 and 96 hrs, making the concentration of PQS present 
in the triple species co-culture significantly lower (P < 0.05) than the PA mono-species or PA-
SA co-culture at the endpoint of incubation. The inverse trend was observed under batch 
culture conditions, as the concentration of PQS present within the triple species co-culture 
was significantly lower (P < 0.05) than the PA mono-species or PA-SA co-culture at T = 24 
hrs. There was a significant (P < 0.0001) 3.3-fold increase in the concentration of PQS 
between 24 and 96 hrs of incubation in the triple species aerobic batch co-culture.  
There was no significant difference in the concentration of OdDHL present in the PA mono-
species culture between T = 24 and 96 hrs under aerobic batch conditions, or between the 
PA-SA co-cultures under both aerobic and stirred batch conditions. A significant increase (P 
< 0.0001) in the concentration of OdDHL present in the PA mono-species stirred batch culture 
occurred between the points of sampling. The concentration of OdDHL present in the PA-SA 
stirred co-culture was significantly higher (P < 0.0001) than the PA mono-species culture at 
after 24 hrs of incubation, but there was no significant difference between the two culture 
combinations at T = 96 hrs. OdDHL was also present at significantly higher (P < 0.05) levels 
in the PA-SA stirred batch culture compared with the same co-culture under aerobic conditions 
at both timepoints. The concentration of OdDHL present in the PA-CA co-culture under both 
aerobic and stirred batch conditions was significantly lower (P < 0.05) than the PA mono-
species or PA-SA co-cultures at all timepoints. Furthermore, for all PA-CA batch co-cultures, 
except T = 96 hrs stirred co-culture, OdDHL was present at less than 0.25 µM and not 
statistically different than the concentration of OdDHL measured in the continuous-flow co-
cultures. No significant difference in OdDHL concentrations were observed between the PA 
mono-species or PA-SA co-culture and triple species co-cultures under grown aerobic 
conditions or at T = 24 hrs under stirred batch conditions. After 96 hrs of incubation the 
concentration of OdDHL present in the triple species stirred batch co-culture was significantly 
lower (P < 0.001) than concentrations within the PA mono-species or PA-SA co-culture.  
No BHL could be detected in the supernatants of any species combinations cultured under 
aerobic batch conditions at T = 96 hrs, except for the PA-CA co-culture where BHL was 
present at less than 0.1 µM. The concentration of BHL present in the triple species aerobic 
batch culture was more than 3-fold higher (P < 0.0001) than the concentration of BHL 
observed for all other aerobic batch species combinations at T = 24 hrs. No significant 
difference in the concentration of BHL was observed between the PA mono-species and PA-
SA co-culture at any time point under stirred batch conditions. BHL was present at a 
significantly higher (P < 0.001) concentration in the supernatant of the PA-CA co-culture 
compared with the PA mono-species ad PA-SA co-culture at T = 96 and 24 hrs respectively. 
By the final point of sampling, the concentration of BHL present in the triple species aerobic 
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batch co-culture was significantly higher (P < 0.001) than all other species combinations grown 
under the same conditions.  
 
4.6.3 Conclusions 
Taken together these findings demonstrate that QS molecules accumulate to a much lower 
concentration in the continuous-flow model compared with batch culture populations. The 
simplest explanation for this finding is the continual dilution of QS signals with fresh media 
occurs in the continuous-flow vessel and causes a washout of QS molecules. However, it is 
crucial to note that previous work within the Welch laboratory has identified that QS molecules 
more than double their concentration over 2 hrs (Davenport et al., 2015). Using the faster 
flowrate of Q = 170 µL min-1, it would take > 6 hrs to dilute the culture vessel by 50%, and all 
the while the culture continues to grow and produce more QS molecules. Assuming similar 
kinetics of QS production in ASM, these molecules should accumulate faster than they are 
diluted within the vessel. This finding therefore suggests that QS plays a less important role 
in populations maintained under continuous-flow conditions as opposed to batch culture 
conditions.  
Unlike populations maintained in the continuous-flow vessel, the presence of co-cultivated 
species had a large and varied impact upon the production of QS molecules by PA under 
batch culture conditions. For example, the presence of SA during batch culture stimulated an 
up-regulation in OdDHL production. It has been demonstrated that OdDHL, but not the shorter 
chain BHL, can specifically bind to the SA membrane and cause a down-regulation in exotoxin 
and agr (the SA QS signalling molecule) production (Qazi et al., 2006). This finding suggests 
that PA QS molecules play a role in competition and the modulating the behaviour of other 
species via direct interaction with other species and not simply through the genes under the 
control of the QS network. The presence of CA caused a depression in the production of 
OdDHL, yet stimulated the production of PQS, and to a lesser extent BHL. It is interesting to 
note that alongside the aforementioned ability of CA produced farnesol to modulate the action 
of PQS signalling, the addition of exogenous PQS to an axenic CA culture stimulates growth 
(Curutiu et al., 2016). This highlights a complex network of direct and indirect cooperative and 
competitive interspecies interactions among polymicrobial populations and shows that the 
presence of a numerically minor species can have large effects on the behaviour of a 
polymicrobial consortium.  
The lack of detectable BHL present in the supernatants of all aerobic batch cultures at T = 96 
hrs and the decrease of OdDHL also observed at this time point is an interesting phenomenon, 
but one that can be answered through the alkaline pH of spent batch culture media (Figure 
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4.8). Hydrolysis of lactone rings is known to occur under alkaline conditions (Gómez-
Bombarelli et al., 2013), causing a breakdown and decrease in the concentration of AHLs 
(BHL and OdDHL) but not the non-AHL PQS signalling molecule.  
 
4.7 pH  
The pH of axenic and mixed species cultures was examined after 96 hrs of incubation under 
the different culture conditions to see if values differed from the starting point of prewarmed 
ASM (≈pH 6.7). The work presented in this section is published in Frontiers in Microbiology 
(O'Brien and Welch, 2019a).  
The endpoint pH of all cultures maintained in the continuous-flow model were significantly 
lower (P < 0.0001) than the pH of species combinations grown under aerobic and stirred batch 
conditions (Figure 4.8). Furthermore, there was no significant difference (P > 0.05) between 
the pH measurements of any combination of species cultured under continuous-flow 
conditions, and the average pH of all continuous-flow populations (pH ≈6.5) was comparable 
to that of sterile ASM. The endpoint pH of batch cultures containing PA and the SA-CA co-
culture was significantly higher than sterile ASM, with an approximate 2-unit or 0.6-unit 
increase in pH observed in the aerobic and stirred batch cultures, respectively. A similar 
increase in pH occurred for the SA axenic culture grown under aerobic batch conditions, yet 
there was no significant difference in pH between the stirred batch and continuous-flow 
cultures. The endpoint pH of the mono-species CA cultured under aerobic batch conditions 
was significantly lower (P < 0.01) than the average pH of the continuous-flow populations and 
there was no significant difference (P > 0.4) in the pH of the stirred batch and continuous-flow 
cultures.  
Unlike specific interspecies interactions, such as the sensing of extracellular secretions or the 
recognition of cell surface motifs, changes in the pH of a culture environment will be felt by all 
members of a population. Although little research has thus far been undertaken to examine to 
what extent changes in pH may play a role in mediating interspecies interactions or the 
competition/survival of species within a polymicrobial population, work on cyanobacteria co-
cultures has established that changes in pH can facilitate out-competition between species 
(Yang et al., 2018). Environmental pH has also been linked to the expression of virulence 
factors by PA, SA and CA (De Bernardis et al., 1998, Harjai et al., 2005, Jenul and Horswill, 
2018) and furthermore changes in pH have been implicated in competition between H. 
influenzae and S. pneumoniae within in vitro models (Tikhomirova and Kidd, 2013) and a 2-
unit drop in the pH of sputum samples has been identified to occur prior to the onset of APEs 












Figure 4.8 pH of microbial cultures. 
Endpoint pH measurements of single-species and co-cultures of P. aeruginosa PAO1 (PA), 
S. aureus 25923 (SA) and C. albicans SC5341 (CA) after 96 hrs of incubation under: 
continuous-flow (black bars); aerobic batch (grey bars); and stirred batch (white bars) culture 





examining the effect of pH on phosphate-solubilising bacteria established that PA cultures 
grew to the highest density at pH 8 (Sankaralingam et al., 2014). Additional studies have also 
showed that PA up-regulates the production of some extracellular virulence factors, such as 
alginate and proteinase, at pH 8 also (Harjai et al., 2005). Contrastingly, an alkaline 
environment has been found to decrease agr expression via the repression of RNAIII 
transcription in SA, thereby decreasing the expression of genes important for virulence and 
competition under the control of the Gram-positive QS network (Regassa and Betley, 1992). 
Similarly, changes in pH are known to control yeast-hyphal morphogenesis in CA, and alkaline 
culture conditions are known to cause fungal stress by impairing nutrient uptake and 
repression of extracellular virulence factor production (Ardon et al., 2001, Vylkova et al., 2011).  
The elevated pH of populations grown under batch culture conditions, where PA outcompetes 
SA and CA (Section 3), combined with previous reports suggesting that PA is able to thrive 
under alkaline conditions (yet SA and CA struggle to grow), suggests that modulations in the 
pH of an environment may play a crucial role in the removal of some species from a 
polymicrobial community. However, it cannot yet be concluded if species such as PA actively 
modulate their environment to favour or inhibit the growth of other members present within a 
polymicrobial community. What is apparent from the results presented in this section is that 
under continuous-flow conditions the pH of populations maintained in a steady-state was near 
neutral and remained close to the pH of sterile ASM. This demonstrates that a degree of 
environmental homeostasis is afforded by the culture model and that this may play a role in 
permitting the long-term maintenance of polymicrobial communities. 
 
4.8 Conclusions 
The results presented within this chapter demonstrate that extracellular secretions associated 
with virulence and interspecies competition, such as siderophores and pyocyanin, alongside 
QS signalling molecules, accumulate to a much lower concentration under continuous-flow 
culture conditions compared with batch culture conditions. Importantly, the measured 
concentration of extracellular products does not appreciably change over time or with the 
presence of different species combinations within a community. This indicates that the co-
culture maintained in the continuous-flow model is stable with respect to interspecies 
competition and also with respect to species titres. Studies using PA and SA co-isolated from 
the same lobe of the CF lungs or co-evolved under in vitro conditions have demonstrated that 
the improved co-existence of these species is also accompanied by a suppression in virulence 
factor production (Baldan et al., 2014, Lorè et al., 2012). This suggests that repression of 
virulence factor production is linked to a decrease in competition between species and that, to 
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an extent, my in vitro model is promoting similar microbial behaviours to those thought to occur 
in the CF airways. However, the in situ behaviour of polymicrobial communities associated 
with this environmental niche are poorly understood, so no further comment can be made on 
this. 
It is interesting to note that under continuous-flow conditions the accumulation of siderophores 
in the culture vessel is significantly decreased compared with the concentrations attained 
under batch culture conditions. This is despite access to iron remaining an essential 
requirement for the proliferation and survival of the same combination of microbial species 
present under both conditions. This is unsurprising given that pyoverdine synthesis is, in part, 
under the control of the lasIR QS system (Stintzi et al., 1998) and that OdDHL accumulated 
to a much lower concentration in the continuous-flow cultures too. However, this observation 
clearly demonstrates that interspecies competition for resources is decreased using the novel 
in vitro culture system described in this work. It could be hypothesised that through the 
provision of a plentiful supply of nutrients, not unlike the overabundance of nutrient rich sputum 
available in the CF airway microenvironment due to the hyperproduction of airway secretions 
(Kreda et al., 2012), there is a suppression of interspecies virulence factor production typically 
used to compete for access to limited resources. Allowing mixed species communities that 
would ordinarily outcompete one another under nutrient-limited batch culture conditions to be 
successfully maintained using the continuous-flow model.  
The presence of co-cultivating species, even if present at less than 0.05% of the total 
population (Section 3.5), caused significant and varied modulations in the accumulation of all 
the measured extracellular compounds under batch culture conditions. These findings are 
consistent with existing reports on the competition between species and a dysregulation of 
virulence factor production under nutrient-limited conditions. This affirms the need to consider 
how the presence of less abundant species, and not simply the principal pathogens, impinges 
upon the network of interspecies interactions present among a polymicrobial consortium.  
Another key conclusion to be drawn from the data presented in this chapter is that the 
mutability of species cultured within the continuous-flow system is not adversely affected by 
the culture conditions, and mutation rates are stable irrespective of time or the presence of 
co-cultivated species. Furthermore, cells in the continuous-flow model appear to be 
maintained in a metabolically active and continually-dividing state for the entirety of the 
incubation period. Taken together these results indicate that the model provides an 
experimentally tractable system suitable for studying how the presence of additional species 
impacts upon the metabolic activity and evolutionary trajectory of mixed species populations 
cultured under nutritionally similar conditions to the CF microenvironment. The results 
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presented in this chapter provide a proof-of-principle to the robustness and versatility of the 
culture model. Any number of biochemical and phenotypic assays could be performed in real-
time on any combination of microbial species maintained as a co-culture in the continuous-
flow model. Thus allowing numerous biological questions pertaining to interspecies 




5. Perturbation of steady-state microbial communities 
5.1 Introduction of PA to SA-CA co-culture 
5.1.1 Introductory Comments 
As previously described (Section 1.2), the establishment of chronic PA infections is correlated 
with a worsened patient prognosis (Cox et al., 2010, Zhao et al., 2012). The airways of infant 
and adolescent patients remain largely free from PA colonisation (Conrad et al., 2013, Rogers 
et al., 2005, Tunney et al., 2008). Yet, by ages 18-20, 60-80% of persons with CF test positive 
for infection with PA (2015, Folkesson et al., 2012, Stressmann et al., 2011). Previous failings 
in the long-term co-cultivation of species associated with the CF microenvironment have 
prevented investigations into how PA interacts with a pre-existing microbial community. The 
continuous-flow model described in this work provides a physiologically relevant and robust 
method for the study of how the introduction of new species perturbs pre-existing, steady-state 
microbial populations. As a proof-of-principal for this concept, I initially studied how the 
introduction of PA, at different inoculum densities, perturbs the microbial titres of pre-
established SA-CA co-cultures grown under continuous-flow conditions.  
 
5.1.2 OD600 nm Measurements 
Average OD600 nm measurements of pre-established steady-state SA-CA co-cultures following 
the introduction of PA at different inoculation densities are shown in Figure 5.1. There was no 
significant difference (P > 0.9) in the optical density of the SA-CA co-cultures before the 
introduction of PA (T = 0 hrs) and there was no statistically significant change (P > 0.5) in the 
optical density of any co-culture between T = 1 h and 8 hrs. Over this incubation period the 
average density of cultures inoculated with PA at an OD600 nm 0.25 or 0.5 were significantly 
higher (P < 0.01) than the other cultures. 
After 24 hrs incubation, there was no significant difference (P > 0.8) in the density of co-
cultures inoculated with OD600 nm 0.05 or 0.1 PA and there was no statistically significant 
change (P > 0.9) in the density of these cultures between T = 24 and 120 hrs. The cell density 
of the culture inoculated with OD600 nm 0.5 PA was significantly higher (P < 0.0001) than all 
other co-cultures at T = 24 hrs and density of the culture inoculated with 0.25 PA was 
significantly higher (P < 0.0001) than the remaining co-cultures at this point of sampling. A 
significant (P < 0.0001) 0.55-unit decrease in the density of the co-culture inoculated with 
OD600 nm 0.25 PA occurred between 24 and 72 hrs of incubation. There was no significant 










Figure 5.1 Population density following the addition of PA to a steady-state SA-CA co-
culture. 
Dual-species co-cultures of S. aureus 25923 and C. albicans SC5314 were grown for 24 hrs 
in ASM under continuous-flow conditions (as shown in Section 3.5). P. aeruginosa PAO1 was 
then inoculated into the culture vessel, at different densities, at T = 0 hrs and OD600 nm 
measured for 120 h. Normalised overnight cultures of PA were introduced to the steady state 
co-cultures at the following densities: OD600 nm 0.05 (black), 0.1 (red), 0.25 (blue) and 0.5 




and there was no statistically significant difference (P > 0.9) between the density of co-cultures 
inoculated with OD600 nm 0.1 or 0.25 PA between T = 72 and 120 hrs. A significant (P < 0.0001) 
≈ 2.5-unit decrease in the density of the culture inoculated with OD600 nm 0.5 PA occurred 
between T = 24 and 120 hrs. There was no significant difference (P > 0.5) in average endpoint 
OD600 nm measurements of the cultures inoculated with OD600 nm 0.1, 0.25 and 0.5 PA) at the 
endpoint of sampling (OD600 nm = 1.61, 1.63 and 1.83, respectively).  
 
5.1.3 Viable cell counts 
Viable cell counts of individual species present in pre-established SA-CA co-cultures following 
the introduction of PA at different inoculation densities are shown in Figures 5.2 and 5.3. There 
was no appreciable difference (P > 0.9) in viable SA or CA cell counts of any steady-state co-
culture before the introduction of PA and the viable cell counts presented in Section 3.5.4. 
Furthermore, there was no significant change (P > 0.9) in SA or CA viable cell counts over the 
incubation period for co-cultures inoculated with OD600 nm 0.05 or 0.1 PA (Figure 5.2.A and 
5.2.B, respectively). Inoculation with OD600 nm 0.05 or 0.1 PA resulted in the introduction of ≈ 8 
x 106 or ≈ 3 x 107 PA CFU mL-1 (respectively) into the steady-state co-culture. A 0.5-log fold 
increase in viable PA cell counts occurred between 0 and 24 hrs incubation for the co-culture 
inoculated with OD600 nm 0.05 PA, although this change was not statistically significant (P > 
0.8). By contrast, a significant (P < 0.01) log-fold increase in PA CFU mL-1 occurred between 
T = 0 and 24 hrs in the culture vessel inoculated with OD600 nm 0.1 PA. There was no significant 
change (P > 0.9) in PA titres in either co-culture after 24 hrs incubation. 
Inoculation of PA into the culture vessel at an optical density of 0.25 resulted in the introduction 
of ≈ 4x108 CFU mL-1 into the steady-state co-culture and there were significantly more (P < 
0.0001) viable PA cells than SA or CA cells at this initial time point (Figure 5.3.A). A significant 
(P < 0.0001) 2.8x108 decrease in PA CFU mL-1 occurred between T = 0 and 6 hrs, but was 
followed by a significant (P < 0.0001) log-fold increase in viable PA cells between T = 6 and 
24 hrs, with ≈3x109 PA CFU mL-1 present within the culture vessel at T = 24 hrs. A significant 
(P < 0.0001) log-fold decrease in viable PA cells present within the co-culture then occurred 
between 24 and 48 hrs incubation and there was no significant change (P > 0.05) in viable PA 
cell counts following T = 48 hrs. A respective 0.5-log and 1-log decrease in viable SA and CA 
cell counts occurred between 8 and 24 hrs incubation, yet this change was not statistically 
significant (P > 0.9). There was no appreciable difference in viable SA cell counts within the 
co-culture between T = 8 hrs and any time point following 48 hrs incubation and viable CA cell 





Figure 5.2 Viable cell counts of individual species following the addition of PA to a 
steady-state SA-CA co-culture.  
Dual-species co-cultures of S. aureus 25923 and C. albicans SC5314 were grown under 
continuous-flow conditions for 24 hrs (as in Section 3.5). At T = 0 P. aeruginosa PAO1 was 
inoculated into the culture vessel at OD600 nm 0.05 (A) or 0.1 (B). Data represented as mean 
viable cell counts of PA (black), SA (white) and CA (grey) ± standard deviation following 





Figure 5.3 Viable cell counts of individual species following the addition of PA to a 
steady-state SA-CA co-culture. 
Dual-species co-cultures of S. aureus 25923 and C. albicans SC5314 were grown under 
continuous-flow conditions for 24 hrs (as in Section 3.5). At T = 0 (above) P. aeruginosa PAO1 
was inoculated into the culture vessel at OD600 nm 0.25 (A) or 0.5 (B). Data represented as 
mean viable cell counts of PA (black), SA (white) and CA (grey) ± standard deviation following 
inoculation of PA from three independent experiments. 
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Inoculation of PA into the culture vessel at OD600 nm 0.5 resulted in ≈8x109 PA CFU mL-1 being 
introduced into the steady-state co-culture (Figure 5.3.B). There was no significant change (P 
> 0.5) in viable PA cell counts between T = 0 and 8 hrs. A significant (P < 0.0001) 2-log fold 
increase in PA viable cell counts occurred between T = 8 and 24 hrs, with ≈8.6x1011 PA CFU 
mL-1 being present in the co-culture at the 24 hrs timepoint. Following this, there was a 
significant (P < 0.0001) log-fold decrease in viable PA cell counts at every point of sampling 
between T = 24 and 96 hrs, and there was no statistically significant change (P > 0.9) in PA 
viable cell counts between 96 hrs and the final point of sampling. A significant (P < 0.0001) 2-
log fold decrease in viable SA and CA cell counts present in the co-culture occurred between 
T = 0 and 24 hrs. Following this decline, an approximate log-fold increase in viable CA and 
SA cells occurred every 24 hrs until the final point of sampling. There was no appreciable 
difference in average viable SA or CA cell counts (≈1.3x108 and ≈4.5x105 CFU mL-1, 
respectively) present in the co-culture between T = 0 or 120 hrs and there was no significant 
difference (P > 0.9) in endpoint PA or SA viable cell counts. It is important to note that there 
was no significant difference in endpoint PA CFU mL-1 counts between the co-cultures 
inoculated with PA at an optical density of 0.1, 0.25 or 0.5. 
 
5.1.3 Conclusions 
The introduction of PA, at any of the above inoculation densities, into pre-established microbial 
co-cultures maintained under continuous-flow conditions resulted in the same steady-state 
endpoint community, with respect to culture density and viable cell counts, maintained in the 
culture vessel. The reduction of viable PA cells observed between 24 and 120 hrs of incubation 
in the co-culture inoculated with the highest PA density (OD600 nm 0.5), indicates that the 
endpoint microbial density measured in the co-cultures is the maximum steady-state carrying 
capacity supported by the in vitro model. The only significant perturbation of steady-state SA 
or CA viable cell counts occurred when introducing PA at the highest density into the culture 
vessel. Given that titres of viable SA and CA cells quickly recover to the level observed prior 
to the inoculation of PA, and that QS molecules and extracellular virulence factors do not 
accumulate in the culture vessel under continuous-flow conditions (Section 4.), this initial 
decrease in SA and CA cell counts may simply be attributed to a temporary displacement of 
cells from the culture vessel and not species out-competition. From the results presented in 
this sub-section, further investigation may be warranted into what changes occur in the gene 
expression and microbial physiology of species maintained in the co-culture between 0 and 
24 hrs incubation in order to discern how PA modulates changes in microbial behaviour and 
what factor(s) are responsible for the initial diminution in the titres of co-cultivated species.  
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5.2 Antimicrobial treatment of single-species and mixed-species populations 
5.2.1 Introductory comments 
In the clinical setting, microbial infections are treated with antimicrobial compounds in an 
attempt to diminish the burden of a principal pathogenic species. For instance, the onset of 
APEs in persons with CF is met with aggressive antimicrobial treatment designed to reduce 
the titre of viable PA cells harboured within the airways. Antimicrobials are often designed with 
the treatment of a specific pathogen in mind and so are commonly developed and validated 
in vitro using axenic microbial cultures, yet little is known about how mixed microbial 
populations respond to antimicrobial intervention. As previously discussed in Section 1 and 
demonstrated in Section 4, microbial species exhibit different behaviours and physiologies 
when grown as polymicrobial communities opposed to axenic cultures. Given the diversity of 
the microbiota associated with CF airway infections, it is likely that pathogens in situ respond 
in an unpredictable manner to the addition of antimicrobials and this may, in part, contribute 
towards refractory responses to treatment (Vandeplassche et al., 2019). 
Understanding how polymicrobial populations respond to antimicrobial perturbation is 
essential if we are to develop improved treatments to manage chronic airway infections. As 
previously detailed in Section 3, competition among species during traditional co-culture 
approaches hinder such studies, as mixed microbial co-cultures cannot be stably maintained 
in vitro. Previous studies have therefore relied on comparing the action of antimicrobials 
against single-species and mixed-species biofilms (Al-Bakri et al., 2005, Burmølle et al., 2006, 
Chen et al., 2019, Elias and Banin, 2012, Kara et al., 2006, Leriche et al., 2003, Whiteley et 
al., 2001). Although these studies are useful for studying a chronic infection scenario, microbial 
species behave very differently when grown as sessile or planktonic communities (Davey and 
O'Toole, 2000). As described in guidelines published by the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST), standardised minimum inhibitory 
concentration (MIC) tests should be performed on liquid cultures (Clinical and Laboratory 
Standards Institute, 2019). It is therefore difficult to compare the results from the antimicrobial 
treatment of biofilms between experiments and with clinical breakpoint data. Furthermore, 
limited studies into the effects of antimicrobials on mixed bacterial populations grown as liquid 
cultures have identified altered responses to antimicrobials compared with axenic cultures 
(Galera-Laporta and Garcia-Ojalvo, 2020) affirming the need for further investigation into this 
phenomenon. As highlighted in Section 1.5, microbial physiology during biofilm growth more 
closely resembles the physiology of species during the stationary phase, where microbes are 
thought to be slow growing and more tolerant against antimicrobial action (Kamble and 
Pardesi, 2020). Conversely, steady-state microbial populations grown in the continuous-flow 
model are consistently maintained in the exponential growth phase (Section 4.2). Hence, the 
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continuous-flow model provides an unparalleled opportunity to robustly study how actively 
growing polymicrobial populations of key CF airway-associated pathogens respond to 
common clinically used antimicrobial compounds under physiologically relevant conditions, a 
feat that is simply not possible using existing in vitro models. 
The results presented in this section describe the perturbation of pre-established steady-state 
mono-species and polymicrobial planktonic cultures of PA, SA and CA with three clinically-
relevant species-specific antimicrobials: colistin, fusidic acid and fluconazole. It is important to 
note that antimicrobial compounds were added to the culture vessel after 24 hrs incubation 
and cultures were incubated under batch culture conditions for one hour before restoring liquid 
flow (as described in Section 2.11.3). As fresh ASM enters the culture vessel it gradually 
dilutes the antimicrobial, loosely mimicking the metabolism and excretion of antimicrobials 
when provided to a patient in situ. 
Colistin (also known as polymyxin E) is a last-resort treatment for multi-drug resistant Gram-
negative species, such as PA. Colistin is a bactericidal polycationic peptide that contains 
hydrophilic and lipophilic moieties. Cationic charges in the polypeptide portion of colistin are 
thought to electrostatically bind to the negatively charged lipopolysaccharide (LPS) in the outer 
membrane of PA. Colistin then displaces the membrane-stabilising divalent cations (Mg2+ and 
Ca2+) in the outer membrane leading to disruption of the membrane integrity and subsequent 
lysis of Gram-negative bacteria in aqueous environments (Bialvaei and Samadi Kafil, 2015). 
Fusidic acid is a bacteriostatic steroidal compound effective against Gram-positive species 
and is primarily used as an antistaphylococcal antibiotic. Fusidic acid inhibits protein 
translation by binding to elongation factor G, preventing conformational changes in the 
enzyme and resulting in inhibition of peptide translocation and ribosome disassembly 
(Fernandes, 2016). Fluconazole is a broad-spectrum fungistatic or fungicidal compound, 
clinically used to treat numerous fungal infections, including candidiasis and cryptococcosis. 
This antifungal agent is a fluorine-substituted, bis-triazole that binds to fungal cytochrome P-
450 and prevents the conversion of lanosterol to ergosterol, an essential component of the 
fungal cell wall (Pasko et al., 1990).  
 
5.2.2 MIC of antimicrobials in ASM 
Firstly, the MIC of the antimicrobial compounds against the different microbial species in ASM 















Minimum Inhibitory Concentration (µg mL-1) 
 
Colistin Fusidic Acid Fluconazole 
P. aeruginosa PAO1 4 >256 >256 
S. aureus 25923 >256 0.0156 >256 
C. albicans SC5314 >256 >256 1 
 
Table 5.1 Minimum inhibitory concentration of antimicrobial compounds. 
Minimum inhibitory concentration (MIC, µg mL-1) of colistin, fusidic acid and fluconazole 
against P. aeruginosa PAO1, S. aureus 25923 and C. albicans SC5314 grown in ASM. MICs 
were determined using the EUCAST broth microdilution method and MIC considered as the 
lowest concentration able to inhibit visible microbial growth after 16 hrs incubation. MIC values 





acid against SA was 15.6 ng mL-1 and the MIC of fluconazole against CA was 1 µg mL-1. As 
expected from previous reports, the compounds were specifically active against the 
aforementioned species only and did not inhibit the growth of the other species at a 
concentration of 256 µg mL-1. The MICs experimentally determined in ASM demonstrated in 
this sub-section are comparable with the published clinical breakpoint values collected using 
cation-adjusted Müller-Hinton II broth (EUCAST, 2020a, EUCAST, 2020b). 
 
5.2.3 Treatment with colistin 
5.2.3.1 Viable Cell Counts 
Viable cell counts of pre-established PA mono-species and polymicrobial populations grown 
in ASM under continuous-flow conditions following the addition of 1 x MIC (4 µg mL-1), 2 x MIC 
(8 µg mL-1) or 5 x MIC (20 µg mL-1) colistin are shown in Figure 5.4, 5.5 and 5.6, respectively. 
There was no appreciable difference in CFU mL-1 counts between any mono-species or 
polymicrobial culture before the addition of colistin. There was no statistically significant 
difference (P > 0.9) in viable cell counts between T = 0 and 24 hrs in the mono-species PA 
culture treated with 1 x MIC colistin (Figure 5.4.A). A significant (P < 0.0001) 2-log fold increase 
in PA CFU mL-1 counts was observed between T = 0 and 48 hrs. Similarly, there was no 
significant change (P > 0.9) in PA titres for the polymicrobial population treated with 1 x MIC 
colistin for the first 24 hrs of incubation and a significant (P < 0.0001) log-fold increase in viable 
PA cells occurred between T = 0 and 48 hrs (Figure 5.4.B). There was no significant change 
(P > 0.9) in SA or CA titres over the course of the incubation period. 
A significant (P < 0.001) 4-log fold decrease in PA titres occurred in the mono-species culture 
vessel treated with 2 x MIC colistin between T = 0 and 3 hrs (Figure 5.5.A). Following this a, 
respective, log-fold and 2-log fold increase in PA CFU mL-1 counts occurred in the culture by 
5 and 8 hrs incubation, although viable cell counts at these points remained significantly lower 
(P < 0.01) than the initial point of sampling. There was a significant (P < 0.001) log-fold 
increase in PA CFU mL-1 counts between T = 0 and 24 hrs and no significant change (P > 0.9) 
in viable cell counts occurred between 24 and 48 hrs incubation. A significant (P < 0.01) 2-log 
fold decrease in PA titres occurred between T = 0 and 3 hrs within the polymicrobial culture 
treated with 2 x MIC colistin. There was a 2-log fold increase in PA titres between T = 3 and 8 
hrs and there was no statistically significant difference (P > 0.9) in PA titres between 0 and 8 
hrs incubation. A significant (P < 0.001) log-fold increase in viable PA cell counts was observed 
between T = 0 and 24 or 48 hrs incubation. No significant change (P > .0.9) in viable SA or 






Figure 5.4 Addition of 1 x MIC colistin to steady-state microbial cultures. 
Mono-species P. aeruginosa PAO1 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1 in steady-state (24 hrs) (A) mono-species PA and (B) mixed-species populations 
following the addition of 4 µg mL-1 colistin to the culture vessel at T = 0 hrs. Data represented 
as the mean ± standard deviation from three independent experiments. Asterisks represent 
significant (**** P < 0.0001) differences in PA CFU mL-1 counts in comparison to counts at the 






Figure 5.5 Addition of 2 x MIC colistin to steady-state microbial cultures. 
Mono-species P. aeruginosa PAO1 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species PA and (B) mixed-species populations 
following the addition of 8 µg mL-1 colistin to the culture vessel at T = 0 hrs. Data represented 
as the mean ± standard deviation from three independent experiments. Asterisks represent 
significant (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001) differences in PA CFU mL-1 






Figure 5.6 Addition of 5 x MIC colistin to steady-state microbial cultures. 
Mono-species P. aeruginosa PAO1 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species PA and (B) mixed-species populations 
following the addition of 20 µg mL-1 colistin to the culture vessel at T = 0 hrs. Data represented 
as the mean ± standard deviation from three independent experiments. Asterisks represent 
significant (** P < 0.01, **** P < 0.0001) differences in PA CFU mL-1 counts in comparison to 
counts at the 0 hrs timepoint. P > 0.05 is considered no significant difference (ns). 
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A significant (P < 0.0001) 4-log fold decrease in PA titres occurred between T = 0 and 1 hrs 
in the mono-species culture perturbed with 5 x MIC colistin (Figure 5.6.A). No viable PA cells 
were recovered from the culture vessel at 3 or 5 hrs incubation and fewer than 3 PA CFU mL-
1 were recovered from the culture vessels at 8 hrs of incubation. Following this, there was a 
significant 7-log fold increase in PA titres and there was no significant difference (P > 0.9) in 
CFU mL-1 counts between T = 0 and 24 hrs. A further log-fold increase in PA cell counts 
occurred between the 24 and 48 hrs timepoints and final viable cell counts were significantly 
higher (P < 0.0001) than the initial point of sampling. A significant (P < 0.01) 2-log fold 
decrease in PA titres occurred between T = 0 and 1 hrs in the steady-state polymicrobial 
population treated with 5 x MIC colistin (Figure 5.6.B). There was no significant change (P > 
0.9) in PA CFU mL-1 counts between 1 and 8 hrs incubation. A 2-log fold increase in PA titres 
occurred between T = 8 and 24 hrs and there was no significant difference in PA CFU mL-1 
counts between 0 and 24 hrs incubation. A further log-fold increase in PA titres occurred 
between 24 and 48 hrs incubation and there was significantly more (P < 0.0001) PA CFU mL-
1 at the endpoint of sampling compared with the initial timepoint. No significant change (P > 
0.9) in viable SA or CA titres was observed across any point of sampling.  
 
5.2.3.2 OD600 nm measurements 
Average OD600 nm measurements of single-species and polymicrobial populations treated with 
1 x, 2 x or 5 x MIC colistin are displayed in Figure 5.7. The cell density of the polymicrobial 
populations were significantly higher (P < 0.0001) than that of the mono-species cultures and 
there was no appreciable difference in the starting OD600 nm measurements of the pre-
established cultures treated with different concentrations of colistin before the addition of the 
antimicrobial. There was no significant difference (P > 0.9) in OD600 nm measurements between 
T = 0 and 8 hrs for both cultures treated with 1 x MIC colistin. There was a significant (P < 
0.05) 0.2-unit increase in the density of the polymicrobial population treated with 1 x MIC 
colistin between 8 and 24 hrs incubation and a further significant (P < 0.05) 0.2-unit increase 
in average OD600 nm measurements between T = 24 and 48 hrs. A significant (P < 0.0001) 0.4-
unit increase in the density of the mono-species PA culture treated with 1 x MIC colistin 
occurred between T = 8 and 24 hrs and there was no significant difference (P > 0.7) in the cell 
density of the culture following this point.  
Again, there was no significant difference (P > 0.8) in the density of both steady-state cultures 
treated with 2 x MIC colistin between T = 0 and 8 h. A significant (P < 0.0001) 0.6-unit increase 
in the density of the mono-species PA culture occurred between T = 0 and 24 hrs and there 










Figure 5.7 Optical density of steady-state cultures following the addition of colistin. 
Mono-species P. aeruginosa PAO1 (squares) and mixed-species cultures of P. aeruginosa 
PAO1, S. aureus 25923 and C. albicans SC5314 (circles) were grown to a steady-state in 
ASM under continuous-flow conditions. Total culture density (OD600 nm) was then measured 
following the addition of (A) 4; (B) 8 and (C) 20 µg mL-1 colistin to the culture vessel. Data 
represented as the mean ± standard deviation from three independent experiments.  
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between 24 and 48 hrs incubation. A significant (P < 0.01) 0.3-unit increase in optical density 
measurements occurred between T = 0 and 24 hrs within the polymicrobial population and a 
further significant (P < 0.01) 0.3-unit increase in cell density occurred between 24 and 48 hrs 
incubation. 
A 0.3-unit decrease in average OD600 nm measurements occurred between T = 0 (OD600 nm 0.38) 
and 8 hrs (OD600 nm 0.08) in the PA mono-species culture treated with 5 x MIC colistin, although 
this change was not statistically significant (P > 0.05). An ≈ 0.4-unit increase in average cell 
density measurements then occurred between 8 and 24 hrs incubation and there was no 
significant difference (P > 0.9) in OD600 nm values at T = 0 or 24 hrs. A further ≈ 0.4-unit increase 
in OD600 nm measurements occurred between 24 and 48 hrs incubation and the average 
endpoint optical density measurements of the mono-species culture (OD600 nm 0.88) were 
significantly higher (P < 0.01) than the initial point of sampling. There was a significant (P < 
0.0001) 0.8-unit increase in the average optical density of the polymicrobial population treated 
with 5 x MIC colistin between T = 0 hrs (OD600 nm 1.35) and 1 h (OD600 nm 2.13). Optical density 
continued to increase until T = 3 hrs (OD600 nm 2.47) and there was a significant (P < 0.0001) 
0.7-unit decline in the density of the culture between 3 and 8 hrs incubation. There was no 
significant difference (P > 0.9) in average OD600 nm measurements of the polymicrobial culture 
between T = 0 and 24 hrs, however optical density measurements of the co-culture at the 
endpoint of sampling (OD600 nm 1.77) were significantly higher (P < 0.05) than the density of 
the culture before the addition of colistin.  
 
5.2.4 Treatment with fusidic acid 
5.2.4.1 Viable Cell Counts 
Viable cell counts of pre-established SA mono-species and polymicrobial populations grown 
in ASM under continuous-flow conditions following the addition of 1 x MIC (15.6 ng mL-1), 2 x 
MIC (31.2 ng mL-1) or 5 x MIC (78 ng mL-1) fusidic acid are shown in Figure 5.8, 5.9 and 5.10, 
respectively. There was no appreciable difference in CFU mL-1 counts between any mono-
species or polymicrobial culture before the addition of fusidic acid. There was no statistically 
significant (P > 0.05) change in SA titres present in the mono-species culture treated with 1 x 
MIC fusidic acid between T = 0 and any subsequent point of sampling (Figure 5.8.A). A 0.4-
log fold decrease in viable cell counts did occur between 0 and 5 hrs incubation and SA CFU 
mL-1 counts at this point were significant lower (P < 0.01) than endpoint CFU counts. There 
was no significant difference (P > 0.6) in viable cell counts of any species within the 






Figure 5.8 Addition of 1 x MIC fusidic acid to steady-state microbial cultures. 
Mono-species S. aureus 25923 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species SA and (B) mixed-species populations 
following the addition of 15.6 ng mL-1 fusidic acid to the culture vessel at T = 0 hrs. Data 





Figure 5.9 Addition of 2 x MIC fusidic acid to steady-state microbial cultures. 
Mono-species S. aureus 25923 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species SA and (B) mixed-species populations 
following the addition of 31.2 ng mL-1 fusidic acid to the culture vessel at T = 0 hrs. Data 





Figure 5.10 Addition of 5 x MIC fusidic acid to steady-state microbial cultures. 
Mono-species S. aureus 25923 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species SA and (B) mixed-species populations 
following the addition of 78 ng mL-1 fusidic acid to the culture vessel at T = 0 hrs. Data 
represented as the mean ± standard deviation from three independent experiments. Asterisks 
represent significant (**** P < 0.0001) differences in SA CFU mL-1 counts in comparison to 
counts at the 0 hrs timepoint. P > 0.05 is considered no significant difference (ns). 
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Similarly, no statistically significant (P > 0.05) change in SA titres could be observed across 
any timepoint for the mono-species SA culture treated with 2 x MIC fusidic acid (Figure 5.9.A). 
As in Figure 5.9.A, there was a non-significant 0.8-log fold decrease in SA CFU mL-1 between 
T = 0 and 8 hrs. There was no significant change in SA or CA titres for the entire period of 
incubation within the polymicrobial population treated with 2 x MIC fusidic acid (Figure 5.9.B). 
Interestingly, a significant (P < 0.001) log-fold increase in PA CFU mL-1 counts occurred 
between T = 0 and 24 hrs and there was no appreciable change (P > 0.9) in viable PA cell 
counts following the 24 hrs point of sampling.  
A significant (P < 0.0001) 1.4-log fold decrease in SA CFU mL-1 counts occurred between T = 
0 and 8 hrs within the mono-species SA culture treated with 5 x MIC fusidic acid (Figure 
5.10.A). SA titres in the culture vessel then increased between 8 and 24 hrs incubation and 
there was no significant difference (P > 0.2) in SA CFU mL-1 counts between T = 0 and 24 hrs. 
Yet, there was a significant (P < 0.0001) 0.5-log fold increase in SA titres between T = 0 and 
48 hrs. There was no statistically significant (P > 0.8) change in SA or CA titres across any 
time point for the polymicrobial culture perturbed with 5 x MIC fusidic acid (Figure 5.10.B). Yet 
an approximate log-fold decrease in average SA CFU mL-1 counts was observed between T 
= 0 and 5 hrs. A significant (P < 0.0001) log-fold increase in PA titres occurred within the 
polymicrobial co-culture between T = 0 and 24 hrs and there was no significant change (P > 
0.9) in PA CFU mL-1 counts following this point of sampling.  
 
5.2.4.2 OD600 nm measurements 
Average OD600 nm measurements of single-species and polymicrobial populations treated with 
1 x, 2 x or 5 x MIC fusidic acid are displayed in Figure 5.11. There was no significant change 
(P > 0.8) in OD600 nm measurements of either of the steady-state cultures treated with 1 x MIC 
fusidic acid or the polymicrobial culture treated with 2 x MIC fusidic acid across all timepoints. 
A significant (P < 0.01) 0.1-unit decrease in average OD600 nm measurements occurred 
between T = 0 and 8 hrs for the SA mono-species population treated with 2 x MIC fusidic acid. 
This was followed by an 0.1-unit increase in optical density measurements between T = 8 and 
24 hrs and a further 0.1-unit increase in OD600 nm values between 24 and 48 hrs incubation. 
The endpoint cell density of the 2 x MIC treated mono-species SA culture was significantly 
higher (P > 0.05) than the density of the culture at the initial point of sampling. There was a 
significant (P < 0.01) 0.2-unit drop in OD600 nm measurements for the SA mono-species steady-
state culture treated with 5 x MIC fusidic acid between T = 0 and 8 hrs. Density of the cell 










Figure 5.11 Optical density of steady-state cultures following the addition of fusidic 
acid. 
Mono-species S. aureus 25923 (squares) and mixed-species cultures of P. aeruginosa PAO1, 
S. aureus 25923 and C. albicans SC5314 (circles) were grown to a steady-state in ASM under 
continuous-flow conditions. Total culture density (OD600 nm) was then measured following the 
addition of (A) 15.6; (B) 31.2 and (C) 78 ng mL-1 fusidic acid to the culture vessel. Data 
represented as the mean ± standard deviation from three independent experiments.  
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significant difference in OD600 nm measurements of the culture at T = 0, 24 or 48 hrs. There 
was no significant difference (P > 0.9) in the optical density of the polymicrobial culture treated 
with 5 x MIC fusidic acid between T = 0 and 8 hrs. A significant (P < 0.0001) 0.45-unit increase 
in average OD600 nm values then occurred between T = 8 and 24 hrs and there was no 
appreciable change (P > 0.9) in the density of the co-culture between 24 and 48 hrs incubation. 
 
5.2.5 Treatment with fluconazole 
5.2.5.1 Viable Cell Counts 
Viable cell counts of pre-established CA mono-species and polymicrobial populations grown 
in ASM under continuous-flow conditions following the addition of 1 x MIC (1 µg mL-1), 2 x MIC 
(2 µg mL-1) or 5 x MIC (5 µg mL-1) fluconazole are shown in Figure 5.12, 5.13 and 5.14, 
respectively. No appreciable difference in CFU mL-1 counts could be observed between any 
mono-species or polymicrobial culture before the addition of fluconazole. There was no 
significant difference (P > 0.7) in CA titres within the mono-species culture treated with 1 x 
MIC fluconazole between T = 0 hrs and any subsequent timepoint (Figure 5.12.A). Similarly, 
there was no statistically significant change (P > 0.9) in CA, PA or SA titres between T = 0 and 
any other point of sampling within the polymicrobial culture treated with 1 x MIC fluconazole 
(Figure 5.12.B). 
A significant (P < 0.01) log-fold decrease in CA titres occurred between T = 0 and 8 hrs in the 
CA mono-species population treated with 2 x MIC fluconazole (Figure 5.13.A). A 0.5-log fold 
increase in CA CFU mL-1 counts then occurred between 8 and 24 hrs of incubation, but viable 
cell counts remained significantly lower (P < 0.05) than the initial point of sampling. At the 
endpoint of incubation, there was no significant difference (P > 0.1) in CA titres compared with 
T = 0 hrs. There was no statistically significant change (P > 0.2) in CA, PA or SA titres across 
all sample points for the polymicrobial population treated with 2 x MIC fluconazole (Figure 
5.13.B). However, a 0.5-log fold decrease in CA titres can be observed between 0 and 8 hrs 
incubation. 
A significant (P < 0.0001) ≈ 2-log fold decrease in CA titres occurred between 0 and 8 hrs 
within the mono-species CA culture treated with 5 x MIC fluconazole (Figure 5.14.A). An 
approximate 0.6-log fold increase in CA CFU mL-1 counts then occurred between T = 8 and 
24 hrs and this was followed by a further 0.6-log fold increase in CA titres present in the culture 
vessel between 24 and 48 hrs incubation. Despite this increase in CA cells, endpoint CA CFU 
mL-1 counts remaining significantly lower (P < 0.05) than the initial point of sampling. As with 
perturbation with 2 x MIC fluconazole. There was no statistically significant change (P > 0.2) 




Figure 5.12 Addition of 1 x MIC fluconazole to steady-state microbial cultures. 
Mono-species C. albicans SC5314 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species PA and (B) mixed-species populations 
following the addition of 1 µg mL-1 fluconazole to the culture vessel at T = 0 hrs. Data 





Figure 5.13 Addition of 2 x MIC fluconazole to steady-state microbial cultures. 
Mono-species C. albicans SC5314 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species PA and (B) mixed-species populations 
following the addition of 2 µg mL-1 fluconazole to the culture vessel at T = 0 hrs. Data 
represented as the mean ± standard deviation from three independent experiments. Asterisks 
represent significant (* P < 0.05, ** P < 0.01) differences in CA CFU mL-1 counts in comparison 




Figure 5.14 Addition of 5 x MIC fluconazole to steady-state microbial cultures. 
Mono-species C. albicans SC5314 and mixed-species cultures of P. aeruginosa PAO1 (black 
bars), S. aureus 25923 (white bars) and C. albicans SC5314 (grey bars) were grown to a 
steady-state in ASM under continuous-flow conditions. Bars represent viable cell counts (CFU 
mL-1) in steady-state (24 hrs) (A) mono-species PA and (B) mixed-species populations 
following the addition of 5 µg mL-1 fluconazole to the culture vessel at T = 0 hrs. Data 
represented as the mean ± standard deviation from three independent experiments. Asterisks 
represent significant (* P < 0.05, ** P < 0.01, **** P < 0.0001) differences in CA CFU mL-1 




treated with 5 x MIC fluconazole (Figure 5.14.B). However, a non-significant ≈log-fold 
decrease in CA titres was observed between 0 and 8 hrs incubation. By contrast, a significant 
(P < 0.001) log-fold increase in PA CFU mL-1 counts occurred between 0 and 24 hrs incubation 
and there was no significant change (P > 0.9) in PA titres following this.  
 
5.2.5.2 OD600 nm measurements 
Average OD600 nm measurements of single-species and polymicrobial populations treated with 
1 x, 2 x or 5 x MIC fluconazole are shown in Figure 5.15. Across all time points there was no 
statistically significant change (P > 0.4) in OD600 nm measurements of the mono-species or 
polymicrobial steady-state cultures treated with 1 x MIC or 2 x MIC fluconazole. There was a 
significant (P < 0.05) 0.3-unit increase in OD600 nm measurements between 0 and 2 hrs 
incubation (OD600 nm 1.78 and 2.08, respectively) for the mono-species CA culture treated with 
5 x MIC fluconazole. This was followed by a significant (P < 0.0001) 0.5-unit decrease in the 
cell density between T = 2 and 8 hrs (OD600 nm 1.54), yet there was no statistically significant 
difference (P > 0.1) the density of the culture between T = 0 and 8 hrs. A steady, but non-
significant (P > 0.9) increase in OD600 nm values then occurred between 8, 24 and 48 hrs of 
incubation. Endpoint average cell density of the mono-species population treated with 5 x MIC 
fluconazole was not statistically different (P > 0.5) from the density at the initial point of 
sampling. A significant (P < 0.0001) 0.4-unit increase in optical density of the polymicrobial 
population treated with 5 x MIC fluconazole occurred between T = 0 and 24 hrs (OD600 nm 1.42 
and 1.84, respectively). There was no appreciable change (P < 0.9) in optical density 
measurements of the polymicrobial co-culture between 24 and 48 hrs incubation.  
 
5.2.6 Conclusions 
Several key conclusions pertaining to the understanding of the antimicrobial perturbation of 
steady-state polymicrobial populations can be drawn from the results presented in this sub-
section. Firstly, the treatment of polymicrobial populations with species-specific antimicrobials 
had less impact on the target microorganism compared with treatment of mono-species 
populations with the same antimicrobial agent. This demonstrates a diminution in the efficacy 
of both microbicidal and microbiostatic compounds when treating mixed species populations. 
Secondly, colistin caused the fastest onset and most pronounced decrease in viable cell 
counts, in both mono-species and polymicrobial cultures, compared with the 
bacteriostatic/fungistatic compounds. This difference might be explained by the rapid lysis of 










Figure 5.15 Optical density of steady-state cultures following the addition of fusidic 
acid. 
Mono-species C. albicans SC5314 (squares) and mixed-species cultures of P. aeruginosa 
PAO1, S. aureus 25923 and C. albicans SC5314 (circles) were grown to a steady-state in 
ASM under continuous-flow conditions. Total culture density (OD600 nm) was then measured 
following the addition of (A) 1; (B) 2 and (C) 5 µg mL-1 fluconazole to the culture vessel. Data 
represented as the mean ± standard deviation from three independent experiments.  
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fluconazole arrest the growth of actively dividing SA and CA cells present in a pre-established 
culture but do not cause cell lysis. Non-replicating populations of SA and CA are then gradually 
displaced from the culture vessel due to the continuous-flow of fresh medium. Incidentally, the 
addition of ASM to the culture vessel dilutes the antimicrobials present and permits the growth 
of species to recommence at later timepoints once sub-MIC concentrations of the antimicrobial 
are reached. These preliminary results suggest that the treatment of pre-established chronic 
microbial infections with bactericidal compounds likely result in more effective clearance of the 
target pathogen. However, further investigation into whether this observation is true for 
different antimicrobial compound classes is required. It is also important to note that the in 
vitro model cannot account for the action of an immune system when clearing microbial 
infections in situ. 
The treatment of steady-state polymicrobial populations with 5 x MIC fusidic acid or 
fluconazole caused a slight inhibition in the growth of the target species. However, this 
decrease in SA and CA titres in the culture vessel was accompanied by a significant increase 
in PA CFU mL-1 counts in both populations. This demonstrates the ability of PA to capitalize 
on exogenous perturbation of a polymicrobial community and increase it’s population in 
response to a diminution in the cell counts of a co-habiting species. This observation is in 
support of the climax-attack model (CAM) of the CF airway-associated microbial ecology 
proposed by Conrad et al. (2013). The CAM hypothesises that PA is a member of both the 
stable and disturbed polymicrobial consortium and becomes the dominant pathogen 
associated with the CF microenvironment by being the most adept at surviving immune 
clearance or clinical intervention. Following the removal of other species during exogenous 
perturbation PA expands into the newly liberated environmental niche previously inhabited by 
other microbial species. Treatment of either steady-state population with colistin or the 
treatment of mono-species SA population with 5 x MIC fusidic acid resulted in a significant 
increase in CFU mL-1 counts between the initial and endpoint of sampling. This finding 
highlights that the failed eradication of a microbial population with antimicrobial compounds 
may select for mutant variants that can rapidly expand to occupy recently-vacated niches 
previously occupied by co-habiting strains/species. Taken in combination, these findings 
affirm the importance of fully understanding how antimicrobial compounds perturb complete 
polymicrobial communities to limit the emergence of pathogenic species whilst treating the 




5.3 Antimicrobial resistance vs tolerance 
5.3.1 Resistance profiles of isolates 
It could not be determined whether the modulated decrease in the titres of a target pathogen 
from a polymicrobial co-culture following the addition of an antimicrobial resulted from an 
increased selection of mutants with inheritable resistance mechanisms within the population 
or if this phenomenon was simply a protective or tolerance effect resulting from the presence 
of other species during co-culture. To investigate this, 48 isolates were randomly collected 
throughout the incubation of both the mono-species and polymicrobial populations treated with 
the different concentration of antimicrobials (as described in Section 2.11.4). The resistance 
profiles of these isolates were compared against the susceptibility of the parental strain 
reported in Section 5.2.2.  
There was no difference in the MIC of fusidic acid required to inhibit growth of the parental SA 
strain and any SA isolate collected from either the mono-species or polymicrobial cultures 
treated with any concentration fusidic acid (data not shown). This demonstrates that the 
decreased removal of viable SA cells from a polymicrobial population following treatment with 
this antimicrobial arises from a protective mechanism owing to the presence of other species 
during co-culture, not an inherited mechanism of resistance.  
The percentage of PA or CA isolates able to grow in the presence of increasing concentrations 
of colistin or fluconazole are shown in Figure 5.16 and Figure 5.17, respectively. The 
resistance profiles of the individual isolates against different antimicrobial concentrations are 
shown in Table 5.2 and Table 5.3, respectively. Unlike the SA isolates, 89.6% and 83.3% of 
the PA strains isolated from the polymicrobial or mono-species cultures, respectively, could 
grow in the concentration of colistin required to inhibit the growth of the parental strain (4 µg 
mL-1). Similarly, 83.3% and 75% of the CA isolates collected from the polymicrobial or mono-
species cultures, respectively, could grow in the concentration of fluconazole required to inhibit 
the parental strain (1 µg mL-1). No CA isolates could grow in the presence of 10 µg mL-1 
fluconazole, yet 31.2% of isolates collected from the polymicrobial culture and 18.8% of the 
isolates from the single-species culture could grow in 5 µg mL-1 fluconazole. Likewise, 29.2% 
and 16.7% of the PA isolates collected from the polymicrobial or mono-species cultures were 
able to grow in 40 µg mL-1 colistin. Furthermore, 14.6% of the polymicrobial culture and 8.3% 
of the axenic culture PA isolates could grow in ASM supplemented with 1 mg mL-1 colistin and 
so are considered fully resistant to this antimicrobial compound. Interestingly, 70.8% of the 
CA isolates and all of the PA isolates able to grow in the presence of the highest concentration 
of the antimicrobials were recovered from the culture vessels treated with 2 x MIC colistin or 













Figure 5.16 Growth of P. aeruginosa isolates in ASM with colistin. 
Percentage (%) of P. aeruginosa PAO1 isolates able to grow in ASM containing the indicated 
concentration of colistin (µg mL-1). Isolates (48 from each condition) were randomly collected 
from single-species (black bars) and mixed-species (white bars) steady-state continuous-flow 
populations challenged with colistin (as described in Section 2.11.4). Ability of isolates to grow 
in different colistin concentrations was determined in microtiter plates incubated at 37°C for 
16 hrs with 100 rpm shaking and results were confirmed over three independent experiments 















Figure 5.17 Growth of C. albicans isolates in ASM with fluconazole. 
Percentage (%) of C. albicans SC5314 isolates able to grow in ASM containing the indicated 
concentration of fluconazole (µg mL-1). Isolates (48 from each condition) were randomly 
collected from single-species (black bars) and mixed-species (white bars) steady-state 
continuous-flow populations challenged with fluconazole (as described in Section 2.11.4). 
Ability of isolates to grow in different colistin concentrations was determined in microtiter plates 
incubated at 37°C for 24 hrs with 100 rpm shaking and results were confirmed over three 






MIC (µg mL-1) of colistin against isolates collected from mono-species culture challenged with: 
1 x MIC colistin 2 x MIC colistin 5 x MIC colistin 
1 4 10 20 20 25 45 >1000 >1000 20 25 45 45 
8 4 10 20 20 20 45 >1000 >1000 20 25 20 20 
24 4 4 4 20 20 20 20 20 20 20 20 20 
48 4 4 4 10 20 20 20 20 20 20 20 20 
 MIC (µg mL
-1) of colistin against isolates collected from polymicrobial co-culture challenged with: 
1 x MIC colistin 2 x MIC colistin 5 x MIC colistin 
1 4 4 4 10 45 45 >1000 >1000 20 20 25 45 
8 20 20 20 20 45 >1000 >1000 >1000 25 25 45 45 
24 4 20 20 20 25 45 >1000 >1000 20 20 25 25 
48 4 10 20 20 20 20 20 20 20 20 20 20 
 
Table 5.2 Resistance profiles of PA isolates collected from steady-state cultures challenged with different concentrations of colistin. 
Isolates of P. aeruginosa were randomly collected from mono-species P. aeruginosa PAO1 (top rows) or polymicrobial P. aeruginosa PAO1, S. 
aureus 25923 and C. albicans SC3514 polymicrobial (bottom rows) steady-state cultures challenged with 1 x minimum inhibitory concentration 
(MIC, left columns), 2 x MIC (middle columns) or 5 x MIC (right columns) colistin (4, 8, 20 µg mL-1, respectively) after 1, 8, 24 or 48 hrs incubation. 
Strains with an MIC of 4, 20, 25 and 45 µg mL-1 colistin are, respectively, denoted by the green, light blue, dark blue, yellow and orange cells. 





MIC (µg mL-1) of fluconazole against isolates collected from mono-species culture challenged with: 
1 x MIC fluconazole 2 x MIC fluconazole 5 x MIC fluconazole 
3 1 1 1 1 2.5 2.5 2.5 10 2.5 2.5 2.5 2.5 
8 1 5 2.5 2.5 5 10 10 10 5 5 10 10 
24 1 1 2.5 2.5 5 5 10 10 2.5 5 5 10 
48 1 1 1 1 2.5 2.5 2.5 2.5 1 2.5 2.5 2.5 
 
MIC (µg mL-1) of fluconazole against isolates collected from polymicrobial co-culture challenged with: 
1 x MIC fluconazole 2 x MIC fluconazole 5 x MIC fluconazole 
3 2.5 2.5 2.5 2.5 5 10 10 10 5 5 5 10 
8 2.5 5 5 10 5 10 10 10 5 5 10 10 
24 1 2.5 5 5 5 5 10 10 2.5 5 5 10 
48 1 1 1 1 2.5 5 10 10 1 1 1 2.5 
 
Table 5.3 Resistance profiles of CA isolates collected from steady-state cultures challenged with different concentrations of 
fluconazole. 
Isolates of C. albicans were randomly collected from mono-species C. albicans SC3541 (top rows) or polymicrobial P. aeruginosa PAO1, S. 
aureus 25923 and C. albicans SC3514 polymicrobial (bottom rows) steady-state cultures challenged with 1 x minimum inhibitory concentration 
(MIC, left columns), 2 x MIC (middle columns) or 5 x MIC (right columns) fluconazole (1, 2, 5 µg mL-1, respectively) after 3, 8, 24 or 48 hrs 
incubation. Strains with an MIC of 1, 2.5, 5 or 10 µg mL-1 fluconazole are, respectively, denoted by the green, yellow, orange and red cells. 
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were collected from the culture vessel at T = 48 hrs. By contrast 17.1%, 45.7% and 31.4% of 
the isolates able to survive the higher antimicrobial challenges were collected at T = 1 or 3, 8 
and 24 hrs, respectively.  
 
5.3.2 Whole genome sequencing of resistant isolates 
To identify the genomic single nucleotide polymorphisms (SNPs) responsible for conferring a 
heritable resistance to the action of 1 mg mL-1 colistin in ASM (Section 5.3.1) whole genome 
sequencing (WGS) was carried out on 8 PA isolates collected from the continuous-flow culture 
vessel challenged with 2 x MIC colistin (8 µg mL-1, Section 5.2.2). Two resistant isolates 
independently collected from the mono-species PA culture after 1 h (isolates A and B) or 8 hrs 
(isolates E and F) exposure to colistin were sequenced alongside the progenitor P. aeruginosa 
PAO1 strain used to inoculate the culture vessel in all experiments. Two resistant isolates 
independently collected from the polymicrobial co-culture after 1 h (isolates C and D) or 8 hrs 
(isolates G and H) exposure to colistin were also sequenced. A summary of the SNPs 
differentiating the genome of the colistin-resistant isolates and the parental strain are shown 
in Table 5.4.  
All sequenced isolates contain the insertion of a single cytosine in the intragenic region of 
dppA1 (PA4496), which encodes a dipeptide ABC transporter substrate-binding protein. 
Although important for the uptake and utilisation of di- and tri-peptides by PA (Pletzer et al., 
2014), this insertion occurs in the non-coding region of dppA1 and so is predicted to have no 
effect on the functionality or expression of the gene product.  
All isolates, except D and H, contain mutations in one of three genes (pilM, pilW or pilF) 
associated with the biogenesis of the type IV fimbrial protein (also called type IV pilin). More 
than 40 genes are involved in the regulation and synthesis of type IV pilin; I refer the reader 
to (Mattick, 2002) for an overview of these. Isolates A, B and C contain a GCGCATAGGA 
insertion at position 531 in pilM (PA5044), resulting in a frameshift mutation at amino acid 177 
onwards. Isolates F and G contain the deletion of a guanosine at position 361 in pilW 
(PA4552), resulting in a frameshift mutation at amino acid 187. Finally, isolate E contains a 
single nucleotide polymorphism (SNP) guanosine to adenine substitution at position 581 in 
pilF (PA3805), resulting in an alanine to valine substitution at amino acid position 194.  
Isolates A, D, E, F and H contain non-synonymous mutations within wzy (PA3154) encoding 
for the B-band O-antigen polymerase. This enzyme catalyses the polymerisation of a 
repeating O-antigen oligosaccharide in the periplasmic space and is essential for 




Table 5.4 Non-synonymous genetic mutations between parental strain and colistin resistant isolates.  
Summary of non-synonymous mutations identified between the genomes of PA isolates resistant to the action of 1 mg mL-1 colistin and the 
genome of the progenitor strain (PAO1) during variant calling analysis. All isolates sequenced were collected from a steady-state continuous-
flow culture after 1 or 8 hrs exposure to 8 µg mL-1 colistin. Culture type identifies if the isolate was obtained from a mono-species (Mono) or 
polymicrobial (Poly) culture. Mutation type is abbreviated to ins (insertion), del (deletion) or SNP (single nucleotide polymorphism). Final columns, 











A Mono 1 
PA3154 wzy B-band O-antigen polymerase SNP missense 1238/ 1317 413/ 438 
PA5044 pilM Type 4 fimbrial biogenesis protein ins frameshift 531/ 1065 177/ 357 
PA4496 dppA1 ABC transporter ins intragenic   




SNP missense 150/1311 50/436 
PA5044 pilM Type 4 fimbrial biogenesis protein ins frameshift 531/ 1065 177/ 357 
PA4496 dppA1 ABC transporter ins intragenic   




SNP missense 701/1080 234/359 
PA5044 pilM Type 4 fimbrial biogenesis protein ins frameshift 531/ 1065 177/ 357 
PA4496 dppA1 ABC transporter ins intragenic   
PA5001 ssg Hypothetical protein SNP missense 569/957 190/318 
D Poly 1 
PA3154 wzy B-band O-antigen polymerase ins frameshift 129/1317 43/438 
PA4496 dppA1 ABC transporter ins intragenic   
E Mono 8 
PA3154 wzy B-band O-antigen polymerase ins frameshift 129/131 43/438 
PA3805 pilF Type 4 fimbrial biogenesis protein SNP missense 581/759 194/252 
PA4496 dppA1 ABC transporter ins intragenic   
F Mono 8 
PA3154 wzy B-band O-antigen polymerase SNP missense 1238/ 1317 413/ 438 
PA4552 pilW Type 4 fimbrial biogenesis protein del frameshift 561/825 187/274 
PA4496 dppA1 ABC transporter ins intragenic   
G Poly 8 
PA4552 pilW Type 4 fimbrial biogenesis protein del frameshift 561/825 187/274 
PA4496 dppA1 ABC transporter ins intragenic   
H Poly 8 
PA3154 wzy B-band O-antigen polymerase ins frameshift 266/1317 89/438 
PA4496 dppA1 ABC transporter ins intragenic   
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ligase (encoded by waaL) attaches a lipid-A core “tail” to the polymerised O-antigen chain to 
anchor the LPS in the outer membrane of PA (Burrows et al., 1996, King et al., 2009). Isolates 
D, E and hrs contain a thymidine insertion at position 129 within wzy, resulting in a frameshift 
mutation from amino acid 43. Isolate A contains a cytosine to thymidine SNP at position 1238, 
resulting in a glycine to aspartic acid substitution at amino acid 413 and isolate F contains a 
guanine to thymidine transversion at position 266 resulting in a premature stop codon at amino 
acid position 89 in the B-band O-antigen polymerase enzyme.  
Isolates B and C contain SNPs in genes belonging to the wbp cluster responsible for the 
biosynthesis of the repeating O-antigen oligosaccharide molecule. Isolate B contains a 
cytosine to adenosine transversion at position 150 in wbpA (PA3159), which encodes a UDP-
N-acetyl-D-glucosamine 6-dehydrogenase (responsible for the dehydrogenation of UDP-D-
GlcNAc to yield UDP-D-GlcNAcA (King et al., 2009)), resulting in a lysine to asparagine 
substitution at amino acid position 50. Isolate C contains a thymidine to cytosine SNP at 
position 701 within wbpE (PA3155), which encodes a UDP-2-acetamido-2-dideoxy-D-ribo-
hex-3-uluronic acid transaminase (responsible for the transamination of UDP-3-keto-D-
GlcNAcA to UDP-D-GlcNAc3NA (King et al., 2009)), resulting in a glycine to arginine 
substation at amino acid position 234.  
Isolate C also contains a SNP thymidine to cytosine substitution at position 569 within ssg 
(PA5001) resulting in a tyrosine to cysteine missense transition at amino acid position 190. 
Although ssg encodes for a hypothetical protein in PA, BLAST alignment of this gene reveals 
an orthologous gene encoding a putative glycotransferase involved in the biosynthesis of LPS 
in Pseudomonas alkylphenolia (Veeranagouda et al., 2011). 
 
5.4 Conclusions  
Examination of the MICs of SA isolates collected from the steady-state axenic and 
polymicrobial cultures challenged with different concentrations of fusidic acid revealed that 
there was no difference in the antimicrobial susceptibility of the parental strain or any 
recovered isolate. This demonstrates that the reduced removal of viable SA cells from a 
steady-state polymicrobial co-culture compared with an axenic SA population is not an 
inherited mechanism of resistance, but is likely to be the result of a protective phenotypic effect 
owing to the presence of PA and/or CA in the co-culture. By contrast, a higher percentage of 
PA or CA isolates collected from the polymicrobial co-cultures treated with colistin or 
fluconazole displayed an increased MIC against the action of the antimicrobials in isolation 
compared with isolates collected from perturbed mono-species steady-state populations. This 
finding is significant as it suggests that PA or CA grown as part of a polymicrobial community 
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increases the emergence of isolates that are inherently resistant to the action(s) of the two 
clinically relevant antimicrobial compounds studied as part of this work.  
WGS of PA isolates resistant to the action of 1 mg mL-1 colistin revealed that there was no 
difference in the non-synonymous mutations identified in the isolates collected from the mono-
species or polymicrobial co-culture populations. This demonstrates that growth as part of a 
polymicrobial population does not cause the emergence of novel mechanisms of colistin 
resistance, but that growth as part of a polymicrobial consortium simply increases the 
prevalence of which these resistance mechanisms arise under continuous-flow conditions. As 
no WGS was performed on the CA isolates with increased resistance profiles, no further 
comments can be made on whether this hypothesis is also true for this microorganism. 
Analysis of the non-synonymous mutations likely to be responsible for conferring the complete 
resistance of PA isolates against the action of colistin identified that all candidate genes 
predicted to impinge upon the production of a functional gene product are involved in the 
biogenesis of LPS or pilin (Table 5.4). It may even by hypothesised that ssg, encoding for a 
hypothetical protein in PA, is also involved in LPS biosynthesis given it’s sequence similarity 
to a putative glycotransferase involved in LPS production in P. alkylphenolia (as mentioned in 
Section 5.2 (Veeranagouda et al., 2011)). Earlier reports have previously implicated the loss 
of functional LPS biosynthesis in Gram-negative bacteria as a mechanism implicated in 
possible resistance against the action of colistin (Han et al., 2018, Kadurugamuwa et al., 1993, 
King et al., 2009). This is perhaps unsurprising, as loss of LPS from the cell envelope prevents 
colistin from forming electrostatic interactions with, and disrupting the integrity, of the outer 
membrane of bacteria. Previous WGS studies have demonstrated that a decrease in the 
expression of genes in the wbp cluster are associated with increased colistin-resistance in 
clinical PA isolates (Gutu et al., 2015). However, the aforementioned study only demonstrated 
that mutations within cprA were responsible for the down-regulation of wbp genes and not 
SNPs within the gene cluster itself. Furthermore, no study has yet demonstrated that SNPs in 
wzy are responsible for conferring colistin-resistance in PA.  
SNPs in genes involved in the biosynthesis of the type IV fimbrial protein were also found in 
most of the sequenced PA isolates in this study. Interestingly, mutations in the pilin biogenesis 
genes have been identified in two separate WGS studies of clinical PA isolates resistant to 
the action of colistin (Lee et al., 2014, Lee et al., 2016). However, no direct evidence has yet 
correlated the loss/mutation of pilin synthesis with conferring colistin resistance or their role in 
the emergence of antimicrobial resistance. Given that isolate G can grow in the presence of 1 
mg mL-1 colistin and only contains a non-synonymous mutation within pilW, this study provides 
strong evidence to suggest that the loss of type IV pilin synthesis pathways can also give rise 
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to colistin-resistant PA strains. The results presented across Section 5.3 identify novel SNPs 
within 7 genes involved in the synthesis of LPS or pilin (wzy, wbpA, wbpE, ssg, pilF, pilM and 
pilW) that are likely to result in resistance to colistin and present a new avenue to pursue the 
targeted inhibition of the emergence of colistin resistance in situ. 
Through examining the MIC of the PA and CA isolates collected over the various time points 
(Table 5.2 and 5.3), it is apparent that isolates gathered from both the mono-species and 
polymicrobial co-cultures at the initial points of sampling (1/3 or 8 hrs post-antimicrobial 
exposure) have higher MICs compared with the isolates collected from the later time points 
(24 or 48 hrs post-antimicrobial exposure). This phenomenon demonstrates a gradual loss of 
inherited resistance mechanisms from the culture vessel over time once the selection pressure 
is removed via the continuous displacement of the antimicrobial compounds with fresh ASM. 
This may indicate a fitness cost associated with the loss of LPS or pilin biosynthetic pathways 
under continuous-flow conditions. However, it should be noted that these genes are generally 
considered to be important in vivo virulence factors important for mediating bacterium-host 
interactions (Bucior et al., 2012, Persat et al., 2015) and evidence in the literature suggests 
they are not important for in vitro growth (Ramphal et al., 1991). Instead, it is possible that the 
overall diminution of microbial titres following an antimicrobial challenge allows for faster 
growing isolates, lacking colistin/fluconazole resistance mechanisms, to emerge in a 
perturbed microbial population within the continuous-flow culture vessel in the absence of a 
selection pressure (as is proposed by the CAM model, discussed in Section 5.2.5 (Conrad et 
al., 2013)). Thus, these faster growing, but more susceptible isolates, reduce the prevalence 
of the resistant isolates maintained in the culture vessel. This hypothesis is supported by the 
significant increase in viable cell counts observed within the culture vessel after 48 hrs 
antimicrobial exposure, despite Q remaining constant. The increased cell density of the culture 
maintained in the continuous-flow vessel at the later points of sampling thereby demonstrates 
an elevated growth rate of species above the rate of dilution previously suitable for maintaining 
a stable, steady-state microbial population in vitro. 
The majority of PA or CA isolates displaying the highest colistin or fluconazole MIC in ASM 
were recovered from the axenic and polymicrobial populations treated with 2 x MIC of the 
antimicrobials discerned in Table 5.1. In combination with the viable cell counts presented 
across Section 5.2, this finding suggests that challenging the continuous-flow culture vessel 
with 1 x MIC of an antimicrobial (quickly becoming a sub-inhibitory concentration of the 
compound due to the flow of fresh ASM) does little to perturb a steady-state microbial 
community and does not exert a significant pressure to select for antimicrobial resistant 
mutants. Conversely, treating a population with a supra-concentration of an antimicrobial (5 x 
MIC) limits the emergence of highly-resistant microbial strains within a population under 
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continuous-flow conditions. These findings therefore indicate that there might be significant 
clinical benefit to treating infections with a high concentration of antimicrobials to limit the 











6. Polymicrobial biofilms 
6.1 Introductory comments 
As described in Section 1.5, biofilm formation is often cited as the major reason chronic 
microbial infections are not effectively cleared by the immune system or display refractory 
responses to therapeutic intervention. In fact, the establishment of chronic PA biofilms during 
CF infection is the best described example of biofilm formation in medicine (Høiby et al., 2017). 
With the importance of understanding how interspecies interactions modulate changes in 
microbial behaviour now apparent, attention is moving towards understanding the formation 
and behaviour of polymicrobial biofilms using a range of models and experimental approaches 
(Haney et al., 2018). However, only a handful of published studies have utilised physiologically 
relevant CF growth medium (i.e. ASM or synthetic cystic fibrosis sputum) for the growth and 
characterisation of microbial biofilms. The work of Sriramulu et al. (2005) successfully 
demonstrated that PA cultured in ASM forms microcolonies resembling in situ CF airway 
growth (Sriramulu et al., 2005) and Diaz Iglesias et al. (2019) have recently characterised the 
growth of SA biofilms in ASM (Diaz Iglesias et al., 2019). The main focus of previous studies 
utilising ASM to study biofilms has focused on understanding the evolutionary diversification 
of PA biofilms (Davies et al., 2017) or assessing the effects of novel therapeutics on single-
species PA biofilms (Grassi et al., 2019, Kosztołowicz et al., 2020, Maisetta et al., 2017). A 
literature search reveals a single paper describing the co-culture of PA and SA biofilms using 
ASM (Haley et al., 2012). 
The work presented in this chapter aims to characterise the temporal formation of axenic and 
polymicrobial biofilms grown in ASM under nutrient limited (batch culture, see Section 2.12.1) 
and nutrient rich (continuous-flow, see Section 2.12.2) conditions. I also sought to develop a 
novel method of biofilm cultivation compatible with my existing continuous-flow model (Section 
2.11.3). A comparison of mono-species and polymicrobial biofilm growth on two different solid 
substrata, agar cubes or sections of ex vivo porcine lung tissue (EVPL), is also presented in 
this chapter. Experiments using EVPL were conducted by myself under the guidance and 
supervision of Dr Freya Harrison at the University of Warwick. 
To address the limitations of commonly-used biofilm assays a complimentary and 
combinatorial approach to assess biofilm growth over time was utilised. Crystal violet (CV) 
staining of microbial populations attached to microtiter plate wells, popularised in the 1990’s 
(Mack et al., 1994, O'Toole et al., 1999), was used as a rapid and cost-effective method of 
quantifying the total adherent biomass of the biofilms. Indiscriminate staining of not just 
microbial cells, but any material adhering to the surface of a plate (e.g. EPS matrix 
components) is the major limitation of the CV staining assay, making it impossible to quantify 
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the exact number of adherent microbes in a biofilm (Merritt et al., 2005). Therefore, a 
colorimetric tetrazolium assay utilising conversion of XTT to an orange formazan product by 
actively respiring cells (see Section 2.12) was used as a proxy to determine the viability of 
biofilms (Corte et al., 2019). Although XTT staining is useful for assessing overall biofilm 
metabolic activity it cannot differentiate between the species present in a polymicrobial culture. 
Hence, as in Section 3., the laborious enumeration of individual species via plating onto 
selective agar plates was used to determine changes in the ecological composition of 
polymicrobial biofilms over time.  
 
6.2 Batch culture polymicrobial biofilms 
6.2.1 Crystal violet staining assays 
Normalised absorbance values (Abs595 nm) measured for single-species and polymicrobial 
biofilms grown in ASM under batch culture conditions and stained using CV (as described in 
Section 2.12.1) are shown in Figure 6.1. There was no significant difference (P < 0.01) in the 
total biomass of the PA and CA single-species cultures for the first 6 hrs of incubation. After 
12 hrs of incubation the biomass of the CA mono-species biofilm was 3-fold greater than that 
of the PA mono-species biofilm. By T = 24 hrs the biomass of the CA mono-species biofilm 
was the largest of all the species combinations tested and there was no significant change (P 
> 0.9) in Abs595 nm values between 24 and 48 hrs of incubation. Biomass of the PA mono-
species biofilm increased 4-fold between T = 12 hrs to T = 24 hrs followed by a subsequent 
4-fold decrease in Abs595 nm values at T = 48 hrs. There was no significant difference (P > 0.9) 
in Abs595 nm values of the PA mono-species biofilm between T = 12 hrs and T = 48 hrs. For the 
24 hrs of incubation the total biomass of the SA mono-species biofilm was significantly lower 
(P < 0.0001) than the biomass of the other mono-species biofilms. This was followed by a 
significant (P < 0.0001) 4-fold increase in total biomass of the SA mono-species biofilm 
between 24 and 48 hrs of incubation. There was no significant difference (P > 0.99) in Abs595 
nm values between the CA and SA mono-species cultures at T = 48 hrs. 
For all co-culture species combinations containing PA, the biofilm biomass increased steadily 
for the first 12 hrs of incubation. After 12 hrs of incubation the triple-species biofilm had the 
greatest total biomass of all the culture combinations. For the PA-SA and triple-species co-
cultures there was a significant (P < 0.001) 3.5-fold decrease in total biofilm mass between T 
= 12 and 24 hrs, followed by a further 2-fold decrease at T = 48 hrs. A similar, yet less 
pronounced, trend was also observed for the PA-CA co-culture. There was no significant 
difference (P > 0.9) in Abs595 nm values between the PA-only, PA-SA, PA-CA and triple-species 












Figure 6.1 Crystal violet-stained batch culture biofilms. 
Normalised Abs595 nm values of solubilised biofilm biomass stained with crystal violet. Single-
species and co-culture populations of P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and 
C. albicans SC5314 (CA) were incubated for 3, 6, 12, 24 and 48 hours (black, white, grey, 
blue and red bars respectively) in ASM in microtiter plates under batch culture conditions (as 





throughout the entire period of incubation, yet at T = 48 hrs, Abs595 nm values for the SA-CA 
co-culture were 1.4-fold lower than either the SA or CA single-species cultures.  
 
6.2.2 XTT staining assays 
Normalised absorbance values (Abs450 nm) measured for XTT assays of single-species and 
polymicrobial biofilms grown in ASM under batch culture conditions are shown in Figure 6.2. 
For the first 12 hrs of incubation the metabolic activity of the CA mono-species biofilm was 
significantly higher than all other species combinations, a significant (P < 0.0001) 1.7-fold 
decrease in Abs450 nm then occurred by T = 24 hrs. There was no significant difference (P > 
0.1) in the metabolic activity of the PA and SA mono-species biofilms for the first 12 hrs of 
incubation. Between T = 12 and 24 hrs, there was a significant (P < 0.0001) 6.4-fold increase 
in the metabolic activity of the SA mono-species biofilm and no significant difference (P > 0.9) 
in Abs450 nm values of the SA biofilm following this point. The SA mono-species biofilm was the 
most metabolically active of all batch culture combinations after 24 hrs of incubation. There 
was no statistically significant difference (P > 0.1) in the metabolic activity of the PA mono-
species biofilm following 12 hrs of incubation.  
For all polymicrobial biofilms, the metabolic activity of the biofilm increased by approximately 
3-fold between 3 and 12 hrs of incubation, although this increase was not statistically 
significant. A significant (P < 0.05) >2-fold decrease in Abs450 nm values then occurred for the 
polymicrobial biofilms containing PA between 12 and 24 hrs of incubation. This was followed 
by an increase in the metabolic activity of PA-containing mixed species biofilms between T 
=24 and 48 hrs, although this trend was only statistically significant (P < 0.0001) in the PA-SA 
co-culture. The metabolic activity of the SA-CA biofilm steadily increased for the first 24 hrs of 
incubation and was followed by a significant (P < 0.0001) 2.3-fold decrease in Abs450 nm 
measurements at T = 48 hrs. There was no significant difference (P > 0.2) in the metabolic 
activity of the CA mono-species, PA-SA and SA-CA biofilms at 48 hrs of incubation.  
 
6.2.3 CFU mL-1 counts 
Viable cell counts for mono-species and polymicrobial biofilms grown under batch culture 
conditions are displayed in Figure 6.3.A and pairwise CFU mL-1 counts from the planktonic 
fraction of the same cultures are displayed in Figure 6.3.B. There was a steady increase in 












Figure 6.2 XTT-stained batch culture biofilms. 
Normalised Abs450 nm values of biofilms incubated with XTT to quantify the metabolic activity 
of the adhered cells. Single-species and co-culture populations of P. aeruginosa PAO1 (PA), 
S. aureus 25923 (SA) and C. albicans SC5314 (CA) were incubated for 3, 6, 12, 24 and 48 
hours (black, white, grey, blue and red bars respectively) in ASM in microtiter plates under 
batch culture conditions (as described in Section 2.11.1). Data represented as the mean ± 








Figure 6.3 CFU mL-1 counts of batch culture biofilms. 
Viable P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and C. albicans SC5314 (CA) cell 
counts (CFU mL-1) in the (A) biofilm and (B) planktonic fraction of single-species and 
polymicrobial cultures incubated for 3, 6, 12, 24 and 48 hours (black, white, grey, red and blue 
bars respectively) in microtiter plates under batch culture conditions, as described in Section 
2.11.1. Data represented as mean ± standard deviation from three independent experiments. 
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reduction in CFU mL-1 counts in the PA mono-species biofilm occurred at T = 48 hrs, 
conversely there was a log-fold increase in viable SA cell counts in the single-species biofilm 
at this point. The SA mono-species biofilm had the fewest cell titres of the single-species 
cultures for the first 24 hrs of incubation, yet by T = 48 hrs there was no significant difference 
(P > 0.9) in viable cell counts between the SA and CA mono-species biofilms. There was no 
significant difference (P > 0.9) in viable cell counts of the PA mono-species biofilm sampled 
at T = 12 or 48 hrs. 
PA cell titres in all mixed species biofilms increased for the first 24 hrs of incubation, reaching 
>5x108 CFU mL-1 by this point in all instances. There was no statistically significant change in 
PA titres for any mixed species biofilm between T = 24 and 48 hrs. The number of viable SA 
cells in the PA-SA biofilm was a log-fold higher than the number of viable cells present in the 
SA mono-species biofilm for the first 12 hrs of incubation. A significant (P < 0.0001) 4-log fold 
reduction in SA CFU mL-1 counts occurred between 12 and 24 hrs of incubation and a further 
2-log fold reduction in viable cell counts occurred at T = 48 hrs. At the final point of sampling 
there were fewer than 300 SA CFU mL-1 present in the PA-SA co-culture biofilm. There was a 
greater than 1-log fold reduction in CA titres present in the PA-CA biofilm compared with the 
CA mono-species culture across all points of sampling. At T = 6 hrs there was ≈2 x 105 CA 
CFU mL-1 present in the PA-CA biofilm and there was no statistically significant change until 
a 2-log fold reduction in CA titres at T = 48 hrs.  
Compared with the SA mono-species biofilm there was a 2-log fold increase in SA CFU mL-1 
present in the SA-CA biofilm for the first 12 hrs of incubation. This was followed by a 3-log fold 
reduction in viable SA counts after 24 hrs of incubation and no change in CFU mL-1 counts 
occurred thereafter. No significant difference (P > 0.9) existed in CA CFU mL-1 present in the 
SA-CA biofilm and the mono-species culture for the first 12 hrs of incubation. However, at T = 
24 and 48 hrs there was a 3-log fold reduction in CA CFU mL-1 counts compared with the 
single-species CA biofilm at these points. Titres of all three species increased for the first 12 
hrs of incubation in the triple species biofilm. There was no significant difference (P > 0.9) in 
PA or CA titres present in the biofilm compared with their respective single-species cultures. 
However, there was a 2-log fold increase in SA CFU mL-1 counts between 3 and 12 hrs of 
incubation. A 2-log fold reduction in viable SA and CA titres then occurred in the triple species 
biofilm between T = 12 and 24 hrs. Followed by a further log-fold reduction in CFU mL-1 counts 
for both species at T = 48 hrs.  
As expected, there was a steady increase in viable cell counts in the planktonic fraction of all 
three mono-species cultures over incubation period (Figure 6.3.B). A similar loss of species 
from the planktonic fraction of the microbial co-cultures was observed as reported for the 
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polymicrobial batch cultures in Section 3. Briefly, no viable SA cells could be recovered from 
the PA-SA and triple-species co-cultures after 24 and 48 hrs respectively. Similarly, no viable 
CA cells were recovered from the PA-CA or triple species co-cultures at T = 48 hrs and a 
reduction in viable SA titres occurred in planktonic fraction of the SA-CA co-culture following 
12 hrs of incubation. 
  
6.2.4 Key Findings  
Under batch culture conditions, SA forms the least dense biofilm with respect to total biomass 
and lowest viable cell counts during the initial 12 hrs of incubation, whereas PA forms the 
biofilm with the most viable cells and CA the greatest total biomass and metabolic activity. 
Despite the small biomass of the SA mono-species biofilm, it is as metabolically active as the 
PA mono-species biofilm for the first 12 hrs of growth. The presence of PA or CA increases 
the initial attachment of SA cells to the biofilm, as evidenced by an increase in SA titres. 
Conversely, the presence of PA or SA reduced the initial number of viable CA cells found in 
the mixed population biofilms.  
A significant reduction in the biomass of the PA mono-species biofilm occurred after 48 hrs of 
growth. This observation may be attributed to dispersal of the mature biofilm in response to 
the depletion of available nutrients under batch culture conditions (Maunders and Welch, 
2017, Sauer et al., 2004). It is interesting to note that a reduction in biomass also occurs for 
all polymicrobial biofilms containing PA and that the total biomass of the PA-SA, PA-CA and 
triple-species biofilms is comparable to that of the mono-species biofilm at the endpoint of 
sampling. This reduction in biomass occurs after only 24 hrs of incubation and coincides with 
a reduction in viable SA and CA titres but no appreciable change in PA titres in the biofilm. 
This finding is in support of existing reports that microbial species, in this instance PA, produce 
extracellular factors that degrade the extracellular matrix of competing species to displace and 
remove these from a biofilm community (Kaplan, 2010).  
Also of note is that the removal of species from the biofilm fraction of the co-cultures was 
significantly lower compared with the loss of species from the planktonic portion of the co-
culture. This observation suggests that the expression of extracellular factors responsible for 
the out-competition of co-cultivated species is decreased during the biofilm mode of growth in 
ASM. In support of this hypothesis, studies into Streptococcus suis and Actinobacillus 
pleuropnrumoniae have demonstrated a decreased expression of virulence associated genes 
during biofilm growth (Li et al., 2008, Wang et al., 2011). Alternatively, the diffusion coefficient 
in biofilms is severely diminished compared to aqueous solutions due to the presence of 
polymeric substances, extracellular DNA and abiotic particles that comprise the EPS in which 
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microbial cells are embedded during biofilm growth (Sankaran et al., 2019, Stewart, 2003). 
This matrix is thought to act as a molecular sieve and may simply retard the diffusion of 
extracellular factors responsible for the out-competition of co-cultivated species through the 
biofilm. This decreased diffusion of extracellular factors may therefore improve the longevity 
of species rapidly removed from the planktonic portion of the co-culture. However, as 
described in Section 3.6, the rate of SA and CA removal from the triple-species biofilm 
population was decreased when compared with the rate of removal from the dual-species 
biofilms. This indicates that modulation of microbial behaviours in response to the presence 
of a co-cultivated species is also evident during the biofilm mode of growth.  
 
6.3 Continuous-flow polymicrobial biofilms  
6.3.1 Crystal violet staining assays 
Normalised absorbance values (Abs595 nm) measured for single-species and polymicrobial 
biofilms grown in ASM under continuous-flow conditions using the Kadouri drip-plate model 
(as described in Section 2.12.2) are displayed in Figure 6.4. A significant increase (P < 0.01) 
in the total biomass of all mono-species biofilms occurred between 6 and 48 hrs of incubation. 
Total biomass of the CA mono-species biofilm was significantly higher (P < 0.0001) than the 
other single-species biofilms across all points of sampling and the SA mono-species biofilm 
had the lowest total biomass of the single-species cultures. There was no significant difference 
(P > 0.1) in the total biomass of any polymicrobial biofilm at T = 6 hrs and a significant (P < 
0.0001) greater than 4-fold increase in total biomass of all polymicrobial biofilms occurred 
between T = 6 and 24 hrs. Abs595 nm values for the PA-SA biofilm then increased by a further 
3-units between T = 24 and 48 hrs. Contrastingly, a significant (P < 0.05) 4-unit decrease in 
Abs595 nm values of the PA-CA biofilm and a significant (P < 0.0001) 50% reduction in the total 
biomass of the triple-species biofilm occurred between T = 24 and 48 hrs. There was no 
significant difference (P > 0.2) in the total biomass of the SA-CA biofilm between 24 and 48 
hrs of incubation.  
 
6.3.2 XTT staining assays 
Normalised absorbance values (Abs450 nm) measured for XTT assays of single-species and 
polymicrobial biofilms grown in ASM under continuous-flow conditions using the Kadouri drip-
plate model (as described in Section 2.12.2) are displayed in Figure 6.5. The metabolic activity 











Figure 6.4 Crystal violet-stained continuous-flow microtiter plate biofilms. 
Normalised Abs595 nm values of solubilised biofilm biomass stained with crystal violet. Single-
species and co-culture populations of P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and 
C. albicans SC5314 (CA) were incubated in ASM in the continuous-flow microtiter plate 
(Kadouri drip-fed) model described in Section 2.11.2. The flowrate was 55 µL min-1. Cultures 
were incubated for 6, 12, 24 and 48 hrs (white, grey, blue and red bars respectively). Data 












Figure 6.5 XTT-stained continuous-flow microtiter plate biofilms. 
Normalised Abs450 nm values of biofilms incubated with XTT to quantify the metabolic activity 
of adhered cells. Single-species and co-culture populations of P. aeruginosa PAO1 (PA), S. 
aureus 25923 (SA) and C. albicans SC5314 (CA) were incubated in ASM in the continuous-
flow microtiter plate (Kadouri drip-fed) model described in Section 2.11.2. The flowrate was 
55 µL min-1. Cultures were incubated for 6, 12, 24 and 48 hrs (white, grey, blue and red bars 




of incubation. The metabolic activity of the CA mono-species biofilm was significantly lower (P 
< 0.0001) than all other species combinations across all points of sampling. At T = 24 hrs, the 
total metabolic activity of the triple species biofilm was significantly higher than the PA mono-
species and PA-CA co-culture (P < 0.0001), CA mono-species (P < 0.01) and SA-CA co-
culture (P < 0.05) biofilms. There was no significant difference (P > 0.05) in Abs450 nm 
measurements between the triple-species and PA-SA co-culture biofilms at 24 hrs of 
incubation. There was no significant difference (P < 0.01) in the metabolic activity of the PA-
SA, SA-CA and CA-only biofilms at T = 24 hrs and Abs450 nm values of the PA mono-species 
biofilm was significantly lower (P < 0.0001) than these co-cultures at this point of sampling.  
There was a significant decrease (P < 0.05) in the metabolic activity of the PA-only, PA-SA, 
PA-CA and SA-CA biofilms between T = 24 and 48 hrs and there was no significant difference 
(P > 0.1) in Abs450 nm values of the SA or CA mono-species and triple-species biofilms between 
these points. At the final point of sampling, the metabolic activity of the triple-species biofilm 
was significantly higher (P < 0.0001) than all other species combinations. There was no 
significant difference (P > 0.4) in Abs450 nm values measured for the CA-only and PA-SA, or 
the mono-species PA and SA-CA biofilms at 48 hrs of incubation. Metabolic activity of the CA 
and PA-SA biofilms was significantly higher (P < 0.01) than the PA and SA-CA biofilms and 
Abs450 nm values measured for the PA-CA biofilm were significantly lower (P < 0.001) than 
those measured for all co-culture combinations at T = 48 hrs.  
 
6.3.3 CFU mL-1 counts 
Viable cell counts for mono-species and polymicrobial biofilms grown under continuous-flow 
conditions using the Kadouri drip-plate model (as described in Section 2.12.2) are displayed 
in Figure 6.6.A and pairwise CFU mL-1 counts from the planktonic fraction of the same culture 
are displayed in Figure 6.6.B. There was a 2-log and 5-log fold increase, respectively, in viable 
cell counts of PA and SA in the mono-species biofilms between T = 6 and 48 hrs. A log-fold 
increase in CFU mL-1 counts occurred in the CA mono-species biofilm between T = 6 and 12 
hrs and there was no significant difference (P > 0.9) in cell titres after this timepoint. The SA 
mono-species biofilm had significantly fewer (P < 0.0001) viable cells over the initial 12 hrs of 
incubation compared to all other species combinations, yet there was no significant difference 
(P > 0.9) in PA or SA titres present in the mono-species biofilms at the final point of sampling. 
There was a >1-log fold decrease in viable PA cell counts in all polymicrobial biofilms for the 
initial 12 hrs of incubation compared with the mono-species PA biofilm. By contrast, a >2-log 
fold increase in SA titres was observed in the polymicrobial biofilms at T = 6 and 12 hrs 





Figure 6.6 CFU mL-1 counts of continuous-flow microtiter plate.  
Viable P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and C. albicans SC5314 (CA) cell 
counts (CFU mL-1) in the (A) biofilm and (B) planktonic fraction of single-species and 
polymicrobial cultures incubated in ASM in the continuous-flow microtiter plate (Kadouri drip-
fed) model described in Section 2.11.2. The flowrate was 55 µL min-1. Cultures were incubated 
for 6, 12, 24 and 48 hrs (white, grey, blue and red bars respectively). Data represented as the 
mean ± standard deviation of three independent experiments. 
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CA cells present in the mono-species or polymicrobial biofilms across the first 12 hrs of 
incubation. In all polymicrobial biofilms there was a significant increase (P < 0.01) in PA CFU 
mL-1 counts between the initial and final points of sampling. By T = 48 hrs, there were 
significantly more (P < 0.01) viable PA cells present in all polymicrobial biofilms compared with 
CFU mL-1 counts of the other species present in their respective biofilm co-cultures. In the PA-
SA biofilm, a log-fold increase in SA CFU mL-1 counts occurred between T = 6 and 24 hrs but 
there was no significant change (P > 0.9) in microbial titres following this. After 24 hrs of 
incubation there were >107 SA CFU mL-1 in the SA-CA and triple-species biofilms, >2-log fold 
more than the PA-SA co-culture and >4-log fold more than the mono-species biofilm at this 
point. In the SA-CA and triple-species biofilms, a significant (P < 0.01) log-fold reduction in 
viable SA titres occurred between T = 24 and 48 hrs.  
At the final point of sampling there were approximately 10 and 100 more SA CFU mL-1 in the 
mono-species biofilm compared, respectively, with the SA-CA and triple-species co-cultures. 
There was no statistically significant difference (P > 0.9) in CA titres of the mono-species and 
any polymicrobial biofilm for the first 12 hrs of incubation. An approximate 2-log increase in 
CA CFU mL-1 occurred in the PA-CA biofilm between T = 12 and 24 hrs. This was 
subsequently followed by a log-fold decrease in CA titres at 48 hrs incubation. A similar, but 
less pronounced, trend can be observed for viable CA counts in the SA-CA biofilm. There was 
no statistically significant difference in CA titres between T = 12 and 48 hrs in both the PA-CA 
and SA-CA polymicrobial biofilms. There was little difference in CA CFU mL-1 counts of the 
triple-species co-culture for the first 24 hrs of incubation, with cell counts never exceeding 
4x105 CFU mL-1. A log-fold reduction in CA cell titres occurred between T = 24 and 48 hrs in 
the triple-species biofilm, however this change was not statically significant (P > 0.9). 
Similar to the continuous-flow results described in Section 3., planktonic CFU mL-1 counts of 
all species in mono-species and co-culture combinations increased for the first 24 hrs of 
growth. However, and unlike the results described in Section 3., there was a significant 
decrease in SA titres in the planktonic fraction of all polymicrobial cultures between T = 24 
and 48 hrs. Additionally, there was a significant decrease in CA CFU mL-1 counts in the PA-
CA and triple-species planktonic fractions between 24 hrs and the final point of sampling. As 
in Section 3., there was no significant difference (P > 0.1) in the cell counts of the planktonic 
fraction of any other species combination between 24 and 48 hrs of growth.  
 
6.3.4 Key Findings 
A continual increase in the total biomass, metabolic activity and viable cell counts of all species 
and culture combinations occurred for the first 24 hrs of incubation using the continuous-flow 
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Kadouri drip-plate culture method. As in Section 6.2, CA formed the largest total biomass yet 
was the least metabolically active of the mono-species biofilms across all points of sampling. 
Conversely, the SA mono-species biofilm was the most metabolically active despite having 
fewer viable cells than the PA mono-species biofilm. Unlike the results described in Section 
6.2.4, biomass and CFU mL-1 of the PA-only biofilm did not decrease between 24 and 48 hrs 
of incubation, suggesting that with an increased supply of nutrients available to the sessile 
community there is a suppression of biofilm dispersal (Sauer et al., 2004). As with the batch 
culture biofilms (Section 6.2.3), the presence of PA or CA increased the initial number of viable 
SA cells present in the polymicrobial biofilms compared with the mono-species culture. 
Furthermore, the presence of PA or SA decreased CA titres present in the polymicrobial 
biofilms across all points of sampling. Crucially, there was no out-competition of SA from the 
PA-SA biofilm co-culture under continuous-flow conditions, as evidenced by no significant 
change in SA CFU mL-1 counts occurring after 24 hrs of incubation. There was a reduction, 
albeit at a much lower rate than that observed in Figure 6.3.A, in SA cell titres present in the 
SA-CA and triple-species biofilms between T = 24 and 48 hrs of incubation. This reduction in 
SA CFU mL-1 was accompanied by a decrease in the total metabolic activity of the biofilms. 
Similarly, the removal of viable CA cells from polymicrobial biofilms was only significant in the 
PA-CA co-culture at the final point of sampling and was accompanied by a decrease in the 
total biomass of the biofilm. 
 
6.4 Biofilms grown in the continuous-flow model 
Viable cell counts for mono-species and polymicrobial biofilms adhered to agar cubes or 
sections of ex vivo porcine lung tissue (EVPL) in the continuous-flow culture vessel (as 
described in Section 2.12.3) are shown in Figure 6.7 and Figure 6.8, respectively. There was 
no significant difference in viable cell counts of the planktonic fraction of any species 
combination compared with the continuous-flow results described in Section 3 (data not 
shown). No PA, SA or CA cells could be isolated from uninfected EVPL sections after any 
period of incubation (data not shown). 
 
6.4.1 Agar associated biofilms 
A significant (P < 0.05) log-fold increase in PA titres occurred in the mono-species biofilm 
between T = 24 and 96 hrs. There was also a significant (P < 0.0001) 2-log fold increase in 
SA titres in the mono-species biofilm over the incubation period. There was no statistically 
significant (P > 0.5) difference in CA titres in the mono-species biofilm or any species in the 








Figure 6.7 CFU mL-1 counts of biofilms adhered to agar chunks. 
Viable P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and C. albicans SC5314 (CA) cell 
counts (CFU mL-1) adhered to 2.5% agar chunks after incubation for 24 (black bars) or 96 
hrs (white bars) in the continuous-flow culture model as described in Section 2.11.3. 
Asterisks represent significant (*P < 0.05, ****P < 0.0001) differences in CFU mL-1 counts 
between the 24 and 96 hrs timepoints of individual species in their respective culture. Data 









Figure 6.8 CFU mL-1 counts of biofilms adhered to porcine bronchiole tissue.  
Viable P. aeruginosa PAO1 (PA), S. aureus 25923 (SA) and C. albicans SC5314 (CA) cell 
counts (CFU mL-1) adhered to sections of ex vivo porcine lung tissue after incubation for 24 
(black bars) or 96 hrs (white bars) in the continuous-flow culture model as described in Section 
2.11.3. Asterisks represent significant (**P < 0.01) differences in CFU mL-1 counts between 
the 24 and 96 hrs timepoints of individual species in their respective culture. Data represented 




(P > 0.8) in PA or SA CFU mL-1 counts in the polymicrobial biofilm at either point of sampling 
and cell counts of both species were 3-log fold (P < 0.0001) higher than CA CFU mL-1 counts 
in the polymicrobial biofilm at T = 24 and 96 hrs. There were 1-log fold fewer CA CFU mL-1 in 
the polymicrobial biofilm compared to the mono-species biofilm at both points of sampling.  
After 24 hrs of incubation, there no significant difference (P > 0.9) between SA or CA CFU mL-
1 counts in the mono-species biofilms and there were significantly more (P < 0.001) PA CFU 
mL-1 in the mono-species PA biofilm at this point. There was no significant difference (P > 0.9) 
in PA CFU mL-1 counts in the mono-species biofilm and PA or SA titres in the polymicrobial 
biofilm at the first point of sampling. At T = 96 hrs, there was no significant difference (P > 0.9) 
in PA or SA CFU mL-1 counts in the mono-species biofilm and the CA mono-species biofilm 
had significantly fewer (P < 0.0001) viable cells at this point. PA and SA titres present in the 
polymicrobial biofilm were 1-log fold fewer than their respective mono-species biofilms after 
96 hrs of incubation. Furthermore, there were 2-log fold fewer CA CFU mL-1 than PA or SA 
CFU mL-1 in the polymicrobial biofilm at the final point of sampling. 
 
6.4.2 EVPL associated biofilms 
A significant (P < 0.01) log-fold increase in viable cell counts in the PA mono-species biofilm 
occurred between T = 24 and 96 hrs. There was no statistically significant (P > 0.1) change in 
SA or CA CFU mL-1 counts in their respective mono-species biofilms between the two points 
of sampling. Likewise, there was no change in CA titres in the polymicrobial biofilm between 
T = 24 and 96 hrs. There was a significant (P < 0.01) log-fold increase in PA CFU mL-1 in the 
polymicrobial biofilm between 24 and 96 hrs of incubation. Conversely, there was a log-fold 
decrease (P < 0.01) in SA CFU mL-1 in the mixed-species biofilm between the first and final 
time points. There was no significant difference (P > 0.9) in cell titres of the PA or SA mono-
species biofilms between either point of sampling and there was less than 1-log fold fewer CA 
CFU mL-1 in the CA mono-species biofilm. Across both timepoints there was 1-log fold fewer 
CA titres in the mono-species biofilm compared to the polymicrobial co-culture.  
At T = 24 hrs, there was no significant difference (P > 0.9) in PA or SA CFU mL-1 counts in the 
polymicrobial biofilm, but the titres of each species were 1-log fold lower than their respective 
mono-species biofilms at this point. SA titres in the polymicrobial biofilm at the final point of 
sampling were 3-log fold lower than PA or SA mono-species cell titres and 1-log fold lower 
than CA mono-species cell counts. There was no significant difference (P > 0.9) in SA or CA 
viable cell counts in the polymicrobial biofilm at T = 96 hrs, yet there were significantly more 
PA CFU mL-1 in the mixed species biofilm.  
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6.4.3 Comparison between agar and EVPL biofilms 
When comparing the formation of biofilms on agar chunks with EVPL sections, there was no 
significant difference (P > 0.8) in viable PA or CA titres in the mono-species or polymicrobial 
biofilms at either T = 24 or 96 hrs. The only appreciable difference in CFU mL-1 counts when 
using different solid substrata was observed for SA titres. There was a log-fold increase in 
viable SA cells adhered to EVPL sections in the mono-species culture at the first point of 
sampling. Yet there is a 2-log fold reduction in SA titres present in the EVPL polymicrobial 
biofilm compared with the agar-associated polymicrobial biofilm at T = 96 hrs. 
 
6.5 Conclusions 
The results presented in this chapter indicate that PA-mediated biofilm dispersal and 
competition among species in a polymicrobial biofilm are suppressed during growth under 
continuous-flow conditions. This was demonstrated by the continual increase in total biomass 
and steady total metabolic rates of all species combinations over time during co-cultivation 
using the Kadouri drip-plate culture method (Section 6.3). This, in combination with the results 
presented in Section 3., highlight the importance of providing fresh nutrients and removing 
excess cells and waste products to ensure the stable in vitro co-culture of CF associated 
species in both the planktonic and sessile modes of growth. It is key to note that antagonistic 
interactions are still observed under continuous-flow conditions in the microtiter plate. A 
significant, albeit decreased, removal of CA and SA does occur in their respective continuous-
flow PA-CA or SA-CA biofilms. Furthermore, the presence of co-cultivated species decreased 
CA CFU mL-1 present in the polymicrobial biofilms compared with CA mono-species biofilms. 
These observations suggest interspecies competition is not simply linked to nutrient limitation. 
As physical space (surface area) is finite in microtiter plate wells and CA forms the largest 
total biomass of any mono-species biofilm, competition for this limited commodity could be 
hypothesised to enhance interspecies competition (Poletto et al., 2015). Alternatively, 
separate contact-dependent cues (Gates et al., 2018) or the recognition of extracellular 
products (Jayathilake et al., 2017) may trigger the up-regulation virulence factors in 
polymicrobial biofilms.  
In the polymicrobial biofilms there is also clear evidence of synergistic interactions between 
species. During the initial 12 hrs of biofilm formation, SA forms the smallest, yet most 
metabolically active, mono-species biofilm adhered to the bottom of the microtiter plates. 
Attachment of SA is significantly improved under both batch and continuous-flow culture 
conditions in the presence of co-cultivated species. This suggests that SA cells are able to 
readily embed themselves in the EPS matrix (Nocelli et al., 2016) produced in abundance by 
184 
 
both PA (Wei and Ma, 2013) and CA (Da et al., 2019) during their biofilm mode of growth. 
Given that SA is known to be an early coloniser of the CF airways (Bogaert et al., 2004, 
Rosenfeld et al., 2012), this finding may be significant as the initial successful attachment of 
this species in the CF microenvironment may also be improved by the presence of other early 
coloniser species (Conrad et al., 2013, Rogers et al., 2005, Tunney et al., 2008). Further 
investigation into these synergistic interactions could lead to the identification of novel 
therapeutic targets for improved management of early airway CF airway infections and the 
prevention of chronic SA colonisation in infants. 
Interestingly, the formation of mono-species SA biofilms on solid substratum in the in vitro 
continuous-flow model after 24 hrs incubation is significantly improved on EVPL sections 
compared with the initial attachment of SA biofilms using agar as a solid substratum. This 
enhanced ability to form biofilms on bronchiole tissue sections sharing a high degree of 
similarity to human airway tissue (Judge et al., 2014) may help explain why SA is an effective 
early coloniser of the CF airways. The growth of biofilms on EVPL sections stimulated a 
decrease of viable SA CFU mL-1 counts in polymicrobial biofilms after 96 hrs incubation; a 
decrease that was not observed using agar chunks as a substratum. Although dual-species 
biofilm co-cultures were not studied due to time constraints and a limitation of available EVPL 
sections in the Harrison Lab, this initial finding suggests that microbial interaction with host 
tissue may up-regulate the localised production of virulence factors and enhanced 
interspecies competition (Döring et al., 2011, Malhotra et al., 2019). This hypothesis is further 
supported by studies using a PA-SA co-culture incubated in the presence of a mono-layer of 
human bronchiole epithelial cells homozygous for the phe508del mutation. These researchers 
reported that an up-regulation of microbial competition, dependent on the action of 
siderophores and 2-heptyl-4-hydroxyquinolone N-oxide, drives SA towards a fermentative 
metabolic profile (Filkins et al., 2015). Furthermore, it can be hypothesised that recognition of 
both airway epithelial cells and SA is required to drive the observed changes in PA behaviour 
under continuous-flow conditions as increased competition is not observed when using an 
abiotic substratum, such as agar chunks. The implications of this finding are twofold: firstly, 
the EVPL biofilm model could be an effective approach for studying how late-stage CF 
pathogens displace species overtime in a physiologically relevant polymicrobial model of CF 
airway infection. Secondly, agar is more suitable substratum for promoting long-term and 
stable, steady-state growth of polymicrobial biofilms in my continuous flow model and so was 
used in subsequent experiments aimed at culturing entire sputum-derived polymicrobial 




7. Growth of Patient-Derived Polymicrobial Populations 
7.1 Introductory Comments 
As demonstrated in Section 3, co-cultures of domesticated microbial species can be stably 
maintained in the continuous-flow model. I sought to further refine culture conditions of the 
culture vessel to permit the recapitulation of entire polymicrobial communities contained in CF 
sputum samples in vitro. Unfortunately, due to the complexity of this task and the global 
outbreak of SARS-CoV-2 this goal was not fully realised. However, the preliminary work 
presented in this chapter provides a framework to guide future optimisation efforts. 
 
7.2 Growth of CF-sputum Samples in ASM 
Clinical strains isolated from patients are found to have extended lag phases compared to 
their commonly studied and well characterised domesticated reference strain counterparts 
(Theophel et al., 2014). The lag phase is the most poorly understood of the microbial growth 
phases and as such has no universally defined physiological or biochemical criteria (Madigan 
and Martinko, 2000). It is however assumed that this phase promotes microbial fitness by 
allowing species to undergo adaptations necessary for nutrient acquisition and the exploitation 
of new environmental conditions (Bertrand, 2019, Madigan and Martinko, 2000, Rolfe et al., 
2012). It is also interesting to note that an extended lag phase may offer a survival advantage 
against antimicrobial stress (Bertrand, 2019, Li et al., 2016), possibly explaining why species 
with extended lag phases can be isolated from chronic clinical infection scenarios.  
To prevent the initial washout of microbial species and ensure the successful growth of 
polymicrobial populations found within expectorated CF sputum samples, I first determined 
the growth rate of the microbial species contained within CF sputum samples in ASM under 
batch culture conditions. OD600 nm measurements afforded a rapid and cost-effective technique 
for estimating the total microbial density of microbial populations of an unknown composition. 
To take automated OD600 nm measurements, the model was fitted with an in-line 
spectrophotometer, as described in Section 2.3.1. To create a “closed-loop” system with no 
net displacement of culture media (i.e. Q = 0 µL min-1) the spectrophotometer outlet was fed 
into the inlet HPLC port on the culture vessel and Q = 200 µL min-1 was applied to cycle culture 
media through the spectrophotometer. Homogenised expectorated sputum sampled (Section 
2.13.1) independently collected from three different persons with CF were inoculated into 
separate culture vessels and OD600 nm measured every 30 min. 
Culture density of CF sputum-associated microbial populations grown in ASM followed a 






















Figure 7.1 Growth of microbial populations from CF sputum in ASM. 
Optical density (OD600 nm) measurements following the growth of pooled homogenised 
expectorated sputum samples from three separate persons with CF in ASM under batch 
culture conditions in the continuous-flow culture vessel. Data represented as the mean ± 






lag phase, with average culture turbidity not exceeding OD600 nm 0.2 for the first 16 hrs of 
incubation. Populations were in the exponential growth phase between T = 17 and 45 hrs, with 
an average doubling time of ≈5 hrs. Changes in OD600 nm measurements plateaued as the 
culture reached the presumed stationary phase of growth. Average peak culture density 
(OD600 nm 2.54) was reached at T = 54 hrs. Microbial populations then entered the presumed 
death phase, as evidenced by an approximate 0.5-unit drop in average OD600 nm values 
occurring between 54 and 72 hrs.  
To account for the long lag phase and prevent species washout from the model, in subsequent 
experiments, culture vessels inoculated with CF sputum were incubated using Q = 0 µL min-1 
for 24 hrs to ensure that microbial populations enter the mid-logarithmic growth phase before 
applying an appropriate flowrate of fresh ASM (determination of Q is described in Section 7.3). 
 
7.3 Flowrate Optimisation 
7.3.1 Comments 
Clinical and environmental isolates often have longer doubling times compared with 
domesticated laboratory strains (Gibson et al., 2018). This slow growth is often cited as a 
survival strategy to support growth in nutrient limited conditions and to withstand starvation 
(Biselli et al., 2020, Chesbro et al., 1990, Eguchi et al., 1996, Postgate and Hunter, 1962). 
Furthermore, slow growth rates are considered a mechanism to tolerate immune clearance 
(Kaldalu and Tenson, 2019) and resist antimicrobial action during growth as planktonic  or 
biofilm communities (Ciofu and Tolker-Nielsen, 2019, Katayama et al., 2017, Pontes and 
Groisman, 2019, Yamaguchi et al., 2019). It may therefore be unsurprising that slow growing 
organisms are often isolated from the polymicrobial communities associated with chronic CF 
airway infections (Burns and Rolain, 2014). The maintenance of slow growing homogenous 
mono-species cultures in continuous-flow conditions is well characterised (Allen and Waclaw, 
2019, Biselli et al., 2020, Chesbro et al., 1990, Smith and Waltman, 1995). It is known that the 
rate of media displacement (retention time, Rt) is essential for maintaining stable steady-state 
microbial populations in continuous-flow culture vessels. If Q is too high, species growth will 
not match the rate of displacement and cultures will be “washed-out” from the system. If Q is 
too low, the culture will grow to a high cell density and enter the stationary phase of growth 
and species out-competition is more likely occur among members of a polymicrobial 
consortium.  
The slow growth of CF sputum-derived microbial populations is evident from the results 
presented in Section 7.1, and the importance of using a suitable value for Q was identified 
while optimising the continuous-flow model to maintain the growth of CA as part of a 
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polymicrobial consortium (Section 3). I therefore performed a screen of different flow rates to 
identify the culture conditions most suitable for permitting a diverse polymicrobial population 
to be maintained. Aliquots of a homogenised CF sputum sample were inoculated into the 
continuous-flow vessel, as described in Section 2.14.2, and variable Q applied. OD600 nm was 
used to measure the total density of the sputum-derived microbial population over time. 
Illumina MiSeq-based sequencing of the hypervariable region of the bacterial 16S rRNA gene 
encoding for the 30S ribosomal subunit was also used to identify changes in bacterial ecology 
between the initial inoculum and populations maintained in the culture vessel after incubation 
for 120 hrs. 
To fully explore changes in microbial composition in the sequencing libraries, a combination 
of phylogenetic metric tests was employed. Faith’s phylogenetic diversity, defined as “the sum 
of branch lengths of a phylogenetic tree connecting all species in the target assembly” (Faith, 
1992), was used as a phylogenetic generalization of species richness and to provide an 
overview of species presence/absence in samples. The Bray-Curtis dissimilarity test was used 
to quantify species dissimilarity among ecological populations by measuring the abundance 
of different operational taxanomic units (OTUs) in sequencing library samples (Bray, 1957). 
UniFrac analysis of variants build upon this dissimilarity metric by incorporating assumed 
phylogenetic differences between compositions when computing taxonomic distance 
(Lozupone and Knight, 2005). Whereas unweighted UniFrac measurements simply account 
for the presence/absence of species providing a qualitative measure of dissimilarity amongst 
samples, the weighted UniFrac analysis accounts for the relative abundance and relatedness 
of OTUs in samples, providing a quantitative measure of dissimilarity.   
 
7.3.2 OD600 nm 
Average OD600 nm values of sputum-associated microbial populations grown under continuous-
flow conditions in ASM are shown in Figure 7.2. There was no significant difference (P > 0.9) 
in the optical density of any sputum derived population for the first 24 hrs of incubation, i.e. 
before Q was applied to the system. Using Q = 145 µL min-1 (the flow rate previously used to 
maintain triple-species populations of reference strains in the model) there was a steady 
decline in total microbial density over time, with an approximate 0.3-unit reduction in OD600 nm 
values occurring between T = 24 and 120 hrs. For all other flowrates a stable steady-state 
carrying capacity, with respect to culture turbidity, was achieved by ≈48 hrs. As could be 
expected from previous studies characterising microbial growth in chemostats (Smith and 













Figure 7.2 Growth of CF sputum-derived microbial populations in the continuous-flow 
model using different flow rates. 
Optical density (OD600 nm) measurements following total microbial density of polymicrobial 
populations derived from homogenised expectorated sputum samples collected from the 
same person with CF in ASM under continuous-flow conditions (Section 2.14). Q = 145 
(yellow); 125 (purple); 95 (green); 75 (orange); 65 (blue) and 55 µL min-1 (red). Data 





linked with Q. A lower flowrate resulted in higher OD600 nm measurements in the culture vessel. 
After 48 hrs incubation an average OD600 nm of 1.15, 1.25 and 1.45 was reached using Q = 
125, 95 and 75 µL min-1, respectively. There was no significant difference (P > 0.9) in the 
average steady-state carrying capacity in the culture vessel (OD600 nm 1.6) using Q = 65 or 55 
µL min-1. 
 
7.3.3 Bacterial Ecology  
7.3.3.1 Relative abundance taxa plots 
Relative abundance taxa bar plots of the initial inoculum and planktonic/biofilm samples after 
120 hrs incubation using variable flowrates are shown in Figure 7.3. Although some 
heterogeneity could be observed for the relative abundance of OTUs present in the initial CF 
sputum aliquots, five OTUs were present in detectable abundancies across all samples. 
Bacteria within the inoculum were present in the following average relative abundancies: P. 
aeruginosa (PA) 67.52 ± 24.4%; Enterobacteriaceae 27.29 ± 25.64%; Lactobacillales 
(unassigned family) 2.49 ± 1.66%; Bacilli (unassigned order) 0.81 ± 0.7% and Anaereosinus 
glycerini (member of the Veillonellaceae family (Strömpl et al., 1999)) 0.78 ± 0.51%. It should 
also be noted that the inoculum sample introduced into the Q = 55 µL min-1 culture vessel also 
contained an OTU corresponding to a Gammaproteobacteria of unassigned taxonomical order 
at a relative abundance of 6.5%.  
Endpoint bacterial populations using Q = 145 µL min-1 were dominated by PA, with the 
planktonic and biofilm samples containing PA at a relative abundance of 99.7% and 99.9%, 
respectively. Only Enterobacteriaceae could be detected at a relative abundance of just 0.23% 
in the endpoint planktonic sample using the highest flowrate. Using Q = 125 and 95 µL min-1 
caused a decrease in the relative abundance of PA in the endpoint planktonic samples. For Q 
= 125 µL min-1 PA was present at 18.74% (43% reduction in relative abundance), whereas 
Lactobacillales comprised 79.11% (76.46% increase in relative abundance) and 
Enterobacteriaceae 2.08% relative abundance at T = 120 hrs. Using Q = 95 µL min-1 PA 
comprised 29.95% of the planktonic sample (28.7% reduction in relative abundance) and 
Lactobacillales and Enterobacteriaceae were present at a relative abundance of 63.33% and 
6.64%, respectively. The endpoint biofilm sample using Q = 125 µL min-1 consisted entirely of 
PA (99.9% relative abundance) and the biofilm sample utilising Q = 95 µL min-1 comprised of 
PA (96.48%), Lactobacillales (3.17%) and Bacilli (0.165%). 
Using Q = 75 and 65 µL min-1 there was a respective 25.11% and 16.9% increase in the 
relative abundance of PA between the inoculum and endpoint sputum samples. For Q = 75 




Figure 7.3 Relative bacterial species abundance in flowrate optimisation sequencing libraries. 
Relative abundance of bacterial species in the initial CF sputum inoculum and in the corresponding endpoint planktonic or biofilm samples 
following 120 hrs incubation. Each bar represents a different sample. Labels below samples denote flowrate (µL min-1, Q) -inoculum (I); -planktonic 














Legend 7.1 Relative bacterial species abundance in flowrate optimisation sequencing 
libraries. 
Legend corresponding to Figure 7.3. Denoting: phylum (P); classification (C); order (O); family 
(F); genus (G) and species (S) at the highest level which could be unambiguously assigned to 





were present at 1.06% and 0.05%, respectively in the planktonic sample at T = 120 hrs. Using 
Q = 65 µL min-1 PA, Lactobacillales and Bacilli were present at a relative abundance of 96.7%, 
3.12% and 0.14%, respectively in the endpoint planktonic sample. Again, PA dominated the 
biofilm fraction of these cultures, being present at a relative abundance of 99.85% and 99.5% 
in the Q = 75 and 65 µL min-1 endpoint biofilm samples, respectively. Importantly, A. glycerini 
an obligate anaerobe could also be detected at a relative abundance of 0.21% in the 
polymicrobial biofilm sample incubated using Q = 65 µL min-1. 
Using the lowest flowrate possible with the digital peristaltic pump (Q = 55 µL min-1) resulted 
in the smallest change (0.52%) in PA relative abundance between the initial inoculum (75.6% 
relative abundance) and endpoint planktonic (75.08% relative abundance) sample. The Q = 
55 µL min-1 planktonic sample contained the most diverse species abundance of any endpoint 
sample, also containing: Enterobacteriaceae (relative abundance 0.1%), Lactobacillales 
(12.91%), Bacilli (11.03%), A. glycerini (0.37%) and unassigned Pseudomonadaceae and 
Bacillaceae (0.37% and 0.15% relative abundance, respectively). There was a respective 
12.75% and 10.6% increase in the relative abundance of Lactobacillales and Bacilli present 
in the initial and planktonic samples over the course of incubation. Conversely, there was a 
15.3% decrease in the relative abundance of Enterobacteriaceae present in the culture vessel 
between T = 0 and 120 hrs. All five distinct OTUs identified in the initial sputum inoculums 
could also be detected in the Q = 55 µL min-1 endpoint biofilm sample. Like the other biofilm 
samples, PA was present in the highest relative abundance (97.6%) and Enterobacteriaceae, 
Lactobacillales, Bacilli and A. glycerini were present at a relative abundance of 0.12%, 01%, 
0.12% and 0.89% respectively. Demonstrating a 0.52% increase in the relative abundance of 
anaerobic A. glycerini between Q = 55 and 65 µL min-1 biofilm samples when using the slower 
flowrate. 
 
7.3.3.2 Faith’s Phylogenetic Diversity  
Box plots representing Faith’s phylogenetic diversity of bacterial communities present in the 
combined initial inoculums and in the combined planktonic and biofilm endpoint samples for 
the different flowrates are shown in Figure 7.4. The phylogenetic biodiversity of the inoculum 
samples was significantly higher (P < 0.05) than all endpoint samples, demonstrating a 
reduction in the overall phylogenetic diversity present in the culture vessels over 120 hrs of 
incubation. Despite it being clear that the phylogenetic diversity of endpoint samples using Q 
= 55 µL min-1 is greater than endpoint samples using higher flowrates, this difference is not 













Figure 7.4 Faith’s phylogenetic diversity of flowrate optimisation samples. 
Boxplots representing Faith’s phylogenetic diversity of bacterial communities in the initial CF 
sputum inoculum and combined endpoint planktonic and biofilm samples after 120 hrs 
incubation in ASM under continuous-flow conditions using different flowrates (Q). n = 6 for 





7.3.3.2 Bray-Curtis Dissimilarity Test 
Principal coordinate analysis (PCoA) plots based upon Bray-Curtis dissimilarity test of 
bacterial communities present in the initial inoculum, endpoint planktonic and endpoint point 
biofilm samples for the different flowrates are shown in Figure 7.5. The PCoA plot resulted in 
a 3-dimensional solution in which PC1 accounted for 53.64% of the variation and PC2 and 
PC3 accounted for 27.71% and 20.35%, respectively. The inoculum samples clustered 
together in one region, with little variance observed in PC1 or PC2. Planktonic samples of the 
three fastest flowrates (145, 125 and 95 µL min-1) did not cluster with each other or the other 
endpoint samples and were the most dissimilar compared with the inoculum samples. All other 
endpoint samples, except Q = 55 µL min-1 planktonic sample, formed a tight cluster with little 
variance compared to the inoculum samples along PC1 and PC2. When compared to the 
cluster of endpoint samples, the Q = 55 µL min-1 planktonic sample was closer to the inoculum 
samples along PC3, approximately equidistant from the inoculum samples along PC2 and 
further from the inoculum samples along PC1.  
 
7.3.3.3 UniFrac Analysis 
PCoA analysis plots based upon unweighted and weighted variants of UniFrac distance for 
the bacterial communities present in the initial inoculum, endpoint planktonic and endpoint 
biofilm samples for the different flowrates are shown in Figure 7.6 and Figure 7.7, respectively. 
The unweighted PCoA plot resulted in a 3-dimensional solution in which PC1 accounted for 
60.15% of the variation and PC2 and PC3 accounted for 9.51% and 7.91%, respectively. The 
inoculum samples clustered together in a region separated from all endpoint samples along 
PC1. There was no obvious clustering of endpoint planktonic and biofilm samples. However, 
Q = 75 and 65 µL min-1 planktonic and Q = 145, 95, 65 and 55 µL min-1 biofilm samples did 
cluster with respect to PC2, this loose cluster showed little variance from the initial inoculum 
samples along PC2. Q = 145, 65 and 55 µL min-1 biofilm samples were least dissimilar from 
the inoculum cluster along PC3. With respect to PC1, Q = 55 µL min-1 planktonic sample was 
closest to the cluster of inoculum samples. As in Figure 7.5, Q = 145, 125 and 95 µL min-1 
planktonic samples were the most dissimilar to the inoculum samples with respect to all axes.  
The weighted PCoA plot resulted in a 3-dimensional solution in which PC1 accounted for 
96.05% of the variance and PC2 and PC3 accounted for 3.48% and 0.31% respectively. All 
samples, except Q = 125, 95 and 55 µL min-1 planktonic samples, clustered tightly with little 
variance with respect to PC1. This cluster can be further split into two distinct clusters along 




Figure 7.5 Bray-Curtis dissimilarity test of flowrate optimisation samples 
Principal coordinate analysis (PCoA) based on Bray-Curtis dissimilarity test of initial inoculum, endpoint planktonic and endpoint biofilm 
samples. Endpoint samples were incubated in ASM under continuous flow conditions for 120 hrs using different flowrates (Q). Top panels 
denote the different flowrates: Q = 145 (yellow); 125 (purple); 95 (green); 75 (orange); 65 (blue) and 55 µL min-1 (red). Bottom panels 




Figure 7.6 Unweighted UniFrac of flowrate optimisation samples 
Principal coordinate analysis (PCoA) based on unweighted variants of UniFrac for inoculum, 
endpoint planktonic and endpoint biofilm bacterial samples. Endpoint samples were incubated 
in ASM under continuous flow conditions for 120 hrs using different flowrates (Q). Left panels 
denote the different flowrates: Q = 145 (yellow); 125 (purple); 95 (green); 75 (orange); 65 
(blue) and 55 µL min-1 (red). Right panels denote the different sample types (fraction): initial 




Figure 7.7 Weighted UniFrac of flowrate optimisation samples 
Principal coordinate analysis (PCoA) based on weighted UniFrac analysis of inoculum, 
endpoint planktonic and endpoint biofilm bacterial samples. Endpoint samples were incubated 
in ASM under continuous flow conditions for 120 hrs using different flowrates (Q). Left panels 
denote the different flowrates: Q = 145 (yellow); 125 (purple); 95 (green); 75 (orange); 65 
(blue) and 55 µL min-1 (red). Right panels denote the different sample types (fraction): initial 
inoculum (blue); endpoint planktonic (orange) and endpoint biofilm (blue).  
199 
 
endpoint sample cluster, the Q = 65 and 55 µL min-1 biofilm samples were least dissimilar to 
their respective inoculum samples and the Q = 65 µL min-1 planktonic sample was the closest 
planktonic sample to its respective inoculum sample. The endpoint samples that did not cluster 
showed little variance from the other samples along PC2 and PC3 and of these samples, Q = 




In combination, the results presented in this sub-section highlight several key conclusions. 
Firstly, using Q = 145 µL min-1 resulted in a washout of sputum-derived microbial species from 
the culture vessel, as evidenced by the decline in culture density over time. All other flowrates 
permitted stable microbial carrying capacities, of various average optical densities, to be 
maintained over the period of incubation. The faster flowrates, 125 and 95 µL min-1, resulted 
in an increase in the relative abundance of Lactobacillales in the planktonic fraction of the 
culture. Whereas Q = 75 and 65 µL min-1 resulted in PA being the dominant bacterial species 
in the planktonic fraction at the endpoint of incubation. 
Importantly Q = 55 µL min-1 permitted the most diverse bacterial populations to be maintained 
in the planktonic and biofilm fractions of the co-culture. This notion is supported by Faith’s 
phylogenetic diversity analysis (Figure 7.4) and that all five OTUs present in the initial inoculum 
are present in the endpoint biofilm and planktonic populations (Figure 7.3). Furthermore, these 
samples are the least dissimilar from the initial culture inoculums with respect to PC1 in the 
PCoA analysis based upon the Bray-Curtis dissimilarity test (Figure 7.5) and unweighted 
UniFrac analysis of variance (Figure 7.6). Taken together, these results demonstrate that Q = 
55 µL min-1 is the most suitable flowrate for the maintenance of diverse sputum-derived 
polymicrobial cultures. Hence this flowrate was used for the culture of sputum samples in all 
subsequent experiments. However, it is clear from the data that there is still a change in 
species diversity over time using this flowrate. For example, the Q = 55 µL min-1 planktonic 
sample shows significant variance from the initial inoculum samples along PC1 in the weighted 
UniFrac PCoA (Figure 7.7). Although this variance is attributed to an increase in the relative 
abundance Lactobacillales in the sample, it demonstrates that optimisation of Q alone is not 
sufficient for the exact recapitulation of microbial communities at the abundancies found in CF 
sputum using the continuous-flow model. 
The results presented in this sub-section also identify distinct differences in the bacterial 
ecology of the planktonic and biofilm populations grown from the same polymicrobial inoculum. 
For example, it is key to note that the biofilms of the two slowest flowrates permitted the growth 
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of A. glycerini, an obligate anaerobe. Biofilms are often found to have hypoxic and anoxic 
regions crucial for permitting the survival of anaerobic species (Karampatzakis et al., 2017, 
Wu et al., 2018). Similarly, the CF microenvironment is found to have steep oxygen gradients 
and hypoxic regions (Worlitzsch et al., 2002) suitable for harbouring the growth of anaerobic 
species. Some key anaerobic species such as Veillonella, Prevotella and Rothia are persistent 
members of chronic CF airway infections (Carmody et al., 2018, Rogers et al., 2004, Tunney 
et al., 2008, Zemanick et al., 2010). Previous studies have demonstrated that these anaerobic 
fermenters, such as A. glycerini, may trigger proinflammatory immune responses (Ghorbani 
et al., 2015, Mirković et al., 2015) and contribute towards the pathogenicity of conventional CF 
pathogens (Flynn et al., 2016). However, the role of anaerobes in CF airway infections is still 
hotly debated (Caverly and LiPuma, 2018). It is therefore important that anaerobes can be 
maintained in the in vitro model to discern their potential role in the modulation of microbial 
physiology via interspecies interactions in future experiments. As well as highlighting the need 
to consider the endpoint composition of both the planktonic and biofilm populations when 
further optimising continuous-flow culture conditions.  
 
7.4 Supplementation of ASM 
7.4.1 Comments 
Optimisation of Q alone was not sufficient for maintaining the full diversity of microorganisms 
found in CF sputum in vitro (Section 7.3). It is well known that fastidious and auxotrophic 
species often require supplementation with exogenous growth factors to promote their growth 
ex situ. I therefore performed a search of the literature to identify exogenous supplements 
previously found improve the laboratory growth of microbial species and then screened the 
following modified ASM compositions to identify factors which enhanced the diversity of 
sputum derived polymicrobial communities maintained in the continuous-flow model:  
(1) ASM + 40 µM FeSO4 (ASM-FeSO4). As described previously (Section 1.) iron acquisition 
is essential for biological growth and a scarcity of this resource has been found to increase 
microbial pathogenesis and competition amongst species (Mashburn et al., 2005). ASM 
containing an excess of free iron (10-times the amount in standard ASM) may reduce 
interspecies competition and provide sufficient free iron to support the in vitro growth of some 
fastidious microorganisms.  
(2) ASM + 50 mg L-1 desferrioxamine (ASM-desferrioxamine). Microbial “cheaters” are often 
isolated from chronic polymicrobial infections. These species do not produce metabolically 
expensive public goods, such as siderophores, but exploit the global production of such 
molecules from other members of a microbial consortium (Kramer et al., 2020, Kümmerli, 
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2015, Vacca, 2017). The cross-recognition and uptake of xenosiderophores by bacterial and 
fungal species is well documented and the addition of exogenous siderophores has been 
shown to improve the growth of some microbial species (Guan et al., 2001, Meyer, 1992, 
Miethke et al., 2013, Visca et al., 2013). I therefore supplemented ASM with desferrioxamine 
(a commercially available bacterial siderophore) at a concentration previously shown to 
improve bacterial growth to investigate if this would support the growth of fastidious species 
that do not encode their own iron scavenging molecules. 
(3) ASM + micronutrients (ASM-micronutrients). Trace elements act as cofactors for some 
essential enzymatic reactions (Nimbalkar et al., 2018). Although different microorganisms 
require different combinations of essential micronutrients (also known as trace elements) the 
usual elements required for bacterial growth are Mn, Co, Zn, Cu and Mo (Costa et al., 2020, 
Demirel  and Scherer, 2011, Glass and Orphan, 2012). ASM was therefore supplemented with 
the micronutrient stock described by LaBauve and Wargo (2012), containing the standard 
essential micronutrients.  
(4) ASM + vitamins (ASM-vitamins). Some bacteria and fungi also require vitamins to support 
their growth. In particular, water-soluble vitamins have been shown to improve microbial 
growth (Omotani et al., 2017). ASM was therefore supplemented with stock solutions of the 
key water-soluble vitamins described in Table 2.9. 
(5) ASM + 1 mM KNO3 (ASM-KNO3). As described in Section 7.3.4, it is essential the model 
can support the growth of anaerobic species. Increased levels of nitrate have previously 
improved the in vitro growth of anaerobic species and supported anoxic growth by 
denitrification of PA at growth rates reported in CF sputum (Line et al., 2014). Hence, ASM-
KNO3 was supplemented with 3.5-times more KNO3 than standard ASM to determine if this 
could promote the growth of sputum-derived microbes under continuous-flow conditions.  
(6) ASM + 5 mM methionine and cysteine (ASM-Met/Cys). Anaerobic fermentation of amino 
acids is a conserved feature of microbial fermentation under anoxic conditions and may be 
crucial for the survival of anaerobes in microaerobic environments (Loddeke et al., 2017, 
Palego, 2015). The breakdown of sulfur-containing amino acids may generate localised anoxic 
regions, particularly in biofilms, as released can react with dissolved oxygen in the media 
(Aklujkar et al., 2014, Alcántara et al., 2004). I therefore supplemented ASM with an excess 
of Met and Cys to see if an increased concentration of sulfur-containing amino acids would 
improve the growth of anaerobic fermenters present in CF sputum.  
(7) ASM + 5% heat-inactivated fetal bovine calf serum (FBS, ASM-FBS). FBS is a common 
cell-culture supplement rich in eukaryotic growth factors that can also improve the growth of 
microorganisms. FBS is an essential supplement for the in vitro growth of Helicobacter pylori 
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(Bessa et al., 2012, Testerman et al., 2001) and further improves the growth of several other 
bacterial species (Giengkam et al., 2015, Gifford et al., 2002, Hanson, 1987, Leonhard et al., 
2018). Heat-inactivated FBS was used as a supplement to minimise the inhibitory effects of 
heat-labile immune factors found in FBS on growth of the microbial consortium. 
(8) ASM + 100 µM sodium pyrophosphate (ASM-Na2H2P2O7). Increased phosphorus 
bioavailability is viewed as the most important factor for permitting the expansion of aquatic 
microbial populations. Furthermore, access to inorganic phosphorus is essential for 
maintaining diverse microbial populations and niche species in activated sludge (Miettinen et 
al., 1997, Zheng et al., 2019). Hence, I supplemented ASM with sodium pyrophosphate to 
increase the concentration of inorganic phosphorus in the growth media and determine the 
effects of this supplement on the growth of sputum derived polymicrobial communities. 
(9) ASM + 1 mg L-1 N-acetylmuramic acid (ASM-NAM). Exogenous NAM, obtained from the 
walls of dead bacterial cells in a polymicrobial consortium in situ (Borisova et al., 2016), has 
been identified as an essential factor for the in vitro growth of some oral and airway-associated 
pathogens (Hottmann et al., 2018, Mayer et al., 2019). Provision of this essential bacterial cell 
wall component may therefore stimulate the growth of such auxotrophic species early during 
incubation, where no NAM is available to be recycled from dead cells and prevent the early 
washout of such species from the culture vessel.  
Aliquots of homogenised CF sputum samples were inoculated into the continuous-flow culture 
vessel containing different ASM compositions, as described in Section 2.14.2. Q = 55 µL min-
1. As in Section 7.3, OD600 nm was used to assess the total density of co-cultures and Illumina 
MiSeq-based 16S rRNA amplicon sequencing was used to identify changes in bacterial 
ecology over 120 hrs incubation.  
 
7.4.2 Micronutrient Supplementation 
7.4.2.1 OD600 nm 
Average OD600 nm values of sputum-associated microbial populations grown under continuous-
flow conditions in different ASM compositions are shown in Figure 7.8. All sputum-derived 
microbial populations, except the population grown in ASM-Met/Cys, reached a total steady-
state microbial carrying capacity by T = 48 hrs. There was no significant difference (P > 0.9) 
in the average OD600 nm measurements of sputum samples cultured in standard ASM 
compared with average culture densities observed using the same flowrate in Section 7.3.2. 













Figure 7.8 Growth of CF sputum derived microbial populations in different ASM 
compositions. 
Optical density (OD600 nm) measurements following total microbial density of microbial 
populations derived from homogenised expectorated sputum samples collected from the 
same person with CF under continuous-flow conditions. Q = 55 µL min-1. Culture media was 
ASM with the following supplements: + no supplement (red); + 40 µM FeSO4 (green); + 5% 
FBS (orange); + micronutrients (cyan); + vitamins (brown); + 5mM methionine and cysteine 
(yellow); + 100 µM sodium pyrophosphate (grey); + 1 mM KNO3 (purple); + 50 mg L-1 
desferrioxamine (purple); + 1 mg L-1 N-acetylmuramic acid (pink). Data represented as the 
mean from two independent experiments. 
204 
 
of populations cultured in: ASM-only (OD600 nm ≈1.6); ASM-FBS (1.67); ASM-micronutrients 
(1.68); ASM-vitamins (1.55); ASM-Na2H2P2O7 (1.58); ASM-KNO3 (1.5) or ASM-NAM (1.59). 
Carrying capacities of sputum-derived microbial populations cultured in ASM supplemented 
with increased FeSO4 or desferrioxamine were significantly higher (P < 0.05) than the density 
of the other cultures, average OD600 nm 1.97 and 1.93 respectively. Sputum-derived 
populations cultured in ASM-Met/Cys did not reach a stable steady-state carrying capacity 
until T = 72 hrs and the average steady-state culture density (OD600 nm 1.3) was significantly 
lower (P < 0.05) than that of the ASM-only culture. 
 
7.4.3 Bacterial Ecology 
7.4.3.1 Taxa Plots 
Relative abundance taxa bar plots of the initial inoculum and planktonic/biofilm samples after 
120 hrs incubation in different compositions of ASM are shown in Figure 7.9. Although there 
was considerable heterogeneity in the relative abundance of the initial bacterial inoculum 
present in the sputum aliquots, three distinct OTUs were present at >1% relative abundance 
across all samples. These three dominant bacteria were present in the following average 
relative abundancies: P. aeruginosa 67.63 ± 19.38%, Lactobacillales (unassigned family) 
19.56 ± 16.13% and Bacilli (unassigned order) 7.8 ± 4.54%. Inoculum samples introduced into 
ASM supplemented with desferrioxamine, NAM, sodium pyrophosphate and increased 
methionine/cysteine also contained a prominent OTU corresponding to Bacteroidetes 
(unassigned classification) at a relative abundance of 15.38 ± 9.34%. Furthermore, the 
samples inoculated into ASM-desferrioxamine or ASM- Met/Cys included Micrococcaceae 
(unassigned genus) at a relative abundance of 2.82% and 1.09%, respectively. The sample 
inoculated into ASM-KNO3 contained Lactobacillales and Enterobacteriaceae at a relative 
abundance of 2% and 41.02%, respectively. Across all samples, the remaining inoculum 
comprised of the other bacteria listed in Legend 7.2 in varied proportions at <0.2% total relative 
abundance.  
A 4.22% decrease in the relative abundance of PA occurred between the initial inoculum 
(relative abundance = 70.93%) and the endpoint planktonic sample (66.71%) cultured in ASM-
only. By contrast, Lactobacillales increased in relative abundance from 21.32 to 31.72% and 
Bacilli decreased in relative abundance from 7.15 to 1.49% over the course of incubation. A 
Gammaproteobacteria (unassigned order) was also present in the ASM-only planktonic 
endpoint sample at a relative abundance of 0.03% but all other inoculum species were lost 





















Figure 7.9 Relative bacterial species abundance in different ASM composition sequencing libraries.  
Relative abundance of bacterial species in the initial CF sputum inoculum and in the corresponding endpoint planktonic or biofilm samples 
following 120 hrs incubation under continuous-flow conditions in different compositions of ASM. Q = 55 µL min-1. Each bar represents a different 
sample. Labels below samples denote the ASM supplement: -inoculum (I); -planktonic (P) or -biofilm (B). For example, Na4P2O7-P ≡ ASM+ 100 











Legend 7.2 Relative bacterial species abundance in different ASM composition 
sequencing libraries. 
Legend corresponding to Figure 7.9. Denoting: phylum (P); classification (C); order (O); family 
(F); genus (G) and species (S) at the highest level which could be unambiguously assigned to 
aligned quality filtered sequence reads. 
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only endpoint biofilm sample (relative abundance 86.86%) and Lactobacillales, Bacilli and 
Pseudomonadaceae (unassigned genus) were present at a relative abundance of 12.7, 0.32 
and 0.01%, respectively. Similar changes in bacterial ecology were observed over time for the 
sputum samples cultured in ASM supplemented with micronutrients and vitamins. Compared 
with the initial inoculums, there was a respective 9.86 and 7.14% increase in the relative 
abundance of PA in endpoint ASM-micronutrients (84.7%) and ASM-vitamins (81.73%) 
planktonic samples. An approximate 13% decrease in the relative abundance of 
Lactobacillales occurred between the initial inoculum and endpoint ASM-micronutrients or 
ASM-vitamins planktonic samples, with this OTU, respectively, present in these samples at 
5.23 and 8.04%. Bacilli, Pseudomonadaceae and Proteobacteria (unassigned classification) 
were, respectively, present at 10.21/10.02%, 0.03/0.09% and 0.06/0.08% relative abundance 
in the ASM-micronutrients or ASM-vitamins samples. The composition of the ASM-vitamins 
biofilm sample closely resembled that of ASM-only, with PA; Lactobacillales; Bacilli and 
Pseudomonadaceae present at a relative abundance of 88.93, 8.99, 1.96 and 0.02%, 
respectively. However, the composition of the ASM-micronutrients biofilm sample was 
markedly different, with Bacilli present at a relative abundance of 34.92% and PA, 
Lactobacillales and Gammaproteobacteria at 64.7, 0.034 and 0.01%, respectively.  
For the planktonic sample cultured in ASM-FeSO4 there was an ≈13% increase/decrease, 
respectively, in the endpoint relative abundance of PA (88.26%) and Lactobacillales (4.41%). 
The relative abundance of Bacilli decreased by just 0.58% over 120 hrs incubation and 
Pseudomonadaceae was present in the endpoint planktonic sample at a relative abundance 
of 0.08%. The composition of the endpoint biofilm sample was similar to the planktonic 
fraction, with PA, Lactobacillales, Bacilli and Pseudomonadaceae present at a relative 
abundance of 86.29, 9.2, 4.4 and 0.07%, respectively. Interestingly, the endpoint planktonic 
sample cultured in ASM-desferrioxamine was dominated by Lactobacillales (relative 
abundance 63.64%). Bacilli, PA and Proteobacteria were present at a relative abundance of 
26.44, 9.66 and 0.03%, respectively. The composition of the endpoint biofilm sample for this 
supplement closely resembled that of the planktonic sample with PA, Lactobacillales, Bacilli 
and Proteobacteria present at a relative abundance of 9.91, 66.55, 23.41 and 0.07%, 
respectively.  
The endpoint planktonic and biofilm samples cultured in ASM-Na2H2P2O7 were both 
dominated by Lactobacillales at a relative abundance of 59.48 and 94.55%, respectively. 
There was an ≈50% decrease and ≈15% increase, respectively, in the endpoint relative 
abundancies of PA (15.98%) and Bacilli (24.36%) in the planktonic fraction, compared with 
the initial inoculum. Unlike the ASM-desferrioxamine endpoint samples, Enterobacteriaceae, 
Pseudomonadaceae, Proteobacteria and Bacillales (unassigned family) were present in the 
208 
 
ASM-Na2H2P2O7 endpoint planktonic fraction at a relative abundance of 0.09, 0.01, 0.04 and 
0.04%, respectively. Alongside the Lactobacillales, the endpoint ASM-Na2H2P2O7 biofilm 
fraction contained PA at a relative abundance of just 1.09%, with Enterobacteriaceae (0.02%), 
Pseudomonadaceae (0.05%) and Bacillales (0.3%). Similarly, endpoint planktonic and biofilm 
samples cultured in ASM-Met/Cys contained Lactobacillales at a relative abundance of 94.99 
and 96.41%, respectively. PA relative abundance decreased by 68.3% over the incubation 
period and this species comprised just 2.26% of the ASM-Met/Cys planktonic fraction at T = 
120 hrs. Bacilli, Firmicutes (unassigned order), Bacillaceae and an OTU corresponding to an 
unclassified bacterium were present in the endpoint ASM-Met/Cys planktonic sample at a 
relative abundance of 0.15, 0.11, 0.27 and 0.23%, respectively. The endpoint biofilm sample 
for this supplement also contained PA, Bacilli and an unassigned bacterium at a relative 
abundance of 2.55, 0.8 and 0.05%, respectively. 
A 55.14% decrease in the relative abundance of PA occurred over the course of incubation in 
ASM-KNO3. Unlike the other endpoint planktonic samples, Firmicutes (unassigned 
classification) comprised 73.94% of the ASM-KNO3 planktonic OTUs, with PA, Lactobacillales, 
Bacilli, Clostridales (unassigned family) and Veillonellaceae (unassigned family) present at a 
relative abundance of 0.3, 6.86, 16.13, 2.7 and 0.05%, respectively. Interestingly, the ASM-
KNO3 biofilm sample was dissimilar to the planktonic sample and comprised the following 
species abundances: PA (1.49%), Lactobacillales (94.09%), Bacilli (4.1%) Enterobacteriaceae 
(0.06%) and Gammaproteobacteria (0.003%). In endpoint planktonic and biofilm samples of 
ASM supplemented with NAM, PA was the dominant species, present at a respective relative 
abundance of 99.85 and 98.99%. Lactobacillales and Enterobacteriaceae comprised the 
remaining 0.09 and 0.02% of the planktonic sample and Lactobacillales, Enterobacteriaceae, 
Gammaproteobacteria and Pseudomonadaceae were present at 0.3, 0.27, 0.31 and 0.2% 
relative abundance in the biofilm sample, respectively.  
Endpoint planktonic and biofilm samples of CF sputum cultured in ASM-FBS contained the 
most diverse bacterial populations. The ASM-FBS endpoint planktonic sample contained: PA 
(5.7%, 69.12% decrease in abundance), Lactobacillales (58.63%, 40.15% increase in 
abundance), Bacilli (26.18%, 20.08% increase in abundance), Enterobacteriaceae (5.5%), 
Bacillaceae (unassigned genus, 2.46%), Gammaproteobacteria (0.24%), 
Pseudomonadaceae (0.45%), Bacillales (0.12%), Listeria weihenstephanensis (0.17%), 
Macrococcus brunensis (0.12%), Pseudomonadales (0.04%), Firmicutes (0.03%) and an 
unassigned OTU (0.29%). The endpoint ASM-FBS biofilm sample resembled the planktonic 
community and consisted of: PA (6.88%), Lactobacillales (78.48%), Bacilli (9.3%), 
Enterobacteriaceae (1.47%), Bacillaceae (2.61%), Gammaproteobacteria (0.08%), 
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Pseudomonadaceae (0.31%), Bacillales (0.24%), L. weihenstephanensis (0.23%), M. 
brunensis (0.1%), Firmicutes (0.11%) and an unassigned OTU (0.18%). 
 
7.4.3.2 Faith’s Phylogenetic Diversity  
Box plots representing Faith’s phylogenetic diversity of bacterial communities present in the 
combined initial inoculum samples and in the combined endpoint planktonic and biofilm 
samples cultured in different ASM compositions are shown in Figure 7.10. The phylogenetic 
biodiversity of the inoculum samples was significantly higher (P < 0.05) than all endpoint 
samples, demonstrating a loss of species diversity in the different ASM compositions over the 
incubation period. The phylogenetic diversity of the combined endpoint ASM-FBS sample was 
significantly higher (P < 0.05) than that of all other endpoint samples cultured using different 
ASM compositions. There was no statistically significant difference (P > 0.1) in the overall 
species diversity of the other endpoint bacterial populations using Faith’s measure of 
biodiversity.  
 
7.4.3.3 Bray-Curtis Dissimilarity Test 
Principal coordinate analysis (PCoA) plots based upon Bray-Curtis dissimilarity test of 
bacterial communities present in the initial inoculum, endpoint planktonic fraction and endpoint 
point biofilm samples cultured in different ASM compositions are shown in Figure 7.11. The 
PCoA plot resulted in a 3-dimensional solution in which PC1 accounted for 68.7% of the 
variation and PC2 and PC3 accounted for 12.17% and 7.82%, respectively. All samples, 
except for the ASM-KNO3 planktonic sample, clustered into three distinct groups. Firstly, the 
initial inoculum clustered in one region with little variance along any axis. Secondly, endpoint 
planktonic and biofilm samples cultured in ASM-only or ASM supplemented with 
micronutrients, vitamins or 40 µM FeSO4 clustered with little variance along PC1 and PC3. 
This cluster was the most similar to the cluster of initial inoculum samples with respect to all 
axis. The third cluster consisted of the endpoint planktonic and biofilm samples cultured in 
ASM supplemented with desferrioxamine, FBS, NAM, 5 mM Met/Cys, sodium pyrophosphate 
and the ASM-KNO3 biofilm sample. The third cluster differed significantly from the initial 
inoculum along PC1 but showed comparatively little variance to this cluster with respect to 









Figure 7.10 Faith’s phylogenetic diversity of supplemented ASM samples. 
Boxplots representing Faith’s phylogenetic diversity of bacterial communities in the initial CF 
sputum inoculum and combined endpoint planktonic and biofilm samples. Endpoint samples 
were incubated in different compositions of ASM under continuous-flow conditions for 120 hrs. 
Q = 55 µL min-1. Sample labels denote the ASM supplement. n = 10 for inoculum and n = 2 




Figure 7.11 Bray-Curtis dissimilarity test of supplemented ASM samples. 
Principal coordinate analysis (PCoA) based on Bray-Curtis dissimilarity test of initial inoculum, 
endpoint planktonic and endpoint biofilm samples. Endpoint samples were incubated in 
different ASM compositions under continuous flow conditions for 120 hrs. Q = 55 µL min-1. Left 
panels denote the different supplements: + no supplement (red); + 40 µM FeSO4 (green); + 
5% FBS (orange); + micronutrients (cyan); + vitamins (brown); + 5mM methionine and 
cysteine (yellow); + 100 µM sodium pyrophosphate (grey); + 1 mM KNO3 (purple); + 50 mg L-
1 desferrioxamine (purple); + 1 mg L-1 N-acetylmuramic acid (pink). Right panels denote the 
different sample types (fraction): initial inoculum (blue); endpoint planktonic (orange) and 




7.4.3.4 UniFrac Analysis 
PCoA analysis plots based upon unweighted and weighted variants of UniFrac distance for 
the bacterial communities present in the initial inoculum, endpoint planktonic fraction and 
endpoint biofilm samples cultured in different ASM compositions are shown in Figure 7.12 and 
Figure 7.13, respectively. The unweighted PCoA plot resulted in a 3-dimensional solution in 
which PC1 accounted for 46.59 % of the variation and PC2 and PC3 accounted for 11.72% 
and 9.05%, respectively. Samples corresponding to the initial inoculum clustered into two 
separate regions, dissimilar only with respect to PC3. The endpoint samples formed a loose 
cluster distributed across PC2. The ASM-FBS biofilm sample was the most dissimilar to the 
other endpoint samples and was closest to the inoculum samples with respect to PC1. 
Interestingly, the ASM-FBS planktonic sample was the highest endpoint sample with respect 
to PC2 and the second closest to the inoculum samples along PC1. The endpoint planktonic 
and biofilm samples for ASM-only, ASM-micronutrients and ASM-FeSO4 clustered tightly at 
the polar end of axis 2 in comparison to the ASM-FBS samples.  
The weighted PCoA plot resulted in a 3-dimensional solution in which PC1 accounted for 
94.96% of the variance and PC2 and PC3 accounted for 2.81% and 1.6%, respectively. The 
endpoint ASM-KNO3 planktonic sample did not cluster with any other sample and the 
remaining samples clustered into four regions. Cluster 1 comprised of a cluster of all initial 
inoculum samples. The ASM-vitamins and ASM-NAM inoculum samples displayed some 
variance within cluster 1 with respect to PC1 and PC2. Importantly, the endpoint ASM-only 
planktonic and ASM-micronutrients biofilm samples clustered in group 1 and were highly 
similar to the ASM-vitamins inoculum sample. Secondly, cluster 2 contained the endpoint 
ASM-only biofilm, ASM-micronutrients planktonic and the ASM-vitamins, ASM-NAM, ASM-
FeSO4 planktonic and biofilm samples. Cluster 2 was distributed along PC1 and showed some 
variance to cluster 1 with respect to PC2. The remaining samples were dissimilar from clusters 
1 and 2 with respect to PC1 and could be divided into two clusters. Cluster 3 contained the 
endpoint ASM-sodium pyrophosphate planktonic and ASM-FBS/ASM-desferrioxamine 
planktonic and biofilm samples. Cluster 3 was similar to cluster 1 with respect to both PC2 and 
PC3. The remaining samples formed a tight cluster that showed little variance to cluster 2 with 
respect to PC2 and PC3. 
 
7.4.4 Conclusions 
Several conclusions can be drawn from the data presented in this sub-section. Firstly, 
increased iron bioavailability, via supplementing ASM with excess FeSO4 or with an 




Figure 7.12 Unweighted UniFrac of supplemented ASM samples. 
Principal coordinate analysis (PCoA) based on unweighted variants of UniFrac of initial 
inoculum, endpoint planktonic and endpoint biofilm samples. Endpoint samples were 
incubated in different ASM compositions under continuous flow conditions for 120 hrs. Q = 55 
µL min-1. Left panels denote the different supplements: + no supplement (red); + 40 µM FeSO4 
(green); + 5% FBS (orange); + micronutrients (cyan); + vitamins (brown); + 5mM methionine 
and cysteine (yellow); + 100 µM sodium pyrophosphate (grey); + 1 mM KNO3 (purple); + 50 
mg L-1 desferrioxamine (purple); + 1 mg L-1 N-acetylmuramic acid (pink). Right panels denote 
the different sample types (fraction): initial inoculum (blue); endpoint planktonic (orange) and 




Figure 7.13 Weighted UniFrac of supplemented ASM samples. 
Principal coordinate analysis (PCoA) based on weighted variants of UniFrac of initial inoculum, 
endpoint planktonic and endpoint biofilm samples. Endpoint samples were incubated in ASM 
supplemented with different ASM compositions under continuous-flow conditions for 120 hrs. 
Q = 55 µL min-1. Left panels denote the different supplements: + no supplement (red); + 40 
µM FeSO4 (green); + 5% FBS (orange); + micronutrients (cyan); + vitamins (brown); + 5mM 
methionine and cysteine (yellow); + 100 µM sodium pyrophosphate (grey); + 1 mM KNO3 
(purple); + 50 mg L-1 desferrioxamine (purple); + 1 mg L-1 N-acetylmuramic acid (pink). Right 
panels denote the different sample types (fraction): initial inoculum (blue); endpoint planktonic 
(orange) and endpoint biofilm (blue)
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culture vessel (Figure 7.8). Simply increasing the concentration of free iron did not improve 
the growth of less abundant species present in the inoculum but permitted PA to grow to a 
higher endpoint titre. This finding may be unsurprising given that PA can produce two 
siderophores with the ability to sequester iron from other species in the culture (Section 4.5). 
Addition of desferrioxamine to ASM enabled Lactobacillales to grow to a higher endpoint titre 
and outcompete PA in the culture vessel, suggesting Lactobacillales, but no other species, 
can recognise and take up this siderophore, perhaps also making it less available to the other 
species present. 
As evidenced by Faith’s measure of phylogenetic diversity, there was an overall decrease in 
bacterial biodiversity over time (Figure 7.10). In general, anaerobic species were lost from 
most ASM compositions. However, supplementing the media with 1 mM KNO3 permitted the 
long-term maintenance of Firmicutes, Veillonellacaeae and Clostridiales. Although anaerobes 
dominated the ASM-KNO3 culture, aerobes were also present at low relative abundance in the 
community at the endpoint of sampling. This finding suggests that, with further optimisation, it 
should be possible to maintain an entire polymicrobial community of aerobic and anaerobic 
species for extended periods of time in the continuous-flow model. 
It is interesting to note that an increase in species diversity is observed across samples in 
which PA is not the dominant bacterium. This supports previous findings that PA encodes for 
an arsenal of extracellular virulence factors able to outcompete other species during co-culture 
(Section 1.4.4) and highlights a link between the presence of PA and a decline in diversity 
amongst the airway-associated microbiota. Furthermore, some evidence suggests that a 
decrease in diversity among the CF-airway associated polymicrobial community is linked with 
a decline in pulmonary function (Zhao et al., 2012, Paganin et al., 2015). This indicates that 
there may be some therapeutic potential in promoting the growth of less abundant species in 
the CF microenvironment.  
Supplementing ASM with FBS maintained the most diverse microbial community and caused 
a significant increase in the relative abundance of species comprising <0.2% of the initial 
inoculum. FBS is an undefined culture supplement, hence the exact factor responsible for the 
increased diversity of these endpoint samples cannot be discerned. Firstly, the cocktail of 
different chemicals in FBS may prove to include essential growth factors for some fastidious 
microbial species. Secondly, albumin (comprising ≈50% of the FBS protein content (Issaq et 
al., 2007)) has recently been found to inhibit QS networks in PA and modulate interspecies 
interactions among polymicrobial communities (Smith et al., 2017).  
A further screen of the following ASM compositions was performed to: (i) discern which 
component of FBS was responsible for enhancing the biodiversity of polymicrobial populations 
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cultured in vitro, and (ii) to screen refined ASM compositions to find a culture medium suitable 
for the steady-state maintenance of sputum-derived polymicrobial communities at a similar 
relative abundancies to inoculum communities. 
(1 – 3) 1%, 5% and 10% FBS, respectively (ASM-1%FBS, ASM-5%FBS, ASM-10%FBS). To 
explore the effects of different FBS concentrations on polymicrobial community growth. 
(4) 2.5% bovine serum albumin (ASM-BSA). Albumin comprises ≈50% of the proteins in FBS, 
hence this concentration is comparable to that present when adding 5% FBS. This supplement 
was used to discern if QS inhibition alone was responsible for promoting the growth of diverse 
sputum-derived polymicrobial communities in vitro. 
(5) 5% charcoal-stripped FBS (ASM-charcoal-FBS). Dextran treated charcoal selectively 
removes hormones and lipids from FBS. This supplement was used to determine if these 
molecules contributed towards increased the increased biodiversity of communities during in 
vitro cultivation. 
(6 – 8) <5, 5-30 and >30 kDa fractions of 5% FBS, respectively (ASM-<5kDa-FBS, ASM-5-
30kDa-FBS and ASM->30kDa-FBS). FBS (5%) was fractionated by passing the supplement 
through 5 and 30 kDa “molecular weight cut-off” membranes to determine which portion of 
FBS contributed towards increasing overall species diversity in the model. 
(9) 0.1 g L-1 hemin (ASM-hemin). Hemin is required some anaerobic species for the reduction 
of nitrate during fermentation (Jacobs et al., 1964), therefore exogenous supplementation of 
this cofactor may promote the growth of such anaerobic fermenters in ASM. Hemin may also 
provide an additional source of iron to promote microbial growth. 
(10) 0.1 g L-1 hemoglobin (ASM-hemoglobin). As above (9), ASM was supplemented with 
hemoglobin to examine how the presence of this heme-group containing protein altered the 
growth and ecology of in vitro polymicrobial populations. 
(11) Micronutrients + vitamins + 40 µM FeSO4 (ASM-micronutrients-vitamins-FeSO4). 
Combination of the three supplements that yielded the least dissimilar endpoint planktonic or 
biofilm sample compositions compared to the initial inoculum samples according to weighted 
UniFrac analysis of variance (Figure 7.13). 
(12) Micronutrients + vitamins + 40 µM FeSO4 + 5% FBS (ASM-micronutrients-vitamins-
FeSO4-FBS). Combination of the above (11) supplements and the supplement yielding the 




7.5 Further ASM Supplementation 
7.5.1 OD600 nm 
Average OD600 nm values of sputum-associated microbial populations grown under continuous-
flow conditions in are shown in Figure 7.14. All sputum-derived microbial populations reached 
a steady-state carrying capacity, with respect to culture density, by T = 48 hrs. Cultures grown 
in ASM supplemented with micronutrients-vitamins-FeSO4 (40 µM), hemoglobin or 
micronutrients-vitamins-FeSO4 (40 µM)-FBS reached significantly higher (P < 0.05) steady 
state carrying capacities (OD600 nm ≈2.0, 1.88 and 1.82, respectively) than other ASM 
compositions (OD600 nm ≈1.6), except ASM supplemented with hemin. Differences in the 
average steady-state culture density of ASM-hemin (OD600 nm ≈1.7) were not statistically 
significant compared with other ASM compositions. 
 
7.5.2 Bacterial Ecology 
7.5.2.1 Taxa plots 
Relative abundance taxa bar plots of initial inoculum and planktonic/biofilm samples after 120 
hrs incubation in additional ASM compositions are shown in Figure 7.15. Inoculum samples 
contained distinct key OTUs at the following average relative abundancies: P. aeruginosa 
45.91 ± 21.97%, Lactobacillales (unassigned family) 25.14 ± 14.89%, Bacilli (unassigned 
order) 12.45 ± 5.67%, Bacteroidetes (unassigned classification) 10.91 ± 11.62%, 
Micrococcaceae (unassigned genus) 1.25 ± 2.66%, Firmicutes (unassigned classification) 0.8 
± 0.9%, Enterobacteriaceae (unassigned genus) 0.83 ± 1.29%, Rothia (unassigned species) 
0.62 ± 2.65% and Gammaproteobacteria (unassigned order) 0.37 ± 0.91%. Across all 
samples, the remaining inoculum comprised of the other bacteria listed in Legend 7.3 in varied 
proportions at <0.1% relative abundance. 
Samples cultured in standard ASM contained bacterial OTUs in the endpoint planktonic/biofilm 
fractions, respectively, at the following relative abundancies: Lactobacillales 23.51/74.96%, 
Bacilli 63.92/21.09%, Bacillaceae (unassigned genus) 11.93/1.38%, Firmicutes 0.1/0.04% and 
Lactobacillaceae (unassigned genus) 0.09/0.39%. Unlike Section 7.3.3 and 7.4.3, PA was lost 
from the endpoint of all culture samples except ASM-micronutrients-vitamins-FeSO4, where 
this species comprised just 0.88% relative abundance of the planktonic sample. This finding 
was unexpected and is discussed further in Section 7.5.3. Despite the loss of detectable PA 
from all culture vessels, some interesting trends can still be inferred from the bacterial ecology 













Figure 7.14 Growth of CF sputum-derived microbial populations in further 
supplemented ASM. 
Optical density (OD600 nm) measurements following total density of microbial populations 
derived from homogenised expectorated sputum samples collected from the same person with 
CF under continuous-flow conditions. Q = 55 µL min-1. Culture medium was ASM 
supplemented with the following: no supplement (red); + 1% FBS (yellow); + 5% FBS (teal); 
10% FBS (cyan); + 2.5% BSA (blue); + 5% charcoal-stripped FBS (orange); + <5 kDa FBS 
fraction (green); + 5-30 kDa FBS fraction (pink); + >30 kDa FBS fraction (purple); 0.1 g L-1 
hemin (brown); + 0.1 g L-1 hemoglobin (grey); + micronutrients, vitamins, 40 µM FeSO4, 5% 
FBS (light blue) +; + micronutrients, vitamins, 40 µM FeSO4 (salmon pink). Data represented 
as the mean from two independent experiments.  
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Figure 7.15 Relative bacterial species abundance in further ASM supplemented 
sequencing libraries.  
Relative abundance of bacterial species in the initial CF sputum inoculum and in the 
corresponding endpoint planktonic or biofilm samples following 120 hrs incubation under 
continuous-flow conditions in different compositions of ASM. Q = 55 µL min-1. Each bar 
represents a different sample. Labels below samples denote the ASM supplement: -inoculum 
(I); -planktonic (P) or -biofilm (B). For example, 2.5%BSA-P ≡ ASM+ 2.5% bovine serum 












Legend 7.3 Relative bacterial species abundance in further ASM supplemented 
sequencing libraries 
Legend corresponding to Figure 7.15. Denoting: phylum (P); classification (C); order (O); 
family (F); genus (G) and species (S) at the highest level which could be unambiguously 




Alongside PA, endpoint planktonic/biofilm samples cultured in ASM-micronutrients-vitamins-
FeSO4 also contained Lactobacillales and Bacilli at a relative abundance of 97.19/97.68% and 
1.96/2.25%, respectively. Similarly, endpoint ASM-BSA samples only contained 
Lactobacillales and Bacilli in the planktonic/biofilm fractions at a relative abundance of 
93.96/68.4% and 5.9/31.54%, respectively. Whereas endpoint planktonic/biofilm samples of 
ASM-micronutrients-vitamins-FeSO4-FBS contained OTUs at the following relative 
abundancies, respectively: Firmicutes (78.35/84.25%), Lactobacillales (3.41/5.33%), Bacilli 
(11.18/6.86%), Bacillaceae (2.07/1.52%), Veillonellaceae (0.8/0.64%) and Clostridiales 
(3.82/2.05%). Endpoint samples cultured in ASM supplemented with 1% or 10% FBS shared 
very similar bacterial ecology. In the ASM-1%FBS samples, Lactobacillales, Firmicutes, 
Bacilli, Bacillaceae and Bacillales comprised: 46.4/69.88%; 39.46/20.54%; 10.89/5.57%; 
2.82/3.73% and 0/0.082% of the planktonic/biofilm samples, respectively. Importantly, 
Veillonellaceae (unassigned genus) was present at a relative abundance of 0.08% in the ASM-
10%FBS planktonic sample. The relative abundance of other OTUs present in 
planktonic/biofilm samples of ASM-10%FBS were as follows: Lactobacillales (28.73/68.65%), 
Firmicutes (60.98/26.76%), Bacilli (8.43/3.03%), Bacillaceae (1.47/0.1%) and Bacillales 
(0.1/0.66%).  
As in Section 7.4, supplementing ASM with 5% FBS resulted in a more diverse endpoint 
microbiota. Firmicutes was the dominant OTU in the endpoint planktonic sample (63.07% 
relative abundance) alongside Lactobacillales (33.57%), Bacilli (1.42%), Bacillaceae (1.58%), 
Clostridiales (0.22%), Veillonellaceae (0.2%) and Lactobacillaceae (0.01%). For the ASM-
5%FBS biofilm sample Lactobacillales was present at a relative abundance of 76.09%, 
followed by Firmicutes (17.07%), Lachnoanaerobaculum orale (2.33%), Bacilli (1.73%), 
Bacillaceae (1.49%), Bacillales (0.74%) and Anaerosinus glycerini (0.49%). Supplementing 
ASM with 5% charcoal-stripped FBS or the 5-30 kDa fraction of 5% FBS resulted in similar 
endpoint bacterial compositions to ASM-5%FBS. Endpoint planktonic/biofilm samples of ASM-
charcoal-FBS contained OTUs at the following relative abundancies, respectively: Firmicutes 
(74.31/75.59%), Lactobacillales (13.89/17.11%), Bacilli (8.71/4.88%), Bacillaceae 
(1.08/0.99%), Veillonellaceae (0.77/0.48%), Bacillales (0.62/0.64%) and Anaerosinus 
glycerini (0.2/0.4%). Endpoint planktonic/biofilm samples of ASM-5-30kDa-FBS contained 
OTUs at the following relative abundancies, respectively: Firmicutes (68.91/72.88%), 
Lactobacillales (17.93/13.43%), Bacilli (5.23/4.32%), Bacillaceae (4.87/6.83%), Bacillales 
(1.32/0.15%), Clostridiales (1.19/1.31%), Lachnoanaerobaculum orale (0.02/0.36%) and 
Anaerosinus glycerini (0/0.65%).  
Supplementing ASM with the >30 kDa or <5kDa fractions of 5% FBS resulted in similar 
bacterial ecologies after 120 hrs incubation. Bacilli and Lactobacillales were the most 
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abundant OTUs in the planktonic and biofilm ASM->30kDa-FBS samples, respectively, and 
the most abundant OTU in the ASM-<5kDa-FBS sample corresponded to Firmicutes of an 
unassigned order. OTUs were present in the ASM->30kDa-FBS planktonic/biofilm endpoint 
samples at the following relative abundancies: Lactobacillales (31.7/73.7%), Bacilli 
(45.48/18.9%), Lactobacillaceae (22.35/7.24%), Firmicutes (0.35/0.04%), Bacteroidetes 
(0/0.01%) and Gammaproteobacteria (0/0.04%). Endpoint ASM-<5kDa-FBS 
planktonic/biofilm samples were comprised of OTUs at the following relative abundancies: 
Lactobacillales (31.55/62.31%), Firmicutes (56/32%), Bacilli (10.24/4.36%), Bacillaceae 
(0.44/0.25%), Bacillales (0.75/0.61%) and Veillonellaceae (0.59/0%).  
Endpoint samples cultured in ASM supplemented with hemin or hemoglobin shared bacterial 
ecologies closely resembling those of the >30 kDa or <5 kDa FBS supplement samples. ASM-
hemin endpoint planktonic/biofilm samples contained OTUs at the following, respective, 
relative abundancies: Lactobacillales (38.07/81.79%), Bacilli (50.26/17.43%), Firmicutes 
(10.8/0.07%), Bacillaceae (0.06/0.14%), Bacillales (0/0.26%) and Enterobacteriaceae 
(0/0.15%). Endpoint ASM-hemoglobin planktonic/biofilm samples comprised of: 
Lactobacillales (11.37/54.78%), Bacilli (15.71/7.8%), Firmicutes (0/0.11%), Bacillaceae 
(66.2/39.34%), Bacillales (5.83/0.19%) and Actinomycetales (0.86/0.7%). 
 
7.5.2.2 Faith’s Phylogenetic Diversity  
Box plots representing Faith’s phylogenetic diversity of bacterial communities present in 
combined initial inoculum and in combined endpoint planktonic and biofilm samples cultured 
in additional ASM compositions are shown in Figure 7.16. The phylogenetic biodiversity of the 
combined inoculum samples was significantly higher (P < 0.05) than all endpoint samples, 
again demonstrating a loss in species diversity over time during in vitro cultivation. Compared 
with the ASM-only endpoint samples, supplementing the growth medium with FBS (any type, 
fraction or concentration), hemin or hemoglobin caused a slight increase in the phylogenetic 
biodiversity of endpoint samples, but this trend is not statistically significant (P > 0.8). 
Conversely, supplementing ASM with BSA (2.5%) caused a noticeable reduction in endpoint 
sample phylogenetic biodiversity, but again this change is not statistically significant (P > 0.2). 
 
7.5.2.3 Principal Coordinate Analysis  
Principal coordinate analysis (PCoA) plots based upon Bray-Curtis dissimilarity test or 
unweighted and weighted variants of UniFrac distance for bacterial communities present in 
the initial inoculum, endpoint planktonic fraction and endpoint biofilm samples cultured in 




Figure 7.16 Faith’s phylogenetic diversity of further supplemented ASM samples 
Boxplots representing Faith’s phylogenetic diversity of bacterial communities in the initial CF 
sputum inoculum and combined endpoint planktonic and biofilm samples. Endpoint samples 
were incubated in different compositions of ASM under continuous-flow conditions for 120 h. 
Q = 55 µL min-1. Sample labels denote the ASM supplement. n = 13 for inoculum and n = 2 
for endpoint samples. 
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respectively. For all PCoA plots the inoculum samples clustered tightly in one region separated 
from all endpoint samples with respect to PC1. This trend is to be expected given the loss of 
a key OTU corresponding to PA from most bacterial communities at the endpoint of sampling. 
The PCoA plot based upon Bray-Curtis dissimilarity test resulted in a 3-dimensional solution 
in which PC1 accounted for 35.7% of the variation and PC2 and PC3 accounted for 23.98% 
and 11.75%, respectively. Endpoint planktonic and biofilm samples cultured in ASM-BSA, 
ASM-micronutrients-vitamins-FeSO4 and biofilm samples cultured in ASM-only, ASM-
>30kDa-FBS and ASM-hemin clustered tightly at the bottom of axis 2 and the remaining 
samples were distributed along this axis. With respect to PC2, planktonic samples cultured in 
ASM-10%FBS, ASM-micronutrients-vitamins-FeSO4-FBS and ASM->30kDa-FBS and both 
endpoint samples from the ASM-5-10kDa-FBS culture were closest to the inoculum samples. 
Yet the ASM-charcoal-FBS planktonic and biofilm samples and ASM-only, ASM-5%FBS and 
ASM->30kDa-FBS planktonic samples were closest to the inoculum with respect to PC1. A 
large cluster of endpoint planktonic and biofilm samples cultured in ASM supplemented with: 
1, 5 and 10% FBS, the <5 and 5-30 kDa fractions of FBS (5%) and micronutrients-vitamins-
FeSO4-FBS(5%) showed little variance to the inoculum cluster with respect to PC3.  
The unweighted PCoA plot resulted in a 3-dimensional solution in which PC1 accounted for 
38.51% of the variation and PC2 and PC3 accounted for 10.92 % and 10.32%, respectively. 
There was little variance, with respect to PC1, amongst all endpoint samples and these 
samples were distributed across axis 3. Endpoint samples could be clustered into two groups 
with respect to PC2. Cluster 1, consisting of planktonic and biofilm samples cultured in 
standard ASM and ASM supplemented with BSA, hemoglobin and micronutrients-vitamins-
FeSO4, was most dissimilar to the inoculum cluster with respect to PC2. Cluster 2 consisted 
of the remaining endpoint samples and displayed little variance along PC2 compared with the 
inoculum samples. Planktonic samples cultured in ASM-1%FBS, ASM-10%FBS and ASM-
<5kDa-FBS formed a tight sub-cluster at the bottom of axis 2 and were more dissimilar to the 
inoculum samples with respect to PC2. 
The weighted PCoA plot resulted in a 3-dimensional solution in which PC1 accounted for 
84.5% of the variance and PC2 and PC3 accounted for 7.82% and 4.06%, respectively. 
Endpoint samples were widely distributed across PC2 and could be split into two clusters 
separated along axis 1. Cluster 1 contained the samples with the most diverse endpoint 
species compositions and consisted of both endpoint samples cultured in ASM-charcoal-FBS, 
ASM-micronutrients-vitamins-FeSO4-FBS and ASM-5-30kDa-FBS and planktonic samples 
cultured in ASM-5%FBS, ASM-10%FBS and ASM-5-10kDa-FBS. Cluster 2 contained the 




Figure 7.17 Bray-Curtis dissimilarity test of further supplemented ASM samples 
Principal coordinate analysis (PCoA) based on Bray-Curtis dissimilarity test of initial inoculum, endpoint 
planktonic and endpoint biofilm samples. Endpoint samples were incubated in different ASM 
compositions under continuous flow conditions for 120 hrs. Q = 55 µL min-1. Left panels denote the 
different supplements: no supplement (red); + 2.5% BSA (blue); + 1% FBS (yellow); + 5% FBS (teal); 
10% FBS (cyan); + 5% charcoal-stripped FBS (orange); + micronutrients, vitamins, 40 µM FeSO4, 5% 
FBS (light blue); + <5 kDa FBS (green); + 5-30 kDa FBS (pink); + >30 kDa FBS (purple); + 0.1 g L-1 
hemin (brown); + 0.1 g L-1 hemoglobin (grey); + micronutrients, vitamins, 40 µM FeSO4 (salmon pink). 
Right panels denote the different sample types (fraction): initial inoculum (blue); endpoint planktonic 




Figure 7.18 Unweighted UniFrac of further supplemented ASM samples 
Principal coordinate analysis (PCoA) based on unweighted variants of UniFrac of initial 
inoculum, endpoint planktonic and endpoint biofilm samples. Endpoint samples were 
incubated in different ASM compositions under continuous flow conditions for 120 hrs. Q = 55 
µL min-1. Left panels denote the different supplements: no supplement (red); + 2.5% BSA 
(blue); + 1% FBS (yellow); + 5% FBS (teal); 10% FBS (cyan); + 5% charcoal-stripped FBS 
(orange); + micronutrients, vitamins, 40 µM FeSO4, 5% FBS (light blue); + <5 kDa FBS 
(green); + 5-30 kDa FBS (pink); + >30 kDa FBS (purple); + 0.1 g L-1 hemin (brown); + 0.1 g L-
1 hemoglobin (grey); + micronutrients, vitamins, 40 µM FeSO4 (salmon pink). Right panels 
denote the different sample types (fraction): initial inoculum (blue); endpoint planktonic 




Figure 7.19 Weighted UniFrac of further supplemented ASM samples 
Principal coordinate analysis (PCoA) based on weighted variants of UniFrac of initial inoculum, 
endpoint planktonic and endpoint biofilm samples. Endpoint samples were incubated in 
different ASM compositions under continuous flow conditions for 120 hrs. Q = 55 µL min-1. Left 
panels denote the different supplements: no supplement (red); + 2.5% BSA (blue); + 1% FBS 
(yellow); + 5% FBS (teal); 10% FBS (cyan); + 5% charcoal-stripped FBS (orange); + 
micronutrients, vitamins, 40 µM FeSO4, 5% FBS (light blue); + <5 kDa FBS (green); + 5-30 
kDa FBS (pink); + >30 kDa FBS (purple); + 0.1 g L-1 hemin (brown); + 0.1 g L-1 hemoglobin 
(grey); + micronutrients, vitamins, 40 µM FeSO4 (salmon pink). Right panels denote the 
different sample types (fraction): initial inoculum (blue); endpoint planktonic (orange) and 
endpoint biofilm (blue). 
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cluster showed little variance with respect to PC3 and consisted: of both samples cultured in 
ASM-1%FBS; biofilm samples cultured in ASM supplemented with 5% FBS, 10% FBS and <5 
kDa FBS fraction and the ASM-hemin planktonic fraction. The remaining samples formed the 
second sub-cluster and were distributed along PC3 but were the least dissimilar from the 
inoculum samples with respect to PC1. 
 
7.5.3 Comments 
As shown in Figure 7.15, PA was lost from the endpoint samples of almost every culture, 
including standard ASM. This is despite all previous sections demonstrating the strong growth 
of this bacterium in ASM under continuous-flow conditions. The reasons for this may be two-
fold. Firstly, sputum samples collected from a different person with CF were inoculated into 
the continuous-flow model. It is possible the strain(s) of PA in these sputum aliquots was slow 
growing and simply washed out from the culture vessel. Yet, given that PA was still present in 
the endpoint planktonic sample cultured in ASM supplemented with micronutrients-vitamins-
FeSO4 this explanation seems unlikely. Secondly, unlike previous experiments studying 
biofilm growth in the continuous-flow vessel, the phenomenon of microbial-mediated 
biocorrosion of the stainless-steel biofilm container was observed (Figure 7.20). Although the 
contribution of polymicrobial consortia towards the biocorrosion of metals has not been 
extensively studied outside of an industrial manufacturing setting, it should be noted that 
species of Bacillus, Clostridium and Pseudomonas (all of which were present in the inoculum 
sample) are thought to cause the biocorrosion of steel via metal oxidation (Kip and van Veen, 
2015, Narenkumar et al., 2019). Furthermore, the ability of some fungi to reduce iron (Ottow 
and Von Klopotek, 1969) or produce organic acids (Liaud et al., 2014) significantly contributes 
towards biocorrosion (Wu et al., 2020). As only the bacterial 16S rRNA was sequenced, the 
presence of such fungal species in the cultures could not be discerned. Nevertheless, this 
finding highlights that stainless-steel is not a suitable material for studying biofilm growth in 
the model and a thermoplastic alternative, e.g. silicon, should be trialled in future experiments.  
Some tentative conclusions can be drawn from the preliminary data presented in this sub-
section, but it is essential to note that all hypotheses should be validated in future experiments. 
As in Section 7.4, an enhanced availability of free iron increased the total steady-state carrying 
capacity of the culture vessel, despite a vastly different composition of bacteria existing in the 
model after 120 hrs incubation. Supplementing the medium with albumin alone caused a 
decrease in endpoint species diversity, indicating that the speculated inhibition of QS networks 
in PA alone is not sufficient for the maintenance of a diverse sputum-derived microbial 
consortium in vitro. Species diversity was enhanced the most when supplementing ASM with 













Figure 7.20 Microbial-mediated biocorrosion of biofilm containers. 
Representative stainless-steel biofilm containers described in Section 2.12.3 (A) Biofilm 
container before incubation in continuous-flow model. (B) Biofilm container after 120 hrs 
incubation in standard ASM inoculated with CF sputum samples described in Section 7.4. (C) 
Biofilm container after 120 hrs incubation in standard ASM inoculated with CF sputum samples 
described in Section 7.5. (B) and (C) were incubated under the same conditions for the same 
time period, yet (C) rusted significantly. As the microbial inoculum was the only difference 





growth factors to enhance the growth of fastidious species and that increased albumin 
concentration (in 10% FBS) inhibits microbial growth. Furthermore, supplementation of ASM 
with charcoal stripped FBS resulted in a similar endpoint microbiota as ASM-5%FBS, 
demonstrating that hormones or other lipids in FBS are likely not the factor contributing to 
increased endpoint species diversity. Similarly, the 5-30 kDa fraction of FBS (lacking albumin, 
molecular weight 66.5 kDa) resulted in a microbiota comparable to 5% FBS, indicating this 
fraction of the undefined culture supplement contained the growth factor(s) most likely to 
improve the growth of diverse CF associated polymicrobial communities in vitro. 
 
7.6 Conclusions 
The key conclusions that can be drawn from the results presented in this chapter will help 
guide future efforts in optimising continuous-flow culture conditions for the in vitro 
recapitulation of entire polymicrobial communities associated with CF airway infections. 
Firstly, an extended lag-phase associated with the growth of sputum-derived microbial 
populations in ASM was noted (Section 7.2). To prevent washout of the culture vessel, sputum 
samples should be incubated under batch culture conditions for 24 hrs before applying media 
flowrate to ensure populations are in the logarithmic phase of growth. Secondly, Q = 55 µL 
min-1 was found to be the most suitable flowrate for maintaining sputum-derived microbial 
populations in a steady-state (Section 7.3). This flowrate permitted some species present at a 
low relative abundance in the initial inoculum, e.g. A. gycerini and Enterobacteriaceae, to be 
maintained in the culture vessel over the incubation period. Using Q = 55 µL min-1 also resulted 
in the smallest change in the relative abundance of PA between the initial and endpoint 
planktonic fraction samples. However, across all samples there was a clear decrease in the 
phylogenetic diversity of sputum-derived bacterial populations grown in vitro, especially the 
loss of anaerobic species from the planktonic fraction. As indicated in Section 7.4, subtly 
optimising the concentration of nitrate in ASM may improve the maintenance of anaerobic 
bacteria in the model at a similar relative abundance to the starting inoculum.  
A loss of PA from endpoint samples generally correlated with an increase in overall species 
diversity. Furthermore, supplementing ASM with FBS clearly increased the bacterial diversity 
of endpoint samples (Section 7.4 and 7.5). Preliminary experiments to decipher which 
component(s) of the FBS supplement were responsible for enhancing bacterial biodiversity 
during in vitro growth suggest that albumin-mediated modulation of interspecies interactions 
(Smith et al., 2017) is not the sole explanation for this observation. As suggested in Section 
7.5, it is likely that an unidentified non-lipid component of FBS, 5-30 kDa in size enhances the 
growth of microbial species present at low abundancies in CF sputum, yet this hypothesis 
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remains to be validated. Overall, these preliminary findings highlight the value in pinpointing 
individual factors to promote the growth of fastidious microbial species, and in utilising these 
to subtly refine the composition of ASM. These approaches should prove a fruitful line of 
investigation in the search for conditions that faithfully recapitulate entire CF polymicrobial 





8.1 Maintenance and characterisation of polymicrobial co-cultures 
The results presented throughout this study clearly demonstrate that the polymicrobial 
populations of pathogenic species associated with CF airway infections – including species 
that would ordinarily outcompete each other using traditional culture methods - can be 
maintained as co-cultures for extended periods of time under continuous-flow conditions. 
Populations were held in a stable, steady-state with respect to microbial titres (Figure 3.3, 3.6, 
3.9 and 3.12), genomic mutability (Figure 4.2) the accumulation of extracellular virulence 
factors (Figure 4.4 and 4.5) and QS molecules (Figure 4.7) in the culture vessel for the entirety 
of the incubation period. To my knowledge, this is the first study to describe the successful in 
vitro co-culture of key CF associated pathogens using ASM. The three reference strains 
chosen for this work (PA, SA and CA) were selected to represent the three different classes 
of microbes commonly associated with CF airway infections (Gram-negative bacteria, Gram-
positive bacteria and fungi, respectively). Crucially, stable microbial titres of each distinct 
species could be readily maintained in the co-culture (Section 3), indicating that other 
combinations of microbial species from the CF microenvironment can also likely be maintained 
in vitro as part of a steady-state co-culture as long as the correct flow rate is established. This 
hypothesis is currently being tested by other members of the Welch laboratory, who are 
working towards the co-culture of additional species associated with CF using my continuous-
flow model.  
The importance of studying mixed microbial populations is reiterated by the findings presented 
in Sections 3 and 4. The presence of numerically minor species (such as CA, which comprised 
just 0.05% by numbers in the polymicrobial consortium (Figure 3.12)), can cause significant 
and varied modulations in the accumulation of extracellular signalling molecules or virulence 
factors (Section 4). Furthermore, the presence of these less-abundant species can modulate 
the microbial titres of a polymicrobial consortium maintained under batch culture conditions 
(Section 3). Given the diversity of the microbiota thought to be associated with the CF airways 
throughout a patient’s life (Carmody et al., 2015, Zhao et al., 2012) and the ubiquitous 
presence of less abundant, or “rare”, species (comprising <0.1% of the total relative 
abundance) in CF sputum samples (Section 7), this work demonstrates the essential need to 
consider the impact of low-abundance species on the modulation of microbial behaviour. They 
also open up the possibility of experimentally examining how inter-species interactions may 
contribute towards an increase/decrease in microbial pathogenicity.   
The stability of individual microbial titres in co-cultures maintained under continuous-flow 
conditions (Section 3) may be attributed to the diminished accumulation of extracellular 
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virulence factors, e.g. siderophores and pyocyanin previously identified to be essential for 
infection in in vivo models (van Delden, 2004) in the culture vessel (Section 4). Although only 
two virulence factors were studied in this work, the diminished accumulation of QS molecules 
under continuous-flow conditions suggests that the expression of other extracellular factors 
under the control of these signalling networks is also likely to be repressed. Precisely why 
these factors do not accumulate in the model system is not yet known. As discussed in Section 
4.6, previous studies suggest that QS molecules should accumulate faster than the rate of 
dilution in the continuous-flow culture vessel (Davenport et al., 2015). Two likely explanations 
may account for the observed decrease in extracellular factors in the culture vessel. First, the 
continuous displacement of spent media with fresh ASM ensures an abundant supply of fresh 
nutrients. This culture method was chosen to loosely represent the overproduction of sputum 
in persons with CF, where PA and SA are known to co-habit over the course of a patient’s life 
(Hogan et al., 2016, Limoli et al., 2016, Wakeman et al., 2016, Zolin et al., 2019). As there is 
a reduced need to compete for available nutrients it is possible that the production of 
“expensive” extracellular goods utilised in competition between species is simply not required. 
Second, as demonstrated in Section 4.2, steady-state microbial populations are maintained in 
an actively growing state for the entirety of the incubation. As secondary metabolites are often 
produced during the stationary growth phase, it is possible that the biosynthesis or secretion 
of these factors is repressed in the actively-growing state. It should be noted that these two 
hypotheses are intrinsically linked. Increasing the retention time (Rt) within the culture vessel, 
via decreasing Q, would cause a population to transition into the stationary phase of growth 
once the carrying capacity in the culture vessel is reached. At the same time, increased Rt 
would decrease nutrient availability in the culture, likely leading to increased interspecies 
competition for limited resources. Hence, no further comment on these assumptions can yet 
be made.  
It is interesting to note that an accumulation of PA mutants lacking functional QS networks 
and strains with repressed virulence factor expression are often isolated from chronic infection 
scenarios, suggesting a diminished importance for these metabolic pathways in situ (Kostylev 
et al., 2019, LaFayette et al., 2015, Waters and Goldberg, 2019). Furthermore, PA isolates 
from late-stage airway infections do not outcompete co-cultivated species as quickly as 
commonly-used reference strains or isolates obtained from acute infection scenarios. For 
example, in certain mucoid strains able to exist in a co-culture with SA, there is a marked 
down-regulation of rhamnolipids, siderophores and HQNO (Briaud et al., 2019, Hotterbeekx 
et al., 2017, Price et al., 2020). These reports, taken in combination with the results provided 
in this study provide strong evidence to suggest the use of a continuous-flow model for the 
study of microbial behaviours associated with the chronic stages of infection. Additionally, 
234 
 
increasing Rt of the culture vessel should also allow the more aggressive acute infection 
scenario to be studied (as competition for limited nutrients would increase).  
As demonstrated in Section 4.2, RT-PCR can be successfully and reproducibly performed on 
microbial populations maintained under continuous-flow conditions. It is important to note that 
the relative expression of any gene can be quantified using RT-PCR, ensuring that the model 
system provides a robust tool to monitor changes in the expression of key genes during growth 
in co-culture. For example, quantifying the expression of the pyocyanin or siderophore 
biosynthetic genes (phz (Mavrodi et al., 2001) or pch/pvd (Bonneau et al., 2020), respectively) 
could indicate if the low accumulation of associated extracellular factors is due to displacement 
from the vessel or due to a decrease in gene expression. An untargeted transcriptomic 
approach, such as using RNA-seq (Owens et al., 2019), to compare the expression profiles of 
axenic and polymicrobial steady-state populations would be a powerful approach to discern 
subtle and unexpected changes in the genetic profiles of species over time. Although 
expensive, this approach could identify key genes important for the successful 
establishment/maintenance of pathogenic species in a polymicrobial consortium and may also 
identify potentially novel therapeutic targets.  
Environmental homeostasis is afforded during growth in the continuous-flow culture model 
(Section 4.7), yet previous reports have implicated changes in environmental conditions, such 
as a decrease in pH, in triggering the onset of APEs (Quinn et al., 2014, Quinn et al., 2015). 
Other studies have further established that changes in available eDNA and mucin 
concentrations in a growth medium can modulate microbial behaviour and promote biofilm 
formation (Sriramulu et al., 2005). As ASM is a chemically-defined culture medium, my in vitro 
model provides an unparalleled opportunity to decipher how changes in environmental 
conditions or chemical factors, via changing pH or the nutritional composition of ASM, alters 
the behaviour of polymicrobial populations. Exogenous molecules could also be added to the 
culture vessel to discern how they impinge upon interspecies interactions among the 
community. For example, purified signalling molecules specific for either Gram-positive or 
Gram-negative QS networks, could be introduced into the culture vessel to determine how the 
activation of these regulatory networks affects steady-state microbial co-cultures. As a 
tractable experimental culture model, any number of subtle interspecies interactions could be 
studied in real-time and at a depth that is simply not possible using in vivo models of infection. 
The genomic mutability of co-cultivated microbial species maintained under continuous-flow 
conditions is extremely stable (Figure 4.2). The model therefore provides a unique research 
tool for studying the co-evolution of mixed microbial species associated with CF infections 
under nutritionally relevant conditions over an indefinite period of incubation. Through 
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comparing the genome sequences of parental strains and their progeny, common conserved 
evolutionary changes likely to be beneficial for survival in the CF environment may be 
identified. Hypermutator strains lacking the DNA mismatch repair genes (e.g. mutS in PA 
(Oliver et al., 2002) and SA (Prunier and Leclercq, 2005) or MSH2 and PMS1 in CA (Legrand 
et al., 2007)) could also be introduced into stable microbial co-cultures to accelerate the rate 
of evolution of species in a seemingly unbiased manner. This approach should however be 
used with caution, as the emergence of fast-growing mutant strains could lead to the 
imbalance of microbial titres and further perturbations in the steady-state community. Tn-Seq 
analysis (van Opijnen et al., 2009) of PA or other key CF pathogens maintained in a co-culture 
could also be used to define the genes essential for survival as part of a polymicrobial 
community. These genes may prove to be attractive targets for the development of novel 
therapeutic treatments to prevent the effective in situ establishment of chronic airway 
infections.  
 
8.2 External perturbation of steady-state microbial populations 
The results presented in Section 5 provide a proof-of-principal for the use of my novel culture 
vessel for studying the robust and tractable perturbation of steady-state microbial communities 
in vitro. These findings demonstrate that my model can be successfully used to study the 
response of stable planktonic co-cultures treated with antimicrobial compounds and the 
introduction of new species or strain variants. Furthermore, the model could be utilised for the 
development of effective combinational therapy approaches designed to limit the emergence 
of antimicrobial resistant isolates in a polymicrobial consortium, and prevent the establishment 
of chronic airway infections with keystone respiratory pathogens. Due to time constraints, only 
a small sub-set of microbial co-cultures and their response to antimicrobial compounds were 
examined in this study. However, hypothetically, it should be possible to study how any 
combination of microbial species or an entire patient-derived polymicrobial population 
responds to exogenous perturbation. 
No matter the cell density of the PA inoculum introduced to a pre-established steady-state SA-
CA co-culture, the same composition of microbial species, with respect to viable cell numbers, 
was achieved by the end point of incubation (Figures 5.2 and 5.3). Given that competition 
among species appears to be mitigated under continuous-flow conditions (Sections 3 and 4), 
this finding indicates that a maximum carrying capacity is achieved during growth in the culture 
vessel. When cell titres reach this maximum carrying capacity, cell numbers converge towards 
the same steady-state over time. Through altering the Rt in the model, it is possible to 
modulate the total microbial carrying capacity, as demonstrated in Figure 7.2. Upon 
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introduction of very high PA titres to a steady-state co-culture (Figure 5.3.B) there was a 
temporary diminution in SA and CA CFU mL-1 during the subsequent 24 hrs of incubation. 
This temporary decrease in SA and CA titres may arise due to a severe limitation of nutrients 
caused by the introduction of a high density of PA cells to the culture vessel. Following this, 
and as PA cells are displaced with fresh ASM, the SA and CA titres recover to the steady-
state titres achieved prior to the exogenous introduction of PA to the microbial community. As 
suggested in Section 8.1, transcriptomic analysis of a steady-state PA-negative microbial 
community following perturbation with a large PA challenge could identify genes up-regulated 
during the initial stages of co-culture with other species. Furthermore, Tn-Seq analysis could 
reveal genes crucial for PA to establish an effective infection in a polymicrobial community. 
The corresponding gene products may prove attractive targets for the development of 
prophylactic therapeutics to prevent the establishment of chronic PA infections in the CF 
airways. 
The decreased efficacy of antimicrobial compounds against their target microorganism when 
grown as part of a polymicrobial community is evident from the results presented in Section 5 
(Figures 5.4 – 5.14). This observation highlights an essential need to consider the role of 
additional species at a site of infection and how they might modulate the response of a 
principal pathogen to therapeutic intervention. From the antimicrobials tested in this study it is 
also clear that bacteriostatic compounds are less efficacious at treating pre-established 
microbial cultures under continuous-flow conditions compared with bactericidal compounds. 
This finding affirms the notion that the use of bactericidal antimicrobials against chronic CF 
infections is preferable in the clinical setting (Pankey and Sabath, 2004). It should be noted 
that the role of a host’s immune system in clearing microbial infections is not accounted for in 
this or any other in vitro model. However, and mitigating, impaired immune clearance of 
infections in the CF airway is well reported in the literature (Cohen and Prince, 2012, Bonfield 
and Chmiel, 2017, Bruscia and Bonfield, 2016, Ratner and Mueller, 2012).  
The decreased loss of viable SA cells from a polymicrobial consortium treated with fusidic 
acid, compared to an axenic SA culture, is not an inherited mechanism of resistance but arises 
due to the presence of PA and/or CA in the co-culture (discussed in Section 5.3). Given that 
antimicrobials are less efficacious against microbial biofilms (Fux et al., 2005, Høiby et al., 
2010a, Parsek, 2003, Sharma et al., 2019, Stewart, 2002) and that SA is found to form 
significantly denser biofilms in the presence of PA and CA (Figures 6.3, 6.6, 6.7 and 6.8 and 
Section 8.3), this phenomenon is likely to arise as a result of enhanced biofilm formation during 
co-culture. This finding supports the importance of ongoing research efforts to disrupt/inhibit 
biofilm formation during the treatment of chronic infections (Verderosa et al., 2019). Future 
research efforts can easily adopt my model to robustly discern the key species responsible for 
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modulating antimicrobial action during co-culture and test the efficacy of novel treatment 
regimens. 
More PA and CA isolates displaying enhanced antimicrobial resistance profiles were collected 
from the steady-state polymicrobial cultures perturbed with either colistin or fluconazole than 
were collected from the perturbed axenic cultures (Figures 5.16 and 5.17). This finding 
demonstrates an increased emergence of inherited mechanisms of resistance, alongside 
increased antimicrobial tolerance (discussed above) during microbial co-culture. WGS 
analysis of PA isolates resistant to the action of 1 mg mL-1 colistin revealed no difference in 
the genes containing SNPs identified between isolates recovered from the axenic or 
polymicrobial cultures. These findings demonstrate that the growth of PA as part of a 
polymicrobial community does not necessarily drive the emergence of novel inherited 
mechanisms of antimicrobial resistance. Instead growth as part of a polymicrobial consortium 
increases the emergence of PA isolates containing SNPs in genes conferring resistance to 
colistin within a mixed microbial population. Interestingly, all of the non-synonymous colistin 
resistance-conferring SNPs in PA were found in genes encoding cell surface-associated 
virulence factors such as LPS and type IV pilin (Table 5.4). Most of these have not previously 
been directly linked to conferring resistance against colistin. This finding suggests that the 
down-regulation of these cell surface moieties may benefit PA growth as part of a 
polymicrobial consortium. Perhaps by preventing the effective recognition of PA by other 
members of a community which may trigger an up-regulation of interspecies competition 
events. Although the affected genes are known to be important for mediating host-bacterium 
interactions (Lam et al., 2011), these genes are not essential for the growth of PA in vitro, and 
pilin-deficient PA strains are proven to effectively interact with purified mucin in vitro (Ramphal 
et al., 1991). Importantly, mutations in LPS and pilin biosynthetic genes are often identified in 
clinical PA isolates recovered from late-stage CF airway infections (Smith et al., 2006). 
Existing studies have also demonstrated that late-stage PA isolates can be co-cultivated with 
other bacterial species for longer periods of time under batch culture conditions due to a 
reduction in virulence factor production (Baldan et al., 2014). This provides some evidence to 
support the hypothesis that a down-regulation of genes encoding cell surface associated 
virulence factors permits improved co-culture of PA with other species. Mutants defective in 
such genes would therefore be expected to be selected for in co-cultures. Although WGS 
analysis of CA isolates displaying increased fluconazole resistance was not performed as part 
of this study, future investigation into this could confirm if there is also an alteration in fungal 
cell surface moieties during growth as a polymicrobial community.  
The stability of microbial mutation rates in co-cultures maintained in the model for extended 
periods of time (Figure 4.2) and the emergence of key genomic mutations commonly identified 
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in situ in CF airway infection scenarios provides strong evidence to support the utility of the 
continuous-flow model for studying the evolutionary trajectory of key CF associated pathogens 
when grown as a part of a polymicrobial community.  
In the cultures treated with supra-MIC concentrations (5 x MIC) of colistin or fusidic acid there 
was a significant increase in viable PA cell counts between the steady-state community prior 
to antimicrobial exposure (T = 0 hrs) and the final point of sampling (T = 48 hrs) (Figures 5.6 
and 5.10). This demonstrates ability of PA to expand into a vacant environmental niche 
following the perturbation of a microbial community. Furthermore, this finding supports the 
CAM model of changes within a polymicrobial community following clinical intervention or 
immune clearance proposed by Conrad et al. (2013). In brief, this hypothesis suggests that 
keystone pathogens of late-stage CF airway infections can resist clearance from the airway 
and acquire adaptations that enable them to occupy a newly-liberated environmental niche. 
This often complicates future treatment regimens and leads to a worsening patient prognosis. 
Given that targeting SA with a large fusidic acid challenge caused a significant increase in PA 
titres and a reduction in SA titres, this observation affirms the importance of understanding 
how an entire polymicrobial population responds to antimicrobial treatment, and not simply the 
principal pathogen being targeted. One key use of the model system in the future is to examine 
how complex and patient-derived polymicrobial consortia respond to global perturbation, i.e. 
antimicrobial action, in order to develop effective combination therapies to limit the emergence 
of key pathogens.  
 
8.3 Formation of polymicrobial biofilms in ASM 
A combined approach of different experimental assays was employed to study the temporal 
formation of biofilms in ASM. This revealed complementary information regarding the 
dynamics of biofilm formation that would otherwise be missed when studying biofilms with a 
single technique. For example, CA initially formed biofilms with the largest total biomass 
(Figure 6.1 and 6.4) but these biofilms were the least metabolically active (Figure 6.2 and 6.5). 
By contrast, SA formed the least dense but most metabolically active biofilms in ASM. Given 
that a number of conventional antimicrobials are more active against vigorously-growing 
microbial populations (Agrawal et al., 2019, Anderl et al., 2003, Keren et al., 2004, Matsuo et 
al., 2011, Pletnev et al., 2015) and that the EPS encasing cells in biofilms is known to hamper 
the penetration of various antimicrobial compounds (Hall and Mah, 2017, Harjai et al., 2005, 
Høiby et al., 2010a), this finding indicates that in situ biofilms comprising of SA may be more 
susceptible to antimicrobial treatment compared with biofilms containing CA. By extension it 
may be reasonable to predict that biofilms containing both PA and CA (showing low metabolic 
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activity and high biomass production) would be more tolerant to antimicrobial action compared 
with biofilms of the other species combinations studied as part of this work. Indeed, it has 
recently been demonstrated that the CA biofilm matrix can protect SA against vancomycin, a 
“last-resort” glycopeptide antimicrobial, during polymicrobial co-culture (Kong et al., 2016). 
Furthermore, PA-derived exogenous alginate can also protect SA from killing during growth 
as a polymicrobial biofilm (Price et al., 2020, Schurr, 2020). Although the perturbation of 
polymicrobial biofilms with antimicrobials was not studied here, the results presented in 
Sections 5 and 6 demonstrate that my model system provides a tractable tool for investigating 
this in detail. No matter the research question being addressed, the results presented in 
Section 6 highlight the importance of using multiple experimental techniques when studying 
biofilm formation, especially in a polymicrobial scenario where it may be impossible to discern 
which species are responsible for the production of extracellular products such as EPS.  
Consistent with previous studies, the out-competition and removal of microbial species during 
co-culture was diminished in the biofilm mode of growth compared with growth as a planktonic 
culture (Figure 6.3 and 6.6). As discussed in Section 6.5, diffusion coefficients of small 
molecules are lower in a biofilm matrix (Sankaran et al., 2019) thereby limiting the rate of 
release of extracellular products from or within the biofilm (Janissen et al., 2015, Jayathilake 
et al., 2017). This is likely to result in a heterogenous distribution of extracellular factors, such 
as those associated with virulence. By extension the diffusion of fresh nutrients into the biofilm 
will also be limited and may explain why increased interspecies competition and a reduction 
in SA and CA titres occurs in some of the polymicrobial biofilms cultured using the Kadouri 
drip-plate continuous-flow method (Figure 6.6). It is also important to note that the flow rate 
was lower during experiments using the continuous-flow microtiter plate format (Q = 55 µL 
min-1 as opposed to >145 µL min-1 during growth in the 100 mL culture vessel). The lower flow 
rate was necessary to prevent rapid washout of cells from the smaller well volume present in 
the drip-plates. However, as described previously (Section 8.1) this, in turn, is likely to increase 
competition amongst microbial species. This notion is supported by the observation that 
polymicrobial biofilms grown on agar in the continuous-flow system (with a higher Q) do not 
demonstrate any microbial out-competition over the 96 hrs incubation period (Figure 6.7). 
Alongside this, biofilms containing PA did not demonstrate signs of biofilm dispersal during 
growth using the Kadouri drip-plate method (Figure 6.4 and 6.6). In combination, these 
findings provide further support for my hypothesis that microbial competition is suppressed 
under growth conditions with an ample supply of nutrients, not unlike the nutrient-rich CF 
microenvironment (Palmer et al., 2005, Palmer et al., 2007, Son et al., 2007). Ultimately these 
findings also demonstrate the suitability of the continuous-flow model for the long-term study 
of sessile polymicrobial communities in vitro. 
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In addition to some microbial competition occurring in the polymicrobial biofilms during the late 
stages of incubation (after 24 hrs incubation), antagonistic and synergistic interspecies 
interactions are also present during the initial stages of mixed species biofilm formation under 
both continuous-flow and batch culture conditions. As discussed in Section 6.5, the presence 
of PA or CA in a co-culture increased the attachment of viable SA cells in the biofilm during 
the first 12 hrs of incubation (Figure 6.3 and 6.6). Conversely, the presence of PA or SA in the 
co-culture decreased the attachment of viable CA cells in the biofilm. Earlier publications have 
established the importance of an EPS matrix for the formation of sessile microbial communities 
(Limoli et al., 2015). Direct evidence also demonstrates that EPS components, such as 
alginate produced by PA, may encapsulate other species in polymicrobial biofilms to provide 
an anchor point for the improved attachment of species to a surface (Flemming and 
Wingender, 2010). Furthermore, polymeric substances can protect co-cultured species from 
antimicrobial action or clearance via the immune system (Paulsson and Riesbeck, 2018). As 
identified through CV staining (Figure 6.1 and 6.4) SA produces the smallest biomass of the 
three reference strains studied throughout this work. When co-cultured with species producing 
a large amount of biomass, i.e. PA or CA, SA appears to be more efficient in attaching to the 
biofilm during the initial stages of biofilm formation. Indeed existing reports have shown that 
Staphylococcus spp. interact synergistically with fungal species, such as CA, during the initial 
stages of biofilm formation (Adam et al., 2002, Costerton et al., 1999, Shirtliff et al., 2009) and 
SA has been demonstrated to show strong adherence to the CA hyphal adhesin protein, 
Als3p, during biofilm growth (Peters et al., 2012b). In contrast, PA can prevent the CA yeast-
hyphal morphogenesis associated with the maturation of fungal biofilms. Such antagonistic 
interactions between species can explain the decrease in viable CA cells in polymicrobial 
biofilms compared with mono-species biofilms observed in the current work (Figure 6.3, 6.6, 
6.7 and 6.8).  
The ability of the solid substratum to modulate microbial behaviour is also evident from the 
results presented in Section 6. Despite being identified as an early coloniser of the CF 
microenvironment and strong biofilm producer in situ (Kiedrowski et al., 2018), SA formed the 
least dense biofilms on abiotic surfaces such as plastic (Figure 6.1, 6.3, 6.4 and 6.6) and agar 
chunks (Figure 6.7) during growth in ASM. When cultured on bronchiole tissue sections 
(Figure 6.8) SA established a significantly denser mono-species biofilms compared with 
growth on agar chunks. The increased attachment of SA to EVPL tissue sections indicates 
that proteins and/or lipids on the surface of the bacterium are involved in the recognition and/or 
adhesion of SA to epithelial cells in the CF microenvironment (Josse et al., 2017), but are not 
as effective at promoting biofilm formation in vitro on abiotic surfaces. Although α-toxin 
produced by SA is essential for the intracellular invasion of human epithelial cells (da Silva et 
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al., 2004), no specific cell-surface receptor has yet been identified as essential for the direct 
interaction of SA with CF airway epithelial cells. Tn-seq analysis of SA (Valentino et al., 2014) 
cultured on EVPL sections in ASM under continuous-flow conditions would prove useful in 
identifying genes important for the initial establishment of SA biofilms in situ, and also genes 
essential for the long-term maintenance of biofilms on epithelial cells. The associated gene 
products may prove to be attractive drug targets to prevent the establishment of chronic 
biofilms in the CF microenvironment.  
When comparing the endpoint viable cell counts of the polymicrobial biofilms grown on agar 
chunks (Figure 6.7) and EVPL sections (Figure 6.8), increased interspecies competition 
among the biofilms grown upon bronchiole tissue sections is clearly evidenced by a reduction 
in SA titres. This diminution in viable cell counts was not observed on agar chunks. This finding 
reinforces the ability of PA and/or CA to recognise bronchiole tissue and modulate their 
behaviour towards a more aggressive state. Due to time constraints, I was unable to examine 
the growth of dual-species biofilms on EVPL sections as part of this collaborative study 
(carried out during a visit to the University of Warwick). However, evidence in the literature 
demonstrates that PA up-regulates the production of extracellular virulence factors, e.g. 
HQNO and siderophores, when grown on a monolayer of airway epithelial cells (Filkins et al., 
2015) and that CA undergoes yeast-to-hyphae morphogenesis to invade tissues when grown 
upon epithelial cells (Maza et al., 2017, Richardson et al., 2018). Combined with a decrease 
in SA titres when co-cultured in batch with either PA or CA (Figure 3.2 and 3.8), it seems likely 
that both PA and CA contribute towards the lower titres of viable SA cells in EVPL-associated 
biofilms, although this hypothesis remains to be proven. As aforementioned (Section 6.5), an 
increase in virulence during culture upon EVPL sections can be exploited in future work 
studying an acute or more aggressive infection scenario. Importantly, histopathological studies 
of EVPL sections cultured with a steady-state microbial population can also be undertaken to 
discern how tissue damage or cell invasion is altered during growth as a polymicrobial 
community. To investigate this further, Dr. Marwa Hassan (University of Warwick) is 
performing histopathological studies on the EVPL sections collected throughout this study as 
part of the ongoing collaboration. In contrast abiotic surfaces, such as agar chunks, do not 
seemingly cause an increase in interspecies competition and so are more likely suited for the 
maintenance of stable polymicrobial biofilms for extended periods of time in the in vitro model 
(Section 7). 
Although not the primary focus of this study, the continuous-flow model provides a defined 
and reproducible tool for the study of interspecies interactions and competition in polymicrobial 
biofilms on various substrata. Overall, it is evident that biofilms behave differently under batch 
and continuous-flow conditions and there is a difference in the ecological composition of 
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patient derived communities between the planktonic and biofilm mode of growth (Figures 7.3 
– 7.19). Through understanding and exploiting such interspecies interactions it may be 
possible to promote the growth of avirulent species, thereby preventing keystone pathogens 
from establishing chronic airway infections. Alternatively, such avirulent species may drive the 
behaviours of pathogens towards a less virulent profile. It should be reiterated that the 
stainless-steel biofilm containers I designed and built throughout this work were suitable for 
co-culturing reference strains but are not suitable for the in vitro cultivation of populations of 
unknown compositions, which may contain strains or species able to oxidise and corrode the 
container (Figure 7.20). The use of a thermostable plastic, e.g. silicone or polypropylene, 
alternative material should be explored in future experiments co-culturing polymicrobial 
populations derived from CF sputum samples.  
 
8.4 In vitro cultivation of patient-derived polymicrobial communities 
With the stable co-culture of domesticated microbial species for extended periods of time 
possible under continuous-flow conditions, I wanted to explore if the recapitulation of an entire 
polymicrobial population derived from the CF airways could be achieved using my in vitro 
model. No published work has yet described the successful co-culture of an entire patient-
specific microbial community, such as those contained in CF sputum samples, using in vitro 
or in vivo models (O'Brien and Welch, 2019b). Success in realising this aim would provide a 
simple and novel research tool to enable the robust and tractable study of true polymicrobial 
consortia in the lab. Furthermore, studying the growth of entire patient-specific microbial 
communities in vitro helps to bridge the “bench-to-bedside research gap” (van der Laan and 
Boenink, 2015) and would no doubt reveal the key interspecies interactions likely to be 
occurring in situ that may prove to be attractive drug targets. Although this goal was not fully 
realised in this study, the results presented across Section 7 provide a useful framework for 
guiding future optimisation efforts to enable the recapitulation of the entire microbiota 
associated with the CF airways in vitro. This work is currently being continued by a PhD 
student, Éva Benyei, in the Welch lab. 
The extended lag phase and slow growth rate of microbial species derived from CF sputum 
samples, compared with the well-studied laboratory reference strains used in the work 
presented in Sections 3 – 6, is clearly evident in Figure 7.1. As previously discussed in Section 
7.2 and 7.3, the longer lag phase and slower doubling time of some microbial species can be 
associated with enhanced resistance and/or tolerance to antimicrobial action and immune 
clearance (Bertrand, 2019, Burns and Rolain, 2014, Ciofu and Tolker-Nielsen, 2019, Kaldalu 
and Tenson, 2019, Li et al., 2016, Pontes and Groisman, 2019, Yamaguchi et al., 2019). Given 
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the aggressive antimicrobial treatment of CF airway associated infections at the onset of APEs 
throughout a patient’s life, it may perhaps be unsurprising that sputum samples collected from 
adult persons with CF (as in this study) contain slow-growing microbial strains more likely to 
survive such clinical intervention. This finding is consistent with previous studies conducted in 
the Welch laboratory into the reduced growth rate of clinical PA isolates collected from the CF 
airway environment and from surgical wound infections (personal communications). 
Importantly, these observations suggested that was essential to pre-incubate sputum-derived 
polymicrobial communities inoculated into the culture vessel under batch culture conditions (0 
µL min-1) for ≈24 hrs until the population had entered the exponential phase of growth. This 
prevented the rapid washout of microbial cells during the initial stages of incubation, where 
not all of the inoculated cells were actively dividing. Furthermore, Q = 55 µL min-1 was identified 
as the optimal flow rate to compensate for the slow growth rate of species associated with CF 
sputum samples. This flow rate also yielded the smallest change in the relative abundance of 
PA between the initial and endpoint sequencing samples in a screen of different flow rates 
(Figure 7.3). This lower flow rate also proved to be suitable for maintaining the most diverse 
microbiota in both the planktonic and biofilm communities for extended periods of incubation 
(Figures 7.3 – 7.7). Alongside Q = 65 µL min-1, the slowest flow rate also enabled the highest 
total microbial carrying capacity, with respect to optical density, to be maintained in vitro 
(Figure 7.2). It is interesting to note that, as in a traditional chemostat or microbial fermenter, 
altering Q increases or decreases the total microbial carrying capacity of the culture vessel. 
This may prove useful in the study of different disease states and interspecies interactions 
occurring between populations of different cell densities in future studies of sputum-derived 
microbial populations.  
As demonstrated in Sections 3 and 4, species of low relative abundance in a polymicrobial 
population, such as CA, which comprised less than 0.05% of the total microbiota in the triple-
species co-cultures (Figure 3.11 and 3.12), can significantly modulate the microbial ecology 
and secretion of extracellular products by other members of the consortium. An assortment of 
low-abundance species comprising less than 0.1% of the total polymicrobial community, such 
as A. glycerini, M. brunensis, S. agalactiae and Rothia/ Prevotella spp., were ubiquitously 
present in all of the cultured sputum samples (Figure 7.3, 7.9 and 7.15). Although the 
“classical” and more abundant bacterial species, such as PA and Streptococcus spp., can be 
easily maintained in my in vitro model, most low-abundance species were lost from the culture 
vessel at the endpoint of sampling under almost every culture condition. Given that little is 
known about the behaviour of such low-abundance species and that they may play an 
essential role in modulating the physiology and behaviour of “classical” CF airway associated 
pathogens in situ, it is crucial that the loss of these species during in vitro growth is mitigated. 
244 
 
As discussed in detail in Section 7.4, I attempted to subtly alter the nutritional composition of 
ASM to identify factors essential for promoting the growth of less abundant species present in 
the sputum samples. With little-to-no research published on the axenic growth of the low 
abundance species identified in the sputum inoculum or the growth of entire polymicrobial 
populations ex situ in general, the empirical selection of suitable ASM supplements was 
challenging. I therefore chose to focus on media supplements previously identified to improve 
the in vitro growth of fastidious microorganisms in the literature (see Section 7.4 for details on 
these supplements). From the results presented across Section 7.4 and 7.5, most nutritional 
supplements tested did not improve the growth of less-abundant microbial species. However, 
it was clear that some supplements did modulate microbial ecology and cause global changes 
in the growth of the population. For instance, increased iron bioavailability or an increase in 
the concentration of sulfur-containing amino acids in the ASM caused a significant increase 
or decrease, respectively, in the total microbial carrying capacity of the system (Figure 7.8).  
As described in Sections 1.1, 1.2, 1.3 and 7.4, obstruction of the CF airways with thick mucus 
plugs ensures the formation of steep oxygen gradients and hypoxic regions in the 
microenvironment (Worlitzsch et al., 2002). The heterogenous distribution of oxic and anoxic 
zones permits a mixture of aerobic and anaerobic microorganisms to be persistent members 
of such microenvironments (Carmody et al., 2018, Rogers et al., 2004, Tunney et al., 2008, 
Zemanick et al., 2010). Furthermore, such anaerobic species have been implicated in 
triggering the onset of severe inflammatory immune responses or worsening the pathogenicity 
of conventional CF pathogens (Flynn et al., 2016, Ghorbani et al., 2015, Mirković et al., 2015). 
Experimental limitations have prevented the successful co-culture of anaerobic and aerobic 
species associated with the CF microenvironment, hindering the study of such behaviours and 
causing the role of anaerobic species in driving changes in microbial physiology to still be 
contested in the literature (Caverly and LiPuma, 2018). Importantly, supplementing ASM with 
an excess of potassium nitrate did enable robust growth of anaerobic species in the in vitro 
model, largely at the expense of the growth of aerobic species (Figure 7.9). However, this 
observation, that a patient-derived population of anaerobic and aerobic bacteria can be 
maintained as a co-culture for 6 days using the continuous-flow model, indicates that by further 
optimising the concentration of nitrate in ASM it should eventually be possible to stably co-
culture a balanced population in the same culture vessel. 
The supplementation of ASM with FBS had the most dramatic and promising effect on 
promoting the growth of less abundant microbial species (Figure 7.3) and increasing the 
endpoint biodiversity of planktonic and sessile bacterial communities cultured in vitro (Figure 
7.4). However, it is important to note that a loss of numerous low-abundance bacterial species 
present in the sputum inoculum still occurred and that altering the nutritional composition of 
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ASM must be treated with caution. Global transcriptomic studies comparing the growth of PA 
in ASM and airway secretions obtained from CF patients have revealed near identical gene 
expression profiles (Fung et al., 2010, Turner et al., 2015, Palmer et al., 2005). Hence, altering 
the chemical composition of the medium may result in a departure of microbial behaviour and 
physiology from what may be occurring in situ. However, this change in the physiological 
similarity of ASM to airway secretions may be a necessary trade-off to permit the in vitro co-
culture of entire patient-derived polymicrobial populations. In Section 7.5 I aimed to screen 
different fractions of FBS to try and decipher the specific component(s) of the supplement 
responsible for enhancing the growth of less abundant and fastidious bacteria. As 
supplementing ASM with a single additive or a small number of key chemically-defined 
additives is the best route towards reproducibility and measuring subtle interspecies 
interactions within confidence. 
As detailed in Section 7.5, it may be hypothesised that a non-lipophilic component of FBS, 5-
30 kDa in size, is responsible for enhancing the endpoint bacterial diversity of polymicrobial 
populations cultured under continuous-flow conditions (Figure 7.14). However, as already 
discussed the biocorrosion of the stainless-steel biofilm containers (Figure 7.20) and the loss 
of PA from all co-cultures (Figure 7.15) means that no further comment on this hypothesis can 
be made at this time. However, further systematic screening of this supplement fraction at 
different concentrations would corroborate and/or identify the key supplement(s) for enhancing 
the growth of less abundant bacteria. My initial hypothesis that albumin-mediated inhibition of 
PA QS networks (Smith et al., 2017) might lead to a decrease in virulence factor production, 
thereby enabling the growth of the rarer sputum-associated bacteria appears to be incorrect. 
This is because the species diversity in endpoint samples obtained from the culture vessel 
supplemented with BSA alone were lower than they were in unadulterated ASM (Figure 7.14). 
Although a complex and onerous undertaking, future systematic refinement of ASM 
supplements will be necessary to maintain a true polymicrobial microbiota in vitro, given that 
optimisation of Q alone is not sufficient for this goal to be realised.  
A correlation between the loss of PA and an increase in overall bacterial species diversity in 
endpoint polymicrobial populations co-cultured in vitro can be observed across the results 
presented in Section 7. This is consistent with existing reports that a worsening of CF patient 
prognosis and pulmonary lung function is linked to both the establishment of chronic infection 
with PA and a decrease in species diversity within the airways (Zhao et al., 2012). Once PA 
establishes an infection in the CF airways it is near-impossible to eradicate with aggressive 
clinical and antimicrobial interventions (Fodor et al., 2012, Pressler et al., 2011). This 
observation may therefore suggest some therapeutic potential in encouraging the controlled 
growth of avirulent species in the CF microenvironment to beneficially provide a degree of 
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colonisation resistance (Kim et al., 2017) against the establishment of chronic infection with 
virulent pathogenic species in situ. Once fully refined, the in vitro continuous-flow model may 
provide an experimentally tractable tool to investigate this hypothesis in future research 
projects.   
It is important to note that, due to the high costs associated with the preparation and 
sequencing of libraries for MiSeq analysis, only the bacterial ecology of sputum samples 
cultured in vitro, via sequencing of the V3/4 hypervariable region of the 16S rRNA gene, was 
assessed throughout this work and is a major limitation of the present study. Hence, changes 
in the ecology of the fungal population (potentially) present in the sputum samples over time 
in response to changes in bacterial ecology could not be discerned. However, MiSeq analysis 
of the ITS region of the 18S rRNA gene from fungal species and comparison of the output with 
the ITS2 gene database (Schultz et al., 2006) would be simple to perform. Combined with 16S 
analysis this would powerfully describe entire community wide changes in microbial ecology 
over time in the model. 
 
8.5 Benefits and limitations of the continuous-flow model 
As an in vitro model, the continuous-flow culture vessel has several advantages and limitations 
compared with existing models used in the study of infections associated with the CF airways. 
First, like all in vitro models it is inexpensive to set up and run, with the largest expense being 
the initial cost of a peristaltic pump and culture vessel components. Furthermore, the model is 
purposefully simple in design to enable users with little-to-no experience to set up and operate. 
In combination these factors make the model very accessible and help promote uptake among 
other research groups regardless of expertise or experience. Samples could even be removed 
from a steady-state microbial population, freeze dried and sent to other research groups using 
the model for reconstitution and further analysis. This would enable effective peer-to-peer 
collaboration, an assurance of experimental reproducibility and the mitigation of user/lab bias 
when studying complex polymicrobial consortia. Second, the simplicity and modular nature of 
the model ensures it is easy to multiplex the number of culture vessels studied in tandem and 
to include additional in-line analytical instruments, such as the in-line spectrophotometer 
described in Section 2.3.1 or novel components such as real-time O2 and pH probes. The only 
limiting factor for increasing the model’s throughput is the labour-intensive production and 
filtration of fresh ASM.  
As an in vitro alternative to animal models, there are no ethical concerns when using the 
continuous-flow system and my model is fully compliant with the “3Rs” (the replacement, 
refinement and reduction of the use of animals in research). Although the exact figures are 
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hard to extract, it is estimated that in the UK alone over 90,000 mice die per annum as a direct 
result of research into respiratory infections (personal communication with the NC3Rs). 
Widespread uptake of my model would therefore directly reduce the burdening cost of animal 
life when studying CF airway infections or polymicrobial community interactions. Perhaps 
more importantly, the conditions in the culture vessels are defined and there need be no 
inherent genetic variation among the host organism inocula. The lack of variation between 
culture vessels ensures that the model is extremely robust, as evidenced by the remarkably 
stable cell titres and small error bars observed between independent experiments presented 
across this study.  
Given that ASM is a biochemically defined growth medium, subtle interspecies interactions 
and changes in environmental homeostasis or microbe behaviour can be measured with 
confidence and not attributed to changes in a host organism’s biology as the result of infection. 
This also enables the facile experimental perturbation of culture conditions, i.e. through 
altering the composition of ASM, environmental conditions such as temperature or the 
exogenous perturbation of a steady-state culture with antimicrobials or new species/strain 
variants, as demonstrated in Section 5. An in vitro model also enables the time-resolved and 
sequential sampling of the same steady-state culture. This enables the longitudinal study of a 
polymicrobial consortium for an indefinite amount of time, something not possible with in situ 
sampling or when sacrificing in vivo models at various time points. These factors ensure that 
the continuous-flow model will prove to be a valuable research tool for the study of chronic CF 
airway infection scenarios.  
The continuous-flow model is also subject to a number of perceived disadvantages. Although 
ASM is biochemically representative of CF airway secretions, and PA gene expression in this 
medium displays virtually no transcriptomic differences compared with growth in CF sputum 
(Fung et al., 2010, Turner et al., 2015), the in vitro model lacks the spatial organisation of the 
CF airway microenvironment in situ. Existing studies have shown that microbial growth ex situ 
on porcine lung tissue, which shares a remarkable degree of spatial homology with the human 
airways (Meurens et al., 2012, Rogers et al., 2008), displays similar behavioural growth 
characteristics to those observed in situ (Harrison et al., 2014, Harrison and Diggle, 2016). 
The introduction of removable sections of solid substrata, i.e. ex vivo porcine lung tissue 
sections (Section 6.4), to the culture vessel also results in significant changes in the dynamics 
of biofilm formation (discussed in Section 8.3). This shows that, where required, an element 
of ex situ spatial organisation can be easily introduced to my in vitro model. However, caution 
should be taken when introducing undefined elements (such as animal tissue) to the 
chemically-defined culture medium to ensure uniformity across experiments. 
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The absence of host cells/tissues and the role of an immune system in modulating microbial 
behaviour is another key limitation of the in vitro model. These factors limit the use of my 
model in the study of host-microbe interactions and how a polymicrobial consortium responds 
to, or causes, changes in environmental conditions, i.e. during acute pulmonary 
exacerbations. This being said, it is important to note that few in vivo models accurately 
capture the human CF airway environment, and no such model has yet been successful in 
recapitulating an entire CF polymicrobial community within the laboratory (O'Brien and Welch, 
2019b). The simplicity and well-defined nature of the continuous-flow model is beneficial for 
the study of purely microbe-microbe interspecies interactions under defined environmental 
conditions. Furthermore, it allows for the direct comparison of results between experiments 
without the added complication of host-microbe interactions and changes driven by the actions 
of an immune system; something difficult to reproducibly achieve when utilising animal 
models. Hypothetically it may be possible to introduce a CF relevant human cell line, such as 
immortalised phe508del CFTR tracheal epithelial cells (Kunzelmann et al., 1993), to the 
culture vessel using bioengineering methods such as hollow fibre cell culture (Storm et al., 
2016). Although complicated to achieve, this may enable the stable co-cultivation of a 
polymicrobial community with clinically relevant host tissues to discern key host-microbe 
interactions that would greatly benefit the development and validation of effective CF 
therapeutics. This notwithstanding, the original aims of this study were to develop a model to 
permit the stable long-term co-culture of microbial communities to enable the future 
investigation of interspecies interactions and changes in community architecture overtime. 
Consequently, the possibilities of stable host-bacterium culture methods were not explored.  
An important experimental consideration and potential limitation when using the continuous-
flow culture model in the study of novel and uncharacterised polymicrobial populations is the 
need to optimise Q between experiments utilising different microorganisms. The optimisation 
of Q is a balancing act of simultaneously preventing species washout while preventing 
population overgrowth and entry into the stationary phase due to nutrient limitation. The 
importance of optimising Q was made apparent throughout this work, both when culturing CA 
as part of a triple-species co-culture (Section 3) and when cultivating the polymicrobial 
communities derived from CF sputum samples (Section 7). As demonstrated in Section 7.3, 
Q can be optimised for the study of entire polymicrobial populations, although some refinement 




9. Final Conclusions 
The role of interspecies interactions in modulating changes in the metabolism, behaviour and 
gene expression of microbial species is now clearly apparent in the field of medical 
microbiology. There is an increasingly important need to consider the presence of co-
cultivated and low-abundance species when studying clinical infection scenarios, something 
particularly relevant in the context of CF airway infections. Chronic obstruction of the airways 
predisposes such patients to lifelong (and often terminal) infections with dense and diverse 
polymicrobial ecosystems. Despite intensive research efforts, once established, these airway 
infections are near impossible to eradicate with existing treatment options; treatment options 
that are often validated against axenic microbial populations. A detailed understanding of how 
an entire microbial community behaves and responds to therapeutic intervention would enable 
the development of more efficacious treatments to treat and limit the establishment of chronic 
airway infections to improve the longevity and welfare of persons with CF. 
Effective research into the behaviours of mixed microbial populations has been hindered by 
the out-competition and removal of species when grown as a co-culture using traditional batch 
techniques. I redress this issue in the current study by describing the development, 
optimisation and characterisation of a novel, continuous-flow model that permits long-term 
maintenance of a diverse group of microbial species including P. aeruginosa (Gram-negative 
bacterium), S. aureus (Gram-positive bacterium) and C. albicans (dimorphic fungi), all of which 
are commonly associated with CF airway infections. To the best of my knowledge, this is the 
first in vitro, in vivo or ex vivo model that permits the stable co-culture of these pathogens with 
respect to cell titres, metabolic state, mutation rates and virulence factor production. I also 
demonstrate that low-abundance species, representing less than 0.05% (by cell numbers) in 
a population, can significantly modulate microbial behaviour and the formation of polymicrobial 
biofilms. Furthermore, I demonstrate an increased refractory response of pre-established 
polymicrobial communities to treatment with clinically-relevant antimicrobial compounds and 
identify novel SNPs in the P. aeruginosa genome that confer a complete resistance to the 
action of colistin.  
Although I was not able to recapitulate an entire, stable polymicrobial consortium derived from 
the airways of a persons with CF, this work provides the groundwork for future research efforts 
in doing so. Success in achieving this aim would enable the facile and detailed experimental 
study of polymicrobial interactions in a reproducible setup. Such a system would also help to 
bridge the bench-to-bedside gap when studying chronic obstructive pulmonary disorders and 
enable the development of improved airway management treatments. The purposefully 
simple, modular and robust nature of my model should hopefully promote widespread uptake 
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of the system by other research groups. In summary, any number of fundamental biological 
questions pertaining to the understanding of interspecies interactions, and to the growth of 
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Appendix 2.1 Preparation of artificial sputum medium (ASM) 
 
The following protocol was used to prepare 1 L of ASM, this modified recipe is a combination 
of previously published protocols for the production of SCFM2 (Palmer et al. (2007) and Turner 
et al. (2015) and ASM (Kirchner et al. (2012)). 
1. Add 5 g of mucin from porcine stomach, type-II (Sigma-Aldrich) to 250 mL of sterile 1 
x PBS (Oxoid) (final concentration = 1.25 g L-1) and leave to dissolve with stirring 
overnight at 4°C. 
2. Add 4 g of fish sperm DNA (Sigma-Aldrich) to 250 mL of sterile double distilled H2O 
(ddH2O) (final concentration = 1 g L-1) and leave to dissolve overnight in a shaking 
water bath at 35°C, 180 rpm. 
3. In a clean beaker, add 250 mL of dH2O and make up the SCFM2 buffered base and 
amino acid mix using the recipe below (Table S1). 
 
Amino acid stocks  
Chemical [Stock] stock 
volume 








 (M) (mL) (g/mol) (g) (mL) (mM) - 
NaH2PO4 0.2 25 137.99 0.690 8.125 1.3 - 
Na2HPO4 0.2 25 141.96 0.710 6.252 1.25 - 
KNO3 1 25 101.103 2.528 0.348 0.348 - 
K2SO4 0.25 25 174.259 1.089 1.084 0.271 - 
 
Add solids below directly to beaker 
 
NH4Cl   53.491 0.124  2.2808 - 
KCl   74.5513 1.116  14.943 - 
NaCl   58.44 3.032  51.848 - 




Ser 0.1 50 105.09 0.525 14.46 1.446 - 
Glu.HCl 0.1 50 183.59 0.918 15.492 1.549 - 
Pro 0.1 50 115.13 0.576 16.612 1.661 - 
Gly 0.1 50 75.07 0.375 12.032 1.203 - 
Ala 0.1 50 89.09 0.445 17.8 1.78 - 
Val 0.1 50 117.15 0.586 11.172 1.117 - 
Met 0.1 50 149.21 0.746 6.332 0.633 - 
Ile 0.1 50 131.17 0.656 11.212 1.121 - 
Leu 0.1 50 131.17 0.656 16.092 1.609 - 
Orn.HCl 0.1 50 168.62 0.843 6.76 0.676 - 
Lys.HCl 0.1 50 182.6 0.913 21.28 2.128 - 
Arg.HCl 0.1 50 210.7 1.054 3.06 0.306 - 
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Trp 0.1 50 204.23 1.021 0.132 0.013 Prep in 
0.2 M 
NaOH 
Asp 0.1 50 133.1 0.666 8.272 0.827 Prep in 
0.5 M 
NaOH 
*Tyr 0.1 50 181.19 0.906 8.02 0.802 Prep in 
1.0 M 
NaOH 
*Thr 0.1 50 119.12 0.596 10.72 1.072 - 
*Cys.HCl 0.1 50 157.6 0.788 1.6 0.16 - 
*Phe 0.1 50 165.19 0.826 5.3 0.53 - 
*His.HCl.H2O 0.1 50 209.6 1.048 5.192 0.519 - 
 
Table S1. Instructions for the preparation of stock solutions required to make the buffered 
base and amino acid mixture. The amount of each solution required to make 1 L of ASM is 
shown alongside the concentration (mM) of each constituent component within the culture 
media. Note that all amino acid stock solutions can be kept in the dark at 4°C for 1 month, 
stock solutions annotated with ‘*’ must be made fresh on the day of preparation. 
 
4. Combine the dissolved mucin and DNA solutions and pellet undissolved particles by 
centrifugation at 4000 × g for 30 min (4°C). 
5. Without disturbing the pellet, carefully remove the supernatant and combine with the 
buffered base amino acid mix. 
6. Adjust the pH of the media to 6.8.  
7. Add the final components of ASM as shown in Table S2. 
 
 
Table S2. Instructions for the preparation of stock solutions of the final reagents required to 
make ASM. The amount of each stock solution required to make 1 L ASM is shown alongside 
the final concentration (mM) of each constituent component within the culture media. Note that 









add to 1L 
mL BB 
[Final]  Notes 
 (M) (mL) (g/mol) (g) (mL) (mM)   
Dextrose (D-
glucose) 
1 25 180.16 4.504 1.2 3  
L-lactic acid 1 25 90.08 2.252 9.3 9.3 
pH stock to 7 
with NaOH 
CaCl2.2H2O 1 25 147.014 3.67535 1.754 1.754  
MgCl2.6H2O 1 25 203.31 5.08275 0.606 0.606  
FeSO4.7H2O 0.0036 50 278.05 0.05 1 0.0036 





0.25 25 221.21 1.383 1.2 0.3  





8. Adjust the final volume to 1 L with dH2O. 
9. Filter sterilise media using a 0.22 µm Millipore stericup (Sigma-Aldrich) attached to a 
vacuum pump. Note that this process can be slow and may take up to two days. 




Appendix 2.2 Production and purification of recombinant lysostaphin 
Addition of mutanolysin, lysostaphin and lysozyme for the efficient lysis of Gram-positive and 
Gram-negative species and improved total genomic DNA (gDNA) extraction from complex 
polymicrobial communities prior to high-throughput sequencing has been described previously 
(Gill et al., 2016, Wada, 2001). . The following protocol details the production and purification 
of recombinant lysostaphin used in this study.  
 
S.2.2.1 Generation of DE3 (pET23Lys) 
Following the manufacturer’s instructions, plasmid pET23Lys was purified from a routine 
overnight culture of DH5α(pET23Lys) using a GeneJET Plasmid Miniprep Kit (ThermoFisher). 
pET23Lys was then transformed into chemically competent Rosetta DE3 cells (Novagen) 
using the standard heat shock protocol described by (Sambrook and Russell, 2006). Correct 
transformants were selected for by plating recovered cells onto LB-A plates supplemented 
with 50 µg mL-1 carbenicillin (plasmid selection) and 25 µg mL-1 chloramphenicol (Rosetta DE3 
selection), incubated overnight at 37°C. 
 
S.2.2.2 Lysostaphin overexpression 
Induction medium was prepared by evenly dividing 800 ml 2xYT broth supplemented with 
appropriate selection (carbenicillin and chloramphenicol) and 0.1 M Isopropyl β-d-1-
thiogalactopyranoside (IPTG, Bioline) to induce protein expression between two 2 L baffled 
flasks. An overnight starter culture of DE3(pET23Lys) was sub-cultured (1 mL) into both flasks 
containing induction medium and incubated at 25°C for 72 hrs with shaking (200 rpm). Cells 
were harvested by centrifugation (5000 x g, 20 min, 4°C) and the supernatant discarded. Cell 
pellets were then resuspended in 30 mL lysis buffer and stored at -80°C.  
 
S.2.2.3 Protein purification 
Frozen cell pellets were thawed at room temperature before 20 mg of lysozyme from chicken 
egg white (Sigma) and 5 µL of DNAse I (ThermoFisher) was added to each pellet. Cells were 
pooled and sonicated on ice using a 3 mm probe, with 60-70% amplitude for 14 cycles of 20 
secs on and 40 secs off. The resulting lysate was centrifuged (18, 000 x g, 45 min, 4°C) to 
sediment cell debris and the supernatant collected and filter sterilised (0.22 µm pore size). 
Using the manufacturers pre-set ‘Affinity AC’ protocol on an ÄKTA start protein purification 
system (GE Life Sciences), His-tagged lysostaphin was purified on a HisTrap FF 5 ml Ni-resin 
column (GE Life Sciences), using ice cold equilibration and elution buffer in lines A and B of 
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the ÄKTA respectively. Fractions containing the eluted protein were pooled in a 3,000 Da 
MWCO dialysis membrane (FisherScientific) and dialysed overnight in 2 L of dialysis buffer at 
4°C.  
 
S.2.2.4 Assessing lysostaphin purity 
The concentration of dialysed lysostaphin was quantified using Quick Start Bradford Protein 
Assay kit (BioRad), following the manufactures instructions and using a bovine serum albumin 
(BSA) standard curve. Recombinant lysostaphin was stored in working aliquots at -80°C.  
1D-SDS PAGE (one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
was used to assess the purity of lysostaphin. Dialysed protein was mixed with SDS sample 
buffer at a 1:1 ratio and boiled at 95°C for 10 min, then left to cool at room temperature. 
Samples were loaded into the wells of a polyacrylamide gel (containing 5% stacking and 8% 
resolving gel, size: 100 mm x 100 mm x 1 mm) alongside a Precision Plus Protein Unstained 
Protein Standard ladder (BioRad). Polyacrylamide gels were resolved in SDS running buffer 
at 200 V for 1 hrs in a Mini-PROTEAN Tetra Vertical Electrophoresis Cell (BioRad). Once 
resolved, gels were visualised by incubation for 1 hrs in Coomassie staining solution followed 
by 24 hrs incubation in destaining solution. Stained gels were imaged using a ChemiDoc 
Imaging System (BioRad). A single clear band corresponding to the approximate molecular 
weight of lysostaphin (26.9 kDa) can be seen on the 1D-SDS PAGE gel, demonstrating 
successful purification of recombinant lysostaphin (Figure S.2.1). 
 
S.2.2.4 Assessing lysostaphin activity 
Lysostaphin is a glycylglycine endopeptidase capable of cleaving crosslinking pentaglycine 
bridges found in the cell wall peptidoglycan of certain Gram-positive bacteria (such as SA), 
causing the lysis of quiescent and actively growing cells (Sugai et al., 1997). To test the 
functionality of purified protein, the kinetics of SA lysis by lysostaphin was assessed by 
following the reduction in turbidity of a bacterial suspension. Cells from overnight cultures were 
harvested by centrifugation (4000 x g, 10 min, room temp) and resuspended in fresh LB at 
OD600 nm 0.5. Normalised cultures were added to wells of a clear, flat-bottomed 96-well plate 
and lysostaphin added to final concentration of 10 µg mL-1. The same volume of fresh dialysis 
buffer was used as a negative control. Plates were incubated at 37°C with 100 rpm shaking in 
a FLUOstar Omega plate reader and OD600 measured every 5 min. Purified lysostaphin 
caused a rapid reduction in turbidity of the bacterial suspension, whereas no difference in 
























Figure S.2.1 Purification of lysostaphin.  
1D-SDS PAGE gel of purified recombinant lysostaphin. Lane I: Precision Plus Protein 
Unstained Protein Standard molecular weight marker (BioRad), molecular weight is indicated 
in kDa. Lane II: purified lysostaphin. A single band approximately 27 kDa in size is clearly 
















Figure S.2.2 Quality check of recombinant lysostaphin activity. 
Lysis of S. aureus 25923 cell suspension by lysostaphin. Normalised bacterial cultures, OD600 
nm 0.5, incubated with 10 µg mL-1 lysostaphin (circles) or dialysis buffer only (triangles). 
Turbidity of bacterial solution was measured at OD600 nm every 5 min. Lysostaphin causes a 
rapid reduction in turbidity of the cell suspension, indicating the purified protein is functional. 





Appendix 2.3 Pipeline and commands for processing sequencing data using 
QIIME2 
Sequence reads from high-throughput paired end sequencing using an Illumina MiSeq 
instrument were returned from the DNA Sequencing Facility as separate paired-end 
demultiplexed fastq. files in the CASAVA 1.8 format. The following protocol details the pipeline 
and commands used to generate relative abundance taxa bar plots and compute core diversity 
metrics from the resulting data using the opensource bioinformatics software QIIME2 
(software version QIIME 2 2020.6.0) within a VirtualBox 64-bit Ubuntu operating system 
(Oracle VM virtualbox). 
 
1. Metadata files for the sequencing data were generated on Google Sheets and 
validated for use in QIIME2 with the Keemai plugin (keemei.qiime2.org/) 
 
2. Files were compiled into a compressed .zip folder named casva-18-paired-
end.zip. The compressed folder and sample metadata file were imported into 
QIIME 2  
 
3. Compressed folder containing sequence data was unzipped: 
unzip -q casava-18-paired-end-demultiplexed.zip 
 
4. Sequence data was imported as a QIIME2 artifact in the qza. file format: 
qiime tools import \ 
  --type 'SampleData[PairedEndSequencesWithQuality]' \ 
  --input-path casava-18-paired-end-demultiplexed \ 
  --input-format CasavaOneEightSingleLanePerSampleDirFmt \ 
  --output-path demux-paired-end.qza 
 
5. Paired-end reads were joined using the q2-vsearch plugin (Rognes et al., 2016) 
(Rognes et al., 2016): 
qiime vsearch join-pairs \ 
  --i-demultiplexed-seqs demux-paired-end.qza \ 
  --o-joined-sequences demux-joined.qza 
 
6. A summary of the demux-joined.qza artifact was generated. The resulting 
interactive qzv. File was used to explore the quality of sequence reads in the artificat 
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and determine a suitable max length of sequence reads (as described in the QIIME2 
tutorial: docs.qiime2.org/2018.2/tutorials/read-joining/): 
qiime demux summarize \ 
  --i-data demux-joined.qza \ 
  --o-visualization demux-joined.qzv 
 
7. Quality control was applied to sequences in the demux-joined.qza artifact: 
qiime quality-filter q-score-joined \ 
  --i-demux demux-joined.qza \ 
  --o-filtered-sequences filtered-demux-joined.qza \ 
  --o-filter-stats filtered-demux-joined-stats.qza 
 
8. Sequences were denoised using Deblur (Amir et al., 2017). With --p-trim-length 
x passed as the sequence length previously selected in step 5: 
qiime deblur denoise-16S \ 
  --i-demultiplexed-seqs filtered-demux-joined.qza \ 
  --p-trim-length x \ 
  --p-sample-stats \ 
  --o-representative-sequences rep-seqs.qza \ 
  --o-table filtered-table.qza \ 
  --o-stats filtered-deblur-stats.qza  
 
9. Rooted and unrooted phylogenetic trees relating features in the sequencing samples 
were then generated: 
qiime phylogeny align-to-tree-mafft-fasttree \ 
  --i-sequences rep-seqs.qza \ 
  --o-alignment aligned-rep-seqs.qza \ 
  --o-masked-alignment masked-aligned-rep-seqs.qza \ 
  --o-tree unrooted-tree.qza \ 
  --o-rooted-tree rooted-tree.qza 
 
10. A summary table of the number of features in samples of the filtered-
table.qza artifact was generated. Passing the mapping file --m-sample-
metadata-file as the imported sample metadata file (sample-metadata.tsv) 
generated in step 1: 
qiime feature-table summarize \ 
  --i-table filtered-table.qza \ 
  --o-visualization filtered-table.qzv \ 




11. Core alpha and beta diversity metrics (see below [1]) were calculated using the q2-
diversity plugin. With --p-sampling-depth x passed as the number of 
features present in the smallest sample identified from the filtered-table.qzv 
file*: 
qiime diversity core-metrics-phylogenetic \ 
  --i-phylogeny rooted-tree.qza \ 
  --i-table filtered-table.qza \ 
  --p-sampling-depth x \ 
  --m-metadata-file sample-metadata.tsv \ 
  --output-dir core-metrics 
 
*Alpha rarefaction plots computed using the qiime diversity alpha-rarefaction 
visualiser were used to determine if the richness of samples was fully observed in the above 
core diversity metrics and sampling depth in the above computation refined accordingly.  
 
12. Significant associations between the microbial composition of samples in the context 
of the sample metadata (contained in the sample-metadata.tsv file) were 
explored within the Faith’s phylogentic (alpha) diversity metric (computed in step 11) 
using Kruskal-Wallis one-way analysis of variance: 
qiime diversity alpha-group-significance \ 
  --i-alpha-diversity core-metrics/faith_pd_vector.qza \ 
  --m-metadata-file sample-metadata.tsv \ 
  --o-visualization core-metrics /faith-pd-group-significance.qzv 
  
13. Taxonomy was assigned to sequences in the FeatureData[sequences] QIIME2 
artifact (generated in step 8) using the pre-trained Naïve Bayes classifier and the q2-
feature-classifier plugin*: 
qiime feature-classifier classify-sklearn \ 
  --i-classifier gg-13-8-99-515-806-nb-classifier.qza \ 
  --i-reads rep-seqs.qza \ 
--o-classification taxonomy.qza 
 
*This classifier (passed as gg-13-8-99-515-806-nb-classifier.qza above) was 
trained on Greengenes 13_8 99% OTUs sample preparation and sequencing parameters, 





14. Finally, bar plots demonstrating taxanomic composition of samples in the sequencing 
libraries were generated using the taxonomy.qza artifact from step 13: 
qiime taxa barplot \ 
  --i-table filtered-table.qza \ 
  --i-taxonomy filtered-taxonomy.qza \ 
  --m-metadata-file sample-metadata.tsv \ 
--o-visualization filtered-taxa-bar-plots.qzv 
 
[1]Core diversity metric outputs generated using this pipeline: 
Alpha diversity metrics: 
• Shannon’s diversity index (a quantitative measure of community richness) 
• Observed OTUs (a qualitative measure of community richness) 
• Faith’s Phylogenetic Diversity (a qualitiative measure of community richness that 
incorporates phylogenetic relationships between the features) 
• Evenness (or Pielou’s Evenness; a measure of community evenness) 
 
Beta diversity metrics: 
• Jaccard distance (a qualitative measure of community dissimilarity) 
• Bray-Curtis distance (a quantitative measure of community dissimilarity) 
• unweighted UniFrac distance (a qualitative measure of community dissimilarity that 
incorporates phylogenetic relationships between the features) 
• weighted UniFrac distance (a quantitative measure of community dissimilarity that 












Figure S.3.1 Single species growth in ASM. 
Growth of (A) Pseudomonas aeruginosa PAO1; (B) Staphylococcus aureus 25923; (C) 
Candida albicans SC5314 in ASM. All cultures were grown in flat-bottomed 96 well microtiter 
plates (Nunc) incubated at 37°C. Measurements were taken every 15 min using a FLUOstar 
Omega plate reader (BGM) with 180 rpm orbital shaking during idle time between reads. 
Optical density at 600 nm is plotted on a log10 scale with data presented as the mean ± 













Figure S.3.2 Growth of dual species PA-SA co-culture under continuous-flow 
conditions. 
Growth (monitored as OD600 nm) of P. aeruginosa PAO1 – S. aureus 25923 co-culture in ASM 
in the continuous-flow culture vessel (Q = 170 µL min-1). Automated OD600 nm measurements 
were taken every 30 min using an in-line spectrometer fitted with a continuous-flow cuvette 













Figure S.3.3 Growth of triple-species (PA-SA-CA) co-culture under continuous-flow 
conditions. 
Growth (monitored as OD600 nm) of P. aeruginosa PAO1, S. aureus 25923 and C. albicans 
SC5314 co-culture in ASM in the continuous-flow culture vessel (Q = 145 µL min-1). Automated 
OD600 nm measurements were taken every 30 min using an in-line spectrometer fitted with a 
continuous-flow cuvette (as described in Section 2.3.1). Data represented as the mean ± 
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A Continuous-Flow Model for in vitro
Cultivation of Mixed Microbial
Populations Associated With Cystic
Fibrosis Airway Infections
Thomas James O’Brien and Martin Welch*
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
The airways of people with cystic fibrosis (CF) provide a nutrient-rich environment
which favours colonisation by a variety of bacteria and fungi. Although the dominant
pathogen associated with CF airway infections is Pseudomonas aeruginosa, it is
becoming increasingly clear that inter-species interactions between P. aeruginosa and
other colonists in the airways may have a large impact on microbial physiology and
virulence. However, there are currently no suitable experimental models that permit long-
term co-culture of P. aeruginosa with other CF-associated pathogens. Here, we redress
this problem by describing a “3R’s-compliant” continuous-flow in vitro culture model
which enables long-term co-culture of three representative CF-associated microbes:
P. aeruginosa, Staphylococcus aureus and Candida albicans. Although these species
rapidly out-compete one another when grown together or in pairs in batch culture,
we show that in a continuously-fed setup, they can be maintained in a very stable,
steady-state community. We use our system to show that even numerically (0.1%) minor
species can have a major impact on intercellular signalling by P. aeruginosa. Importantly,
we also show that co-culturing does not appear to influence species mutation rates,
further reinforcing the notion that the system favours stability rather than divergence.
The model is experimentally tractable and offers an inexpensive yet robust means of
investigating inter-species interactions between CF pathogens.
Keywords: cystic fibrosis, continuous-flow, co-culture, in vitro, Pseudomonas aeruginosa, Staphylococcus
aureus, Candida albicans
INTRODUCTION
Cystic fibrosis (CF) is the most common life-limiting genetic disorder within the Caucasian
population (Cystic Fibrosis Foundation, 2019), with 1 in 40 people estimated to carry
the common 1F508 mutation in the CF transmembrane conductance regulator (CFTR)
gene (Bobadilla et al., 2002; Cystic Fibrosis Mutation Database, 2019). The most striking
consequence of dysfunctional CFTR activity is the overproduction of nutrient-rich, mucilaginous
sputum. This blocks the airways and generates a heterogenous environment with steep
oxygen gradients and a lowered pH (Boucher, 2002; Tate et al., 2002; Worlitzsch et al.,
2002). This environmental niche is rich in nutrients such as mucin, amino acids, iron,
and nitrate making the CF airway prone to colonisation by a variety of microbial
species (Grasemann et al., 1998; Jones et al., 2000; Palmer et al., 2007; Ghio et al., 2013).
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The resulting infections often persist for decades, leading to
respiratory failure and eventually, premature death (Lyczak et al.,
2002; Rajan and Saiman, 2002; Carmody et al., 2013, 2015;
Elborn, 2016). Traditionally, these CF-associated infections have
been linked with a relatively small number of easily-culturable
pathogens, such as Pseudomonas aeruginosa or Staphylococcus
aureus. However, the introduction of culture-independent
molecular profiling approaches revealed that expectorated CF
sputum samples often contain a much wider range of bacterial
and fungal species (Sibley et al., 2006, 2008; Rogers et al., 2010a;
Zhao et al., 2012; Carmody et al., 2013, 2015; Short et al., 2014;
Boutin et al., 2015). This suggests that the CF airways may
harbour a highly-diverse microbial community, although this
notion has been challenged recently through the direct sampling
of lavage fluid from the lungs of CF children. These new data
suggest that to a large extent, the diversity of the previously
reported CF-associated microbiome arises from contamination
of the sample during passage through the oral cavity, and
following sample processing (Jorth et al., 2019). Nevertheless,
these newer studies still suggest that the CF airways harbour
a core population of “non-conventional” pathogens, including
Prevotella, Veillonella and Staphylococcus species, as well as
“traditional CF pathogens” such as P. aeruginosa (PA).
The polymicrobial character of many CF-associated airway
infections makes it crucial to consider what impact inter-species
interactions have on the physiology and composition of the
microbial consortium. Previous reports demonstrate that co-
culturing bacterial species in vitro and in vivo causes significant
alterations in gene essentiality (Ibberson et al., 2017). This
can lead to changes in microbial lifestyle, impacting upon the
expression of virulence factors (Rogers et al., 2009, 2010a,b;
Hibbing et al., 2010; Leekha et al., 2011; Elias and Banin,
2012; Quinn et al., 2014; Limoli et al., 2016). For example,
PA senses peptidoglycan shed from Gram-positive bacteria, and
this stimulates the production of extracellular lytic virulence
factors (Korgaonkar et al., 2013). Polymicrobial communities
also display altered responses to therapeutic intervention.
This may explain why many of the currently used clinical
interventions designed to target PA show varying degrees of
efficacy between patients (Lopes et al., 2012; Peters et al., 2012).
As a consequence of these conceptual realisations, research
focus is gradually moving away from studying individual species
in isolation toward co-cultivating the major CF associated
pathogens (Spasenovski et al., 2010; Bragonzi et al., 2012;
Filkins et al., 2015; Magalhães et al., 2016; Lopes et al., 2017;
Makovcova et al., 2017). However, these efforts are hampered
by the paucity of adequate polymicrobial infection models. The
development of a model which enables the stable and long-
term recapitulation of CF polymicrobial communities is therefore
highly-desirable.
Here we describe the development of a simple in vitro
continuous-flow co-culture model which utilises artificial sputum
medium (ASM). ASM is known to physiologically recapitulate
the nutritional composition of CF airway secretions (Palmer
et al., 2007; Kirchner et al., 2012; Turner et al., 2015). To
the best of our knowledge, our co-culture model (Figure 1)
is the first to permit the long-term, steady-state co-culture
of three distinct microbial species: PA, Staphylococcus aureus
(SA), and Candida albicans (CA). Through viable cell counting
and optical density measurements, we demonstrate that the
abundance of each member of this microbial population remains
unchanged over the course of 4 days and that a total carrying
capacity can be reached and maintained within the culture
vessel. By contrast, and in line with previous reports, when
these species are co-cultured under batch conditions, PA
rapidly outcompetes the other species (Machan et al., 1992;
Duan et al., 2003; Hogan et al., 2004; Mashburn et al., 2005;
McAlester et al., 2008; Cugini et al., 2010; Holcombe et al.,
2010; Morales et al., 2010; Park et al., 2012; Korgaonkar
et al., 2013; Baldan et al., 2014; Fugère et al., 2014; Rüger
et al., 2014; Barnabie and Whiteley, 2015; Filkins et al., 2015;
Nguyen et al., 2015; Zago et al., 2015; Nguyen and Oglesby-
Sherrouse, 2016). Our in vitro model provides a defined and
experimentally tractable system which can be used to dissect
interspecies interactions and determine the long-term impact of
co-cultivation on the physiology and gene expression profiles
of CF-associated pathogens. Our in vitro model also provides
a robust and cheaper alternative to existing in vivo infection
models, making it compliant with the current trend toward
the refinement, replacement and reduction (3Rs) of animal
models in research.
The species chosen for inoculation into our co-culture model
represent three distinct classes of microorganisms; a Gram-
negative species and dominant CF-associated pathogen (PA), a
Gram-positive species, often associated with CF airway infections
(SA) and a dimorphic fungus (CA), also commonly found in CF
airway secretions (Conrad et al., 2013). As such, our continuous-
flow model lays a solid groundwork for the development and
optimisation of an in vitro co-culture model which can be directly
inoculated with expectorated CF sputum. This will hopefully
enable, in the longer-term, full recapitulation of the CF-associated
polymicrobial community in defined laboratory conditions.
MATERIALS AND METHODS
Microbial Strains and Culture Conditions
The bacterial/fungal strains used in this study are shown
in Table 1. All bacterial strains were routinely cultured in
lysogeny broth (LB) (Formedium) with vigorous aeration at
37◦C overnight. Where necessary, cultures were supplemented
with 50 µg mL−1 carbenicillin (to maintain pSB1057 in the
N-(3-Oxododecanoyl)-L-homoserine lactone OdDHL biosensor
strain) or 10 µg mL−1 tetracycline (to maintain pSB536 in the
N-butanoyl-L-homoserine lactone BHL biosensor strain).
Artificial sputum medium was used for every mono-, dual-,
and triple-species cultivation. ASM was made using a modified
version of the recipe published by Turner et al. (2015). Briefly,
bovine maxillary mucin was replaced with 1.25 g L−1 porcine
stomach mucin type-II (Sigma-Aldrich) and salmon sperm
DNA was replaced with 1 g L−1 fish sperm DNA (Sigma-
Aldrich) as described by Kirchner et al. (2012). A detailed
protocol for preparing ASM can be found in the Supplementary
Information (SI.1).
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FIGURE 1 | Schematic diagram of the in vitro continuous-flow culture system used in this study. The main culture vessel (centre) is a 100 mL Duran bottle fitted with
a 4-port HPLC GL80 screwcap lid, containing 4 sealable inlet/outlet ports. A multichannel peristaltic pump delivers fresh media (ASM) into the culture vessel from a
reservoir, and also removes waste culture at the same rate of flow (Q). Arrows show the direction of flow. The culture vessel is incubated at 37◦C and the contents
are kept homogenous through gentle stirring. If required, an in-line spectrophotometer fitted with a continuous-flow cuvette can be included in the setup prior to the
discard jar. The value for Q depends on the microbial species being cultured within the vessel.
Continuous-Flow Culture Vessel and Culture
Conditions
A schematic of the continuous-flow culture system is shown in
Figure 1. The culture vessel consists of a 100 mL flask (Duran),
fitted with an assembled 4-port HPLC GL80 screw cap (Duran).
A 24-channel IPC ISM934C standard-speed digital peristaltic
pump (Ismatec) was used to deliver sterile ASM at a defined
flow rate (Q) through 1.5 mm bore sterilin silicon tubing (Fisher
Scientific) to the culture vessel. A different channel on the same
pump was used to remove waste culture into a discard jar at the
same flow-rate. The culture vessel was maintained at 37◦C and
its contents were kept homogenous by stirring (100 rpm) using a
magnetic stir bar. When necessary, the culture optical density was
monitored at 600 nm (OD600 nm) by passing the removed waste
culture through an in-line 6715 UV series spectrophotometer
(Jenway) fitted with a continuous-flow cuvette.
Overnight cultures were washed three times in sterile
1 × phosphate buffered saline (PBS, Oxoid) prior to inoculating
the culture vessel. Pre-warmed ASM (100 mL) in the culture
vessels was inoculated with the required combination of
microbial species. Each species was introduced into the culture
vessel to achieve a starting OD600 nm of 0.05. The vessel was
incubated for 3 h prior to staring the flow of medium. For mono-
species and co-culture experiments not containing CA, the flow
rate (Q) was set at 170 µL min−1. For co-culture experiments
including CA, Q was decreased to 145 µL min−1. For all
continuous-flow experiments, samples (1 mL volume) for cell
enumeration were withdrawn using a syringe fitted with a sterile
needle inserted through the rubber septa in the HPLC ports.
Aerobic and Stirred Batch Culture Conditions
For aerobic batch cultures, 250 mL Erlenmeyer flasks containing
pre-warmed ASM (inoculated with the indicated strains to a
starting OD600 nm of 0.05) were incubated at 37◦C with vigorous
shaking (180 rpm). Stirred batch cultures were set up as described
for the continuous-flow experiments (see section “Continuous-
Flow Culture Vessel and Culture Conditions”), except with
Q = 0 µL min−1. For both types of batch culture, samples (1 mL
volume) were taken from the culture vessel for OD600 nm analysis
and viable cell counting.
Microbial CFU mL−1 Enumeration
Colony forming units (CFU) per mL of culture were determined
using the single plate-serial dilution spotting (SP-SDS), as
described previously (Thomas et al., 2015). Serial dilutions
were made in sterile PBS and 20 µL of each dilution was
spotted onto the appropriate selective agar. PA was isolated using
pseudomonas agar base (Oxoid) supplemented with cetrimide
(200 µg mL−1) and sodium nalidixate (15 µg mL−1). SA was
isolated on mannitol salt agar (Oxoid). CA was isolated on
BiGGY agar (Oxoid). During co-culture experiments involving
CA, the agar plates used to isolate PA and SA were further
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TABLE 1 | Microbial strains used in this study.
Strain Description References
PAO1 Pseudomonas aeruginosa, spontaneous chloramphenicol-resistant derivative. Used worldwide as a
laboratory reference strain (isolated Melbourne, 1954).
Holloway, 1955
ATCC 25923 Staphylococcus aureus Rosenbach (ATCC R© 25923D-5TM), methicillin sensitive clinical isolate. Laboratory
reference strain lacking recombinases and mecA (isolated Seattle, 1945).
Treangen et al., 2014
SC5314 Candida albicans, clinical isolate commonly used as a wild-type laboratory reference strain (isolated
New York, 1980s).
Gillum et al., 1984
PAO1 1pqsA CTX-lux::pqsA PQS biosensor strain. 1pqsA mutant of PAO1 containing a pqsA promoter:: luxCDABE fusion integrated at
a neutral site in the chromosome.
Fletcher et al., 2007
JM109 (pSB1057) OdDHL biosensor strain. Escherichia coli JM109 containing pSB1057. Winson et al., 1998
JM109 (pSB536) BHL biosensor strain. Escherichia coli JM109 containing pSB536. Winson et al., 1998
supplemented with 5 µg mL−1 itraconazole to inhibit the growth
of CA. All plates were incubated at 37◦C. Pseudomonas agar
base and mannitol salt plates were incubated overnight (16 h).
BiGGY agar plates were incubated for 24 h. CFU mL−1 counts
are averages taken from three technical repeats. There was no
significant difference between total CFU mL−1 counts of pure
microbial cultures plated onto either non-selective (LB-agar) or
any of the selective agar (data not shown).
Quantification of Quorum Sensing
Molecules
Aliquots (1.5 mL) of culture were collected after 24 and 96 h (as
indicated) of incubation. The cells were pelleted by centrifugation
(15,000 × g, 5 min, 20◦C) and the supernatant was filtered
(0.22 µm pore size). Aliquots of the supernatant were snap
frozen in liquid N2 and stored at −20◦C until use. OdDHL
was detected using JM109 (pSB1057). BHL was detected using
JM109 (pSB536). PQS was detected using PAO1 1pqsA CTX-
lux::pqsA. Overnight starter cultures of the reporter strains were
sub-cultured in LB supplemented with the appropriate antibiotics
and grown to OD600nm = 1.0. Following this, aliquots (60 µL
volume) of the normalised cell culture were transferred to a
sterile clear-bottomed black opaque 96-well plate (Greiner Bio-
One) containing an equal volume of thawed culture supernatant.
The plates were incubated at 30◦C with shaking (100 rpm)
for 3 h. Bioluminescence was recorded using a FLOUstar
Omega plate reader (BMG). Standard curves to calibrate the
biosensor outputs were constructed using known concentrations
of synthetic quorum sensing molecules dissolved in ASM.
Quantification of Pyocyanin
Pyocyanin quantification was performed following chloroform
extraction of the pigment (Knight et al., 1979). Aliquots (10 mL
volume) of culture were collected after 96 h growth and the cells
were pelleted (4000 × g, 30 min, 4◦C). The culture supernatants
were filter sterilised (0.22 µm pore size). Chloroform (4.5 mL)
was added to 7.5 mL of the cell-free culture supernatant and
the suspension was vigorously vortexed for 30 s. The immiscible
layers were separated by centrifugation (4000 × g, 10 min,
4◦C). An aliquot (3 mL volume) of the blue-green chloroform
phase was removed and mixed with 1.5 mL 0.2M HCl. The
immiscible layers were then separated by centrifugation and
1 mL of the rose-pink phase was transferred to a cuvette.
The pyocyanin absorbance was measured at 520 nm using a
BioSpectrometer Kinetic spectrophotometer (Eppendorf) and
converted to concentration (µg mL−1) by multiplying the
A520 nm value by 26.6.
Estimation of Mutation Rates
Mutation rates in the chemostat were measured as described
by Foster (2006). Initially, the rate constant (λ) associated with
exponential growth of PA and SA co-cultured in ASM, was
determined by enumeration of CFU mL−1 on selective agar
plates. Next, the total cell count (N) within the culture vessel at
steady-state growth was determined. The number of spontaneous
rifampicin resistant PA or SA mutants, r, was measured after
t1 = 0 h, t2 = 24 h and t3 = 96 h of incubation. Total cell
numbers in the chemostat did not change appreciably between
24 and 96 h. The value of r was determined by plating aliquots
(100 µL volume) of culture onto either pseudomonas isolation
agar supplemented with 60 µg mL−1 rifampicin (for PA), or
mannitol salt agar supplemented with 0.05 µg mL−1 rifampicin
(for SA). The mutation rate per cell per generation (m) was







Unless otherwise stated, all data represent the mean ± SD of
three independent biological experiments. Results were analysed
by one-way or two-way ANOVA (as indicated), or Student’s
unpaired t-test using GraphPad Prism version 8.2.0, with




As a first step, we confirmed that PA, SA and CA could all
grow in ASM. This was done by inoculating each species into
flat-bottomed microtitre plates containing ASM. The plates were
incubated at 37◦C with vigorous shaking (180 rpm) in a FluoStar
Omega plate reader, and the culture optical density (OD600)
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FIGURE 2 | Growth of P. aeruginosa in ASM in batch and continuous flow culture conditions. Growth (monitored as OD600) of PA in ASM during (A) continuous-flow
culture (Q = 170 µL min–1); (B) batch culture (Q = 0 µL min–1). Data represent the mean ± standard deviation from three independent experiments.
was monitored every 15 min. PA, SA and CA grew rapidly in
ASM, achieving a final OD600 of > 1 after 24 h in all cases
(Supplementary Figure S1).
Next, we measured whether a mono-species culture of PA
could be maintained with stable steady-state titres in our
continuous-flow setup. The laboratory reference strain, PAO1,
was inoculated into the continuous-flow system using a flow-rate
Q = 170 µL min−1 and the OD600 was measured every 30 min
as described in Section “Continuous-Flow Culture Vessel and
Culture Conditions.” The OD600 increased almost linearly for the
first 8 h and then reached a plateau (OD600 ≈ 0.4) after 10 h of
incubation (Figure 2A). By comparison, during growth in the
same medium and experimental setup with Q = 0 µL min−1
(i.e., in stirred batch mode), the PA culture reached a final OD600
of > 1 (Figure 2B). We conclude that during continuous-flow
operation, the setup allows the culture to achieve a steady-state
carrying capacity with an OD600 well-below the final OD600
associated with entry into the stationary phase of growth in
the same medium.
Dual-Species Co-culture (PA-SA)
Staphylococcus aureus is also associated with CF airway infection
and is particularly prevalent in adolescent patients (Goss and
Muhlebach, 2011; Conrad et al., 2013; Jorth et al., 2019). Despite
PA and SA being frequently co-isolated from CF patients,
numerous antagonistic interactions have been identified between
these species, and PA readily outcompetes SA in vitro in mixed
cultures (Machan et al., 1992; Duan et al., 2003; Mashburn et al.,
2005; Park et al., 2012; Korgaonkar et al., 2013; Baldan et al.,
2014; Fugère et al., 2014; Rüger et al., 2014; Filkins et al., 2015;
Nguyen et al., 2015). We therefore wanted to determine if the
two species could be stably maintained in our continuous-flow
culture system. We found that a mixed species co-culture of
PA and SA could be readily maintained to yield an apparently
stable steady-state composition using Q = 170 µL min−1. The
CFU counts for each species are shown in Figure 3A, and the
co-culture OD600 measurements are shown in Supplementary
Figure S2. A steady state composition of around 107 SA CFU
mL−1 and 108 PA CFU mL−1 was established by 24 h of growth,
and there were no significant differences in the viable cell counts
following this (P > 0.05) up to 96 h of growth. By contrast,
during aerobic batch culture in flasks, PA rapidly outcompeted
SA and no viable SA could be recovered at the 96 h sampling
point (Figure 3B). PA also outcompeted SA during stirred batch
co-culture conditions (Q = 0 µL min−1) in the continuous-flow
vessel (Figure 3C), albeit at a slower rate. Taken together, these
data indicate that a continual supply of fresh media and removal
of waste products is crucial for permitting a successful PA-SA
co-culture in vitro.
Dual-Species Co-culture (PA-CA)
Fungi, such as Candida sp. and Aspergillus sp. are also associated
with CF airway infections (Williams et al., 2016; Bouchara et al.,
2018). We therefore examined whether Candida albicans (CA)
could be maintained alongside PA in the continuous-flow setup.
This is important because inter-kingdom interactions between
PA and CA have been previously shown to affect virulence factor
production by both species (Hogan et al., 2004; McAlester et al.,
2008; Cugini et al., 2010; Holcombe et al., 2010). We found that
a co-culture of PA and CA could be readily maintained in the
continuous-flow setup (Figure 4A), although to prevent a wash-
out of CA from the culture vessel over time we had to decrease
the flow rate (Q = 145 µl min−1). The culture carrying capacity
for CA (ca. 105 CFU mL−1) was lower than it was for PA (ca.
108 CFU mL−1), but once a steady-state had been achieved
(after 24 h incubation) no statistically significant differences
in PA or CA viable cell counts were observed (P > 0.05). In
contrast, CA titres rapidly declined during aerobic batch co-
culture (Figure 4B). A similar, albeit slower decline in CA titres
was observed during stirred batch growth (Figure 4C).
Dual-Species Co-culture (SA-CA)
We next wanted to confirm that a stable co-culture of SA
and CA could be maintained independent of PA. Using
Q = 145 µL min−1, this was indeed the case (Figure 5A),
and after 24 h growth, the ratio of SA:CA remained essentially
unchanged. As in the PA-CA co-culture, at steady-state, the
carrying capacity (ca. 105 CFU mL−1) for CA was lower than
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FIGURE 3 | Continuous-flow culture allows P. aeruginosa and S. aureus to be maintained in a stable steady-state. Viable cell counts [colony forming units (CFUs)] of
P. aeruginosa PAO1 (PA, black bars) and S. aureus 25923 (SA, white bars) during co-culture in ASM using: (A) a continuous-flow setup; (B) aerobic batch culture;
and (C) stirred batch culture. Data represent as mean ± standard deviation from three independent experiments. Asterisks represent significant (∗P < 0.05)
differences in CFU mL–1 counts in comparison with the data from the 24 h time point.
it was for SA (ca. 108 CFU mL−1). Unexpectedly, we noted that
following aerobic and stirred batch culture, the CA outcompeted
the SA (Figures 5B,C). This confirms that in mixed cultures, a
species comprising just 0.1% of the microbiota can potentially
have a major impact on titres of the [initially] numerically-
dominant organism.
Triple-Species Co-culture
With the continuous-flow culture system clearly capable of
maintaining dual-species co-cultures of PA-SA, PA-CA and CA-
SA, we next wanted to determine if all three species could be
co-cultured to achieve a stable steady-state composition. We
found that setting Q = 145 µL min−1, a mixed population of all
three microbial species could be maintained at a steady state for
96 h of incubation (Figure 6A; the corresponding in-line OD600
data are shown in Supplementary Figure S3). Once the steady-
state had been achieved (i.e., after 24 h of growth) there were no
significant differences in the CFU mL−1 counts for each species
for the remaining duration of the co-culture (P > 0.1). The
PA and SA titres remained at around 108–109 CFU mL−1, and
the CA titres remained at around 105 CFU mL−1. By contrast,
when co-cultured in aerobic batch culture, both SA and CA were
outcompeted by PA (Figure 6B). Indeed, there was a progressive
decrease in the number of SA CFUs in each of the samples
harvested after the 24 h time-point (P < 0.0005), and by 72 h,
no viable CA CFU could be recovered. However, and unlike
the PA-SA aerobic dual cultures (Figure 3B), SA could still be
recovered at the 96 h sampling point, suggesting that the presence
of CA affords a degree of protection, perhaps by decreasing the
direct competition between PA and SA for shared resources. The
stirred batch co-cultures yielded a somewhat different pattern
(Figure 6C). Here, following the 24 h sampling point, PA titres
remained high (ca. 109–1010 CFU mL−1) and constant, but there
was a significant and progressive decrease in SA titres (P < 0.05).
Unlike the aerobic batch culture, this was accompanied by a much
slower decline in CA titres.
Quantification of P. aeruginosa Quorum
Sensing Molecules
Quorum sensing (QS) mediated signalling pathways are linked
to the regulation of secondary metabolite and extracellular
virulence factor production by PA. Some of these QS-regulated
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FIGURE 4 | Continuous-flow culture allows P. aeruginosa and C. albicans to be maintained in a stable steady-state. Viable cell counts (CFU) of P. aeruginosa PAO1
(PA, black bars) and C. albicans SC5314 (CA, grey bars) during co-culture in ASM using: (A) a continuous-flow setup; (B) aerobic batch culture; and (C) stirred
batch culture. Data represent as mean ± standard deviation from three independent experiments. Asterisks represent significant differences in CFU mL–1 counts in
comparison with the data from the 24 h time point (∗∗P < 0.005, ∗∗∗∗P < 0.0001).
factors have been implicated in mediating interactions with
other microbial species (Gambello et al., 1993; Smith and
Iglewski, 2003; Lau et al., 2004; Schuster and Greenberg, 2006;
Dekimpe and Déziel, 2009; Antunes et al., 2010). To examine
how other microbial species might impinge on QS in PA, we
therefore determined the concentration of the Pseudomonas
quinolone signal (PQS), N-(3-Oxododecanoyl)-L-homoserine
lactone (OdDHL) and N-butanoyl-L-homoserine lactone (BHL)
in the culture supernatant of single and mixed species co-cultures
(Figures 7A–C, respectively).
The concentration of all three QS molecules was significantly
(P < 0.0001) lower in the continuous-flow setup compared with
the aerobic- and stirred-batch cultures. In the continuous-flow
setup, there was no significant difference in the concentration of
PQS between the 24 and 96 h sampling points, or of OdDHL
between these sampling points (P > 0.1), although we did note
an increase in BHL concentration in the PA-CA co-culture over
this period (P > 0.05). In contrast, QS molecules accrued to
much higher concentrations in the aerobic- and stirred-batch
cultures. Moreover, the presence of co-cultivated species had a
large, but differential impact on QS molecule production by PA.
For example, in batch culture, SA appeared to stimulate OdDHL
production, whereas CA appeared to depress OdDHL levels and
stimulate PQS (and to a lesser extent, also BHL) production.
Taken together, our data indicate that QS molecules accumulate
to a much lower concentration in the continuous-flow setup
compared with batch cultures.
Quantification of Pyocyanin
Pyocyanin is a redox-active PA secondary metabolite, and is
linked with virulence and competition between microbial species
in the CF lung (Castric, 1975; Hoffman et al., 2006; Voggu
et al., 2006; Biswas et al., 2009; Filkins et al., 2015; Noto et al.,
2017). We measured pyocyanin levels in the different culture
setups at the endpoint of each experiment (Figure 8). Pyocyanin
concentrations were significantly lower for all microbial species
combinations in the continuous-flow setup compared with the
aerobic- or stirred-batch cultures (P < 0.0001). No significant
differences were observed in pyocyanin accumulation between
the different microbial co-culture combinations following growth
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FIGURE 5 | Continuous-flow culture allows S. aureus and C. albicans to be maintained in a stable steady-state. Viable cell counts of S. aureus 25923 (SA, white
bars) and C. albicans SC5314 (CA, grey bars) co-cultures in ASM in: (A) a continuous-flow setup; (B) aerobic batch culture; and (C) stirred batch culture. Data
represented as mean ± standard deviation of three independent experiments. CFU mL–1 values are plotted on a log10 scale and asterisks represent significant
differences in CFU mL–1 counts in comparison with the data from the 24 h time point (∗∗P < 0.005, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001).
in the continuous-flow setup (P > 0.3). However, we did
note that in the batch cultures, the presence of CA depressed
pyocyanin accumulation.
Estimation of Mutation Rates in
Co-cultures of P. aeruginosa and
S. aureus
One possible use of the continuous-flow system described here
would be to investigate how the presence of co-habiting species
affects evolutionary trajectory(s). To gauge this, we measured the
mutation rate of each species during co-culture. Mutation rates
were measured as described by Foster (2006) and were assessed
shortly after the steady-state had been attained (i.e., at the 24 h
time-point) and at the end of the experiment (96 h time-point).
The mean number of RifR-conferring mutations per cell division
was comparable with previously-reported values [≈10−8–10−9
mutations/cell/division (Schaaff et al., 2002; Dettman et al.,
2016)] and was consistently low for both PA and SA, with
no statistically significant differences between the 24 and 96 h
sampling points (P > 0.1) (Figure 9). We conclude that PA and
SA do not exhibit abnormal mutability in the continuous-flow
setup and that co-culture of these species has no apparent impact
on their respective mutation rate.
Continuous-Flow Cultures Maintain a
Constant pH
We also examined the endpoint pH of mixed-species cultures
to see whether this differed from the starting pH of ASM
(pH 6.7). We found that irrespective of the microbes and
combinations of microbes being tested, the continuous flow
cultures maintained a remarkably constant pH that was close to
the starting pH. Stirred batch cultures maintained a pH of ca.
7, whereas aerobic batch cultures exhibited an endpoint pH > 8
(Supplementary Figure S4).
DISCUSSION
In this work, we have shown that a simple in vitro continuous-
flow co-culture system enables long-term co-culture of three
distinct microbial species (PA, SA and CA) associated with CF
airway infections. When co-cultured in batch, these organisms
ordinarily outcompete one another, leading to domination by
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FIGURE 6 | Continuous-flow culture allows P. aeruginosa, C. albicans, and S. aureus to be maintained in a stable steady-state. Viable cell counts of P. aeruginosa
PAO1 (PA, black bars) S. aureus 25923 (SA, white bars) and C. albicans SC5314 (CA, grey bars) co-cultures in ASM in: (A) a continuous-flow setup; (B) aerobic
batch culture; and (C) stirred batch culture. Data represented as mean ± standard deviation of three independent experiments. CFU mL–1 values are plotted on a
log10 scale and asterisks represent significant differences in CFU mL–1 counts in comparison with the data from the 24 h time point (∗∗P < 0.05, ∗∗∗P < 0.001).
a single species. However, in the setup described here, once a
steady-state has been achieved (after around 24 h incubation)
each inoculated species can be maintained at a constant titre,
presumably reflecting the carrying capacity for each organism
in the culture. Significantly, we show that even low-abundance
species (represented by CA in our model) can be stably
maintained, and that the presence of such species can have
a major impact on the population trajectory of numerically
more-abundant organisms such as SA, as well as inter-cellular
signalling by PA.
The airways of people with CF have been shown to harbour a
diverse polymicrobial community, comprising both bacteria and
fungi (Sibley et al., 2006, 2008; Rogers et al., 2010a; Zhao et al.,
2012; Carmody et al., 2013, 2015; Short et al., 2014; Boutin et al.,
2015), and through the efforts of several teams, we now have a
well-defined ASM for in vitro analyses. Indeed, PA grown in ASM
has an almost identical gene expression profile compared with
PA grown directly in sputum derived from CF patients (Turner
et al., 2015). In spite of this, to date, there have been no reports
describing the successful, long-term co-culture of CF-associated
microbes in ASM. As we demonstrate in the current work,
simply adding mixed-species inocula into ASM is not a recipe
for the long-term maintenance of a stable population. Perhaps
the best measure of the lack of progress on this front is seen
when considering PA and SA. These two species are common
in CF infections, and decades of work have revealed a wealth of
knowledge about their physiology and nutritional requirements
in axenic culture. However, until now, there have been no studies
describing the successful long-term co-cultivation of these two
species in vitro. One possible reason for this is that in iron limited
conditions, PA lyses SA and uses the resulting lysate as a source
of iron (Mashburn et al., 2005). By providing a continual supply
of fresh media (which presumably mimics the unrelenting and
exuberant production of airway secretions in the CF lung) we
speculate that this nutritional limitation may be overcome.
The in vitro system described here offers a number of
advantages. First, it is inexpensive to set up, making it accessible
as a model to most researchers. Second, it is compliant with
the “3Rs” (the replacement, refinement and reduction of animal
research). Third, it is robust, as attested by the remarkably
constant titres of each species following attainment of the steady-
state condition. Fourth, early indications are that it can faithfully
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FIGURE 7 | Quorum sensing molecule accumulation in the different culture setups. Concentration of the indicated P. aeruginosa quorum sensing molecules in the
supernatant of single-species or multi-species co-cultures after 24 and 96 h incubation (as indicated). (A) Pseudomonas quinolone signal (PQS);
(B) N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL); (C) N-butanoyl-L-homoserine lactone (BHL). Data represented as mean ± standard deviation of three
independent experiments.
maintain species diversity when patient-derived CF sputum is
being used to inoculate the system, and our progress on that
aspect of the model will be published presently. Fifth, the system
is far more defined and controlled than an animal model,
allowing facile experimental perturbation. This experimental
tractability means that we can address biological questions
in a way that is just not possible with, e.g., animal models.
For example, new species or defined mutants can be readily
introduced to examine their impact on succession dynamics, and
the action of antibiotics on the entire community can be accessed.
We have also been exploring ways of modifying the setup to
promote biofilm growth in the culture vessel, and again, these
findings will be published in the near future.
Our in vitro setup is also subject to a number of perceived
disadvantages. Unlike an animal model, it does not incorporate
any immune response. This may be significant since the
immune response would be expected to play a major role in
clearance of microbes from the airways, and therefore exerts
a selective pressure on the microbial community. Also, our
model does not incorporate other types of host cell. This may
be significant because in some circumstances (e.g., in patients
carrying the DF508 CFTR mutation) the altered cell surface
on the epithelia lining the airways has been implicated in
promoting microbial colonisation (Campodónico et al., 2008).
Mitigating these features, we note that few animal models
accurately recapitulate the human CF airway environment,
and aside from the difficulties associated with controlling and
sampling such models, as far as we are aware, none of these
models have yet been developed for maintaining a polymicrobial
community of CF pathogens (O’Brien and Welch, 2019). One
other potential disadvantage of our model is the requirement
for continual flow. On the one hand, this is a feature that
does allow maintenance of a stable steady-state community of
microbes. On the other hand, even at low Q values, “washout”
may prevent slow-growing species/variants from thriving, or key
molecules from accumulating. For example, we noted that QS
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FIGURE 8 | Pyocyanin accumulation in the different culture setups. The
concentration (µg mL–1) of pyocyanin in the supernatants of single-species
and co-cultures after 96 h of incubation under: continuous-flow (black bars);
aerobic batch (grey bars) and; stirred batch (white bars) culture conditions.
Data represented as mean ± standard deviation of three independent
experiments, P > 0.05 is considered no significant difference (ns).
FIGURE 9 | Mutation rates of P. aeruginosa and S. aureus during co-culture in
the continuous-flow setup. Assumed mutation rates of P. aeruginosa PAO1
(black bars) and S. aureus 25923 (white bars) in the continuous-flow culture
vessel after 24 and 96 h of incubation. Mutation rates were calculated as the
number of RifR-conferring mutations per cell per cell division, calculated as
described by Foster (2006). The bars represent the mean ± standard
deviation from three independent experiments. P > 0.05 is considered not
significantly different (ns).
molecules (and pyocyanin) fail to accumulate in the continuous-
flow system, whereas these compounds reached high levels in
batch culture. The most likely explanation for this is simple
washout (through continual dilution) of the QS signals. However,
it should be noted that with Q = 170 µL min−1, it would
take > 6 h to dilute the vessel contents by 50%, and all the
while, the contained culture continues to grow and elaborate
more QS molecules. To put this into context, previous work has
shown that QS molecules more than double their concentration
in batch cultures in a 2 h period (Davenport et al., 2015),
so assuming similar kinetics in ASM, these molecules should
accumulate faster than they are diluted. If so, this suggests that
QS plays a less important role in continuous-flow cultures than
it does in batch cultures. The low steady-state concentrations
of QS molecules documented here may also be advantageous
(for the experimenter). First of all, the metabolic physiology of
the community is defined and stable over the experiment’s time
course and we would not expect to see the bursts of metabolic
activity which would normally accompany the accumulation of
QS molecules in the post-quorate period (Davenport et al., 2015).
Second, and if the effect(s) of QS molecules on community
interactions does need to be examined, this can be easily
be done through the addition of defined concentrations of
exogenous QS molecules.
We conclude that the setup described here enables facile
maintenance of PA, SA and CA (a Gram-negative bacterial
species, a Gram-positive bacterial species and dimorphic fungus,
respectively). Our approach provides a framework for potentially
recapitulating the entire polymicrobial community associated
with CF airway infections. The setup will provide leverage
to access to key biological problems regarding inter-species
interactions, the impact of antibiotics, and the impact that newly-
introduced species may have on the community trajectory.
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The airways of persons with cystic fibrosis are prone to infection by a diverse and dynamic polymicrobial
consortium. Currently, no models exist that permit recapitulation of this consortium within the labora-
tory. Such microbial ecosystems likely have a network of interspecies interactions, serving to modulate
metabolic pathways and impact upon disease severity. The contribution of less abundant/fastidious mi-
crobial species on this cross-talk has often been neglected due to lack of experimental tractability. Here,
we critically assess the existing models for studying polymicrobial infections. Particular attention is paid
to 3Rs-compliant in vitro and in silico infection models, offering significant advantages over mammalian
infection models. We outline why these models will likely become the ‘go to’ approaches when recapitu-
lating polymicrobial cystic fibrosis infection.
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Cystic fibrosis (CF) is the most common life-limiting genetic disease within the Caucasian population and is
estimated to affect 70,000 people worldwide [1]. It results from an autosomal recessive defect within the cystic
fibrosis transmembrane conductance regulator (CFTR) gene [2] and a myriad of different mutations have been
described that bring about the onset of CF [3]. Dysfunctional CFTR activity leads to complications in multiple
organs, but perhaps the most striking presentation of CF is the overproduction of a nutrient rich, viscous mucus
in the CF-airways [4]. Defective mucociliary clearance mechanisms further contribute toward airway obstruction
which results in the CF airways being a highly heterogenous environment, typically characterized by steep oxygen
gradients, lowered pH and an abundance of mucin, amino acids, nitrate and iron [5–10]. This unique environmental
niche is prone to chronic microbial colonization, and such infections contribute toward the death of 80–95% of CF
patients [11–15] through triggering bouts of excessive inflammation, termed acute pulmonary exacerbations (APEs).
Cumulatively, these lead to tissue destruction and a steady decline in lung function [14,15].
Traditionally, culture-based microbiological investigation of sputum samples expectorated from CF-patients
have been used to establish which microbial species are associated with chronic infection of the CF airways. It
was suggested, in line with Koch’s postulates, that single-microbial species were the primary cause of infection [16],
with Staphylococcus aureus being prevalent in the early stages of life, before being outcompeted as Pseudomonas
aeruginosa (PA) becomes the dominant pathogen alongside occasional co-infections from other ‘keystone’ respiratory
pathogens [17–19]. More recently, culture-independent molecular profiling techniques, for example, sequencing of
the hypervariable bacterial 16S rDNA and fungal ITS regions, suggest that a previously unanticipated diverse
polymicrobial population of both bacteria and fungi are associated with CF-airway infections [14,15,18–22]. However,
this notion has been strongly contended by the recent work of Jorth et al., who sampled lavage fluid directly from the
lungs of CF-children displaying stable lung function. These authors suggest that the previously reported diversity
of the CF-associated microbiome may arise from the sampling of oral contaminants. This notwithstanding, Jorth
et al. did suggest that a core population of ‘nonconventional’ bacterial species are found alongside the traditional
CF-pathogens [23].
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With the CF airways containing a polymicrobial ecosystem, it could be hypothesised that members of this
community interact with one another either through quorum sensing, the recognition of cell surface proteins
and the secretion of other small metabolites. Indeed, it has been demonstrated that the co-culture of different
bacterial species leads to large alterations in their gene expression profile, both in vivo and in vitro [24]. Such
changes can be synergistic or antagonistic in nature [25,26] and may cause members of the community to adopt
different lifestyles and activate distinct metabolic pathways. These changes could alter the expression of virulence
factors and influence the chemical environment, causing deviations from behaviors observed when studying single
species in isolation [21,25,27–30]. For example PA is able to sense the presence of peptidoglycan shed from Gram-
positive bacteria. This stimulates the production of extracellular factors that are lytic against both prokaryotic and
eukaryotic cells [31]. Ultimately, polymicrobial infections display altered responses to therapeutic interventions.
Such interventions are often aimed at decreasing the microbial load of a principal pathogen, and differentially
impact disease severity between patients [32].
The microbial consortium present within the CF airway is thought to consist of both stable and disturbed
states [25], yet little is known about what triggers the switch between the two. A better understanding of the extent
of interactions occurring within the CF airway, and of how the architecture of polymicrobial communities adapts
over time and responds to clinical intervention, may lead to the identification of novel therapeutic targets. It is
possible that less abundant and poorly characterized species, typically viewed as avirulent when studied in isolation,
could trigger the adoption of a more pathogenic lifestyle by known pathogens or in species classically thought to be
nonpathogenic or nonconventional. Through targeting the pathways involved, and the chemical changes inducing
the onset of a decline in lung function, it may be possible to delay or prevent key CF pathogens from dominating
the patient’s airways.
Despite the likely role played by interspecies interactions on the severity of disease within CF and other
polymicrobial infections, relatively little is understood about this, or about how interspecies interactions impinge
upon adaptation in the airways. This lack of understanding is, at least partially, attributable to the complexity
of mixed-species interactions, and the paucity of polymicrobial models available for studying such interactions.
Although research focus is now gradually moving away from studying single species in isolation, and moving
more toward cocultivating the major members of mixed populations, these studies often ignore the presence of
less abundant and hard-to-cultivate members of the community, thereby neglecting their impact as drivers of
population change.
It would be of enormous benefit for models to be developed within the laboratory that enable the stable
recapitulation of the whole polymicrobial community derived from the airways of CF-patients, in other words, those
associated with sputum or bronchoalveolar lavage fluid (BALF) samples. These models would better represent the
nature of the CF airway community and shed light on how both key pathogens and less represented species
might be influenced by external perturbations. Such a model system would allow for a multitude of biological
questions to be addressed relating to interspecies interactions and evolution within mixed microbial populations.
The community-wide impact of external perturbations, either through antimicrobial treatment or through the
introduction of new species/strain variants, could all be studied in a robust and reproducible manner.
This commentary aims to provide a critical overview of the existing models used to study microbial infection in
relation to CF, and we hope to clarify how such approaches might be utilized to develop true polymicrobial infection
models utilizing the microbial communities derived from CF sputum. Close attention is paid to the development
of in vitro and in silico infection models that comply with the 3Rs guidelines for the reduction, replacement and
refinement for the more humane use of animal models within research. Additionally, we highlight the need to
consider CF as a mixed-species infection scenario, in order to identify novel targets for therapeutic intervention
and understand the progression of disease within a more physiologically relevant context.
Mammalian CF infection models
Animals have long served in the field of comparative biology as a proxy for studying human genetic disease, and CF
is no exception to this trend. In 1992, just 3 years after the identification and initial characterization of the CFTR
gene, the first CF-mouse model was generated through gene targeting of embryonic stem cells to abolish CFTR
activity [33]. In recent years, countless advances in gene editing techniques have led to the generation of a wealth of
CF-animal models aimed at mimicking the mutations associated with the disease in humans, with varying success.
However, some of these CF-animal models have been pivotal in furthering our understanding of the underlying
mechanisms of CF pathology and the development of therapeutics now approved for the treatment of patients
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carrying a distinct subset of CFTR mutations. This notwithstanding, our aim here is to provide an overview into
how models can be used to study CF-associated infections, and as such we will not review further the utility of
animal models for developing gene therapy treatments [34–36].
The comparatively low cost, rapid reproduction rate and ease of genetic manipulation ensure that mice are usually
the first point of call when developing transgenic mammalian models. To date at least 14 different CF-mouse models
have been reported, with differing CFTR mutations and genetic backgrounds available [37]. Despite this impressive
selection of models at hand, numerous issues have plagued the use of mice for studying CF-associated microbial
infections. The biggest issue seems to arise from differences in the spatial structure of murine airways and an
inability to spontaneously develop airway infection [33], even with CF-mice demonstrating impaired mucociliary
clearance. The CFTR protein is known to play a key role in innate lung immunity and several studies have since
been undertaken to determine why even the ‘β-NaEC’ mouse [38] and other backgrounds lacking residual CFTR
expression fail to develop infection [39,40].
Lack of an existing microbial community could be considered a ‘clean-slate’ for inoculating CF-mice with
polymicrobial communities derived from patients. However, the introduction of pathogens into these mice leads
to rapid microbial clearance [41], and repeat infections cause death [42]. Infection timescales using murine hosts can
be considered semi-chronic at best, with successful infection (when achieved) typically lasting no more than a few
days and reliant upon immobilizing the bacteria (PA) within agarose/alginate/agar beads that are directly instilled
into the lung [41–50]. Using specific hypermucoid strains (e.g., NH57388A) it has been possible to maintain strain
specific PA infections of up to 3 months within a host that bears the hallmarks of chronic CF infection [44,50]. An
alternative inoculation approach that avoids the mechanical immobilization of microbial species and attempts to
better represent a natural route of infection is the intranasal inoculation of mouse models. A persistent infection
lasting 28 days could be established in non-CF mice following the respiratory inhalation of the transmissible
Liverpool epidemic strain (LES) of PA [51]. Bacteria were found to be harbored in the nasopharynx throughout
the experiment, and no PA could be detected in the lungs even by day 14. However, on day 28, PA could once
again be isolated at low levels from the lung (26 CF per lung). These findings demonstrate that persistence in
the nasopharynx allows reseeding of the lower airways and support the hypothesis that the upper respiratory tract
provides a ‘silent reservoir’ able to harbor CF-associated species that can then be aspirated in to the lungs of CF
patients. It would certainly be interesting to compare how a CF-mouse model responds to the respiratory inhalation
route of infection and if multiple microbial species could be maintained within the nasopharynx. The intranasal
inoculation of PA isolates recovered longitudinally over the course of a patient’s life into CF-mice revealed that
only late-stage ‘CF-adapted’ isolates could establish persistent infection [45,49]. It has also been suggested that older
CF-mice may be more predisposed to microbial infection, but little work has been carried out to determine if such
mice have an expanded range of infective capabilities [47,52].
Co-infection studies have been trialed in recent years, but again these have been limited to an acute infection
timescale (often just 18 h) until the clearance of non-PA species occurs. Importantly, these studies have revealed
that co-infection of PA with S. aureus or Burkholderia cenocepacia enhances the murine immune response and
upregulates virulence factor production in the lungs [43,48,53]. Furthermore, in vivo coinfection studies of PA and S.
aureus found that ‘late-stage’ PA isolates had undergone phenotypic adaptation associated with enhanced persistence
in the CF lung, and demonstrated a reduced capacity to outcompete S. aureus during co-culture [48]. Interestingly,
immobilizing B. cenocepacia in PA-derived alginate caused increased microbial persistence, inflammation and
mortality rates [46]. Such studies provide clear evidence that interspecies interactions drive modulations in microbial
lifestyles, and that these changes have a major impact upon disease severity.
Mouse infection models aim to provide an insight into the mechanisms underlying host-responses to infection
but are severely limited by the small subset of PA isolates proven to be able to establish an infection once physically
immobilized. Further research is required into how CF mice rapidly clear airway infections; this may lead to the
generation of novel transgenic models with an improved propensity for sustaining mixed species infections. Until
this is achieved, CF mice need to be considered with caution as models for polymicrobial CF infection. The impact
of this is that researchers need to consider critically the impact that other members within a mixed community have
on driving PA adaptation and host-immune responses in these systems, due to concerns regarding the physiological
relevance of the model.
The inability of CF mice to spontaneously develop lung disease comparable to that observed in human patients
led researchers to develop CF models within larger mammals that share a higher degree of airway similarity with
humans. CF models have now been reported in ferrets [54–56], pigs [57–60] and more recently sheep [61], all with
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higher levels of CFTR homology with the human gene (92, 91 and 91% respectively, and in contrast to just 78%
in mice). Crucially, these larger mammals do develop spontaneous airway infections, demonstrating a reliance
on functioning CFTR protein for effective airway clearance. Despite their apparent predisposition for microbial
infection, these models are not without limitations and multiple issues hamper their use in studying polymicrobial
CF-associated infections.
Soon after birth, CF ferrets develop spontaneous bacterial infection and severe lung pathologies mirroring
those observed in humans. Examination of BALF established that members of the Streptococcus, Staphylococcus,
Enterococcus and Pseudomonas genera were present at low levels and could not be eradicated from the airways [53–55].
This presence of a diverse airway microbiota suggests CF ferrets are permissive for microbial colonization, yet
they are limited in their suitability for the inoculation of human-derived polymicrobial communities. Abnormal
inflammation is believed to begin in utero, before being excessively amplified upon bacterial exposure at birth [55].
Single-species intratracheal microbial challenges with PA and B. cenocepacia in CF ferrets led to a hyperinflammatory
response from the host macrophages and increased mortality rates [40], supporting the notion of bacterially driven
immune modulation. The extreme severity of bacteria-associated lung pathologies result in neonatal CF ferrets
relying on antimicrobial therapy to survive weaning [62], limiting their use in studying chronic infection. No studies
have challenged a ferret model with a microbial co-culture, although given the spontaneous development of neonatal
infection, it may be possible to develop acute infection models with polymicrobial communities derived from CF
patients. It would be interesting to compare whether there are any similarities between the hyperinflammatory
response(s) observed in CF ferrets with those observed during APEs in CF patients. In this regard, the acute
ferret infection model could potentially provide a physiologically relevant framework for understanding better the
mechanisms of host-microbe responses leading up to APEs.
Gut-corrected, humanized CF pig models provide an in vivo system that parallels human CF lung pathophysiology
remarkably well. CF pigs develop spontaneous airway infections with diverse and varied microbial populations a
few months after birth, and fail to eradicate bacteria as effectively as wild-type pigs [57–60]. The microbiota of older
CF pigs mostly resembles that of adolescent human patients, with S. aureus being the most commonly isolated
pathogen [20,57,59]. Infection studies have not yet been carried out on CF pigs, although introducing PA isolates
into the established microbial population in vivo would provide unique insight into how this key CF pathogen
initially adapts within the CF airways. Alternatively, a polymicrobial community derived from CF patients could
be introduced into CF pigs to examine the host-microbe response and interspecies interactions that occur within
an environment that is close to being physiologically representative of the human CF lung. However, the high costs
and requirement for specialized expertise and dedicated lab space for conducting research using porcine models
has restricted experimental sample size, widespread uptake, and length of studies; more so than many other in vivo
models.
Plant & invertebrate infection models
With key differences in physiology being apparent between plants/invertebrates and the human airways, the use of
such hosts cannot (strictly speaking) be considered CF-infection models. However, their low cost, basic equipment
requirements and minimal technical skill requirements, as well as a lack of ethical concerns, means such models
provide a highly attractive, high-throughput approach to screen mutant libraries for genes essential for virulence
and growth in vivo.
Limited similarities exist between the immune response of mammals and such simple host systems, yet they
do enable some insights into the host-response to infection. How closely invertebrates approximate mammalian
models is still cause for debate. These models are primarily limited by which microbial species have the capability
to establish an infection, and there is little chemical or spatial similarity in the infection environment compared
with human hosts. The small size of invertebrate models means very low microbial inoculums are rapidly fatal [63]
and ensures that in general only acute, single-species infection studies can be readily undertaken. Mutant knockout
libraries of ‘rare’ or less abundant CF-associated microbial species simply do not currently exist, and cannot be
subject to systematic screens or included within co-infection studies, in spite of the likely role(s) played by these
species in modulating pathogenesis during CF infection. The result of library screens using plant and insect hosts
must be viewed with caution as essential genes for infection within mammalian models may have been missed,
yet such high-throughput screens are certainly useful in the identification of potential virulence genes that can be
further characterized in vitro or in larger in vivo model systems.
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Multiple plant-based infection assays have been reported, including: Arabidopsis thaliana [63], lettuce stems [64]
and mung bean seedlings [65]. With a limited range of human pathogens able to establish infections within these
models, the majority of studies simply focus on PA isolates and mutants. Infection assays often compare the extent
of destruction within stem or leaf infiltration assays or compare the growth of seedlings infected with wild-type or
mutant strains, enabling a rough quantitative measure of the contribution that specific genes have toward causing
virulence in vivo. However, as several mutants can be introduced into the same model, for example, multiple mutant
strains inoculated within a single lettuce stem [64], plants provide an extremely rapid fitness screening system for a
limited number of microbial species.
Caenorhabditis elegans is a very well-characterized, well-established laboratory model organism and is susceptible
to infection by a range of both bacterial and fungal species [66,67], including some that have been isolated from
the CF-lung and are associated with worsened patient prognosis. Microbial species are introduced as a top lawn
or bacterial suspension containing the nematodes during feeding, limiting infection studies to species that can
be successfully cultivated in vitro. In order to establish a co-culture within C. elegans both species must first be
successfully grown together without one outcompeting the other and is something which may not be possible for
the polymicrobial communities associated with CF. Vega and Gore (2017) describe the successful co-culture of
two members of the Enterobacteriaceae in C. elegans [68]. However, they also report the dominance of one species
over the other within the intestine during ‘slow colonization’ further demonstrating the limitation of nematodes as
a vehicle for maintaining both the rare and the dominant microbial species associated with CF. When grown on
nutrient-rich media, PA isolates cause ‘fast-killing’ of nematodes due to the production of hydrogen cyanide and
phenazine compounds [69], yet when grown on minimal media PA replicated within the digestive tract to cause
‘slow-killing’ [70]. Such results demonstrate that nematodes are susceptible to death from secreted metabolites and
that the growth media used in the screening of mutant libraries must be carefully considered.
Galleria mellonella (waxmoth larvae) are an alternative invertebrate model used for studying key CF-pathogens.
Although waxmoths are infected by a limited range of pathogens, they are susceptible to infection from PA and some
fungal species associated with the CF-airway [71]. Comparative studies have established that the waxmoth infection
model shows good correlation of antimicrobial efficacy, pharmacokinetics [72] and essential virulence requirements
with mouse models [70], suggesting this system is more representative of mammalian infection than the plant or
nematode models. However, waxmoths are extremely susceptible to infection, with as little as ten bacterial cells
being fatal, thus limiting use of this model to acute single-species infection only. This notwithstanding, serial
passage of microbial populations through waxmoths could be used to represent a more chronic infection, and
reports suggest the phenotypic adaptation of PA isolates does reflect limited elements of evolution within the CF
airways [73].
Drosophila melanogaster presents the most plausible invertebrate model for studying polymicrobial infections.
Not only are there a large number of genetic tools available for the generation of mutant flies (enabling detailed
genetic dissection of host-microbe interactions occurring during infection), but successful S. aureus-PA coinfection
models have been reported [31,74]. These studies build upon previously described single-species feeding models
which demonstrate that bacteria replicate within the fly-crop and cause host mortality. Using this invertebrate
co-infection model it was found that PA can sense peptidoglycan shed from the walls of Gram-positive species,
triggering an enhancement in toxin and antimicrobial production [31]. This not only causes a 1000-fold decrease in
the Gram-positive flora, it also enhanced host mortality. A mutant PA strain, PA601, which lacks the peptidoglycan
receptor, did not increase mortality rates upon co-infection with S. aureus, and these results were verified using a
murine infection model [75]. Such co-infection studies not only provide strong evidence for the need to understand
interspecies interactions in a suitable host model, but also provide clear insights into the mechanisms underpinning
these. The Drosophila model also relies on feeding bacteria to the host, again severely limiting which species can be
studied and preventing this model from being utilized for inoculation with patient-derived polymicrobial samples.
As with all infection studies, it can be difficult to pinpoint which of the multifarious biological interactions that
occur within a host model are crucial for driving changes in human disease severity. A reductionist approach could
be taken to systematically screen mutant libraries within an invertebrate co-infection model to identify key genes
for subsequent study in more advanced model systems. In vivo models provide a system for studying host-microbe
interactions, but they are ill-suited to analyse interspecies microbe–microbe interactions. This is because the added
complexity of an immune response strongly limits the likelihood of sustaining a polymicrobial model mimicking
the chronic infections often associated with CF patients. With emerging evidence suggesting that co-infection
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drives changes in microbial lifestyles, that in turn impact upon disease severity, models that enable the real-time
tracking of microbial populations are urgently required.
In vitro & ex vivo models of CF-infection
Emerging evidence suggests that chemical, not spatio-temporal, challenges have the greatest impact on driving
changes in microbial lifestyles [76,77]. Inherent natural variation between in vivo models leads to local variations in
the chemical environment and immune responses, adding an additional layer of variability. There is clear need for a
robust and reproducible model recapitulating a physiologically relevant environment that allows the chemical and
genetic changes within a mixed population to be dissected. In vitro models present a defined and easily perturbable
environment, that can potentially provide simple, tractable and high-throughput systems for studying mixed species
populations derived from CF patient sputa. The real-time tracking of a model microbial population would allow
a number of fundamental biological questions to be addressed, making it possible to identify novel therapeutic
avenues that might be missed in in vivo infection models.
A number of microbial species associated with CF-airway infections are known to have a narrow host-range of
infection, for example, Haemophilus influenza does not infect nonhuman hosts. Therefore, it may be impossible to
develop certain in vivo polymicrobial infection models. Conversely, several species have been identified in in vivo
CF-models that are not known to infect humans, adding an extra layer of complexity when trying to recapitulate
human infection-associated microbial consortia in vivo. Rearing animal models under gnotobiotic conditions
can potentially reduce the presence of animal-specific species, although this does add significantly to the cost of
maintaining the model.
A combination of targeted and untargeted culture-independent molecular approaches can be used to follow
the composition of a polymicrobial community over time in an in vitro infection model. Culture-independent
molecular analyses allow the influence of less abundant and hard-to-isolate species to be tracked effectively within
models representative of chronic infections. The utility of untargeted molecular approaches, such as sequencing
the hypervariable 16S rDNA and ITS regions of bacteria and fungi (respectively), has been reviewed by Rogers et
al. [21]. Moreover, the development of revolutionary, high-throughput and sensitive targeted gene assays such as the
NanoString nCounter system allows the expression of up to 800 different genes to be studied in a single reaction [78].
Utilizing probes designed against known 16S rDNA and ITS regions alongside key virulence genes has allowed
accurate determination of the microbial consortium associated with CF-sputum samples [79], alongside tracking
the composition and transcriptome profiles of complex, mock microbial communities [80]. Probes targeting mRNA
molecules provide a more sensitive indication of the metabolically active members of a community, identifying the
key drivers that potentially influence community adaptation and responses to environmental challenges.
Artificial sputum medium (ASM) or synthetic cystic fibrosis sputum (SCFM), is a highly defined synthetic
growth medium that closely mimics the nutritional composition of sputum found in the CF-airway [76,81–85].
Comparison of the essential genome of PA isolates following growth in patient-derived sputum or ASM found
virtually no difference between the two [83], providing compelling evidence that ASM is a physiologically relevant in
vitro culture medium to support the growth of CF isolates. This notwithstanding, Cornforth et al. recently showed
that machine learning approaches can discriminate PA grown in vivo from PA grown in vitro in ASM based on
transcriptional profiling. However, little account was taken in that study of possible differences in the in vivo/in
vitro transcriptome data arising from the presence of less abundant non-PA species in the human samples [86].
ASM induces PA to grow as microcolonies closely associated with the mucin, strongly resembling the growth
observed in CF-sputum [81]. However, numerous modified recipes for ASM have been proposed, each of which is
associated with distinct changes in microbial growth phenotype [82,87], thus demonstrating the need to standardise
this complex media to ensure reliability and reproducibility between in vitro experiments. In vitro models allow
facile experimental tuning of growth conditions to mimic different disease states; something that is simply not
possible using in vivo models. Using ASM, the long-term maintenance of both PA and S. aureus in mixed species
biofilms has been made possible [84], something previously not attainable using conventional laboratory media [88]
despite the co-isolation of both species from the airways of ∼31% of CF-patients [89]. Although no published
studies have yet attempted the cultivation of a CF-associated polymicrobial community within ASM, similarities
in nutrient availability allow us to postulate that in these conditions, the microbiota might be experimentally
maintained in vitro. Direct inoculation of the ‘complete’ microbial community contained within sputum samples
would permit inter-species cross-feeding to occur between cohabiting organisms. This may permit the growth of
fastidious and auxotrophic strains known to be associated with the CF-airways [90].
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In addition to the ease with which in vitro models can be experimentally perturbed, such systems are free
from the temporal limitations imposed by animal infection studies. Longitudinal sampling of an in vitro model
inoculated with a diverse polymicrobial community would reveal the chain of evolutionary events preceding the
latest sampling point, essentially allowing a direct experimental analysis of Gould’s speculations about ‘rewinding
the tape of evolution’. Whether parallel, identically inoculated multi-species populations that are subject to the same
(intensely competitive) selection pressures can demonstrably follow the same independent evolutionary trajectory
becomes an experimentally tractable problem. Such studies that examine compositional and genetic changes within
communities can also be supported with chemical analyses to link how these changes affect the chemical environment
of the airways. A novel Winogradsky-based culture model (WinCF) using a number of different chemical indicators
has been used to monitor the growth of sputum samples in ASM. The study revealed a 2 unit reduction in the
pH and 30% increase in gas production due to the increased abundance of fermentative anaerobes present in the
sputum prior to the onset of APEs [76]. We also note that sequential sampling the secretome of a polymicrobial
community is possible within an in vitro model, allowing a direct analysis of the impact of inter-species interactions
on virulence factor secretion.
Introducing sputum samples taken from disease states within the same CF patient, in other words, before,
during and after APEs, into an in vitro system would allow differences in the polymicrobial composition to be
studied and could shed light into how subtle differences within these complex communities contribute to a decline
in lung function. Sousa et al. utilized ASM to develop a long-term (10 days) in vitro culture system mimicking
the physiological conditions of the airways to determine how clinically used antibiotics affected the phenotypic
diversification of PA isolates [85]. That study found that sub-inhibitory concentrations of ciprofloxacin drove
diversification in CF isolates but not in laboratory reference strains. Similar studies using polymicrobial cocultures
could be undertaken to examine how therapeutic intervention drives phenotypic changes within the total microbial
consortium associated with CF airways.
New species or strain variants, including ‘keystone’ CF pathogens such as PA, could be introduced into an
established steady-state in vitro polymicrobial community to simulate the events following initial introduction of
such variants in the patient airways. Such events are very difficult indeed to capture through direct analysis of
patient sputa. Furthermore, such an in vitro model provides the unparalleled opportunity to study the genetic and
phenotypic changes that occur in both the ‘invading’ species and in the endogenous polymicrobial population.
Similarly, hypermutator strains, for example, mutS mutants [91], could be introduced into CF derived polymicrobial
populations to examine the impact of what happens to all the species present when one of them is allowed to ‘step
on the evolutionary gas pedal’. A knowledge of the order of succession of major CF pathogens in a polymicrobial
community may reveal clinically relevant insights into the types of interspecies signaling pathways involved in
maintaining stable community architectures [92].
Biofilm formation may be the biggest contributor toward enhancing infection persistence, decreasing antimicro-
bial susceptibility, and elevating mutation rates within the CF airways [26,29,84,93–96]. Unsurprisingly the formation
of biofilms has been extensively studied in vitro, with a focus in recent years on moving away from mono-species
biofilms in favor of co-cultures more representative of real infection scenarios [53,77,84,94–98]. Using mixed-species
biofilm models it has been found that species co-isolated from the CF lung can either increase or decrease the antimi-
crobial susceptibility [77,95] and the production of biomass [52,84,95] by other species present, and that strain variants
provide cross-protection against different host-generated antimicrobials [98]. Furthermore, in vitro co-cultures of
PA–S. aureus biofilms show that the mutation rates within these species can be increased up to 500-fold, and that S.
aureus adopts a drastically different growth phenotype reminiscent of isolates recovered directly from the CF lung.
To date, there is only one report in which a polymicrobial biofilm derived from CF sputum has been reconstituted
in vitro [99]. That study focused on how antimicrobials affect the population, and growth conditions were not
optimized to represent the physiology in the CF airway. By more closely recapitulating the CF-associated chemical
environment, it may be possible to maintain polymicrobial biofilms more representative of those residing in the
airways of CF patients.
One major limitation of in vitro models is the lack of spatial organization closely resembling that of a host, and
which is provided to some degree in in vivo infection models. To overcome this deficiency of in vitro model systems,
an ex vivo infection model has recently been developed [100] to provide a tractable and high-throughput system
that can be easily used to mimic the airway architecture within a laboratory environment. Using porcine lungs, a
waste by-product of the food industry, and ASM, this ex vivo model provides an effective and ethical solution to
introducing spatial organization into longitudinal culture studies. Furthermore, different sections of lung tissue can
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be used to mimic either upper or lower respiratory tract infections [101]. So far only PA isolates have been cultured
within this model and these results demonstrate that ex vivo models are an effective experimental approach to study
CF infection. It would be fascinating to introduce the polymicrobial community derived from CF sputum into an
ex vivo model and assess how this shapes the trajectory of, for example, PA evolution.
Perhaps the largest barrier to the use of in vitro polymicrobial infection models is a lack of host cells that likely
play a role in influencing the composition and behavior of the microbial consortium. In vitro models will prove
crucial for the study of microbe-microbe interactions and will effectively reveal information about how species are
able to interact with one another. In vivo models on the other hand are not as well suited to study interspecies
interactions, nor are they as experimentally reproducible or tractable. They do (however) allow a more direct insight
into how hosts respond to infection. A combination of both in vitro and in vivo polymicrobial models would allow
for changes in microbial populations and in the chemical environment to be correlated with host responses.
Human cell–culture infection models provide an alternative approach to introduce elements of the host response
into in vitro studies, and in the future, may allow more direct investigation of human–microbe interactions. Such
in vitro cell culture infection models have already been successfully used to study a monolayer of human bronchiole
epithelial cells homozygous for the F508 CFTR mutation infected with a co-culture of S. aureus and PA [102]. It was
found that PA decreases the viability of S. aureus and causes the species to adopt fermentative metabolic pathways.
These results strongly correlate with changes reported to occur prior to the onset of APEs, and provide clear
evidence that this type of in vitro infection model may effectively represent the CF airway environment. Advances
in cell culture procedures and gene editing tools mean that it may soon be feasible to routinely culture cell lines
derived directly from individual CF patients [103], which could, in turn, be infected with polymicrobial populations
gathered from the sputum of the same patient. The generation of such ‘personalized infection models’ would allow
an unparalleled advantage over the use of ‘generic’ cell-lines and in vitro models to study microbial populations,
allowing a more efficacious testing of antimicrobial action prior to treatment, bridging the ‘bench-to-bedside’ gap.
In silico polymicrobial models
The study of polymicrobial communities is not simply confined to ‘the wet lab’. With our understanding of
microbial metabolic pathways being continually refined, new, more accurate in silico modeling of polymicrobial
communities is becoming readily available. Advancements in the semi-curation of complex microbial communities,
using software such as ModelSeed and AGORA, have led to the metabolic modeling of CF-associated bacterial
communities from published 16S rDNA data [104]. With better formulation for ensuring host-derived metabolite
balance across the community (through use of SteadyCom software), sample-specific heterogenous communities
can be generated that accurately predict which CF-pathogens come to dominate a polymicrobial community. In
silico models are becoming a highly valued tool to derive metabolic inferences that may be difficult to obtain or
observe experimentally and provide a theoretical framework for interpreting in vitro studies.
Computational predictive models are limited by the type and quality of data gathered from experimental studies.
This means that they poorly predict the rare and hard to cultivate microbial species present within CF-associated
microbial communities. Additionally, strain variants and evolutionary ‘cheats’ cannot yet be accounted for within
in silico models, meaning that these models do not predict or incorporate phenotypic adaptation among the
species present. Similarly, the striking spatial heterogeneity reported within the airways of CF patients is not easily
captured in in silico models. Despite these limitations, in silico models do provide a useful a framework for further
experimental analyses, informing on experimental design and interpretation.
Conclusion & future perspective
Culture-independent examination of sputum samples expectorated from CF patients have revealed that a diverse
and varied microbial population (including bacteria and fungi) is associated with the airways of CF patients [14,15,18–
22]. Increasing evidence suggests that interspecies interactions between members of this microbial consortium elicit
mutual influence on the gene expression profile and metabolic pathways adopted by both pathogenic and typically
nonpathogenic species. It is now clear that CF-associated infections must be considered as polymicrobial in nature,
and that a better understanding of how microbial cross talk impacts upon the expression of virulence factors will
be essential if we are to develop improved therapeutic interventions.
A lack of models enabling the stable, long-term cultivation of polymicrobial communities derived from CF
patients, as well as some historical bias, has meant that until recently, most researchers focused their studies on the
primary CF-associated pathogens, for example, PA and S. aureus, neglecting the impact of less abundant or more
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fastidious species. The generation of such polymicrobial-infection models would be of enormous benefit to the
research community, allowing the physiologically representative response(s) of the whole microbial community to
common therapeutic interventions to be more effectively monitored. Furthermore, the phenotypic adaptation and
evolutionary events leading to dominance of key pathogens, or the onset of a decline in lung function could be
picked apart and better understood. Through understanding how interspecies interactions and changes within a
microbial population lead to a worsened disease status, it may be possible to identify novel or improved therapeutic
interventions to help alleviate disease symptoms and improve the quality of life for CF patients.
Animal models of CF are paramount for studying the pathophysiological progression of the disease within
mammalian systems. However, as discussed earlier, the closer these models come to mimicking the human disease,
the more complex and experimentally costly they become. Improvements in CF pigs and the development of CF
sheep likely present the best chance for the development of an effective animal-based infection model, yet a lack
of experimental evidence within the literature makes it difficult to conclude whether this will ever be realized. The
introduction of PA to the existing microbiota of CF pigs would certainly help to reveal if an in vivo polymicrobial
infection model could be attained in principle.
In vitro models provide a feasible approach for the recapitulation of sputum-derived polymicrobial communities
within the laboratory, especially given the development of ASM and ex vivo porcine lung models. In vitro models are
cost-effective, lack ethical concerns (i.e., are 3Rs-compliant) and hopefully will allow for high-throughput, chronic
models of infection to be easily set up without the need for specialized animal handling facilities. A highly defined,
experimentally tuneable chemical environment and lack of host-to-host variability means in vitro models would
provide the perfect system to identify subtle, but key, changes occurring in the community.
Over the course of the next decade we predict that a viable and physiologically representative in vitro polymicrobial
models will be developed and see widespread uptake. Such models will hopefully allow the economical recapitulation
of an entire CF-associated polymicrobial community in the laboratory environment. Key areas to be examined
using such an experimental model would include: understanding how the introduction of PA to an established
polymicrobial population influences changes in community architecture and the chemical environment (secretome,
nutrient availability etc), how the microbial population responds to external stressors such as antimicrobial agents,
identification of the signaling pathways driving key phenotypic adaptations, and so on. Following their successful
development and implementation, such in vitro models may allow novel therapeutic avenues to be explored,
potentially leading to an improvement in quality of life for CF patients and possibly other chronic respiratory
diseases involving polymicrobial infection.
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Executive summary
Cystic fibrosis is a polymicrobial disease
• Culture-independent profiling has revealed a diverse and varied polymicrobial community is associated with the
cystic fibrosis (CF) airways.
• Members of this community interact with one another, causing modulations in gene expression that potentially
impact upon disease severity.
• No models currently exist that permit the recapitulation of a true CF-associated polymicrobial community in the
laboratory.
Murine models of CF
• CF mice are incapable of developing spontaneous airway infections and microbial challenges are rapidly cleared.
• Only Pseudomonas aeruginosa isolates immobilized within beads that are instilled into the lung allow a
semi-chronic infection scenario to be established.
• Although mice provide limited insights into the host-response to infection, murine models are not suited for the
development of polymicrobial infection models.
Ferret & pig models of CF
• Both CF ferrets and CF pigs develop spontaneous airway infection with a range of microbial species soon after
birth.
• Infections in CF ferrets induce fatal, hyperinflammatory immune responses that severely limit their use for
development as polymicrobial models.
• The airway microbiota of CF pigs most closely resembles that of adolescent human patients, although infection
with P. aeruginosa has not been examined.
• Costs and complexity hinder the uptake of CF pig models, and as a result, little research has been undertaken into
airway infections using this model.
Plant & invertebrate models of CF
• Plant and invertebrate models provide high-throughput platforms to screen mutant libraries for a limited range
of genes required for in vivo growth and virulence.
• Plant and invertebrate models support the growth of only a limited spectrum of CF-associated microbial species.
In vitro polymicrobial models
• The development of in vitro polymicrobial models provides a cost-effective, tractable and robust system for
studying subtle interspecies interactions.
• In vitro models potentially allow long-term, ‘chronic infection’ to be recapitulated.
• Artificial sputum media is a defined synthetic medium closely mimicking the nutritional composition of
CF-derived sputum. artificial sputum media provides a physiologically relevant in vitro culture medium to permit
the growth of CF-associated species.
• Using sections of porcine lungs, an ex vivo culture system has been developed that introduces a spatial structure
similar to that of the CF-airway into in vitro models.
In silico polymicrobial models
• In silico models can be used to accurately recapitulate polymicrobial communities from published experimental
data inputs, and can yield information that may be difficult to obtain experimentally, but can help to guide
experimental design in in vitro and in vivo models.
• Such models are limited by the quality and quantity of data gathered from experimental studies and so poorly
represent hard-to-cultivate microbial species. However, as more (and better) input data is gathered, in silico
models will inevitably improve.
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A B S T R A C T   
Many low-middle income countries in Africa have poorly-developed infectious disease monitoring systems. Here, 
we employed whole genome sequencing (WGS) to investigate the presence/absence of antimicrobial resistance 
(AMR) and virulence-associated (VA) genes in a collection of clinical and municipal wastewater Escherichia coli 
isolates from Kakamega, west Kenya. We were particularly interested to see whether, given the association 
between infection and water quality, the isolates from these geographically-linked environments might display 
similar genomic signatures. Phylogenetic analysis based on the core genes common to all of the isolates revealed 
two broad divisions, corresponding to the commensal/enterotoxigenic E. coli on the one hand, and uropathogenic 
E. coli on the other. Although the clinical and wastewater isolates each contained a very similar mean number of 
antibiotic resistance-encoding genes, the clinical isolates were enriched in genes required for in-host survival. 
Furthermore, and although the chromosomally encoded repertoire of these genes was similar in all sequenced 
isolates, the genetic composition of the plasmids from clinical and wastewater E. coli was more habitat-specific, 
with the clinical isolate plasmidome enriched in AMR and VA genes. Intriguingly, the plasmid-borne VA genes 
were often duplicates of genes already present on the chromosome, whereas the plasmid-borne AMR de-
terminants were more specific. This reinforces the notion that plasmids are a primary means by which infection- 
related AMR and VA-associated genes are acquired and disseminated among these strains.   
1. Introduction 
Intestinal pathogenic Escherichia coli are the leading bacterial cause 
of diarrheal infection in low-middle income countries (LMICs) (Jafari 
et al., 2012). This situation is complicated by poorly-developed infec-
tious disease monitoring programs, especially with regards to antimi-
crobial resistance (AMR) and pathogen surveillance (Vernet et al., 
2014). In many LMICs, the lack of high-quality data frequently leads to 
inadequate treatment guidelines and poor infection management. One 
potentially transformative technology that could help improve pathogen 
surveillance programs in developing countries is whole genome 
sequencing (WGS) achieved through next generation sequencing (NGS) 
technologies. When coupled with epidemiological and environmental 
investigations, WGS can deliver ultimate resolution for detecting and 
analysing transmission routes and in tracing the source(s) of epidemics 
and outbreaks (Cao et al., 2017; Besser et al., 2018; Rantsiou et al., 
2018). In addition, WGS offers the unrivalled opportunity to monitor the 
gene content of microbial virulence determinants in isolates, and to map 
the spread of antimicrobial drug resistance determinants (European 
Centre for Disease Prevention and Control, 2018). The technology is also 
particularly good at identifying mobile genetic elements such as plas-
mids, transposons and integrons, which are increasingly recognized as 
playing a key role in disseminating AMR and virulence determinants 
(Bezuidt et al., 2009). 
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In the current study, we employed WGS to monitor the genetic 
structure of E. coli recovered from patients visiting a referral health fa-
cility and from a nearby wastewater treatment plant in Kakamega, 
western Kenya. Previous studies have shown that the wastewater 
treatment sites in Kakamega are inefficient in controlling or removing 
pathogens from the water-supply system (Malaho et al., 2018). This 
inefficient wastewater treatment may therefore plausibly provide means 
by which multi-drug resistant and/or pathogenic E. coli are disseminated 
among the local populace. Phylogenic relationships between the E. coli 
isolates associated with nosocomial infections and wastewater treat-
ment sites were inferred, and multilocus sequence typing of the isolates 
was performed. This revealed over-representation of one particular 
sequence type (ST 43) in the wastewater and clinical isolates. We also 
paid particular attention to the relative distribution of virulence- 
associated (VA) genes and antimicrobial resistance (AMR) genes on 
mobile genetic elements. Various VA and AMR genes were found in 
genomic islands (GIs) and plasmids of the sequenced strains. However, 
whereas VA and AMR genes were distributed among the GIs in both 
clinical and wastewater isolates, there was a marked enrichment of these 
genes in the plasmid DNA borne by the clinical isolates. This suggests 
that plasmid-mediated horizontal gene transfer may play a key role in 
defining the pathogenicity of these geographically linked E. coli isolates. 
2. Materials and methods 
2.1. Strains, isolation, and culture conditions 
The E. coli strains from human were recovered from patients being 
treated at the Kakamega County Teaching and Referral Hospital, in 
western Kenya. Briefly, midstream urine specimens were cultured on 
cystine–lactose–electrolyte-deficient (CLED) medium (Hi-Media, India). 
The wound sample was collected from an abdominal surgical wound. 
Wastewater isolates were recovered from the Masinde Muliro University 
of Science and Technology (MMUST) wastewater treatment plant during 
the period March – June 2016. The wastewater and wound-derived 
samples were cultured on MacConkey agar (Hi-Media, India). 
All cultures were incubated overnight at 37 ◦C. Pure (single colony) 
isolates were confirmed as E. coli using API20E biochemical test strips 
(Biomerieux) following the manufacturer’s instructions. The isolates 
were further subjected to antibiotic susceptibility profiling using the 
Kirby Bauer disc diffusion method against the following panel of anti-
biotics: trimethoprim/sulfamethoxazole, amoxicillin/clavulanate, 
tetracycline, gentamicin, ceftazidime, cefuroxime, cefotaxime, ceftri-
axone, meropenem, amikacin/cefepime, piperacillin/tazobactam, 
ampicillin, sulbactam, nitrofurantoin, imipenem, and ciprofloxacin. 
Escherichia coli ATCC 25922 was used as a reference for interpretation of 
the data based on the guidelines from the Clinical and Laboratory 
Standards Institute (CLSI) (2017). Cultures of the E. coli isolates were 
stored at − 80 ◦C in trypticase soy broth supplemented with 15% v/v 
glycerol. 
2.2. DNA sequencing 
Whole genome sequencing was carried out by MicrobesNG (Bir-
mingham, UK) using an Illumina HiSeq 2500 platform Briefly, a single 
colony of each strain was picked and suspended in 100 μL of sterile 1 ×
phosphate-buffered saline (PBS) (Oxoid, UK). The suspension was 
spread thickly (using a sterile loop) onto a fresh LB-agar plate and 
incubated at 37 ◦C overnight. Dense colony growth was then scraped off 
and sent to MicrobesNG in supplied bar-coded bead tubes. Sequencing 
was carried out using an Illumina HiSeq 2500 platform, with 2 × 250 bp 
paired-end reads. The reads were trimmed using Trimmomatic v0.30 
with a sliding window quality cut-off of Q15. Taxonomic classification 
of the sequences and assessment of sequence contamination was done 
using Kraken (Wood and Salzberg, 2014). The de novo assembly of 
contigs was done using SPAdes version 3.14.0 with default settings. 
2.3. Annotation of contigs and prediction of chromosomal or plasmid 
affiliation 
Automated annotation of the contigs was performed using Prokka 
v1.12. Antibiotic resistance genes were predicted using an internet- 
based algorithm, RGI (https://card.mcmaster.ca/analyze) imple-
mented in the Web-service CARD (Alcock et al., 2020). Putative 
virulence-associated genes were identified via BLASTP alignment of all 
translated open reading frames (ORFs) against the sequences of known 
virulence associated proteins (Sarowska et al., 2019). Reference protein 
sequences were obtained from the NCBI GenBank database. To predict 
the putative plasmid affiliation of the assembled contigs, an internet- 
based program, mlplasmids - version 1.0.0 (https://sarredondo.shiny 
apps.io/mlplasmids/) was used (Arredondo-Alonso et al., 2018) with 
default parameters. All other contigs were considered as being chro-
mosomal in origin. Genomic islands were identified using SeqWord 
Gene Island Sniffer (http://seqword.bi.up.ac.za/sniffer/index.html) 
(Bezuidt et al., 2009). 
2.4. Multi-locus sequence typing 
MLST was carried out using the interactive batch sequence query 
available at the Institute Pasteur E. coli MLST database (https://bigsdb. 
pasteur.fr/ecoli/) and using the automated interactive MLST CGE Server 
(https://cge.cbs.dtu.dk/services/MLST/) (Larsen et al., 2012). Concat-
enated chromosomal contigs in FASTA format were queried against the 
MLSTwithMissingData database to predict sequence types based on the 
sequences of eight diagnostic genes: dinB, icdA, pabB, polB, trpA, trpB and 
uidA, which are defined as E. coli MLST marker loci in the EnterBase 
database (Zhou et al., 2020). Sequence types (ST) unambiguously pre-
dicted by at least one of the servers were recorded. 
2.5. Gene ortholog prediction 
Clusters of orthologous genes (COGs) in sequenced genomes were 
predicted using the program OrthoFinder (Emms and Kelly, 2015) with 
default parameters. Sequences of every COG were aligned using the 
MUSCLE algorithm (Edgar, 2004). Alignments were quality-controlled 
and ambiguous parts of the alignments were removed using the pro-
gram Gblocks (Talavera and Castresana, 2007) with the default 
parameter settings. COG alignments were concatenated using BioPython 
scripts into a superstring alignment for further phylogenetic inferences. 
2.6. Phylogenetic inferencing and clustering 
Concatenated alignments of COGs were used to infer phylogenetic 
relations between the genome sequences. This was done using a 
Neighbor-Joining (NJ) algorithm with MEGA X and a bootstrap value of 
100 (Kumar et al., 2018). For clustering of genomic islands (GIs), a 
distance matrix was built for all GIs, where the distance between two 
GIs, i and j, was calculated according to Eq. (1): 







where, #shared_genes is the number of orthologous genes shared by two 
GIs, and #GIi genes and #GIj genes, respectively, are the total numbers of 
genes in the first and second GIs. A dendrogram of GI clusters was then 
generated based on the distance matrix using the program neighbor.exe 
(NJ algorithm) of the PHYLIP 3.69 package (http://evolution.genetics. 
washington.edu/phylip.html). 
The phylogenetic clustering approach outlined above tends to arti-
ficially group long plasmids around the root of the dendrogram, as they 
have a higher chance of sharing multiple genes. To circumvent this, 
phylogenetic clustering of the plasmids was done using a binary parsi-
mony algorithm. A table of COGs shared by at least two plasmids was 
generated, with the absence and presence of orthologous genes in each 
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plasmid designated by 0 and 1, respectively. This binary table was 
formatted as an input file for the dollo parsimony algorithm (Huson and 
Steel, 2004) implemented in the program dollop.exe of the PHYLIP 3.69 
package. Dendrograms were visualized using Dendroscope 3 (Huson and 
Scornavacca, 2012). It should be noted that in both aforementioned 
cases, the dendrograms should not (in stricto sensu) be considered as 
phylogenetic trees but as cladograms. 
3. Results 
3.1. Antibiotic resistance of E. coli environmental and clinical isolates 
In total, 23 strains of E. coli were recovered from a referral hospital 
and a nearby municipal wastewater processing plant in western Kenya. 
The source and pattern of antibiotic resistance in each of the strains are 
shown in Table 1. Nine isolates (denoted A, F, H, K, L, N, O, P, Q) were 
derived from the wastewater source (located ca. 1.5 km from the referral 
hospital) and 14 isolates were obtained from the clinic (denoted E2, E4, 
E7, E8, E10-E15, and E17-E20). Of the clinical isolates, 13 were obtained 
from patients with urinary tract infections, and one (E10) was from a 
wound. Almost all isolates from both the clinical and wastewater sources 
were resistant to trimethoprim- sulfamethoxazole and amoxicillin, and 
the clinical isolates showed generally greater resistance (compared with 
the wastewater isolates) to co-amoxiclav (amoxicillin/clavulanate), 
ampicillin-sublactam, tetracycline, gentamicin, amikacin, cefuroxime, 
cephalexin, ceftazidime, and ciprofloxacin. The majority of isolates from 
both environments remained resistant to nitrofurantoin and 
chloramphenicol. 
3.2. Phylogenetic relationships between the isolates and MLST assignation 
To study phylogenetic relationships between the E. coli isolates, 2637 
orthologous genes shared by all the genomes were identified and aligned 
using MUSCLE. We also included a selection of reference strains (as 
“signposts”) deposited in the NCBI. Alignments of the encoded protein 
sequences were concatenated into a “superstring alignment” comprised 
of 805,265 amino acid residues, and an NJ phylogenetic tree was con-
structed (Fig. 1). 
The strains segregated in the tree into two broad clades, corre-
sponding to commensal/enterotoxigenic E. coli variants (red shading in 
Fig. 1), and uropathogenic isolates (blue shading). Although the clinical 
isolates were roughly equally distributed between these two clusters, 
most of the wastewater isolates fell into the commensal/enterotoxigenic 
variant grouping (red shading). The isolates were associated with a 
diverse range of known MLSTs. Indeed, the only ST represented by more 
than a single isolate was ST 43, which was associated with a phyloge-
netic cluster comprising three clinical isolates and two wastewater iso-
lates, as well as the uropathogenic E. coli strain NA114. ST 43 is widely 
distributed around the world, and of the 91 recorded ST 43 strains in the 
Institute Pasteur E. coli MLST database, 9 are clinical uropathogenic 
isolates. It is also noteworthy that although ST 131 is widely reported as 
one of the most common clinical E. coli isolates worldwide (Pitout and 
Laupland, 2008; Nicolas-Chanoine et al., 2014), there were no repre-
sentatives of this ST among the E. coli strains we examined. Conversely, 
Table 1 
Antibiotic resistance profile and origin of the E. coli strains selected for WGS analysis in this study. 
Key: WW = wastewater; ST = trimethoprim-sulfamethoxazole; A = amoxicillin; AM = amoxicillin clavulanate; S = ampicillin- 
sulbactam; T = tetracycline; N = nitrofurantoin; G = gentamicin; AK = amikacin; C = chloramphenicol; CX = cefuroxime; CN 
= cephalexin; CA = ceftazidime; CP = ciprofloxacin; Red = resistant; Green = intermediate or sensitive. 
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our collection also included several strains with STs not yet recorded in 
the E. coli MLST database. For example, the uropathogenic isolate, E8, 
possessed unique combinations of variants in the sequences of all marker 
genes except uidA, indicating that E8 likely represents a completely new 
ST of E. coli. 
3.3. Distribution of antibiotic resistance and virulence-associated genes 
The WGS data for all of the isolates indicated that they encode 
numerous multidrug efflux pumps (including mdlAB, mdtABCD, mdtIJ, 
mdtK, mdtEF, acrAB-acrD-acrEF, cmr, yddA, yojI, yjiO, emrAB, emrD, 
emrKY, and hsrA) and a selection of known antibiotic resistance genes, 
including rarD and cmlA for chloramphenicol resistance, and the β-lac-
tamases, ampH, ampC, blr. AMR-genes were searched by the program 
CARD_RGI looking for similarities of protein sequences with records of 
it’s own comprehensive database of AMR-proteins (Alcock et al., 2020). 
A summary of the antibiotic resistance genes identified by CARD-RGI in 
each isolate is shown in Table 2. Interestingly, the mean number of all 
classes of AMR-associated genes was similar in both the wastewater and 
clinical isolates. 
The genome sequences of the isolates also contained multiple genes 
known to be associated with virulence. Sarowska et al. (2019) listed 
Fig. 1. An NJ phylogenetic tree of clinical and wastewater E. coli isolates (sequenced in this study) compared with a selection of NCBI reference strains. Bootstrap 
numbers are shown at each intermediate split in the tree. The identified MLST of the strains is shown in the corresponding column. The tree divided early on into two 
broad branches, enriched in either commensal/enterotoxigenic E. coli variants (red shading), or uropathogenic isolates (blue shading). [Note that in the wastewater 
isolate K, the icdA was fragmented in the contig preventing definitive assignation of a ST for this strain. However, based on the sequence profile of the other marker 
genes in isolate K, it may belong either to ST 735, or ST 910.] 
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several key groups of virulence factors frequently found in pathogenic 
E. coli isolates, including several classes of adhesins, siderophores, toxins 
and proteins important for intracellular survival of pathogens, coloni-
zation of non-GI tract tissues, and immune system avoidance. A sum-
mary of distribution of virulence-associated determinants in the isolates 
studied here is shown in Table 3. The data indicate an enrichment of 
genes associated with survival in the host among the clinical isolates 
including virulence-associated siderophores of five classes, aer, iuc, irp, 
iron and sit, which were present on the chromosomes of all the 
sequenced isolates. In several cases, additional copies of these side-
rophore genes were also found on plasmids (see Fig. 3 and discussion 
below). 
3.4. Genomic islands and the distribution of drug resistance and 
virulence-associated genes 
We next examined the genomic context of the AMR and virulence- 
associated (VA) genes i.e., are these genes located in the conserved 
“core chromosome”, or are they associated with the variable “accessory” 
genome (GIs and plasmids)? The genome sequences of all the isolates 
contained multiple horizontally-acquired GIs, including prophages, 
transposable elements and integrons. The GIs were clustered based on 
the “shared gene” algorithm in Eq. 1. We then further interrogated each 
resulting GI cluster for its AMR and VA gene content (Fig. 2). 
Although the gene content of GIs was generally highly variable, this 
clustering approach revealed some intriguing genetic conservation. In 
the left-top corner of the cladogram (Fig. 2), there is a clutch of indi-
vidual GIs bearing several VA genes. For example, the small multidrug 
resistance efflux transporter emrE is located on a GI found only in 
environmental isolate F, whereas the cell invasion gene ibeB, along with 
several genes conferring resistance to copper (collectively named “copR” 
in the figure) and a multidrug resistance gene (emrK) were found in two 
GIs from isolate E19. Clockwise from these, there is a cluster of five 
highly similar GIs found in isolates F, K, L, E17 and E20, which bear 
genes for arsenate resistance (collectively named arsR in the figure) and 
the mdtEF multidrug efflux operon. Another individual GI found in 
isolate E9 contains the multiple stress resistance gene, bhsA. A large 
group of 13 GIs from both clinical and environmental isolates contains 
an operon encoding fimbria-like genes (yadCKLMN and ecpD), which are 
known to function as virulence-associated adhesins in enter-
ohaemorrhagic and uropathogenic E. coli (Spurbeck et al., 2011; 
Chingcuanco et al., 2012; Stacy et al., 2014). Within this group, seven 
GIs from isolates N, E7, E9, E13, E14, E16 and E19 form a distinct sub- 
cluster possessing the daunorubicin/ doxorubicin resistance-associated 
gene, drrA. Four GIs from the genome sequences of isolates P, Q, E2 
and E10 contain virulence-associated toxin-encoding genes, including 
sat, vat and pic, together with a virulence regulon transcriptional 
activator-encoding gene, virF. Eight GIs from isolates K, L, E4, E7, E11, 
E16 and E20 contain the ygiLGHIJK operon, which encodes another set 
of virulence-associated fimbria-like proteins (Spurbeck et al., 2011). A 
very large group of 23 GIs, which were shared many of the sequenced 
isolates, comprises additional fimbria-encoding genes, afa, fim and pap. 
The E. coli fimbrial protein YehB is responsible for adhesion to abiotic 
surfaces (Ravan and Amandadi, 2015) and as such may contribute to the 
dissemination of nosocomial infections in hospitals, and possibly, also 
survival in the environment. This gene was found in eight GIs from 
isolates F, K, O, E4, E11, E13, E19 and E20. Another adhesion gene, flu 
(agn43), in combination with a persistence and stress-resistance toxin- 
antitoxin system, pasTI, was present in seven GIs from isolates H, E7, 
E11, E14, E16, E19 and E20. Twelve GIs from isolates H, O, K, E7, E8, 
E11, E13, E14, E15, E16, E17 and E20 carry the multidrug resistance 
operon, emrYK, and six GIs from environmental isolates A, H, N, O, P and 
Q encode a colanic acid biosynthetic pathway. Colanic acid is a capsular 
carbohydrate of uropathogenic bacteria and is known to be important 
for biofilm formation (Prigent-Combaret et al., 2000; Hanna et al., 
2003). A short operon, rfaPY, which encodes a pair of lipopolysaccha-
ride core heptose kinases (I and II), was found in 21 GIs. These genes 
may encode potential virulence factors, since the activation of heptose 
precursors is used in the biosynthesis of lipopolysaccharides (LPS), and 
LPS is known to contribute towards the pathogenicity of enterotoxigenic 
E. coli (Maigaard Hermansen et al., 2018). Interestingly, orthologues of 
the sat and vat toxins mentioned above are encoded on another group of 
four GIs from isolates E10, E11, E14 and E18. We note that isolate E10 
also encodes sat and vat on a different GI. An increased copy number of 
these genes may influence the virulence of this strain (Elliott et al., 2013; 
Slager and Veening, 2016). Similarly, we also noted that the invasin, 
ipaB, was distributed between nine GIs which segregated into two 
distinct clusters (Venkatesan et al., 1988). The smaller of these clusters 
contains GIs from isolates E4, E8 and E19, whereas the larger one 
comprises GIs from E2, E8, E10, E14, E18 and E19. Once again, we noted 
that two of the isolates (E8 and E19) carried paralogous copies of ipaB in 
two separate GIs. Nine GIs from isolates H, K, L, E7, E8, E13, E16, E19 
and E20 carry a large operon encoding a type III secretion system (Tree 
et al., 2009). The anti-phagocytosis factor-encoding gene, neuA, was 
found in three related GIs from isolates P, Q and E17. Three GIs from 
isolates E4, E8 and E19 carried a multidrug resistance gene, mdtL, and a 
chloramphenicol resistance gene cmlA. A group of 12 large GIs con-
tained a polypeptide synthase gene (irp) encoding the siderophore, 
yersiniabactin. Host organisms often sequester iron to inhibit the growth 
of pathogens. Consequently, iron acquisition systems are often consid-
ered to be virulence factor/ survival mechanisms associated with path-
ogenicity (Skaar, 2010). Several other virulence-associated siderophores 
are involved in iron scavenging and transportation. The genes encoding 
the synthesis and transport of these siderophores were abundant in the 
isolates (Table 2). Orthologues of the multidrug resistance-associated 
gene, mdtN, were also found in two loosely clustered GIs from isolates 
E8 and E9. The same GI from E9 carries also another siderophore (aer-
obactin) encoding gene, aer. Finally, a group of 16 GIs contains several 
regulatory genes including the blue light- and temperature-regulated 
Table 2 
Antibiotic resistance gene distribution in the chromosomal DNA of the indicated 
sequenced isolates. The numbers in each column represent the number of genes 
encoding the indicated antibiotic resistance mechanism identified in each 
isolate.  
Isolate β-lactamases Efflux pump 
components 
Drug resistance genes of other 
categoriesa 
Wastewater isolates 
A 2 30 23 
F 2 30 23 
H 2 30 22 
K 2 30 22 
L 2 30 22 
N 2 30 22 
O 2 29 22 
P 1 30 22 
Q 1 30 22  
Clinical isolates 
E2 1 30 22 
E4 2 28 23 
E7 2 28 22 
E8 2 30 22 
E10 1 30 22 
E11 2 30 22 
E13 2 30 22 
E14 1 30 22 
E15 2 29 22 
E16 2 30 22 
E17 1 28 22 
E18 1 30 22 
E19 2 30 23 
E20 2 30 22  
a This column combines all other types of AMR genes including known tran-
scriptional regulators of drug resistance response, antibiotic-modifying enzymes 
and uncharacterized drug resistance proteins. 
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anti-repressor bluF. BluF is light and temperature sensing protein, which 
regulates biofilm formation (Tschowri et al., 2009). While it is not 
considered as a virulence factor, it may influence the survival of bacteria 
in the environment. These GIs were found in both the environmental and 
clinical samples (specifically, isolates A, F, L, P, Q, E2, E4, E7, E10, E11, 
E14, E16, E17, E19 and E20). Notably, in the genome of isolate E2, this 
GI was duplicated. 
Not all virulence genes were associated with specific clusters of GIs. 
For example, the major fimbrial subunit gene lpfA, which influences 
epithelial cell invasion by mastitis-associated E. coli (Dogan et al., 2012), 
was found in seven unrelated GIs from clinical isolates E4, E9, E11, E13, 
E14, E15 and E20. We also noted that many GIs were enriched in genes 
encoding phage-related proteins and integrases (suggesting the likely 
mode of horizontal transmission), and many others also encoded 
metabolic enzymes and transmembrane transporters. It is possible that 
these cargo genes are involved in adaptation to specific environments, 
and may indirectly impact on virulence, AMR or survival in the face of 
environmental challenges. 
3.5. Role of plasmids in distribution of drug resistance and virulence 
associated genes 
Predicted plasmid-borne contigs were identified in the assemblies 
from all of the isolates. These contigs contained between 4 coding se-
quences (CDS) in E8 up to 288 CDS in E11. It should be noted that as-
sembly of plasmid contigs is problematic due to a higher level of 
sequence variability in these regions. Therefore, we note that the ob-
tained contigs may not represent whole sequences of the plasmids in the 
studied isolates. Grouping of concatenated plasmid-born contigs from 
different isolates based on shared homologous genes is shown in Fig. 3. 
This figure also summarizes the numbers of AMR and VA genes found in 
these contigs. 
It is immediately clear from inspection of the data in Fig. 3 that the 
plasmid-borne DNA from clinical isolates is enriched in AMR and VA 
Table 3 
Known virulence determinants in the sequenced isolates. Black cells = presence of gene, white cells = absence of gene. BLASTP 
cutoff values for assignment of gene presence/absence were 0.0001. 
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genes compared with the wastewater isolates. Indeed, the plasmids from 
environmental isolates A, H, K, F, and L encoded no virulence-associated 
genes and only one or no AMR determinants. Exceptions to this trend 
included plasmids from the environmental isolates P and Q, which 
contained multiple AMR and VA genes, whereas the largest plasmid- 
associated contig in the dataset (from clinical isolate E8) contained no 
AMR or virulence determinants. The largest number of AMR de-
terminants was identified in the plasmid DNA from E17, E18, E11 and 
E9, with the highest number of virulence-associated genes found in the 
plasmid from isolate E14. Interestingly, the plasmid-borne virulence- 
associated genes were often duplicates of genes already present on the 
chromosome, whereas the plasmid-borne AMR determinants were more 
specific. 
4. Discussion 
In this study, we found that clinical and wastewater isolates 
possessed similar overall numbers of chromosomally encoded AMR and 
VA genes, irrespective of their origin (Tables 2 and 3). However, the 
clinical isolates displayed an enrichment of AMR and VA genes in their 
plasmidome. Of note, a number of these genes were present in multiple 
paralogous copies (either on the chromosome, in GIs, or on plasmids). 
Gene duplication is a key driver of functional diversification and is also a 
facile means of increasing gene expression through increased copy 
number (Elliott et al., 2013; Slager and Veening, 2016). In bacteria, 
there are several examples of genes encoding basic metabolic functions 
being present in two copies, with one copy on the chromosome and the 
other on a plasmid (Zheng et al., 2015). Our observation, that plasmids 
from the clinical isolates were enriched in AMR and VA genes indicates 
that these mobile elements may play a key role in pathogenicity. The 
plasmids associated with environmental isolates P and Q were excep-
tions to this general trend, since these were enriched with AMR and 
virulence-associated genes. Isolates P and Q are notable since they are 
phylogenetically related to the clinical isolates E2, E10 and E18, and all 
five isolates belonging to the uropathogenic ST 43 (Fig. 1). There may be 
two non-exclusive explanations for this observation. First, P and Q may 
be disseminated “clinical isolates” that just happen to have been 
captured in the local watershed following e.g., human discharge activ-
ities. Alternatively, these particular plasmids may confer a fitness 
advantage in the wastewater environment. The factors increasing the 
survival of these uropathogenic strains may include the presence of 
colanic acid biosynthetic genes and the light- and temperature-sensing 
anti-repressor, bluF. These genes have been shown to play an impor-
tant role in the modulation of biofilm formation (Prigent-Combaret 
et al., 2000; Hanna et al., 2003; Tschowri et al., 2009) and therefore 
confer a potential advantage to ST 43 for survival in both non-host and 
host environments. 
Collectively, our data suggest that plasmid-borne functions confer an 
advantage to E. coli in terms of infection and/or withstanding exposure 
to the antimicrobials commonly used to treat these infections. At the 
Fig. 2. Clustering of GIs based on gene 
content using an NJ algorithm (in turn, 
based on the distance matrix given in Eq. 1). 
A single line radiating from the center to the 
edge of the cladogram indicates a GI in a 
specific isolate. Branched radiating lines 
indicate diversification of a GI present in 
multiple isolates. The clustered GIs were 
further interrogated to identify AMR and 
virulence-associated genes using BLASTP. 
Groups of GIs containing known AMR and 
virulence-associated genes are shown red. 
GIs with the blue light- and temperature- 
regulated genes are shown blue.   
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same time, these genes presumably confer a significant burden on bac-
terial growth and replicative potential during transit through the envi-
ronment. Consequently, when not infecting a host, there is likely a 
selection pressure on bacterial populations to lose these plasmid-borne 
genes. This presumably generates a drive towards redistributing the 
encoded functions from the plasmid to the chromosome, which may be 
another reason why we see apparently multiple paralogous copies of 
some genes (Andersson and Hughes, 2010; Kussell, 2013; Melnyk et al., 
2015). 
In conclusion, our data confirm and extend previous reports indi-
cating the high genomic diversity of E. coli in humans from tropical areas 
(Escobar-Páramo et al., 2004; Richter et al., 2018), and furthermore, 
implicate plasmids as a key driver of AMR and VA gene dissemination, 
especially among clinical isolates. Although plasmids come with an 
intrinsic fitness cost associated with their replication, we noted that in 
some circumstances (e.g., the isolates of ST 43) plasmid-borne AMR and 
VA genes were also associated with the environmental isolates. This 
ability to maintain plasmid-borne functions outside the host may 
contribute towards the global success of this sequence type. 
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Szynalski, K., Amézquita, A., 2018. Next generation microbiological risk assessment: 
opportunities of whole genome sequencing (WGS) for foodborne pathogen 
surveillance, source tracking and risk assessment. Int. J. Food Microbiol. 287, 3–9. 
https://doi.org/10.1016/j.ijfoodmicro.2017.11.007. 
Ravan, H., Amandadi, M., 2015. Analysis of yeh fimbrial gene cluster in Escherichia coli 
O157:H7 in order to find a genetic marker for this serotype. Curr. Microbiol. 71 (2), 
274–282. https://doi.org/10.1016/j.ijfoodmicro.2017.11.007. 
Richter, T.K.S., Hazen, T.H., Lam, D., Coles, C.L., Seidman, J.C., You, Y., Silbergeld, E.K., 
Fraser, C.M., Rasko, D.A., 2018. Temporal variability of Escherichia coli diversity in 
the gastrointestinal tracts of Tanzanian children with and without exposure to 
antibiotics. mSphere 3 (6), 3. https://doi.org/10.1128/mSphere.00558-18 e00558- 
18.  
Sarowska, J., Futoma-Koloch, B., Jama-Kmiecik, A., Frej-Madrzak, M., Ksiazczyk, M., 
Bugla-Ploskonska, G., Choroszy-Krol, I., 2019. Virulence factors, prevalence and 
potential transmission of extraintestinal pathogenic Escherichia coli isolated from 
different sources: recent reports. Gut Pathog. 11, 10. https://doi.org/10.1186/ 
s13099-019-0290-0. 
Skaar, E.P., 2010. The battle for iron between bacterial pathogens and their vertebrate 
hosts. PLoS Pathog. 6 (8), e1000949 https://doi.org/10.1371/journal. 
ppat.1000949. 
Slager, J., Veening, J.W., 2016. Hard-wired control of bacterial processes by 
chromosomal gene location. Trends Microbiol. 24 (10), 788–800. https://doi.org/ 
10.1016/j.tim.2016.06.003. 
Spurbeck, R.R., Stapleton, A.E., Johnson, J.R., Walk, S.T., Hooton, T.M., Mobley, H.L., 
2011. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: 
contribution of ygi and yad fimbriae. Infect. Immun. 79 (12), 4753–4763. https:// 
doi.org/10.1128/IAI.05621-11. 
Stacy, A.K., Mitchell, N.M., Maddux, J.T., De la Cruz, M.A., Durán, L., Girón, J.A., 
Curtiss 3rd., R., Mellata, M., 2014. Evaluation of the prevalence and production of 
Escherichia coli common pilus among avian pathogenic E. coli and its role in 
virulence. PLoS One 9 (1). https://doi.org/10.1371/journal.pone.0086565 e86565.  
Talavera, G., Castresana, J., 2007. Improvement of phylogenies after removing divergent 
and ambiguously aligned blocks from protein sequence alignments. Syst. Biol. 56, 
564–577. https://doi.org/10.1080/10635150701472164. 
Tree, J.J., Wolfson, E.B., Wang, D., Roe, A.J., Gally, D.L., 2009. Controlling injection: 
regulation of type III secretion in enterohaemorrhagic Escherichia coli. Trends 
Microbiol. 17 (8), 361–370. https://doi.org/10.1016/j.tim.2009.06.001. 
Tschowri, N., Busse, S., Hengge, R., 2009. The BLUF-EAL protein YcgF acts as a direct 
anti-repressor in a blue-light response of Escherichia coli. Genes Dev. 23 (4), 
522–534. https://doi.org/10.1101/gad.499409. 
Venkatesan, M., Buysse, J.M., Vandendries, E., Kopecko, D.J., 1988. Development and 
testing of invasion-associated DNA probes for detection of Shigella spp. and 
enteroinvasive Escherichia coli. J. Clin. Microbiol. 26 (2), 261–266. PMCID: 
PMC266263.  
Vernet, G., Mary, C., Altmann, D.M., Doumbo, O., Morpeth, S., Bhutta, Z.A., Klugman, K. 
P., 2014. Surveillance for antimicrobial drug resistance in under-resourced 
countries. Emerg. Infect. Dis. 20 (3), 434–441. https://doi.org/10.3201/ 
eid2003.121157. 
Wood, D.E., Salzberg, S.L., 2014. Kraken: ultrafast metagenomic sequence classification 
using exact alignments. Genome Biol. 15, R46. https://doi.org/10.1186/gb-2014- 
15-3-r46. 
Zheng, J., Guan, Z., Cao, S., Peng, D., Ruan, L., Jiang, D., Sun, M., 2015. Plasmids are 
vectors for redundant chromosomal genes in the Bacillus cereus group. BMC 
Genomics 16 (1), 6. https://doi.org/10.1186/s12864-014-1206-5. 
Zhou, Z., Alikhan, N.F., Mohamed, K., Fan, Y., Brown, D., Chattaway, M., Dallman, T., 
Delahay, R., Kornschober, C., Pietzka, A., Malorny, B., Petrovska, L., Davies, R., 
Robertson, A., Tyne, W., Weill, F.X., Accou-Demartin, M., Williams, N., Achtman, M., 
2020. The EnteroBase user’s guide, with case studies on Salmonella transmissions, 
Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 30 
(1), 138–152. https://doi.org/10.1101/gr.251678.119. 
S.A. Wawire et al.                                                                                                                                                                                                                              
